Last active
August 9, 2026 11:47
-
-
Save heyitshurberto/e101cc0739b67d7f32aa9b678a0d6c06 to your computer and use it in GitHub Desktop.
nine
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| [ | |
| { | |
| "ticker": "AIDX", | |
| "title": "8-K - 20/20 Biolabs, Inc. (0001139685) (Filer)", | |
| "companyName": "20/20 Biolabs, Inc.", | |
| "filerName": null, | |
| "price": 0.448, | |
| "fav": "5.29", | |
| "volume": 44666, | |
| "averageVolume": 809614, | |
| "float": 4280710, | |
| "sharesOutstanding": 12251198, | |
| "soRatio": "34.94%", | |
| "marketCap": 5488537, | |
| "isShort": true, | |
| "ftd": 1305538, | |
| "intent": "Clinical Success, FDA Approved, Commercial Inflection, Failed Trial", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Maryland", | |
| "filingDate": "2026-08-05T12:00:42-04:00", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Primary Endpoint" | |
| ], | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth", | |
| "Repeat Business" | |
| ], | |
| "Failed Trial": [ | |
| "Primary Endpoint Missed" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "F-1", | |
| "F-3", | |
| "13D", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1139685", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Maryland (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "direction": "SHORT", | |
| "recordedAt": "2026-08-05T16:01:51.759Z", | |
| "recordId": "AIDX-1785945711759", | |
| "expiresAt": "2026-08-10T16:01:51.759Z", | |
| "highest5Day": 0.448, | |
| "highest5DayPercent": 0, | |
| "lowest5Day": 0.448, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": null, | |
| "percentAfter30m": null, | |
| "priceAfter1h": null, | |
| "percentAfter1h": null, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null | |
| }, | |
| { | |
| "ticker": "LEE", | |
| "title": "8-K - LEE ENTERPRISES, Inc (0000058361) (Filer)", | |
| "companyName": "LEE ENTERPRISES, Inc", | |
| "filerName": null, | |
| "price": 8.14, | |
| "fav": "62.45", | |
| "volume": 35980, | |
| "averageVolume": 79288, | |
| "float": 4951621, | |
| "sharesOutstanding": 22229936, | |
| "soRatio": "22.27%", | |
| "marketCap": 180951680, | |
| "isShort": false, | |
| "ftd": 63722, | |
| "intent": "Commercial Inflection, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Iowa", | |
| "filingDate": "2026-08-06T15:45:39-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Asset Disposition": [ | |
| "Divested" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "58361", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Media", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Iowa (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-08-06T19:46:49.360Z", | |
| "recordId": "LEE-1786045609361", | |
| "expiresAt": "2026-08-11T19:46:49.361Z", | |
| "direction": "LONG", | |
| "highest5Day": 8.14, | |
| "highest5DayPercent": 0, | |
| "lowest5Day": 8.14, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": null, | |
| "percentAfter30m": null, | |
| "priceAfter1h": null, | |
| "percentAfter1h": null, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null | |
| }, | |
| { | |
| "ticker": "GEOS", | |
| "title": "8-K - GEOSPACE TECHNOLOGIES CORP (0001001115) (Filer)", | |
| "companyName": "GEOSPACE TECHNOLOGIES CORP", | |
| "filerName": null, | |
| "price": 6.82, | |
| "fav": "6.28", | |
| "volume": 116720, | |
| "averageVolume": 159267, | |
| "float": 1000000, | |
| "sharesOutstanding": 12935603, | |
| "soRatio": "7.73%", | |
| "marketCap": 88220816, | |
| "isShort": false, | |
| "ftd": 454, | |
| "intent": "Commercial Inflection, Revenue Loss, Asset Disposition", | |
| "incorporated": "Texas", | |
| "located": "Texas", | |
| "filingDate": "2026-08-07T08:36:48-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Revenue Loss": [ | |
| "Decrease In Revenue" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "1001115", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Energy", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-08-07T12:37:55.524Z", | |
| "recordId": "GEOS-1786106275524", | |
| "expiresAt": "2026-08-12T12:37:55.525Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.82, | |
| "highest5DayPercent": 0, | |
| "lowest5Day": 6.82, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": null, | |
| "percentAfter30m": null, | |
| "priceAfter1h": null, | |
| "percentAfter1h": null, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null | |
| }, | |
| { | |
| "ticker": "PRE", | |
| "title": "6-K - Prenetics Global Ltd (0001876431) (Filer)", | |
| "companyName": "Prenetics Global Ltd", | |
| "filerName": null, | |
| "price": 17.86, | |
| "fav": "52.93", | |
| "volume": 126884, | |
| "averageVolume": 238689, | |
| "float": 12634526, | |
| "sharesOutstanding": 15419419, | |
| "soRatio": "81.94%", | |
| "marketCap": 303627008, | |
| "isShort": true, | |
| "ftd": 18092, | |
| "intent": "Licensing Deal, Related-Party Transaction, Credit Default", | |
| "incorporated": "Cayman Islands", | |
| "located": "Kowloon Bay, Hong Kong", | |
| "filingDate": "2026-08-07T08:51:06-04:00", | |
| "signals": { | |
| "Licensing Deal": [ | |
| "Exclusive License" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "Credit Default": [ | |
| "Loan Default", | |
| "Event Of Default" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1", | |
| "EX-99.2" | |
| ], | |
| "cik": "1876431", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Kowloon Bay, Hong Kong (via Cayman Islands)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-08-07T12:52:10.900Z", | |
| "recordId": "PRE-1786107130900", | |
| "expiresAt": "2026-08-12T12:52:10.900Z", | |
| "direction": "SHORT", | |
| "highest5Day": 17.86, | |
| "highest5DayPercent": 0, | |
| "lowest5Day": 17.86, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": null, | |
| "percentAfter30m": null, | |
| "priceAfter1h": null, | |
| "percentAfter1h": null, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null | |
| } | |
| ] |
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| [] |
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| [ | |
| { | |
| "ticker": "HSAI", | |
| "title": "6-K - Hesai Group (0001861737) (Filer)", | |
| "companyName": "Hesai Group", | |
| "filerName": null, | |
| "price": 27.94, | |
| "wa": "18.58", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Deutsche Bank", | |
| "filingTimeBonus": 1.2, | |
| "soBonus": 1.05, | |
| "volume": 1236261, | |
| "averageVolume": 2511740, | |
| "float": 26998861, | |
| "sharesOutstanding": 130143350, | |
| "soRatio": "20.75%", | |
| "marketCap": 4460113408, | |
| "isShort": true, | |
| "ftd": 279711, | |
| "ftdPercent": "1.04", | |
| "intent": "Convertible Dilution, Going Dark, Asset Disposition, Partnership, Strategic Minerals Partnership", | |
| "incorporated": "Cayman Islands", | |
| "located": "Shadong, China", | |
| "filingDate": "2026-01-26", | |
| "signals": { | |
| "Convertible Dilution": [ | |
| "Convertible Securities" | |
| ], | |
| "Going Dark": [ | |
| "Deregister" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-99.2" | |
| ], | |
| "filingType": "6-K, 20-F, Form D, EX-99.1, EX-99.2", | |
| "cik": "1861737", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-26T14:12:51.640Z", | |
| "recordId": "HSAI-1769436771640", | |
| "expiresAt": "2026-01-31T14:12:51.640Z", | |
| "direction": "SHORT", | |
| "highest5Day": 19.13, | |
| "highest5DayPercent": -31.53, | |
| "lowest5Day": 19.13, | |
| "lowest5DayPercent": 31.53 | |
| }, | |
| { | |
| "ticker": "CRDL", | |
| "title": "6-K - Cardiol Therapeutics Inc. (0001702123) (Filer)", | |
| "companyName": "Cardiol Therapeutics Inc.", | |
| "filerName": null, | |
| "price": 1, | |
| "wa": "0.68", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "soBonus": 1.15, | |
| "volume": 252014, | |
| "averageVolume": 466968, | |
| "float": 10384616, | |
| "sharesOutstanding": 99997648, | |
| "soRatio": "10.38%", | |
| "marketCap": 99997648, | |
| "isShort": false, | |
| "ftd": 90556, | |
| "ftdPercent": "0.87", | |
| "intent": "Clinical Success, Underwritten Offering", | |
| "incorporated": "Ottawa, Canada", | |
| "located": "Ottawa, Canada", | |
| "filingDate": "2026-01-26", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Efficacy", | |
| "Patient Population" | |
| ], | |
| "Underwritten Offering": [ | |
| "Bought Deal" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, 20-F, EX-99.1", | |
| "cik": "1702123", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-26T18:13:17.487Z", | |
| "recordId": "CRDL-1769451197487", | |
| "expiresAt": "2026-01-31T18:13:17.487Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.475, | |
| "highest5DayPercent": 47.5, | |
| "lowest5Day": 0.8974, | |
| "lowest5DayPercent": -10.26 | |
| }, | |
| { | |
| "ticker": "BIYA", | |
| "title": "6-K - Baiya International Group Inc. (0001944712) (Filer)", | |
| "companyName": "Baiya International Group Inc.", | |
| "filerName": null, | |
| "price": 3.95, | |
| "wa": "2.07", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "soBonus": 1, | |
| "volume": 36349, | |
| "averageVolume": 687987, | |
| "float": 12680000, | |
| "sharesOutstanding": 1185784, | |
| "soRatio": "1069.3%", | |
| "marketCap": 4936651, | |
| "isShort": true, | |
| "ftd": 137283, | |
| "ftdPercent": "1.08", | |
| "intent": "Artificial Inflation, Convertible Dilution, Asset Disposition, Share Consolidation, Partnership, Stock Split", | |
| "incorporated": "Cayman Islands", | |
| "located": "New York", | |
| "filingDate": "2026-01-26", | |
| "signals": { | |
| "Artificial Inflation": [ | |
| "Consolidation Of Shares", | |
| "Share Consolidation" | |
| ], | |
| "Convertible Dilution": [ | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposed", | |
| "Disposition" | |
| ], | |
| "Share Consolidation": [ | |
| "Consolidation" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Stock Split": [ | |
| "Share Split" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "reverseSplitRatio": 1002, | |
| "reverseSplitReason": "Nasdaq minimum bid price requirement", | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-3.1" | |
| ], | |
| "filingType": "6-K, 20-F, EX-3.1", | |
| "cik": "1944712", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-26T21:16:29.874Z", | |
| "recordId": "BIYA-1769462189874", | |
| "expiresAt": "2026-01-31T21:16:29.874Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.14, | |
| "highest5DayPercent": -71.14, | |
| "lowest5Day": 1.14, | |
| "lowest5DayPercent": 71.14 | |
| }, | |
| { | |
| "ticker": "FAT", | |
| "title": "8-K - Fat Brands, Inc (0001705012) (Filer)", | |
| "companyName": "Fat Brands, Inc", | |
| "filerName": null, | |
| "price": 0.392, | |
| "wa": "0.23", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "soBonus": 1.05, | |
| "volume": 86572, | |
| "averageVolume": 395745, | |
| "float": 5960700, | |
| "sharesOutstanding": 16668520, | |
| "soRatio": "35.76%", | |
| "marketCap": 7272103, | |
| "isShort": true, | |
| "ftd": 18433, | |
| "ftdPercent": "0.31", | |
| "intent": "Credit Default, Financing Events, Executive Departure Non-Planned", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Financing Events": [ | |
| "Capital Structure" | |
| ], | |
| "Executive Departure Non-Planned": [ | |
| "Departure Of Directors" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 1.03", | |
| "Item 2.04", | |
| "Item 5.02", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, EX-99.1, Item 1.03, Item 2.04, Item 5.02, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1705012", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T11:23:20.302Z", | |
| "recordId": "FAT-1769513000302", | |
| "expiresAt": "2026-02-01T11:23:20.302Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.1626, | |
| "highest5DayPercent": -58.52, | |
| "lowest5Day": 0.1626, | |
| "lowest5DayPercent": 58.52 | |
| }, | |
| { | |
| "ticker": "TWNP", | |
| "title": "8-K - Twin Hospitality Group Inc. (0002011954) (Filer)", | |
| "companyName": "Twin Hospitality Group Inc.", | |
| "filerName": null, | |
| "sector": "Consumer Cyclical", | |
| "price": 0.5308, | |
| "wa": "0.29", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "soBonus": 1.2, | |
| "volume": 60726, | |
| "averageVolume": 591603, | |
| "float": 2621500, | |
| "sharesOutstanding": 54455856, | |
| "soRatio": "4.81%", | |
| "marketCap": 30428564, | |
| "isShort": true, | |
| "ftd": 163917, | |
| "ftdPercent": "6.25", | |
| "intent": "Credit Default, Financing Events, Executive Departure Non-Planned", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Financing Events": [ | |
| "Capital Structure" | |
| ], | |
| "Executive Departure Non-Planned": [ | |
| "Departure Of Directors" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 1.03", | |
| "Item 2.04", | |
| "Item 5.02", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, EX-99.1, Item 1.03, Item 2.04, Item 5.02, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "2011954", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T11:26:59.164Z", | |
| "recordId": "TWNP-1769513219164", | |
| "expiresAt": "2026-02-01T11:26:59.164Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.0711, | |
| "highest5DayPercent": -86.61, | |
| "lowest5Day": 0.0711, | |
| "lowest5DayPercent": 86.61 | |
| }, | |
| { | |
| "ticker": "CNL", | |
| "title": "6-K - Collective Mining Ltd. (0001953575) (Filer)", | |
| "companyName": "Collective Mining Ltd.", | |
| "filerName": null, | |
| "price": 16.78, | |
| "wa": "13.58", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "soBonus": 1.05, | |
| "volume": 95945, | |
| "averageVolume": 59085, | |
| "float": 45940500, | |
| "sharesOutstanding": 92264749, | |
| "soRatio": "49.79%", | |
| "marketCap": 1551043584, | |
| "isShort": false, | |
| "ftd": 2946, | |
| "ftdPercent": "0.01", | |
| "intent": "FDA Approved, Capital Raise, Mining Operations", | |
| "incorporated": "Ottawa, Canada", | |
| "located": "Canada (Federal Level)", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "FDA Approved": [ | |
| "Approves" | |
| ], | |
| "Capital Raise": [ | |
| "Strategic Investor" | |
| ], | |
| "Mining Operations": [ | |
| "Mining Operation" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "F-3", | |
| "FWG", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, F-3, FWG, 20-F, EX-99.1", | |
| "cik": "1953575", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T12:06:10.278Z", | |
| "recordId": "CNL-1769515570279", | |
| "expiresAt": "2026-02-01T12:06:10.279Z", | |
| "direction": "LONG", | |
| "highest5Day": 13.3201, | |
| "highest5DayPercent": -20.62, | |
| "lowest5Day": 13.3201, | |
| "lowest5DayPercent": -20.62 | |
| }, | |
| { | |
| "ticker": "NTLA", | |
| "title": "8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)", | |
| "companyName": "Intellia Therapeutics, Inc.", | |
| "filerName": null, | |
| "price": 13.95, | |
| "wa": "10.47", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.1, | |
| "soBonus": 1, | |
| "volume": 6409144, | |
| "averageVolume": 6373178, | |
| "float": 110020000, | |
| "sharesOutstanding": 115829926, | |
| "soRatio": "94.98%", | |
| "marketCap": 1615827456, | |
| "isShort": false, | |
| "ftd": 20851, | |
| "ftdPercent": "0.02", | |
| "intent": "Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 3", | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "Investigational New Drug", | |
| "Patient Enrollment" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1652130", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T13:19:48.566Z", | |
| "recordId": "NTLA-1769519988566", | |
| "expiresAt": "2026-02-01T13:19:48.566Z", | |
| "direction": "LONG", | |
| "highest5Day": 12.71, | |
| "highest5DayPercent": -8.89, | |
| "lowest5Day": 12.71, | |
| "lowest5DayPercent": -8.89 | |
| }, | |
| { | |
| "ticker": "OM", | |
| "title": "8-K - Outset Medical, Inc. (0001484612) (Filer)", | |
| "companyName": "Outset Medical, Inc.", | |
| "filerName": null, | |
| "price": 4.97, | |
| "wa": "3.00", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "soBonus": 1, | |
| "volume": 255597, | |
| "averageVolume": 989757, | |
| "float": 10342500, | |
| "sharesOutstanding": 18153090, | |
| "soRatio": "56.97%", | |
| "marketCap": 90220856, | |
| "isShort": true, | |
| "ftd": 14499, | |
| "ftdPercent": "0.14", | |
| "intent": "FDA Approved, ADR Regulation Risk", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Clearance" | |
| ], | |
| "ADR Regulation Risk": [ | |
| "Subject To Risks" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "F-4", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, F-4, EX-99.1, Item 8.01, Item 9.01", | |
| "cik": "1484612", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T14:11:19.063Z", | |
| "recordId": "OM-1769523079063", | |
| "expiresAt": "2026-02-01T14:11:19.063Z", | |
| "direction": "SHORT", | |
| "highest5Day": 3.055, | |
| "highest5DayPercent": -38.53, | |
| "lowest5Day": 3.055, | |
| "lowest5DayPercent": 38.53 | |
| }, | |
| { | |
| "ticker": "CBU", | |
| "title": "8-K - COMMUNITY FINANCIAL SYSTEM, INC. (0000723188) (Filer)", | |
| "companyName": "COMMUNITY FINANCIAL SYSTEM, INC.", | |
| "filerName": null, | |
| "price": 61.77, | |
| "wa": "47.91", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "soBonus": 1.2, | |
| "volume": 282734, | |
| "averageVolume": 230070, | |
| "float": 52959, | |
| "sharesOutstanding": 52661489, | |
| "soRatio": "0.10%", | |
| "marketCap": 3264981760, | |
| "isShort": true, | |
| "ftd": 50, | |
| "ftdPercent": "0.09", | |
| "intent": "Revenue Growth, Share Consolidation, Stock Buyback, Dividend Raise", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "Revenue Growth": [ | |
| "Organic Growth" | |
| ], | |
| "Share Consolidation": [ | |
| "Consolidation" | |
| ], | |
| "Stock Buyback": [ | |
| "Repurchase Program" | |
| ], | |
| "Dividend Raise": [ | |
| "Dividend Increase" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "723188", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T14:18:32.145Z", | |
| "recordId": "CBU-1769523512145", | |
| "expiresAt": "2026-02-01T14:18:32.145Z", | |
| "direction": "SHORT", | |
| "highest5Day": 55.605, | |
| "highest5DayPercent": -9.98, | |
| "lowest5Day": 55.605, | |
| "lowest5DayPercent": 9.98 | |
| }, | |
| { | |
| "ticker": "ANEB", | |
| "title": "8-K - Anebulo Pharmaceuticals, Inc. (0001815974) (Filer)", | |
| "companyName": "Anebulo Pharmaceuticals, Inc.", | |
| "filerName": null, | |
| "price": 1.08, | |
| "wa": "0.70", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "soBonus": 1.15, | |
| "volume": 26570, | |
| "averageVolume": 61614, | |
| "float": 4897188, | |
| "sharesOutstanding": 41084731, | |
| "soRatio": "11.92%", | |
| "marketCap": 44371512, | |
| "isShort": true, | |
| "ftd": 10958, | |
| "ftdPercent": "0.22", | |
| "intent": "Clinical Success, Capital Raise, ADR Regulation Risk", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3" | |
| ], | |
| "Capital Raise": [ | |
| "Oversubscribed" | |
| ], | |
| "ADR Regulation Risk": [ | |
| "Subject To Risks" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, EX-99.1, Item 8.01, Item 9.01", | |
| "cik": "1815974", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T14:25:18.060Z", | |
| "recordId": "ANEB-1769523918060", | |
| "expiresAt": "2026-02-01T14:25:18.060Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.3727, | |
| "highest5DayPercent": -65.49, | |
| "lowest5Day": 0.3727, | |
| "lowest5DayPercent": 65.49 | |
| }, | |
| { | |
| "ticker": "OSRH", | |
| "title": "8-K - OSR Holdings, Inc. (0001840425) (Filer)", | |
| "companyName": "OSR Holdings, Inc.", | |
| "filerName": null, | |
| "price": 0.72, | |
| "wa": "0.41", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "soBonus": 1.05, | |
| "volume": 809052, | |
| "averageVolume": 5278213, | |
| "float": 7850482, | |
| "sharesOutstanding": 25672788, | |
| "soRatio": "30.58%", | |
| "marketCap": 18484408, | |
| "isShort": true, | |
| "ftd": 205124, | |
| "ftdPercent": "2.61", | |
| "intent": "Underwritten Offering, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Washington", | |
| "filingDate": "2026-01-27", | |
| "signals": { | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "F-4", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 2.01", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, F-4, 20-F, 20-F/A, EX-99.1, Item 2.01, Item 7.01, Item 9.01", | |
| "cik": "1840425", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-01-27T14:27:27.644Z", | |
| "recordId": "OSRH-1769524047644", | |
| "expiresAt": "2026-02-01T14:27:27.644Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.6924, | |
| "highest5DayPercent": -3.83, | |
| "lowest5Day": 0.39, | |
| "lowest5DayPercent": 45.83 | |
| }, | |
| { | |
| "ticker": "ENGN", | |
| "title": "8-K - enGene Holdings Inc. (0001980845) (Filer)", | |
| "companyName": "enGene Holdings Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 8.68, | |
| "fav": "84.12", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Montreal, Canada (via Vancouver, British Columbia, Canada)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 165337, | |
| "averageVolume": 314298, | |
| "float": 26437500, | |
| "sharesOutstanding": 66989466, | |
| "soRatio": "39.47%", | |
| "marketCap": 581468544, | |
| "isShort": false, | |
| "ftd": 13373, | |
| "ftdPercent": "0.05", | |
| "intent": "FDA Approved, FDA Breakthrough, FDA Filing, Clinical Success", | |
| "incorporated": "Vancouver, British Columbia, Canada", | |
| "located": "Montreal, Canada", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval", | |
| "FDA approval" | |
| ], | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "FDA Filing": [ | |
| "BLA Submission" | |
| ], | |
| "Clinical Success": [ | |
| "Positive Results", | |
| "Phase 2", | |
| "Efficacy" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "F-4", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, F-4, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1980845", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:05:20.714Z", | |
| "recordId": "ENGN-1773054320714", | |
| "expiresAt": "2026-03-14T11:05:20.714Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.6, | |
| "highest5DayPercent": -23.96, | |
| "lowest5Day": 6.6, | |
| "lowest5DayPercent": -23.96 | |
| }, | |
| { | |
| "ticker": "IBIO", | |
| "title": "8-K - iBio, Inc. (0001420720) (Filer)", | |
| "companyName": "iBio, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 2.61, | |
| "fav": "8.27", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 335233, | |
| "averageVolume": 3271242, | |
| "float": 27058300, | |
| "sharesOutstanding": 34543561, | |
| "soRatio": "78.33%", | |
| "marketCap": 90158688, | |
| "isShort": false, | |
| "ftd": 152844, | |
| "ftdPercent": "0.56", | |
| "intent": "Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Biomarker", | |
| "Statistically Significant" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient", | |
| "Patient Dosed", | |
| "First Dose" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-8", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-8, Form D, EX-99.1, EX-99.2, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1420720", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:05:35.255Z", | |
| "recordId": "IBIO-1773054335255", | |
| "expiresAt": "2026-03-14T11:05:35.255Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.48, | |
| "highest5DayPercent": -43.3, | |
| "lowest5Day": 1.48, | |
| "lowest5DayPercent": -43.3 | |
| }, | |
| { | |
| "ticker": "NBP", | |
| "title": "6-K - NovaBridge Biosciences (0001778016) (Filer)", | |
| "companyName": "NovaBridge Biosciences", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 3.5, | |
| "fav": "59.54", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Maryland (via Cayman Islands)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 1583670, | |
| "averageVolume": 714330, | |
| "float": 42530441, | |
| "sharesOutstanding": 115291032, | |
| "soRatio": "36.89%", | |
| "marketCap": 403518624, | |
| "isShort": false, | |
| "ftd": 388156, | |
| "ftdPercent": "0.91", | |
| "intent": "Clinical Success, Clinical Milestone, Underwritten Offering", | |
| "incorporated": "Cayman Islands", | |
| "located": "Maryland", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Positive Results", | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Trial Results", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Primary Endpoint", | |
| "Topline Data", | |
| "Favorable Safety", | |
| "Positive Topline Results" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Enrollment" | |
| ], | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-1", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1", | |
| "EX-99.2" | |
| ], | |
| "filingType": "6-K, S-1, S-8, F-3, 20-F, EX-99.1, EX-99.2", | |
| "cik": "1778016", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:06:06.446Z", | |
| "recordId": "NBP-1773054366446", | |
| "expiresAt": "2026-03-14T11:06:06.446Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.27, | |
| "highest5DayPercent": -35.14, | |
| "lowest5Day": 2.27, | |
| "lowest5DayPercent": -35.14 | |
| }, | |
| { | |
| "ticker": "BOLD", | |
| "title": "8-K - Boundless Bio, Inc. (0001782303) (Filer)", | |
| "companyName": "Boundless Bio, Inc.", | |
| "filerName": "dei_EntityAddressAddressLine1 Namespace Prefix: dei_ Data Type: xbrli:normalizedStringIt", | |
| "sector": "Biotechnology", | |
| "price": 1.13, | |
| "fav": "126.81", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 51393, | |
| "averageVolume": 128825, | |
| "float": 16336162, | |
| "sharesOutstanding": 22385611, | |
| "soRatio": "72.98%", | |
| "marketCap": 25295742, | |
| "isShort": false, | |
| "ftd": 27162, | |
| "ftdPercent": "0.17", | |
| "intent": "Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "Investigational New Drug" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-4", | |
| "Form D", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 5.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, S-4, Form D, EX-99.1, Item 2.02, Item 5.02, Item 9.01", | |
| "cik": "1782303", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:06:26.119Z", | |
| "recordId": "BOLD-1773054386119", | |
| "expiresAt": "2026-03-14T11:06:26.119Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.56, | |
| "highest5DayPercent": 38.05, | |
| "lowest5Day": 1.08, | |
| "lowest5DayPercent": -4.42 | |
| }, | |
| { | |
| "ticker": "RLMD", | |
| "title": "8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)", | |
| "companyName": "RELMADA THERAPEUTICS, INC.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 4.45, | |
| "fav": "43.57", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Nevada)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 450015, | |
| "averageVolume": 676464, | |
| "float": 29474569, | |
| "sharesOutstanding": 73333622, | |
| "soRatio": "40.19%", | |
| "marketCap": 326334624, | |
| "isShort": false, | |
| "ftd": 51692, | |
| "ftdPercent": "0.18", | |
| "intent": "Merger/Acquisition, Clinical Success, Clinical Milestone, Activist 13D Filing, Asset Disposition, Partnership", | |
| "incorporated": "Nevada", | |
| "located": "Florida", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Primary Endpoint", | |
| "Favorable Safety" | |
| ], | |
| "Clinical Milestone": [ | |
| "Program Initiation" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "EX-10.1", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-3, EX-10.1, EX-4.1, Item 1.01, Item 3.02, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1553643", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:11:55.431Z", | |
| "recordId": "RLMD-1773054715431", | |
| "expiresAt": "2026-03-14T11:11:55.431Z", | |
| "direction": "LONG", | |
| "highest5Day": 7.64, | |
| "highest5DayPercent": 71.69, | |
| "lowest5Day": 4.45, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "KLRS", | |
| "title": "8-K - Kalaris Therapeutics, Inc. (0001754068) (Filer)", | |
| "companyName": "Kalaris Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 9.82, | |
| "fav": "18.24", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New Jersey (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 41326, | |
| "averageVolume": 100188, | |
| "float": 1827000, | |
| "sharesOutstanding": 18702418, | |
| "soRatio": "9.77%", | |
| "marketCap": 183657744, | |
| "isShort": false, | |
| "ftd": 3761, | |
| "ftdPercent": "0.21", | |
| "intent": "FDA Approved, Clinical Success, Clinical Milestone, Capital Raise", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New Jersey", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval", | |
| "FDA approved", | |
| "FDA approval" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "Trial Initiation", | |
| "Patient Dosed" | |
| ], | |
| "Capital Raise": [ | |
| "Oversubscribed" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-1", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, S-1, EX-99.1, Item 7.01, Item 9.01", | |
| "cik": "1754068", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:16:40.778Z", | |
| "recordId": "KLRS-1773055000778", | |
| "expiresAt": "2026-03-14T11:16:40.779Z", | |
| "direction": "LONG", | |
| "highest5Day": 5.53, | |
| "highest5DayPercent": -43.69, | |
| "lowest5Day": 5.53, | |
| "lowest5DayPercent": -43.69 | |
| }, | |
| { | |
| "ticker": "KRRO", | |
| "title": "8-K - Korro Bio, Inc. (0001703647) (Filer)", | |
| "companyName": "Korro Bio, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 11.18, | |
| "fav": "45.11", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 65416, | |
| "averageVolume": 219927, | |
| "float": 9920643, | |
| "sharesOutstanding": 9417295, | |
| "soRatio": "105.3%", | |
| "marketCap": 105285360, | |
| "isShort": true, | |
| "ftd": 5025, | |
| "ftdPercent": "0.05", | |
| "intent": "Merger/Acquisition, Convertible Debt, Activist 13D Filing, Reverse Split Event, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes", | |
| "Convertible Securities" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 2.02", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-10.1, EX-4.1, Item 1.01, Item 2.02, Item 3.02, Item 7.01, Item 9.01", | |
| "cik": "1703647", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:36:04.540Z", | |
| "recordId": "KRRO-1773056164540", | |
| "expiresAt": "2026-03-14T11:36:04.540Z", | |
| "direction": "SHORT", | |
| "highest5Day": 14.79, | |
| "highest5DayPercent": 32.29, | |
| "lowest5Day": 10.48, | |
| "lowest5DayPercent": 6.26 | |
| }, | |
| { | |
| "ticker": "FCEL", | |
| "title": "8-K - FUELCELL ENERGY INC (0000886128) (Filer)", | |
| "companyName": "FUELCELL ENERGY INC", | |
| "filerName": null, | |
| "sector": "Electrical Equipment", | |
| "price": 7.6, | |
| "fav": "21.06", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Connecticut (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 1390717, | |
| "averageVolume": 2288472, | |
| "float": 48206002, | |
| "sharesOutstanding": 52947032, | |
| "soRatio": "91.05%", | |
| "marketCap": 402397440, | |
| "isShort": true, | |
| "ftd": 28730, | |
| "ftdPercent": "0.06", | |
| "intent": "Clinical Success, Reverse Split Event, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Connecticut", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Partnership": [ | |
| "Development Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": "1-for-202", | |
| "reverseSplitReason": "Nasdaq minimum bid price requirement", | |
| "formType": [ | |
| "8-K", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Form D, EX-99.1, EX-99.2, Item 2.02, Item 7.01, Item 9.01", | |
| "cik": "886128", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:36:29.513Z", | |
| "recordId": "FCEL-1773056189513", | |
| "expiresAt": "2026-03-14T11:36:29.513Z", | |
| "direction": "SHORT", | |
| "highest5Day": 6.27, | |
| "highest5DayPercent": -17.5, | |
| "lowest5Day": 6.27, | |
| "lowest5DayPercent": 17.5 | |
| }, | |
| { | |
| "ticker": "XENE", | |
| "title": "8-K - Xenon Pharmaceuticals Inc. (0001582313) (Filer)", | |
| "companyName": "Xenon Pharmaceuticals Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 41.94, | |
| "fav": "84.73", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "British Columbia, Canada (via Toronto, Canada)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 1084871, | |
| "averageVolume": 916825, | |
| "float": 77681000, | |
| "sharesOutstanding": 77275005, | |
| "soRatio": "100.5%", | |
| "marketCap": 3240913664, | |
| "isShort": false, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "FDA Filing, Clinical Success, Clinical Milestone, Asset Disposition", | |
| "incorporated": "Toronto, Canada", | |
| "located": "British Columbia, Canada", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Filing": [ | |
| "NDA Submission" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 3", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Primary Endpoint", | |
| "Data Readout", | |
| "Topline Data", | |
| "Mechanism Of Action", | |
| "Favorable Safety", | |
| "Strong Efficacy", | |
| "Statistically Significant", | |
| "Met Primary Endpoint", | |
| "Positive Phase 3", | |
| "Positive Topline Results" | |
| ], | |
| "Clinical Milestone": [ | |
| "Investigational New Drug" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, EX-99.1, EX-99.2, Item 7.01, Item 9.01", | |
| "cik": "1582313", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:37:54.956Z", | |
| "recordId": "XENE-1773056274956", | |
| "expiresAt": "2026-03-14T11:37:54.956Z", | |
| "direction": "LONG", | |
| "highest5Day": 63.95, | |
| "highest5DayPercent": 52.48, | |
| "lowest5Day": 41.94, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "CRBP", | |
| "title": "8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)", | |
| "companyName": "Corbus Pharmaceuticals Holdings, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 8.01, | |
| "fav": "36.25", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 164997, | |
| "averageVolume": 275883, | |
| "float": 10000000, | |
| "sharesOutstanding": 17553037, | |
| "soRatio": "56.97%", | |
| "marketCap": 140599824, | |
| "isShort": false, | |
| "ftd": 2248, | |
| "ftdPercent": "0.02", | |
| "intent": "FDA Breakthrough, Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Trial Results", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Favorable Safety" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Dosed", | |
| "First Dose", | |
| "Dose Escalation" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "F-1", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, F-1, EX-99.1, EX-99.2, Item 2.02, Item 7.01, Item 9.01", | |
| "cik": "1595097", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:44:10.090Z", | |
| "recordId": "CRBP-1773056650090", | |
| "expiresAt": "2026-03-14T11:44:10.090Z", | |
| "direction": "LONG", | |
| "highest5Day": 10.73, | |
| "highest5DayPercent": 33.96, | |
| "lowest5Day": 8.01, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "PLX", | |
| "title": "8-K - Protalix BioTherapeutics, Inc. (0001006281) (Filer)", | |
| "companyName": "Protalix BioTherapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 2.62, | |
| "fav": "56.82", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New Jersey (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 843283, | |
| "averageVolume": 1184000, | |
| "float": 67276000, | |
| "sharesOutstanding": 80421181, | |
| "soRatio": "83.65%", | |
| "marketCap": 210703488, | |
| "isShort": false, | |
| "ftd": 50637, | |
| "ftdPercent": "0.08", | |
| "intent": "FDA Approved, Clinical Success", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New Jersey", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval", | |
| "FDA approval" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, EX-99.1, Item 8.01, Item 9.01", | |
| "cik": "1006281", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T11:52:01.969Z", | |
| "recordId": "PLX-1773057121969", | |
| "expiresAt": "2026-03-14T11:52:01.969Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.04, | |
| "highest5DayPercent": -22.14, | |
| "lowest5Day": 2.04, | |
| "lowest5DayPercent": -22.14 | |
| }, | |
| { | |
| "ticker": "GEL", | |
| "title": "8-K - GENESIS ENERGY LP (0001022321) (Filer)", | |
| "companyName": "GENESIS ENERGY LP", | |
| "filerName": null, | |
| "sector": "Energy", | |
| "price": 18.09, | |
| "fav": "342.98", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 108597, | |
| "averageVolume": 268215, | |
| "float": 91991842, | |
| "sharesOutstanding": 122424321, | |
| "soRatio": "75.14%", | |
| "marketCap": 2215379456, | |
| "isShort": true, | |
| "ftd": 29724, | |
| "ftdPercent": "0.03", | |
| "intent": "Merger/Acquisition, Credit Default", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 1.02", | |
| "Item 2.03" | |
| ], | |
| "filingType": "8-K, Item 1.01, Item 1.02, Item 2.03", | |
| "cik": "1022321", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T12:01:22.895Z", | |
| "recordId": "GEL-1773057682895", | |
| "expiresAt": "2026-03-14T12:01:22.895Z", | |
| "direction": "SHORT", | |
| "highest5Day": 17.15, | |
| "highest5DayPercent": -5.2, | |
| "lowest5Day": 17.15, | |
| "lowest5DayPercent": 5.2 | |
| }, | |
| { | |
| "ticker": "MBX", | |
| "title": "8-K - MBX Biosciences, Inc. (0001776111) (Filer)", | |
| "companyName": "MBX Biosciences, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 30.55, | |
| "fav": "20.47", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Indiana (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 591573, | |
| "averageVolume": 713742, | |
| "float": 14609972, | |
| "sharesOutstanding": 44902302, | |
| "soRatio": "32.54%", | |
| "marketCap": 1371765376, | |
| "isShort": false, | |
| "ftd": 1107, | |
| "ftdPercent": "0.01", | |
| "intent": "FDA Filing, Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Indiana", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Filing": [ | |
| "NDA Submission" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy", | |
| "Primary Endpoint" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13G", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13G, EX-99.1, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1776111", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T12:04:08.672Z", | |
| "recordId": "MBX-1773057848672", | |
| "expiresAt": "2026-03-14T12:04:08.672Z", | |
| "direction": "LONG", | |
| "highest5Day": 26.42, | |
| "highest5DayPercent": -13.52, | |
| "lowest5Day": 26.42, | |
| "lowest5DayPercent": -13.52 | |
| }, | |
| { | |
| "ticker": "ALOY", | |
| "title": "8-K - REALLOYS INC. (0001567900) (Filer)", | |
| "companyName": "REALLOYS INC.", | |
| "filerName": null, | |
| "sector": "Technology", | |
| "price": 17.5, | |
| "fav": "8.01", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Nevada)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 3407078, | |
| "averageVolume": 337276, | |
| "float": 2702702, | |
| "sharesOutstanding": 57111167, | |
| "soRatio": "4.73%", | |
| "marketCap": 999445440, | |
| "isShort": true, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "Merger/Acquisition, Credit Default, Accounting Restatement, Asset Disposition, Partnership", | |
| "incorporated": "Nevada", | |
| "located": "Florida", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Partnership Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "S-8", | |
| "EX-1.1", | |
| "Item 1.01", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-3, S-8, EX-1.1, Item 1.01, Item 7.01, Item 9.01", | |
| "cik": "1567900", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T12:58:18.061Z", | |
| "recordId": "ALOY-1773061098061", | |
| "expiresAt": "2026-03-14T12:58:18.061Z", | |
| "direction": "SHORT", | |
| "highest5Day": 7.6008, | |
| "highest5DayPercent": -56.57, | |
| "lowest5Day": 7.6008, | |
| "lowest5DayPercent": 56.57 | |
| }, | |
| { | |
| "ticker": "ACXP", | |
| "title": "8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)", | |
| "companyName": "Acurx Pharmaceuticals, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.35, | |
| "fav": "24.91", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 62475, | |
| "averageVolume": 52247, | |
| "float": 1301227, | |
| "sharesOutstanding": 2546717, | |
| "soRatio": "51.09%", | |
| "marketCap": 3438068, | |
| "isShort": false, | |
| "ftd": 5573, | |
| "ftdPercent": "0.43", | |
| "intent": "FDA Approved, Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval", | |
| "FDA approval" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Phase 3", | |
| "Trial Results", | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Enrollment", | |
| "First Patient" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "F-3", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 5.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, F-3, 20-F, 20-F/A, EX-99.1, Item 5.02, Item 8.01, Item 9.01", | |
| "cik": "1736243", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T13:00:24.050Z", | |
| "recordId": "ACXP-1773061224050", | |
| "expiresAt": "2026-03-14T13:00:24.050Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.63, | |
| "highest5DayPercent": 391.11, | |
| "lowest5Day": 1.35, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "ALLR", | |
| "title": "8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)", | |
| "companyName": "Allarity Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.24, | |
| "fav": "73.64", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 591378, | |
| "averageVolume": 166588, | |
| "float": 12266826, | |
| "sharesOutstanding": 16080980, | |
| "soRatio": "76.28%", | |
| "marketCap": 19940416, | |
| "isShort": false, | |
| "ftd": 3035, | |
| "ftdPercent": "0.02", | |
| "intent": "FDA Approved, Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval", | |
| "FDA approval" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Efficacy", | |
| "Clinical Benefit", | |
| "Statistically Significant" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Enrollment" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, EX-99.1, Item 8.01, Item 9.01", | |
| "cik": "1860657", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T13:03:03.700Z", | |
| "recordId": "ALLR-1773061383700", | |
| "expiresAt": "2026-03-14T13:03:03.700Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.055, | |
| "highest5DayPercent": -14.92, | |
| "lowest5Day": 1.055, | |
| "lowest5DayPercent": -14.92 | |
| }, | |
| { | |
| "ticker": "ONDS", | |
| "title": "8-K - Ondas Inc. (0001646188) (Filer)", | |
| "companyName": "Ondas Inc.", | |
| "filerName": null, | |
| "sector": "Communications", | |
| "price": 9.83, | |
| "fav": "3.89", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Nevada)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 160635256, | |
| "averageVolume": 93930854, | |
| "float": 365703586, | |
| "sharesOutstanding": 450092050, | |
| "soRatio": "81.25%", | |
| "marketCap": 4424404992, | |
| "isShort": true, | |
| "ftd": 4697839, | |
| "ftdPercent": "1.28", | |
| "intent": "Merger/Acquisition, Credit Default, Reverse Split Event, Asset Disposition, Licensing Deal", | |
| "incorporated": "Nevada", | |
| "located": "Florida", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Item 1.01, Item 3.02, Item 8.01, Item 9.01", | |
| "cik": "1646188", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T13:20:11.663Z", | |
| "recordId": "ONDS-1773062411663", | |
| "expiresAt": "2026-03-14T13:20:11.663Z", | |
| "direction": "SHORT", | |
| "highest5Day": 11.345, | |
| "highest5DayPercent": 15.41, | |
| "lowest5Day": 8.54, | |
| "lowest5DayPercent": 13.12 | |
| }, | |
| { | |
| "ticker": "DRTS", | |
| "title": "6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)", | |
| "companyName": "Alpha Tau Medical Ltd.", | |
| "filerName": null, | |
| "sector": "Health Care", | |
| "price": 6.71, | |
| "fav": "172.16", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "volume": 348717, | |
| "averageVolume": 360816, | |
| "float": 62116800, | |
| "sharesOutstanding": 85264146, | |
| "soRatio": "72.85%", | |
| "marketCap": 572122432, | |
| "isShort": false, | |
| "ftd": 137858, | |
| "ftdPercent": "0.22", | |
| "intent": "FDA Approved, Clinical Milestone", | |
| "incorporated": "Tel Aviv, Israel", | |
| "located": "Tel Aviv, Israel", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval", | |
| "FDA approval" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, S-8, F-3, 20-F, EX-99.1", | |
| "cik": "1871321", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:04:22.071Z", | |
| "recordId": "DRTS-1773086662071", | |
| "expiresAt": "2026-03-14T20:04:22.071Z", | |
| "direction": "LONG", | |
| "highest5Day": 7.83, | |
| "highest5DayPercent": 16.69, | |
| "lowest5Day": 6.1, | |
| "lowest5DayPercent": -9.09 | |
| }, | |
| { | |
| "ticker": "SUN", | |
| "title": "8-K - Sunoco LP (0001552275) (Filer)", | |
| "companyName": "Sunoco LP", | |
| "filerName": null, | |
| "sector": "Energy", | |
| "price": 63.158, | |
| "fav": "238.06", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Oklahoma)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 492464, | |
| "averageVolume": 452738, | |
| "float": 107777000, | |
| "sharesOutstanding": 136894754, | |
| "soRatio": "78.73%", | |
| "marketCap": 11899722752, | |
| "isShort": true, | |
| "ftd": 31527, | |
| "ftdPercent": "0.03", | |
| "intent": "Merger/Acquisition, Activist 13D Filing, Credit Default, Asset Disposition, Partnership", | |
| "incorporated": "Oklahoma", | |
| "located": "Texas", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Material Definitive Agreement" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Sale Of Assets", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, EX-4.1, Item 1.01, Item 2.03, Item 9.01", | |
| "cik": "1552275", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:06:02.692Z", | |
| "recordId": "SUN-1773086762693", | |
| "expiresAt": "2026-03-14T20:06:02.693Z", | |
| "direction": "SHORT", | |
| "highest5Day": 67.79, | |
| "highest5DayPercent": 7.33, | |
| "lowest5Day": 62.61, | |
| "lowest5DayPercent": 0.87 | |
| }, | |
| { | |
| "ticker": "SGP", | |
| "title": "8-K - SpyGlass Pharma, Inc. (0001778922) (Filer)", | |
| "companyName": "SpyGlass Pharma, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 27.12, | |
| "fav": "65.39", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 186966, | |
| "averageVolume": 149670, | |
| "float": 9787123, | |
| "sharesOutstanding": 33317414, | |
| "soRatio": "29.38%", | |
| "marketCap": 903568320, | |
| "isShort": false, | |
| "ftd": 3275, | |
| "ftdPercent": "0.03", | |
| "intent": "Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 3", | |
| "Trial Results", | |
| "Efficacy", | |
| "Primary Endpoint" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Enrollment" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-9", | |
| "424B4", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, 424B4, EX-99.1, Item 8.01, Item 9.01", | |
| "cik": "1778922", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:06:08.743Z", | |
| "recordId": "SGP-1773086768743", | |
| "expiresAt": "2026-03-14T20:06:08.743Z", | |
| "direction": "LONG", | |
| "highest5Day": 20.63, | |
| "highest5DayPercent": -23.93, | |
| "lowest5Day": 20.63, | |
| "lowest5DayPercent": -23.93 | |
| }, | |
| { | |
| "ticker": "ZVRA", | |
| "title": "8-K - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer)", | |
| "companyName": "ZEVRA THERAPEUTICS, INC.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 9.12, | |
| "fav": "4.59", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 922063, | |
| "averageVolume": 876574, | |
| "float": 4024157, | |
| "sharesOutstanding": 56297535, | |
| "soRatio": "7.15%", | |
| "marketCap": 513433536, | |
| "isShort": true, | |
| "ftd": 5550, | |
| "ftdPercent": "0.14", | |
| "intent": "Clinical Success, Credit Default, Licensing Deal", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy", | |
| "Statistically Significant" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-10.1", | |
| "Item 2.02", | |
| "Item 5.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Form D, EX-99.1, EX-10.1, Item 2.02, Item 5.02, Item 9.01", | |
| "cik": "1434647", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:07:02.577Z", | |
| "recordId": "ZVRA-1773086822577", | |
| "expiresAt": "2026-03-14T20:07:02.577Z", | |
| "direction": "SHORT", | |
| "highest5Day": 11.3999, | |
| "highest5DayPercent": 25, | |
| "lowest5Day": 8.73, | |
| "lowest5DayPercent": 4.28 | |
| }, | |
| { | |
| "ticker": "DSGN", | |
| "title": "8-K - Design Therapeutics, Inc. (0001807120) (Filer)", | |
| "companyName": "Design Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 10.37, | |
| "fav": "74.55", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 159946, | |
| "averageVolume": 329667, | |
| "float": 24576400, | |
| "sharesOutstanding": 56963757, | |
| "soRatio": "43.14%", | |
| "marketCap": 590714112, | |
| "isShort": false, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Efficacy", | |
| "Biomarker" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Enrollment" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-4", | |
| "F-1", | |
| "13G", | |
| "13D", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, S-4, F-1, 13G, 13D, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1807120", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:07:12.888Z", | |
| "recordId": "DSGN-1773086832888", | |
| "expiresAt": "2026-03-14T20:07:12.888Z", | |
| "direction": "LONG", | |
| "highest5Day": 12.77, | |
| "highest5DayPercent": 23.14, | |
| "lowest5Day": 9.69, | |
| "lowest5DayPercent": -6.56 | |
| }, | |
| { | |
| "ticker": "HPE", | |
| "title": "8-K - Hewlett Packard Enterprise Co (0001645590) (Filer)", | |
| "companyName": "Hewlett Packard Enterprise Co", | |
| "filerName": null, | |
| "sector": "Technology", | |
| "price": 21.82, | |
| "fav": "70.43", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 26286150, | |
| "averageVolume": 18855194, | |
| "float": 1327994000, | |
| "sharesOutstanding": 1328808444, | |
| "soRatio": "99.94%", | |
| "marketCap": 29119512576, | |
| "isShort": false, | |
| "ftd": 134286, | |
| "ftdPercent": "0.01", | |
| "intent": "Clinical Success, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Form D", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Form D, EX-99.1, Item 2.02, Item 7.01, Item 9.01", | |
| "cik": "1645590", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:09:25.852Z", | |
| "recordId": "HPE-1773086965853", | |
| "expiresAt": "2026-03-14T20:09:25.853Z", | |
| "direction": "LONG", | |
| "highest5Day": 26.405, | |
| "highest5DayPercent": 21.01, | |
| "lowest5Day": 20.6, | |
| "lowest5DayPercent": -5.59 | |
| }, | |
| { | |
| "ticker": "OXY", | |
| "title": "8-K - OCCIDENTAL PETROLEUM CORP /DE/ (0000797468) (Filer)", | |
| "companyName": "OCCIDENTAL PETROLEUM CORP /DE/", | |
| "filerName": null, | |
| "sector": "Energy", | |
| "price": 55.02, | |
| "fav": "77.76", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 29291309, | |
| "averageVolume": 12633750, | |
| "float": 982449804, | |
| "sharesOutstanding": 986266656, | |
| "soRatio": "99.61%", | |
| "marketCap": 54264389632, | |
| "isShort": true, | |
| "ftd": 64393, | |
| "ftdPercent": "0.01", | |
| "intent": "Merger/Acquisition, Credit Default, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Divested" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 3.03", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, EX-99.2, EX-4.1, Item 1.01, Item 3.03, Item 8.01, Item 9.01", | |
| "cik": "797468", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:20:01.060Z", | |
| "recordId": "OXY-1773087601060", | |
| "expiresAt": "2026-03-14T20:20:01.060Z", | |
| "direction": "SHORT", | |
| "highest5Day": 65.5388, | |
| "highest5DayPercent": 19.12, | |
| "lowest5Day": 52.05, | |
| "lowest5DayPercent": 5.4 | |
| }, | |
| { | |
| "ticker": "CACI", | |
| "title": "8-K - CACI INTERNATIONAL INC /DE/ (0000016058) (Filer)", | |
| "companyName": "CACI INTERNATIONAL INC /DE/", | |
| "filerName": null, | |
| "sector": "Professional Services", | |
| "price": 633.21, | |
| "fav": "75.64", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Virginia (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 374347, | |
| "averageVolume": 288440, | |
| "float": 21817700, | |
| "sharesOutstanding": 22085774, | |
| "soRatio": "98.79%", | |
| "marketCap": 13984933888, | |
| "isShort": true, | |
| "ftd": 2300, | |
| "ftdPercent": "0.01", | |
| "intent": "Merger/Acquisition, Activist 13D Filing, Bankruptcy Filing, Credit Default, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Virginia", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Acquisition Agreement", | |
| "Material Definitive Agreement" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Bankruptcy Filing": [ | |
| "Insolvency Proceedings" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Asset Disposition", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "Form D", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 2.03", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, Form D, EX-10.1, Item 1.01, Item 2.01, Item 2.03, Item 8.01, Item 9.01", | |
| "cik": "16058", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T20:46:18.965Z", | |
| "recordId": "CACI-1773089178965", | |
| "expiresAt": "2026-03-14T20:46:18.965Z", | |
| "direction": "SHORT", | |
| "highest5Day": 533.58, | |
| "highest5DayPercent": -15.73, | |
| "lowest5Day": 533.58, | |
| "lowest5DayPercent": 15.73 | |
| }, | |
| { | |
| "ticker": "OPAL", | |
| "title": "8-K - OPAL Fuels Inc. (0001842279) (Filer)", | |
| "companyName": "OPAL Fuels Inc.", | |
| "filerName": null, | |
| "sector": "Energy", | |
| "price": 2.12, | |
| "fav": "10.93", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Cayman Islands)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 158349, | |
| "averageVolume": 274425, | |
| "float": 3000000, | |
| "sharesOutstanding": 28996177, | |
| "soRatio": "10.35%", | |
| "marketCap": 367597824, | |
| "isShort": true, | |
| "ftd": 416, | |
| "ftdPercent": "0.01", | |
| "intent": "Merger/Acquisition, Credit Default, Reverse Split Event, DTC Eligible Restored, Warrant Redemption, Asset Disposition, Partnership", | |
| "incorporated": "Cayman Islands", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-09", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "DTC Eligible Restored": [ | |
| "DTC Eligible" | |
| ], | |
| "Warrant Redemption": [ | |
| "Warrant Exercised" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "DTC Chill Lift": "DTC_CHILL_LIFT" | |
| }, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-3.1", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 3.02", | |
| "Item 5.03", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-3.1, EX-4.1, Item 1.01, Item 2.03, Item 3.02, Item 5.03, Item 7.01, Item 9.01", | |
| "cik": "1842279", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-09T21:24:48.144Z", | |
| "recordId": "OPAL-1773091488144", | |
| "expiresAt": "2026-03-14T21:24:48.144Z", | |
| "direction": "SHORT", | |
| "highest5Day": 2.73, | |
| "highest5DayPercent": 28.77, | |
| "lowest5Day": 2.025, | |
| "lowest5DayPercent": 4.48 | |
| }, | |
| { | |
| "ticker": "LEGN", | |
| "title": "6-K - Legend Biotech Corp (0001801198) (Filer)", | |
| "companyName": "Legend Biotech Corp", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 19.14, | |
| "fav": "37.37", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "New Jersey (via Cayman Islands)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 1379941, | |
| "averageVolume": 2439230, | |
| "float": 91145224, | |
| "sharesOutstanding": 184689565, | |
| "soRatio": "49.35%", | |
| "marketCap": 3534958336, | |
| "isShort": false, | |
| "ftd": 11459, | |
| "ftdPercent": "0.01", | |
| "intent": "Clinical Success, Clinical Milestone, Licensing Deal", | |
| "incorporated": "Cayman Islands", | |
| "located": "New Jersey", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Trial Results", | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, S-8, F-3, 20-F, EX-99.1", | |
| "cik": "1801198", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T11:01:04.331Z", | |
| "recordId": "LEGN-1773140464331", | |
| "expiresAt": "2026-03-15T11:01:04.331Z", | |
| "direction": "LONG", | |
| "highest5Day": 16.97, | |
| "highest5DayPercent": -11.34, | |
| "lowest5Day": 16.97, | |
| "lowest5DayPercent": -11.34 | |
| }, | |
| { | |
| "ticker": "QTTB", | |
| "title": "8-K - Q32 Bio Inc. (0001661998) (Filer)", | |
| "companyName": "Q32 Bio Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 5.1, | |
| "fav": "9.23", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 232680, | |
| "averageVolume": 180583, | |
| "float": 1666679, | |
| "sharesOutstanding": 12858047, | |
| "soRatio": "12.96%", | |
| "marketCap": 65576040, | |
| "isShort": true, | |
| "ftd": 9915, | |
| "ftdPercent": "0.59", | |
| "intent": "Clinical Success, Convertible Debt, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Efficacy", | |
| "Data Readout", | |
| "Topline Data" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1661998", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T11:05:43.085Z", | |
| "recordId": "QTTB-1773140743086", | |
| "expiresAt": "2026-03-15T11:05:43.086Z", | |
| "direction": "SHORT", | |
| "highest5Day": 7.8, | |
| "highest5DayPercent": 52.94, | |
| "lowest5Day": 4.4028, | |
| "lowest5DayPercent": 13.67 | |
| }, | |
| { | |
| "ticker": "RAPP", | |
| "title": "8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)", | |
| "companyName": "Rapport Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 30.54, | |
| "fav": "84.92", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 887970, | |
| "averageVolume": 360577, | |
| "float": 30618500, | |
| "sharesOutstanding": 47661138, | |
| "soRatio": "64.24%", | |
| "marketCap": 1455571200, | |
| "isShort": false, | |
| "ftd": 39454, | |
| "ftdPercent": "0.13", | |
| "intent": "Clinical Success, Clinical Milestone, Licensing Deal", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "Investigational New Drug" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "2012593", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T11:12:34.455Z", | |
| "recordId": "RAPP-1773141154455", | |
| "expiresAt": "2026-03-15T11:12:34.455Z", | |
| "direction": "LONG", | |
| "highest5Day": 36.15, | |
| "highest5DayPercent": 18.37, | |
| "lowest5Day": 26.48, | |
| "lowest5DayPercent": -13.29 | |
| }, | |
| { | |
| "ticker": "IRD", | |
| "title": "8-K - Opus Genetics, Inc. (0001228627) (Filer)", | |
| "companyName": "Opus Genetics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 4.77, | |
| "fav": "12.37", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "North Carolina (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 1216872, | |
| "averageVolume": 807244, | |
| "float": 9985854, | |
| "sharesOutstanding": 68964208, | |
| "soRatio": "14.48%", | |
| "marketCap": 328959264, | |
| "isShort": false, | |
| "ftd": 3, | |
| "ftdPercent": "0.00", | |
| "intent": "FDA Breakthrough, Clinical Success", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "North Carolina", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Priority Review" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 3", | |
| "Efficacy" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1228627", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T11:17:59.947Z", | |
| "recordId": "IRD-1773141479947", | |
| "expiresAt": "2026-03-15T11:17:59.947Z", | |
| "direction": "LONG", | |
| "highest5Day": 5.7, | |
| "highest5DayPercent": 19.5, | |
| "lowest5Day": 4.3218, | |
| "lowest5DayPercent": -9.4 | |
| }, | |
| { | |
| "ticker": "ESPR", | |
| "title": "8-K - Esperion Therapeutics, Inc. (0001434868) (Filer)", | |
| "companyName": "Esperion Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 3.04, | |
| "fav": "45.36", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Michigan (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 7405333, | |
| "averageVolume": 4914891, | |
| "float": 222935000, | |
| "sharesOutstanding": 239063437, | |
| "soRatio": "93.25%", | |
| "marketCap": 726752832, | |
| "isShort": true, | |
| "ftd": 7567, | |
| "ftdPercent": "0.00", | |
| "intent": "Clinical Success, Clinical Milestone, Convertible Debt", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Michigan", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ], | |
| "Clinical Milestone": [ | |
| "Investigational New Drug" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1434868", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T11:18:15.850Z", | |
| "recordId": "ESPR-1773141495850", | |
| "expiresAt": "2026-03-15T11:18:15.850Z", | |
| "direction": "SHORT", | |
| "highest5Day": 2.05, | |
| "highest5DayPercent": -32.57, | |
| "lowest5Day": 2.05, | |
| "lowest5DayPercent": 32.57 | |
| }, | |
| { | |
| "ticker": "CGEM", | |
| "title": "8-K - Cullinan Therapeutics, Inc. (0001789972) (Filer)", | |
| "companyName": "Cullinan Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 15.31, | |
| "fav": "49.83", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 864736, | |
| "averageVolume": 834225, | |
| "float": 41567200, | |
| "sharesOutstanding": 59076259, | |
| "soRatio": "70.36%", | |
| "marketCap": 904457536, | |
| "isShort": false, | |
| "ftd": 90, | |
| "ftdPercent": "0.00", | |
| "intent": "FDA Breakthrough, FDA Filing, Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "FDA Filing": [ | |
| "NDA Submission" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Biomarker" | |
| ], | |
| "Clinical Milestone": [ | |
| "Dose Escalation" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1789972", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T11:24:05.079Z", | |
| "recordId": "CGEM-1773141845079", | |
| "expiresAt": "2026-03-15T11:24:05.079Z", | |
| "direction": "LONG", | |
| "highest5Day": 12.4396, | |
| "highest5DayPercent": -18.75, | |
| "lowest5Day": 12.4396, | |
| "lowest5DayPercent": -18.75 | |
| }, | |
| { | |
| "ticker": "WELL", | |
| "title": "8-K - WELLTOWER INC. (0000766704) (Filer)", | |
| "companyName": "WELLTOWER INC.", | |
| "filerName": null, | |
| "sector": "Real Estate", | |
| "price": 207.68, | |
| "fav": "203.84", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Ohio (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 3757495, | |
| "averageVolume": 3418316, | |
| "float": 696803587, | |
| "sharesOutstanding": 697752530, | |
| "soRatio": "99.86%", | |
| "marketCap": 144909238272, | |
| "isShort": true, | |
| "ftd": 2027, | |
| "ftdPercent": "0.00", | |
| "intent": "Merger/Acquisition, Activist 13D Filing, Bankruptcy Filing, Credit Default, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Ohio", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Acquisition Agreement", | |
| "Material Definitive Agreement" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Bankruptcy Filing": [ | |
| "Insolvency Proceedings" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "F-1", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, F-1, EX-10.1, Item 1.01, Item 9.01", | |
| "cik": "766704", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T12:11:21.122Z", | |
| "recordId": "WELL-1773144681122", | |
| "expiresAt": "2026-03-15T12:11:21.122Z", | |
| "direction": "SHORT", | |
| "highest5Day": 193.39, | |
| "highest5DayPercent": -6.88, | |
| "lowest5Day": 193.39, | |
| "lowest5DayPercent": 6.88 | |
| }, | |
| { | |
| "ticker": "TKO", | |
| "title": "8-K - TKO Group Holdings, Inc. (0001973266) (Filer)", | |
| "companyName": "TKO Group Holdings, Inc.", | |
| "filerName": null, | |
| "sector": "Media", | |
| "price": 204.07, | |
| "fav": "3.22", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Wilmington, Delaware)", | |
| "custodianBonusName": "New York", | |
| "filingTimeBonus": 1.1, | |
| "volume": 1228749, | |
| "averageVolume": 974615, | |
| "float": 3136179, | |
| "sharesOutstanding": 77966338, | |
| "soRatio": "4.02%", | |
| "marketCap": 16105687040, | |
| "isShort": true, | |
| "ftd": 15850, | |
| "ftdPercent": "0.51", | |
| "intent": "Merger/Acquisition, Activist 13D Filing, Bankruptcy Filing, Credit Default, Asset Disposition, Stock Buyback, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Acquisition Agreement", | |
| "Material Definitive Agreement" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Bankruptcy Filing": [ | |
| "Insolvency Proceedings" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Disposition" | |
| ], | |
| "Stock Buyback": [ | |
| "Share Repurchase", | |
| "Repurchase Program" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, EX-10.1, Item 1.01, Item 2.03, Item 8.01, Item 9.01", | |
| "cik": "1973266", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T12:21:09.446Z", | |
| "recordId": "TKO-1773145269446", | |
| "expiresAt": "2026-03-15T12:21:09.446Z", | |
| "direction": "SHORT", | |
| "highest5Day": 186.96, | |
| "highest5DayPercent": -8.38, | |
| "lowest5Day": 186.96, | |
| "lowest5DayPercent": 8.38 | |
| }, | |
| { | |
| "ticker": "KDP", | |
| "title": "8-K - Keurig Dr Pepper Inc. (0001418135) (Filer)", | |
| "companyName": "Keurig Dr Pepper Inc.", | |
| "filerName": null, | |
| "sector": "Beverages", | |
| "price": 28.19, | |
| "fav": "0.91", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 10723458, | |
| "averageVolume": 11320377, | |
| "float": 10350000, | |
| "sharesOutstanding": 1358666059, | |
| "soRatio": "0.76%", | |
| "marketCap": 38300798976, | |
| "isShort": true, | |
| "ftd": 67601, | |
| "ftdPercent": "0.65", | |
| "intent": "Merger/Acquisition, Activist 13D Filing, Bankruptcy Filing, Credit Default, Regulatory Breach, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Activist 13D Filing": [ | |
| "Beneficial Ownership" | |
| ], | |
| "Bankruptcy Filing": [ | |
| "Insolvency Proceedings" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Regulatory Breach": [ | |
| "Product Recall" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-10.1, Item 1.01, Item 2.03, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1418135", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T12:51:23.685Z", | |
| "recordId": "KDP-1773147083685", | |
| "expiresAt": "2026-03-15T12:51:23.685Z", | |
| "direction": "SHORT", | |
| "highest5Day": 25.195, | |
| "highest5DayPercent": -10.62, | |
| "lowest5Day": 25.195, | |
| "lowest5DayPercent": 10.62 | |
| }, | |
| { | |
| "ticker": "EB", | |
| "title": "8-K - Eventbrite, Inc. (0001475115) (Filer)", | |
| "companyName": "Eventbrite, Inc.", | |
| "filerName": null, | |
| "sector": "Media", | |
| "price": 4.51, | |
| "fav": "44.60", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 19512320, | |
| "averageVolume": 1743937, | |
| "float": 77784000, | |
| "sharesOutstanding": 84795275, | |
| "soRatio": "91.73%", | |
| "marketCap": 452958144, | |
| "isShort": true, | |
| "ftd": 37983, | |
| "ftdPercent": "0.05", | |
| "intent": "Merger/Acquisition, Going Dark, Asset Disposition, Executive Departure, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Going Dark": [ | |
| "Form 15", | |
| "Deregistration" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Executive Departure": [ | |
| "Step Down" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-3.1", | |
| "EX-3.2", | |
| "Item 1.02", | |
| "Item 2.01", | |
| "Item 3.01", | |
| "Item 3.03", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-3.1, EX-3.2, Item 1.02, Item 2.01, Item 3.01, Item 3.03, Item 5.01, Item 5.02, Item 5.03, Item 9.01", | |
| "cik": "1475115", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T12:56:50.543Z", | |
| "recordId": "EB-1773147410543", | |
| "expiresAt": "2026-03-15T12:56:50.544Z", | |
| "direction": "SHORT", | |
| "highest5Day": 4.49, | |
| "highest5DayPercent": -0.44, | |
| "lowest5Day": 4.49, | |
| "lowest5DayPercent": 0.44 | |
| }, | |
| { | |
| "ticker": "LIXT", | |
| "title": "8-K - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Filer)", | |
| "companyName": "LIXTE BIOTECHNOLOGY HOLDINGS, INC.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 2.57, | |
| "fav": "74.14", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 30732, | |
| "averageVolume": 76844, | |
| "float": 5697000, | |
| "sharesOutstanding": 8703077, | |
| "soRatio": "65.46%", | |
| "marketCap": 22366908, | |
| "isShort": false, | |
| "ftd": 4249, | |
| "ftdPercent": "0.07", | |
| "intent": "Merger/Acquisition, Going Dark, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Florida", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Going Dark": [ | |
| "Deregister" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-10.1, Item 1.01, Item 9.01", | |
| "cik": "1335105", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T20:01:40.159Z", | |
| "recordId": "LIXT-1773172900159", | |
| "expiresAt": "2026-03-15T20:01:40.159Z", | |
| "direction": "LONG", | |
| "highest5Day": 3.28, | |
| "highest5DayPercent": 27.63, | |
| "lowest5Day": 2.57, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "ZCSH", | |
| "title": "8-K - Grayscale Zcash Trust (ZEC) (0001720265) (Filer)", | |
| "companyName": "Grayscale Zcash Trust (ZEC)", | |
| "filerName": null, | |
| "sector": "Financials", | |
| "price": 15.6, | |
| "fav": "43.88", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Connecticut (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 16643, | |
| "averageVolume": 79715, | |
| "float": 3497926, | |
| "sharesOutstanding": 4829300, | |
| "soRatio": "87448150.0%", | |
| "marketCap": "110591162", | |
| "isShort": false, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "Merger/Acquisition, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Connecticut", | |
| "filingDate": "2026-03-10", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 5.07", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-4.1, Item 1.01, Item 5.07, Item 9.01", | |
| "cik": "1720265", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-10T20:10:31.353Z", | |
| "recordId": "ZCSH-1773173431353", | |
| "expiresAt": "2026-03-15T20:10:31.353Z", | |
| "direction": "LONG", | |
| "highest5Day": 30.25, | |
| "highest5DayPercent": 93.91, | |
| "lowest5Day": 15.02, | |
| "lowest5DayPercent": -3.72 | |
| }, | |
| { | |
| "ticker": "GLUE", | |
| "title": "8-K - Monte Rosa Therapeutics, Inc. (0001826457) (Filer)", | |
| "companyName": "Monte Rosa Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 16.35, | |
| "fav": "8.02", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 616447, | |
| "averageVolume": 1621522, | |
| "float": 13000000, | |
| "sharesOutstanding": 76242761, | |
| "soRatio": "17.05%", | |
| "marketCap": 1246569216, | |
| "isShort": false, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "FDA Filing, Clinical Success, Clinical Milestone, Licensing Deal", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-17", | |
| "signals": { | |
| "FDA Filing": [ | |
| "IND Application" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy", | |
| "Favorable Safety", | |
| "Clinical Benefit" | |
| ], | |
| "Clinical Milestone": [ | |
| "IND Application" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1826457", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-17T11:04:48.332Z", | |
| "recordId": "GLUE-1773745488332", | |
| "expiresAt": "2026-03-22T11:04:48.332Z", | |
| "direction": "LONG", | |
| "highest5Day": 14.3, | |
| "highest5DayPercent": -12.54, | |
| "lowest5Day": 14.3, | |
| "lowest5DayPercent": -12.54 | |
| }, | |
| { | |
| "ticker": "ABEO", | |
| "title": "8-K - ABEONA THERAPEUTICS INC. (0000318306) (Filer)", | |
| "companyName": "ABEONA THERAPEUTICS INC.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 4.95, | |
| "fav": "1.77", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Ohio (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 1583505, | |
| "averageVolume": 1130644, | |
| "float": 2000000, | |
| "sharesOutstanding": 54191361, | |
| "soRatio": "3.69%", | |
| "marketCap": 268247216, | |
| "isShort": false, | |
| "ftd": 355860, | |
| "ftdPercent": "17.79", | |
| "intent": "FDA Approved, FDA Breakthrough, Clinical Milestone, Underwritten Offering", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Ohio", | |
| "filingDate": "2026-03-17", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "FDA Breakthrough": [ | |
| "Priority Review" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient" | |
| ], | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "318306", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-17T11:31:01.927Z", | |
| "recordId": "ABEO-1773747061927", | |
| "expiresAt": "2026-03-22T11:31:01.927Z", | |
| "direction": "LONG", | |
| "highest5Day": 4.31, | |
| "highest5DayPercent": -12.93, | |
| "lowest5Day": 4.31, | |
| "lowest5DayPercent": -12.93 | |
| }, | |
| { | |
| "ticker": "GALT", | |
| "title": "8-K - GALECTIN THERAPEUTICS INC (0001133416) (Filer)", | |
| "companyName": "GALECTIN THERAPEUTICS INC", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 3.18, | |
| "fav": "101.98", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Georgia (via Nevada)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 250185, | |
| "averageVolume": 449145, | |
| "float": 45802761, | |
| "sharesOutstanding": 64472792, | |
| "soRatio": "71.04%", | |
| "marketCap": 205043888, | |
| "isShort": false, | |
| "ftd": 10062, | |
| "ftdPercent": "0.02", | |
| "intent": "FDA Breakthrough, Clinical Success", | |
| "incorporated": "Nevada", | |
| "located": "Georgia", | |
| "filingDate": "2026-03-17", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Positive Results" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 5.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 5.02, Item 9.01", | |
| "cik": "1133416", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-17T11:51:13.986Z", | |
| "recordId": "GALT-1773748273986", | |
| "expiresAt": "2026-03-22T11:51:13.986Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.19, | |
| "highest5DayPercent": -31.13, | |
| "lowest5Day": 2.19, | |
| "lowest5DayPercent": -31.13 | |
| }, | |
| { | |
| "ticker": "CANF", | |
| "title": "6-K - Can-Fite BioPharma Ltd. (0001536196) (Filer)", | |
| "companyName": "Can-Fite BioPharma Ltd.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 3.58, | |
| "fav": "0.88", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "volume": 75082, | |
| "averageVolume": 920261, | |
| "float": 811772, | |
| "sharesOutstanding": 1309212, | |
| "soRatio": "62.00%", | |
| "marketCap": 4686979, | |
| "isShort": false, | |
| "ftd": 65486, | |
| "ftdPercent": "8.07", | |
| "intent": "FDA Breakthrough, Clinical Success", | |
| "incorporated": "Tel Aviv, Israel", | |
| "located": "Tel Aviv, Israel", | |
| "filingDate": "2026-03-17", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy", | |
| "Safety Profile", | |
| "Mechanism Of Action" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, S-8, F-3, 20-F, EX-99.1", | |
| "cik": "1536196", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-17T11:51:28.338Z", | |
| "recordId": "CANF-1773748288338", | |
| "expiresAt": "2026-03-22T11:51:28.338Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.9014, | |
| "highest5DayPercent": -18.96, | |
| "lowest5Day": 2.9014, | |
| "lowest5DayPercent": -18.96 | |
| }, | |
| { | |
| "ticker": "CV", | |
| "title": "8-K - CapsoVision, Inc (0001378325) (Filer)", | |
| "companyName": "CapsoVision, Inc", | |
| "filerName": null, | |
| "sector": "Health Care", | |
| "price": 6.18, | |
| "fav": "8.75", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 492672, | |
| "averageVolume": 327659, | |
| "float": 2867089, | |
| "sharesOutstanding": 46843225, | |
| "soRatio": "6.12%", | |
| "marketCap": 289491104, | |
| "isShort": false, | |
| "ftd": 86, | |
| "ftdPercent": "0.00", | |
| "intent": "Merger/Acquisition, FDA Breakthrough, Clinical Success, Going Dark, Reverse Split Event, Asset Disposition, Partnership, Licensing Deal", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-20", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Acquisition Agreement", | |
| "Material Definitive Agreement" | |
| ], | |
| "FDA Breakthrough": [ | |
| "Breakthrough Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Primary Endpoint" | |
| ], | |
| "Going Dark": [ | |
| "Deregister" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Strategic Alliance" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-8", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.02", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-8, EX-10.1, Item 1.01, Item 2.02, Item 3.02, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1378325", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-20T12:05:19.619Z", | |
| "recordId": "CV-1774008319619", | |
| "expiresAt": "2026-03-25T12:05:19.619Z", | |
| "direction": "LONG", | |
| "highest5Day": 9.15, | |
| "highest5DayPercent": 48.06, | |
| "lowest5Day": 5.84, | |
| "lowest5DayPercent": -5.5 | |
| }, | |
| { | |
| "ticker": "NXST", | |
| "title": "8-K - NEXSTAR MEDIA GROUP, INC. (0001142417) (Filer)", | |
| "companyName": "NEXSTAR MEDIA GROUP, INC.", | |
| "filerName": null, | |
| "sector": "Media", | |
| "price": 223.05, | |
| "fav": "86.63", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 410873, | |
| "averageVolume": 325079, | |
| "float": 28162900, | |
| "sharesOutstanding": 30327997, | |
| "soRatio": "92.86%", | |
| "marketCap": 6764659712, | |
| "isShort": false, | |
| "ftd": 5241, | |
| "ftdPercent": "0.02", | |
| "intent": "Merger/Acquisition, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-03-20", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Acquisition Closing", | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 2.03", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 1.01, Item 2.01, Item 2.03, Item 7.01, Item 9.01", | |
| "cik": "1142417", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-20T12:05:55.725Z", | |
| "recordId": "NXST-1774008355725", | |
| "expiresAt": "2026-03-25T12:05:55.725Z", | |
| "direction": "LONG", | |
| "highest5Day": 173.38, | |
| "highest5DayPercent": -22.27, | |
| "lowest5Day": 173.38, | |
| "lowest5DayPercent": -22.27 | |
| }, | |
| { | |
| "ticker": "RYTM", | |
| "title": "8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)", | |
| "companyName": "RHYTHM PHARMACEUTICALS, INC.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 90.31, | |
| "fav": "78.06", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 960783, | |
| "averageVolume": 710510, | |
| "float": 55462000, | |
| "sharesOutstanding": 68285039, | |
| "soRatio": "81.22%", | |
| "marketCap": 6166821888, | |
| "isShort": false, | |
| "ftd": 33706, | |
| "ftdPercent": "0.06", | |
| "intent": "FDA Approved, Clinical Success, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-20", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Trial Results", | |
| "Efficacy", | |
| "Primary Endpoint", | |
| "Topline Data", | |
| "Statistically Significant", | |
| "Positive Phase 3" | |
| ], | |
| "Commercial Inflection": [ | |
| "Proof Of Concept" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-1", | |
| "S-8", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, S-1, S-8, EX-99.1, EX-99.2, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1649904", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-20T13:21:06.154Z", | |
| "recordId": "RYTM-1774012866155", | |
| "expiresAt": "2026-03-25T13:21:06.155Z", | |
| "direction": "LONG", | |
| "highest5Day": 100, | |
| "highest5DayPercent": 10.73, | |
| "lowest5Day": 80.7, | |
| "lowest5DayPercent": -10.64 | |
| }, | |
| { | |
| "ticker": "SLE", | |
| "title": "8-K - Super League Enterprise, Inc. (0001621672) (Filer)", | |
| "companyName": "Super League Enterprise, Inc.", | |
| "filerName": null, | |
| "sector": "Media", | |
| "price": 4.32, | |
| "fav": "4.78", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 5830, | |
| "averageVolume": 137158, | |
| "float": 656250, | |
| "sharesOutstanding": 1160000, | |
| "soRatio": "56.57%", | |
| "marketCap": 5011200, | |
| "isShort": false, | |
| "ftd": 12953, | |
| "ftdPercent": "1.97", | |
| "intent": "Merger/Acquisition, Credit Default, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-20", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Partnership Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Item 1.01, Item 7.01, Item 9.01", | |
| "cik": "1621672", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-20T19:12:26.000Z", | |
| "recordId": "SLE-1774033946000", | |
| "expiresAt": "2026-03-25T19:12:26.000Z", | |
| "direction": "LONG", | |
| "highest5Day": 3.42, | |
| "highest5DayPercent": -20.83, | |
| "lowest5Day": 3.42, | |
| "lowest5DayPercent": -20.83 | |
| }, | |
| { | |
| "ticker": "RNXT", | |
| "title": "8-K - RenovoRx, Inc. (0001574094) (Filer)", | |
| "companyName": "RenovoRx, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1, | |
| "fav": "28.15", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 276540, | |
| "averageVolume": 299738, | |
| "float": 8438790, | |
| "sharesOutstanding": 36649916, | |
| "soRatio": "23.03%", | |
| "marketCap": 36649916, | |
| "isShort": false, | |
| "ftd": 18, | |
| "ftdPercent": "0.00", | |
| "intent": "Merger/Acquisition, Reverse Split Event, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-4.1", | |
| "EX-4.2", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-4.1, EX-4.2, Item 1.01, Item 3.02, Item 8.01, Item 9.01", | |
| "cik": "1574094", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T11:01:32.422Z", | |
| "recordId": "RNXT-1774263692422", | |
| "expiresAt": "2026-03-28T11:01:32.422Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.19, | |
| "highest5DayPercent": 19, | |
| "lowest5Day": 0.9, | |
| "lowest5DayPercent": -10 | |
| }, | |
| { | |
| "ticker": "AVTX", | |
| "title": "8-K - Avalo Therapeutics, Inc. (0001534120) (Filer)", | |
| "companyName": "Avalo Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 13.42, | |
| "fav": "24.12", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Pennsylvania (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 477507, | |
| "averageVolume": 449352, | |
| "float": 10838100, | |
| "sharesOutstanding": 18512757, | |
| "soRatio": "58.54%", | |
| "marketCap": 248441184, | |
| "isShort": false, | |
| "ftd": 2100, | |
| "ftdPercent": "0.02", | |
| "intent": "Clinical Success, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Pennsylvania", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Trial Results", | |
| "Efficacy", | |
| "Topline Data" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-9", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1534120", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T11:01:57.950Z", | |
| "recordId": "AVTX-1774263717950", | |
| "expiresAt": "2026-03-28T11:01:57.950Z", | |
| "direction": "LONG", | |
| "highest5Day": 17.76, | |
| "highest5DayPercent": 32.34, | |
| "lowest5Day": 13.075, | |
| "lowest5DayPercent": -2.57 | |
| }, | |
| { | |
| "ticker": "PYXS", | |
| "title": "8-K - Pyxis Oncology, Inc. (0001782223) (Filer)", | |
| "companyName": "Pyxis Oncology, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.47, | |
| "fav": "48.12", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 188118, | |
| "averageVolume": 827611, | |
| "float": 39828600, | |
| "sharesOutstanding": 62264215, | |
| "soRatio": "63.97%", | |
| "marketCap": 91528400, | |
| "isShort": false, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "FDA Breakthrough, Clinical Success, Clinical Milestone, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Positive Results", | |
| "Phase 1", | |
| "Efficacy", | |
| "Mechanism Of Action" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Dosed", | |
| "First Dose", | |
| "Dose Escalation" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Form D, EX-99.1, EX-99.2, Item 2.02, Item 7.01, Item 9.01", | |
| "cik": "1782223", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T11:13:24.548Z", | |
| "recordId": "PYXS-1774264404548", | |
| "expiresAt": "2026-03-28T11:13:24.548Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.71, | |
| "highest5DayPercent": 16.33, | |
| "lowest5Day": 1.35, | |
| "lowest5DayPercent": -8.16 | |
| }, | |
| { | |
| "ticker": "TRIP", | |
| "title": "8-K - TripAdvisor, Inc. (0001526520) (Filer)", | |
| "companyName": "TripAdvisor, Inc.", | |
| "filerName": null, | |
| "sector": "Media", | |
| "price": 9.35, | |
| "fav": "3.23", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 6915247, | |
| "averageVolume": 3339528, | |
| "float": 10774996, | |
| "sharesOutstanding": 114755221, | |
| "soRatio": "9.39%", | |
| "marketCap": 1093092992, | |
| "isShort": false, | |
| "ftd": 696931, | |
| "ftdPercent": "6.47", | |
| "intent": "Merger/Acquisition, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-10.1", | |
| "EX-3.1", | |
| "Item 1.01", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, EX-10.1, EX-3.1, Item 1.01, Item 5.02, Item 5.03, Item 7.01, Item 9.01", | |
| "cik": "1526520", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T12:36:01.599Z", | |
| "recordId": "TRIP-1774269361599", | |
| "expiresAt": "2026-03-28T12:36:01.599Z", | |
| "direction": "LONG", | |
| "highest5Day": 11.565, | |
| "highest5DayPercent": 23.69, | |
| "lowest5Day": 9.25, | |
| "lowest5DayPercent": -1.07 | |
| }, | |
| { | |
| "ticker": "CRCW", | |
| "title": "8-K - Crypto Co (0001688126) (Filer)", | |
| "companyName": "Crypto Co", | |
| "filerName": null, | |
| "sector": "Crypto", | |
| "price": 0.002, | |
| "fav": "3.62", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Nevada)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 4784266, | |
| "averageVolume": 9303559, | |
| "float": 33633691, | |
| "sharesOutstanding": 5522401915, | |
| "soRatio": "0.61%", | |
| "marketCap": 11044804, | |
| "isShort": true, | |
| "ftd": 2188158, | |
| "ftdPercent": "6.51", | |
| "intent": "Merger/Acquisition, Convertible Debt, Asset Disposition", | |
| "incorporated": "Nevada", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 3.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, EX-10.1, Item 1.01, Item 2.03, Item 3.02, Item 8.01, Item 9.01", | |
| "cik": "1688126", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T13:01:32.884Z", | |
| "recordId": "CRCW-1774270892884", | |
| "expiresAt": "2026-03-28T13:01:32.884Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.001, | |
| "highest5DayPercent": -50, | |
| "lowest5Day": 0.001, | |
| "lowest5DayPercent": 50 | |
| }, | |
| { | |
| "ticker": "STRO", | |
| "title": "8-K - SUTRO BIOPHARMA, INC. (0001382101) (Filer)", | |
| "companyName": "SUTRO BIOPHARMA, INC.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 21.33, | |
| "fav": "54.77", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Unknown)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 298845, | |
| "averageVolume": 143671, | |
| "float": 7868383, | |
| "sharesOutstanding": 16387775, | |
| "soRatio": "48.01%", | |
| "marketCap": 349551264, | |
| "isShort": false, | |
| "ftd": 1272, | |
| "ftdPercent": "0.02", | |
| "intent": "Merger/Acquisition, Clinical Success, Clinical Milestone, Commercial Inflection", | |
| "incorporated": "Unknown", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Favorable Safety" | |
| ], | |
| "Clinical Milestone": [ | |
| "Trial Initiation" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "Form D", | |
| "EX-99.1", | |
| "Item 1.02", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-3, Form D, EX-99.1, Item 1.02, Item 2.02, Item 9.01", | |
| "cik": "1382101", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T20:33:49.025Z", | |
| "recordId": "STRO-1774298029025", | |
| "expiresAt": "2026-03-28T20:33:49.025Z", | |
| "direction": "LONG", | |
| "highest5Day": 28.78, | |
| "highest5DayPercent": 34.93, | |
| "lowest5Day": 19.11, | |
| "lowest5DayPercent": -10.41 | |
| }, | |
| { | |
| "ticker": "NTHI", | |
| "title": "8-K - NEONC TECHNOLOGIES HOLDINGS, INC. (0001979414) (Filer)", | |
| "companyName": "NEONC TECHNOLOGIES HOLDINGS, INC.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 7.88, | |
| "fav": "41.25", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 30219, | |
| "averageVolume": 53867, | |
| "float": 2222222, | |
| "sharesOutstanding": 24368798, | |
| "soRatio": "9.12%", | |
| "marketCap": 192026128, | |
| "isShort": true, | |
| "ftd": 1078, | |
| "ftdPercent": "0.05", | |
| "intent": "Merger/Acquisition, Convertible Debt, Reverse Split Event, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-23", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes", | |
| "Convertible Securities" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "Form D", | |
| "EX-10.1", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-1, Form D, EX-10.1, EX-4.1, Item 1.01, Item 3.02, Item 9.01", | |
| "cik": "1979414", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-23T21:01:00.418Z", | |
| "recordId": "NTHI-1774299660418", | |
| "expiresAt": "2026-03-28T21:01:00.418Z", | |
| "direction": "SHORT", | |
| "highest5Day": 4.61, | |
| "highest5DayPercent": -41.5, | |
| "lowest5Day": 4.61, | |
| "lowest5DayPercent": 41.5 | |
| }, | |
| { | |
| "ticker": "KPTI", | |
| "title": "8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer)", | |
| "companyName": "Karyopharm Therapeutics Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 6.66, | |
| "fav": "1.72", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 964752, | |
| "averageVolume": 597945, | |
| "float": 1030354, | |
| "sharesOutstanding": 18343968, | |
| "soRatio": "5.62%", | |
| "marketCap": 122170824, | |
| "isShort": false, | |
| "ftd": 11225, | |
| "ftdPercent": "1.09", | |
| "intent": "Merger/Acquisition, Clinical Success, Convertible Debt, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Phase 3", | |
| "Primary Endpoint", | |
| "Topline Data", | |
| "Statistically Significant" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes", | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "EX-4.1", | |
| "EX-4.2", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-3, EX-4.1, EX-4.2, Item 1.01, Item 3.02, Item 7.01, Item 8.01, Item 9.01", | |
| "cik": "1503802", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T12:01:40.153Z", | |
| "recordId": "KPTI-1774353700153", | |
| "expiresAt": "2026-03-29T12:01:40.153Z", | |
| "direction": "LONG", | |
| "highest5Day": 0, | |
| "highest5DayPercent": -100, | |
| "lowest5Day": 0, | |
| "lowest5DayPercent": -100, | |
| "finalPrice": 6.66, | |
| "finalPercent": 0 | |
| }, | |
| { | |
| "ticker": "ZSPC", | |
| "title": "8-K - zSpace, Inc. (0001637147) (Filer)", | |
| "companyName": "zSpace, Inc.", | |
| "filerName": null, | |
| "sector": "Diversified Consumer Services", | |
| "price": 0.1564, | |
| "fav": "10.69", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 1024243, | |
| "averageVolume": 1269472, | |
| "float": 13572200, | |
| "sharesOutstanding": 33302983, | |
| "soRatio": "40.75%", | |
| "marketCap": 5208586, | |
| "isShort": true, | |
| "ftd": 51125, | |
| "ftdPercent": "0.38", | |
| "intent": "Merger/Acquisition, Bankruptcy Filing, Credit Default, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Bankruptcy Filing": [ | |
| "Insolvency Proceedings" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "Item 1.01", | |
| "Item 1.02", | |
| "Item 2.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-10.1, EX-10.2, Item 1.01, Item 1.02, Item 2.03, Item 9.01", | |
| "cik": "1637147", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T12:01:58.156Z", | |
| "recordId": "ZSPC-1774353718156", | |
| "expiresAt": "2026-03-29T12:01:58.156Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.0689, | |
| "highest5DayPercent": -55.95, | |
| "lowest5Day": 0.0689, | |
| "lowest5DayPercent": 55.95 | |
| }, | |
| { | |
| "ticker": "LENZ", | |
| "title": "8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)", | |
| "companyName": "LENZ Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 11, | |
| "fav": "21.03", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 1478776, | |
| "averageVolume": 953693, | |
| "float": 20052200, | |
| "sharesOutstanding": 31289969, | |
| "soRatio": "64.09%", | |
| "marketCap": 344189632, | |
| "isShort": false, | |
| "ftd": 44837, | |
| "ftdPercent": "0.22", | |
| "intent": "FDA Approved, FDA Filing, Clinical Success, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "FDA Filing": [ | |
| "Regulatory Filing" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 3", | |
| "Positive Phase 3" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1815776", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T12:11:33.009Z", | |
| "recordId": "LENZ-1774354293009", | |
| "expiresAt": "2026-03-29T12:11:33.009Z", | |
| "direction": "LONG", | |
| "highest5Day": 8.85, | |
| "highest5DayPercent": -19.55, | |
| "lowest5Day": 8.85, | |
| "lowest5DayPercent": -19.55 | |
| }, | |
| { | |
| "ticker": "WBUY", | |
| "title": "6-K - WEBUY GLOBAL LTD (0001946703) (Filer)", | |
| "companyName": "WEBUY GLOBAL LTD", | |
| "filerName": null, | |
| "sector": "Retail", | |
| "price": 0.959, | |
| "fav": "51.07", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.15, | |
| "volume": 30972, | |
| "averageVolume": 391598, | |
| "float": 20000000, | |
| "sharesOutstanding": 3563336, | |
| "soRatio": "561.3%", | |
| "marketCap": 3417239, | |
| "isShort": true, | |
| "ftd": 2733, | |
| "ftdPercent": "0.01", | |
| "intent": "Credit Default, Accounting Restatement, Asset Disposition", | |
| "incorporated": "Cayman Islands", | |
| "located": "Cayman Islands", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "F-1", | |
| "F-3", | |
| "20-F", | |
| "13D", | |
| "EX-10.1" | |
| ], | |
| "filingType": "6-K, F-1, F-3, 20-F, 13D, EX-10.1", | |
| "cik": "1946703", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T12:31:03.865Z", | |
| "recordId": "WBUY-1774355463865", | |
| "expiresAt": "2026-03-29T12:31:03.865Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.23, | |
| "highest5DayPercent": 28.26, | |
| "lowest5Day": 0.9009, | |
| "lowest5DayPercent": 6.06 | |
| }, | |
| { | |
| "ticker": "ENLV", | |
| "title": "6-K - Enlivex Ltd. (0001596812) (Filer)", | |
| "companyName": "Enlivex Ltd.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.11, | |
| "fav": "15.94", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Israel (via Tel Aviv, Israel)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 269084, | |
| "averageVolume": 352803, | |
| "float": 5622300, | |
| "sharesOutstanding": 237381498, | |
| "soRatio": "2.37%", | |
| "marketCap": 263493472, | |
| "isShort": true, | |
| "ftd": 696682, | |
| "ftdPercent": "12.39", | |
| "intent": "Convertible Debt, Credit Default, Regulatory Breach, Reverse Split Event, Asset Disposition, Stock Buyback, Partnership", | |
| "incorporated": "Tel Aviv, Israel", | |
| "located": "Israel", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Regulatory Breach": [ | |
| "Warning Letter" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Stock Buyback": [ | |
| "Share Repurchase", | |
| "Repurchase Program" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "13D", | |
| "EX-10.1" | |
| ], | |
| "filingType": "6-K, S-8, F-3, 20-F, 13D, EX-10.1", | |
| "cik": "1596812", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T12:35:55.058Z", | |
| "recordId": "ENLV-1774355755058", | |
| "expiresAt": "2026-03-29T12:35:55.058Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.816, | |
| "highest5DayPercent": -26.49, | |
| "lowest5Day": 0.816, | |
| "lowest5DayPercent": 26.49 | |
| }, | |
| { | |
| "ticker": "NRSN", | |
| "title": "6-K - NeuroSense Therapeutics Ltd. (0001875091) (Filer)", | |
| "companyName": "NeuroSense Therapeutics Ltd.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 0.7456, | |
| "fav": "62.44", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.15, | |
| "volume": 58672, | |
| "averageVolume": 220479, | |
| "float": 13767800, | |
| "sharesOutstanding": 33396608, | |
| "soRatio": "41.23%", | |
| "marketCap": 24900510, | |
| "isShort": false, | |
| "ftd": 13262, | |
| "ftdPercent": "0.10", | |
| "intent": "FDA Approved, Clinical Success", | |
| "incorporated": "Tel Aviv, Israel", | |
| "located": "Tel Aviv, Israel", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Clearance" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 3", | |
| "Biomarker", | |
| "Statistically Significant" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "S-9", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, S-8, F-3, 20-F, EX-99.1", | |
| "cik": "1875091", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T14:12:14.045Z", | |
| "recordId": "NRSN-1774361534045", | |
| "expiresAt": "2026-03-29T14:12:14.045Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.63, | |
| "highest5DayPercent": -15.5, | |
| "lowest5Day": 0.63, | |
| "lowest5DayPercent": -15.5 | |
| }, | |
| { | |
| "ticker": "BMEA", | |
| "title": "8-K - Biomea Fusion, Inc. (0001840439) (Filer)", | |
| "companyName": "Biomea Fusion, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.13, | |
| "fav": "47.88", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 1006802, | |
| "averageVolume": 1093113, | |
| "float": 52342502, | |
| "sharesOutstanding": 70703639, | |
| "soRatio": "74.03%", | |
| "marketCap": 79895112, | |
| "isShort": false, | |
| "ftd": 57152, | |
| "ftdPercent": "0.11", | |
| "intent": "Clinical Success, Clinical Milestone, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Safety Profile", | |
| "Primary Endpoint", | |
| "Topline Data", | |
| "Mechanism Of Action" | |
| ], | |
| "Clinical Milestone": [ | |
| "Patient Enrollment" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1840439", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T20:10:14.623Z", | |
| "recordId": "BMEA-1774383014623", | |
| "expiresAt": "2026-03-29T20:10:14.624Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.985, | |
| "highest5DayPercent": 75.66, | |
| "lowest5Day": 1.07, | |
| "lowest5DayPercent": -5.31 | |
| }, | |
| { | |
| "ticker": "CETX", | |
| "title": "8-K/A - CEMTREX INC (0001435064) (Filer)", | |
| "companyName": "CEMTREX INC", | |
| "filerName": null, | |
| "sector": "Electrical Equipment", | |
| "price": 0.5976, | |
| "fav": "1.89", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 144898, | |
| "averageVolume": 3746379, | |
| "float": 7077875, | |
| "sharesOutstanding": 10078089, | |
| "soRatio": "70.23%", | |
| "marketCap": 6022666, | |
| "isShort": false, | |
| "ftd": 127045, | |
| "ftdPercent": "1.79", | |
| "intent": "Merger/Acquisition, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Agreed To Acquire", | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "8-K/A", | |
| "S-3", | |
| "S-8", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 8-K/A, S-3, S-8, EX-99.1, EX-99.2, Item 1.01, Item 2.01, Item 9.01", | |
| "cik": "1435064", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T20:16:39.664Z", | |
| "recordId": "CETX-1774383399664", | |
| "expiresAt": "2026-03-29T20:16:39.664Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.29, | |
| "highest5DayPercent": 115.86, | |
| "lowest5Day": 0.5919, | |
| "lowest5DayPercent": -0.95 | |
| }, | |
| { | |
| "ticker": "XELB", | |
| "title": "8-K - XCel Brands, Inc. (0001083220) (Filer)", | |
| "companyName": "XCel Brands, Inc.", | |
| "filerName": null, | |
| "sector": "Retail", | |
| "price": 1.5, | |
| "fav": "84.95", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 9568, | |
| "averageVolume": 41777, | |
| "float": 3548786, | |
| "sharesOutstanding": 5893815, | |
| "soRatio": "60.21%", | |
| "marketCap": 8840722, | |
| "isShort": true, | |
| "ftd": 3860, | |
| "ftdPercent": "0.11", | |
| "intent": "Merger/Acquisition, Credit Default, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-1, EX-10.1, Item 1.01, Item 2.03, Item 9.01", | |
| "cik": "1083220", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T20:20:47.208Z", | |
| "recordId": "XELB-1774383647208", | |
| "expiresAt": "2026-03-29T20:20:47.209Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.28, | |
| "highest5DayPercent": -14.67, | |
| "lowest5Day": 1.28, | |
| "lowest5DayPercent": 14.67 | |
| }, | |
| { | |
| "ticker": "CING", | |
| "title": "8-K - Cingulate Inc. (0001862150) (Filer)", | |
| "companyName": "Cingulate Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 6.71, | |
| "fav": "12.52", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Kansas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 576190, | |
| "averageVolume": 446901, | |
| "float": 5596934, | |
| "sharesOutstanding": 11628613, | |
| "soRatio": "48.13%", | |
| "marketCap": 78027992, | |
| "isShort": true, | |
| "ftd": 6941, | |
| "ftdPercent": "0.12", | |
| "intent": "Merger/Acquisition, Regulatory Breach, Going Dark, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Kansas", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Regulatory Breach": [ | |
| "Warning Letter" | |
| ], | |
| "Going Dark": [ | |
| "Deregister" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "EX-1.1", | |
| "Item 1.01", | |
| "Item 5.07" | |
| ], | |
| "filingType": "8-K, S-3, EX-1.1, Item 1.01, Item 5.07", | |
| "cik": "1862150", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T21:16:20.614Z", | |
| "recordId": "CING-1774386980614", | |
| "expiresAt": "2026-03-29T21:16:20.614Z", | |
| "direction": "SHORT", | |
| "highest5Day": 5.35, | |
| "highest5DayPercent": -20.27, | |
| "lowest5Day": 5.35, | |
| "lowest5DayPercent": 20.27 | |
| }, | |
| { | |
| "ticker": "SLGL", | |
| "title": "6-K - Sol-Gel Technologies Ltd. (0001684693) (Filer)", | |
| "companyName": "Sol-Gel Technologies Ltd.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 80.01, | |
| "fav": "30.53", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Israel (via Tel Aviv, Israel)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 55743, | |
| "averageVolume": 27372, | |
| "float": 835675, | |
| "sharesOutstanding": 2785787, | |
| "soRatio": "30.00%", | |
| "marketCap": 222890816, | |
| "isShort": false, | |
| "ftd": 7129, | |
| "ftdPercent": "0.85", | |
| "intent": "FDA Approved, Clinical Success, Capital Raise, Regulatory Breach, Partnership, Licensing Deal", | |
| "incorporated": "Tel Aviv, Israel", | |
| "located": "Israel", | |
| "filingDate": "2026-03-24", | |
| "signals": { | |
| "FDA Approved": [ | |
| "Approval Granted" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ], | |
| "Capital Raise": [ | |
| "Oversubscribed" | |
| ], | |
| "Regulatory Breach": [ | |
| "Warning Letter" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Partnership Agreement" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-1.1" | |
| ], | |
| "filingType": "6-K, S-8, F-3, 20-F, EX-1.1", | |
| "cik": "1684693", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-24T21:17:10.070Z", | |
| "recordId": "SLGL-1774387030070", | |
| "expiresAt": "2026-03-29T21:17:10.070Z", | |
| "direction": "LONG", | |
| "highest5Day": 93.525, | |
| "highest5DayPercent": 16.89, | |
| "lowest5Day": 71.11, | |
| "lowest5DayPercent": -11.12 | |
| }, | |
| { | |
| "ticker": "MAZE", | |
| "title": "8-K - Maze Therapeutics, Inc. (0001842295) (Filer)", | |
| "companyName": "Maze Therapeutics, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 49, | |
| "fav": "28.44", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 550253, | |
| "averageVolume": 488452, | |
| "float": 13892516, | |
| "sharesOutstanding": 48119444, | |
| "soRatio": "28.87%", | |
| "marketCap": 2357852672, | |
| "isShort": false, | |
| "ftd": 74613, | |
| "ftdPercent": "0.54", | |
| "intent": "Clinical Success, Clinical Milestone, Licensing Deal, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-25", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Efficacy", | |
| "Topline Data" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient" | |
| ], | |
| "Licensing Deal": [ | |
| "Exclusive License", | |
| "License Agreement" | |
| ], | |
| "Commercial Inflection": [ | |
| "Proof Of Concept", | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "S-8", | |
| "13G", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 5.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, S-8, 13G, EX-99.1, EX-99.2, Item 2.02, Item 5.02, Item 7.01, Item 9.01", | |
| "cik": "1842295", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-25T11:08:44.790Z", | |
| "recordId": "MAZE-1774436924790", | |
| "expiresAt": "2026-03-30T11:08:44.790Z", | |
| "direction": "LONG", | |
| "highest5Day": 26.17, | |
| "highest5DayPercent": -46.59, | |
| "lowest5Day": 26.17, | |
| "lowest5DayPercent": -46.59 | |
| }, | |
| { | |
| "ticker": "KALV", | |
| "title": "8-K - KalVista Pharmaceuticals, Inc. (0001348911) (Filer)", | |
| "companyName": "KalVista Pharmaceuticals, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 16.46, | |
| "fav": "37.87", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 645549, | |
| "averageVolume": 982154, | |
| "float": 37197780, | |
| "sharesOutstanding": 50546293, | |
| "soRatio": "73.59%", | |
| "marketCap": 831991936, | |
| "isShort": false, | |
| "ftd": 50513, | |
| "ftdPercent": "0.14", | |
| "intent": "FDA Filing, Clinical Success, Commercial Inflection", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-25", | |
| "signals": { | |
| "FDA Filing": [ | |
| "Regulatory Filing" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 3", | |
| "Efficacy" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "F-4", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, F-4, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1348911", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-25T11:17:26.404Z", | |
| "recordId": "KALV-1774437446404", | |
| "expiresAt": "2026-03-30T11:17:26.404Z", | |
| "direction": "LONG", | |
| "highest5Day": 21, | |
| "highest5DayPercent": 27.58, | |
| "lowest5Day": 15.945, | |
| "lowest5DayPercent": -3.13 | |
| }, | |
| { | |
| "ticker": "TERN", | |
| "title": "8-K - Terns Pharmaceuticals, Inc. (0001831363) (Filer)", | |
| "companyName": "Terns Pharmaceuticals, Inc.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 50, | |
| "fav": "1.10", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "volume": 2422504, | |
| "averageVolume": 2164449, | |
| "float": 2380952, | |
| "sharesOutstanding": 108767281, | |
| "soRatio": "2.19%", | |
| "marketCap": 5438364160, | |
| "isShort": true, | |
| "ftd": 55487, | |
| "ftdPercent": "2.33", | |
| "intent": "Merger/Acquisition, Accounting Restatement, Going Dark, Reverse Split Event, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-25", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Going Dark": [ | |
| "Deregistration" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split", | |
| "Consolidation Of Shares" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, Item 1.01, Item 7.01, Item 9.01", | |
| "cik": "1831363", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-25T11:17:49.991Z", | |
| "recordId": "TERN-1774437469991", | |
| "expiresAt": "2026-03-30T11:17:49.991Z", | |
| "direction": "SHORT", | |
| "highest5Day": 52.965, | |
| "highest5DayPercent": 5.93, | |
| "lowest5Day": 48.144, | |
| "lowest5DayPercent": 3.71 | |
| }, | |
| { | |
| "ticker": "PMN", | |
| "title": "8-K - ProMIS Neurosciences Inc. (0001374339) (Filer)", | |
| "companyName": "ProMIS Neurosciences Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 17.43, | |
| "fav": "12.40", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Ottawa, Canada (via Vancouver, British Columbia, Canada)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 16394, | |
| "averageVolume": 178869, | |
| "float": 2218425, | |
| "sharesOutstanding": 8967693, | |
| "soRatio": "24.74%", | |
| "marketCap": 156306896, | |
| "isShort": false, | |
| "ftd": 188019, | |
| "ftdPercent": "8.48", | |
| "intent": "FDA Breakthrough, Clinical Success, Capital Raise, Commercial Inflection", | |
| "incorporated": "Vancouver, British Columbia, Canada", | |
| "located": "Ottawa, Canada", | |
| "filingDate": "2026-03-25", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy", | |
| "Safety Profile", | |
| "Biomarker", | |
| "Favorable Safety" | |
| ], | |
| "Capital Raise": [ | |
| "Oversubscribed" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1374339", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-25T12:19:08.463Z", | |
| "recordId": "PMN-1774441148463", | |
| "expiresAt": "2026-03-30T12:19:08.463Z", | |
| "direction": "LONG", | |
| "highest5Day": 10.7, | |
| "highest5DayPercent": -38.61, | |
| "lowest5Day": 10.7, | |
| "lowest5DayPercent": -38.61 | |
| }, | |
| { | |
| "ticker": "IBG", | |
| "title": "6-K - Innovation Beverage Group Ltd (0001924482) (Filer)", | |
| "companyName": "Innovation Beverage Group Ltd", | |
| "filerName": null, | |
| "sector": "Beverages", | |
| "price": 1.21, | |
| "fav": "7.52", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Australia (via Brisbane, Australia)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 242686, | |
| "averageVolume": 597901, | |
| "float": 4497450, | |
| "sharesOutstanding": 1815881, | |
| "soRatio": "247.7%", | |
| "marketCap": 2197216, | |
| "isShort": false, | |
| "ftd": 42957, | |
| "ftdPercent": "0.96", | |
| "intent": "Merger/Acquisition, Credit Default, Reverse Split Event, Asset Disposition, Partnership", | |
| "incorporated": "Brisbane, Australia", | |
| "located": "Australia", | |
| "filingDate": "2026-03-25", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "20-F", | |
| "13D", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "EX-10.3" | |
| ], | |
| "filingType": "6-K, 8-K, 20-F, 13D, EX-10.1, EX-10.2, EX-10.3", | |
| "cik": "1924482", | |
| "skipReason": "", | |
| "alertType": "CTB Squeeze", | |
| "recordedAt": "2026-03-25T12:31:14.389Z", | |
| "recordId": "IBG-1774441874389", | |
| "expiresAt": "2026-03-30T12:31:14.389Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.99, | |
| "highest5DayPercent": -18.18, | |
| "lowest5Day": 0.99, | |
| "lowest5DayPercent": -18.18 | |
| }, | |
| { | |
| "ticker": "PRTS", | |
| "title": "8-K - CarParts.com, Inc. (0001378950) (Filer)", | |
| "companyName": "CarParts.com, Inc.", | |
| "filerName": null, | |
| "sector": "Retail", | |
| "price": 0.83, | |
| "fav": "11.08", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 626592, | |
| "averageVolume": 902598, | |
| "float": 10000000, | |
| "sharesOutstanding": 66691662, | |
| "soRatio": "14.99%", | |
| "marketCap": 55354080, | |
| "isShort": true, | |
| "ftd": 3109, | |
| "ftdPercent": "0.03", | |
| "intent": "Merger/Acquisition, Convertible Debt, Accounting Restatement, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-03-25", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition", | |
| "Divested" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13D, EX-10.1, Item 1.01, Item 3.02, Item 8.01, Item 9.01", | |
| "cik": "1378950", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-25T13:02:23.487Z", | |
| "recordId": "PRTS-1774443743487", | |
| "expiresAt": "2026-03-30T13:02:23.487Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.85, | |
| "highest5DayPercent": 2.41, | |
| "lowest5Day": 0.8218, | |
| "lowest5DayPercent": 0.99 | |
| }, | |
| { | |
| "ticker": "QNTM", | |
| "title": "6-K - Quantum Biopharma Ltd. (0001771885) (Filer)", | |
| "companyName": "Quantum Biopharma Ltd.", | |
| "filerName": null, | |
| "sector": "Pharmaceuticals", | |
| "price": 4.35, | |
| "fav": "26.05", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Ontario, Canada (via Ottawa, Canada)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 1153863, | |
| "averageVolume": 135764, | |
| "float": 3536700, | |
| "sharesOutstanding": 3842935, | |
| "soRatio": "92.03%", | |
| "marketCap": 16716950, | |
| "isShort": false, | |
| "ftd": 108808, | |
| "ftdPercent": "3.08", | |
| "intent": "FDA Filing, Clinical Success, Clinical Milestone", | |
| "incorporated": "Ottawa, Canada", | |
| "located": "Ontario, Canada", | |
| "filingDate": "2026-03-26", | |
| "signals": { | |
| "FDA Filing": [ | |
| "IND Application" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Efficacy", | |
| "Mechanism Of Action" | |
| ], | |
| "Clinical Milestone": [ | |
| "Investigational New Drug", | |
| "IND Application" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, 20-F, EX-99.1", | |
| "cik": "1771885", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-26T12:01:07.498Z", | |
| "recordId": "QNTM-1774526467498", | |
| "expiresAt": "2026-03-31T12:01:07.498Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.2099, | |
| "highest5DayPercent": 42.76, | |
| "lowest5Day": 3.02, | |
| "lowest5DayPercent": -30.57 | |
| }, | |
| { | |
| "ticker": "DNTH", | |
| "title": "8-K - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Filer)", | |
| "companyName": "Dianthus Therapeutics, Inc. /DE/", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 79.61, | |
| "fav": "42.59", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "volume": 1027499, | |
| "averageVolume": 984011, | |
| "float": 41908200, | |
| "sharesOutstanding": 52942083, | |
| "soRatio": "79.16%", | |
| "marketCap": 4214719232, | |
| "isShort": false, | |
| "ftd": 526916, | |
| "ftdPercent": "1.26", | |
| "intent": "FDA Approved, Clinical Success, Clinical Milestone", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New York", | |
| "filingDate": "2026-03-26", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA approved" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy Demonstrated", | |
| "Phase 1", | |
| "Phase 2", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Meaningful Improvement", | |
| "Favorable Safety", | |
| "Clinical Benefit", | |
| "Statistically Significant" | |
| ], | |
| "Clinical Milestone": [ | |
| "Trial Initiation" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "FWG", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, EX-99.1, Item 8.01, Item 9.01", | |
| "cik": "1690585", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-26T12:01:35.198Z", | |
| "recordId": "DNTH-1774526495198", | |
| "expiresAt": "2026-03-31T12:01:35.198Z", | |
| "direction": "LONG", | |
| "highest5Day": 94.91, | |
| "highest5DayPercent": 19.22, | |
| "lowest5Day": 79.61, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "MTVA", | |
| "title": "8-K - MetaVia Inc. (0001638287) (Filer)", | |
| "companyName": "MetaVia Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.3, | |
| "fav": "40.16", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 101020, | |
| "averageVolume": 249033, | |
| "float": 10000000, | |
| "sharesOutstanding": 3315164, | |
| "soRatio": "301.6%", | |
| "marketCap": 4309713, | |
| "isShort": false, | |
| "ftd": 171196, | |
| "ftdPercent": "1.71", | |
| "intent": "Clinical Success, Clinical Milestone, Licensing Deal", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-03-26", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 1", | |
| "Phase 2", | |
| "Efficacy", | |
| "Data Readout", | |
| "Favorable Safety", | |
| "Statistically Significant" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-99.1, Item 2.02, Item 9.01", | |
| "cik": "1638287", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-26T12:32:00.034Z", | |
| "recordId": "MTVA-1774528320034", | |
| "expiresAt": "2026-03-31T12:32:00.034Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.5, | |
| "highest5DayPercent": 15.38, | |
| "lowest5Day": 1.18, | |
| "lowest5DayPercent": -9.23 | |
| }, | |
| { | |
| "ticker": "CANF", | |
| "title": "6-K - Can-Fite BioPharma Ltd. (0001536196) (Filer)", | |
| "companyName": "Can-Fite BioPharma Ltd.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 3.23, | |
| "fav": "3.68", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "volume": 7388, | |
| "averageVolume": 905027, | |
| "float": 3333334, | |
| "sharesOutstanding": 2105081, | |
| "soRatio": "158.3%", | |
| "marketCap": 7090764, | |
| "isShort": false, | |
| "ftd": 65486, | |
| "ftdPercent": "1.96", | |
| "intent": "FDA Breakthrough, Clinical Success, Commercial Inflection", | |
| "incorporated": "Tel Aviv, Israel", | |
| "located": "Tel Aviv, Israel", | |
| "filingDate": "2026-03-26", | |
| "signals": { | |
| "FDA Breakthrough": [ | |
| "Fast Track Designation" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy", | |
| "Safety Profile", | |
| "Primary Endpoint" | |
| ], | |
| "Commercial Inflection": [ | |
| "Proof Of Concept" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, 20-F, EX-99.1", | |
| "cik": "1536196", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-03-26T13:30:17.891Z", | |
| "recordId": "CANF-1774531817891", | |
| "expiresAt": "2026-03-31T13:30:17.891Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.9014, | |
| "highest5DayPercent": -10.17, | |
| "lowest5Day": 2.9014, | |
| "lowest5DayPercent": -10.17 | |
| }, | |
| { | |
| "ticker": "FFWM", | |
| "title": "8-K - First Foundation Inc. (0001413837) (Filer)", | |
| "companyName": "First Foundation Inc.", | |
| "filerName": null, | |
| "sector": "Banking", | |
| "price": 5.9, | |
| "fav": "60.17", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Toronto, Canada)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 2291182, | |
| "averageVolume": 831044, | |
| "float": 50000000, | |
| "sharesOutstanding": 82926292, | |
| "soRatio": "60.29%", | |
| "marketCap": 489265120, | |
| "isShort": false, | |
| "ftd": 158, | |
| "ftdPercent": "0.00", | |
| "intent": "Merger/Acquisition, Going Dark, Reverse Split Event, Asset Disposition, Partnership", | |
| "incorporated": "Toronto, Canada", | |
| "located": "Texas", | |
| "filingDate": "2026-04-01", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration" | |
| ], | |
| "Going Dark": [ | |
| "Form 15", | |
| "Deregistration" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Stock Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "Shell Recycling": "Shell Recycling" | |
| }, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": "1-for-364", | |
| "reverseSplitReason": "Listing standard compliance", | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "13G", | |
| "Item 2.01", | |
| "Item 3.01", | |
| "Item 3.03", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 6-K/A, 8-K, 20-F, 20-F/A, 13G, Item 2.01, Item 3.01, Item 3.03, Item 5.01, Item 5.02, Item 5.03, Item 9.01", | |
| "cik": "1413837", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-04-01T18:31:25.654Z", | |
| "recordId": "FFWM-1775068285654", | |
| "expiresAt": "2026-04-06T18:31:25.654Z", | |
| "direction": "LONG", | |
| "highest5Day": 5.6075, | |
| "highest5DayPercent": -4.96, | |
| "lowest5Day": 5.6075, | |
| "lowest5DayPercent": -4.96 | |
| }, | |
| { | |
| "ticker": "ONTF", | |
| "title": "8-K - ON24 INC. (0001110611) (Filer)", | |
| "companyName": "ON24 INC.", | |
| "filerName": null, | |
| "sector": "Technology", | |
| "price": 8.1, | |
| "fav": "46.38", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 534642, | |
| "averageVolume": 539139, | |
| "float": 25002600, | |
| "sharesOutstanding": 42993702, | |
| "soRatio": "58.15%", | |
| "marketCap": 348249024, | |
| "isShort": false, | |
| "ftd": 4753, | |
| "ftdPercent": "0.02", | |
| "intent": "Merger/Acquisition, Going Dark, Asset Disposition, Partnership", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-04-01", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Agreed To Acquire", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Going Dark": [ | |
| "Form 15", | |
| "Deregister" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "Shell Recycling": "Shell Recycling" | |
| }, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "8-K", | |
| "13G", | |
| "EX-3.1", | |
| "EX-3.2", | |
| "Item 1.02", | |
| "Item 2.01", | |
| "Item 3.01", | |
| "Item 3.03", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, 13G, EX-3.1, EX-3.2, Item 1.02, Item 2.01, Item 3.01, Item 3.03, Item 5.01, Item 5.02, Item 5.03, Item 9.01", | |
| "cik": "1110611", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-04-01T20:16:24.916Z", | |
| "recordId": "ONTF-1775074584916", | |
| "expiresAt": "2026-04-06T20:16:24.916Z", | |
| "direction": "LONG", | |
| "highest5Day": 8.11, | |
| "highest5DayPercent": 0.12, | |
| "lowest5Day": 8.1, | |
| "lowest5DayPercent": 0 | |
| }, | |
| { | |
| "ticker": "FMST", | |
| "title": "6-K - Foremost Clean Energy Ltd. (0001935418) (Filer)", | |
| "companyName": "Foremost Clean Energy Ltd.", | |
| "filerName": null, | |
| "sector": "Metals & Mining", | |
| "price": 1.78, | |
| "fav": "66.38", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "British Columbia, Canada (via Toronto, Canada)", | |
| "filingTimeBonus": 1.15, | |
| "volume": 47638, | |
| "averageVolume": 219813, | |
| "float": 14590380, | |
| "sharesOutstanding": 14590380, | |
| "soRatio": "100.0%", | |
| "marketCap": 25970876, | |
| "isShort": false, | |
| "ftd": 6954, | |
| "ftdPercent": "0.05", | |
| "intent": "Merger/Acquisition, Underwritten Offering, Nasdaq Delisting, Asset Disposition, Partnership, Unregistered Equity Sales", | |
| "incorporated": "Toronto, Canada", | |
| "located": "British Columbia, Canada", | |
| "filingDate": "2026-04-01", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Going Private" | |
| ], | |
| "Underwritten Offering": [ | |
| "Bought Deal" | |
| ], | |
| "Nasdaq Delisting": [ | |
| "Notice Of Non-Compliance" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "private placement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "filingType": "6-K, F-3, 20-F, EX-99.1", | |
| "cik": "1935418", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-04-01T21:07:52.973Z", | |
| "recordId": "FMST-1775077672973", | |
| "expiresAt": "2026-04-06T21:07:52.973Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.5496, | |
| "highest5DayPercent": -12.94, | |
| "lowest5Day": 1.5496, | |
| "lowest5DayPercent": -12.94 | |
| }, | |
| { | |
| "ticker": "VTIX", | |
| "title": "8-K - Virtuix Holdings Inc. (0001606242) (Filer)", | |
| "companyName": "Virtuix Holdings Inc.", | |
| "filerName": null, | |
| "sector": "Technology", | |
| "price": 6.38, | |
| "fav": "47.54", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 109101, | |
| "averageVolume": 395989, | |
| "float": 18823338, | |
| "sharesOutstanding": 27349447, | |
| "soRatio": "68.83%", | |
| "marketCap": 203199488, | |
| "isShort": true, | |
| "ftd": 511408, | |
| "ftdPercent": "2.72", | |
| "intent": "Merger/Acquisition, Convertible Debt, Credit Default, Reverse Split Event, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-04-02", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Reverse Split Event": [ | |
| "Reverse Split" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "purchase agreement", | |
| "placement agent" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": "1-for-101", | |
| "reverseSplitReason": "Nasdaq minimum bid price requirement", | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 9.01" | |
| ], | |
| "filingType": "8-K, EX-10.1, EX-10.2, Item 1.01, Item 2.03, Item 9.01", | |
| "cik": "1606242", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-04-02T13:00:53.893Z", | |
| "recordId": "VTIX-1775134853893", | |
| "expiresAt": "2026-04-07T13:00:53.893Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0, | |
| "highest5DayPercent": -100, | |
| "lowest5Day": 0, | |
| "lowest5DayPercent": 100, | |
| "finalPrice": 6.38, | |
| "finalPercent": 0 | |
| }, | |
| { | |
| "ticker": "BCDA", | |
| "title": "8-K - BioCardia, Inc. (0000925741) (Filer)", | |
| "companyName": "BioCardia, Inc.", | |
| "filerName": null, | |
| "sector": "Biotechnology", | |
| "price": 1.16, | |
| "fav": "61.20", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "volume": 62428, | |
| "averageVolume": 67918, | |
| "float": 4156867, | |
| "sharesOutstanding": 10612734, | |
| "soRatio": "39.17%", | |
| "marketCap": 12310771, | |
| "isShort": false, | |
| "ftd": false, | |
| "ftdPercent": null, | |
| "intent": "FDA Approved, FDA Breakthrough", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-04-02", | |
| "signals": { | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "FDA Breakthrough": [ | |
| "Breakthrough Designation" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "filingType": "6-K, 8-K, EX-99.1, Item 7.01, Item 9.01", | |
| "cik": "925741", | |
| "skipReason": "", | |
| "alertType": null, | |
| "recordedAt": "2026-04-02T13:01:18.370Z", | |
| "recordId": "BCDA-1775134878370", | |
| "expiresAt": "2026-04-07T13:01:18.370Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.28, | |
| "highest5DayPercent": 10.34, | |
| "lowest5Day": 1.115, | |
| "lowest5DayPercent": -3.88 | |
| }, | |
| { | |
| "ticker": "GLOO", | |
| "title": "8-K - Gloo Holdings, Inc. (0002069785) (Filer)", | |
| "companyName": "Gloo Holdings, Inc.", | |
| "filerName": null, | |
| "price": 6.16, | |
| "fav": "23.28", | |
| "volume": 110189, | |
| "averageVolume": 62890, | |
| "float": 1464286, | |
| "sharesOutstanding": 11290196, | |
| "soRatio": "12.97%", | |
| "marketCap": 498085568, | |
| "isShort": false, | |
| "ftd": 3785, | |
| "intent": "Underwritten Offering, Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Colorado", | |
| "filingDate": "2026-04-14T16:13:55-04:00", | |
| "signals": { | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 1.5M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 3.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "2069785", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Technology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Colorado (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "recordedAt": "2026-04-14T20:14:57.622Z", | |
| "recordId": "GLOO-1776197697622", | |
| "expiresAt": "2026-04-19T20:14:57.622Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.49, | |
| "highest5DayPercent": 5.36, | |
| "lowest5Day": 6.09, | |
| "lowest5DayPercent": -1.14 | |
| }, | |
| { | |
| "ticker": "CUPR", | |
| "title": "6-K - Cuprina Holdings (Cayman) LTD (0001995704) (Filer)", | |
| "companyName": "Cuprina Holdings (Cayman) LTD", | |
| "filerName": null, | |
| "price": 0.3341, | |
| "fav": "3.89", | |
| "volume": 145052, | |
| "averageVolume": 1893108, | |
| "float": 7365000, | |
| "sharesOutstanding": 7365000, | |
| "soRatio": "100.0%", | |
| "marketCap": 7166445, | |
| "isShort": true, | |
| "ftd": 85457, | |
| "intent": "Merger/Acquisition, Convertible Debt, Going Dark, Bid Price Delisting, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Cayman Islands", | |
| "located": "Singapore", | |
| "filingDate": "2026-04-21T09:20:25-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Going Private" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Going Dark": [ | |
| "Deregister" | |
| ], | |
| "Bid Price Delisting": [ | |
| "Minimum Bid Price" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: such holder", | |
| "Shares: 0.0M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "VStock": "VStock Setup", | |
| "Third Party": [ | |
| "VStock Transfer" | |
| ] | |
| }, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "cik": "1995704", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Singapore (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "recordedAt": "2026-04-21T13:21:15.897Z", | |
| "recordId": "CUPR-1776777675897", | |
| "expiresAt": "2026-04-26T13:21:15.897Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.2996, | |
| "highest5DayPercent": -10.33, | |
| "lowest5Day": 0.295, | |
| "lowest5DayPercent": 11.7 | |
| }, | |
| { | |
| "ticker": "TNL", | |
| "title": "8-K - Travel & Leisure Co. (0001361658) (Filer)", | |
| "companyName": "Travel & Leisure Co.", | |
| "filerName": null, | |
| "price": 76.15, | |
| "fav": "8.88", | |
| "volume": 618758, | |
| "averageVolume": 675737, | |
| "float": 6000000, | |
| "sharesOutstanding": 62421616, | |
| "soRatio": "9.61%", | |
| "marketCap": 4753405952, | |
| "isShort": false, | |
| "ftd": 367, | |
| "intent": "Asset Disposition, Stock Buyback, Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Florida", | |
| "filingDate": "2026-04-22T06:31:17-04:00", | |
| "signals": { | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Stock Buyback": [ | |
| "Share Repurchase" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 7.01" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1361658", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Hotels, Restaurants & Leisure", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "recordedAt": "2026-04-22T10:32:03.943Z", | |
| "recordId": "TNL-1776853923943", | |
| "expiresAt": "2026-04-27T10:32:03.943Z", | |
| "direction": "LONG", | |
| "highest5Day": 67.32, | |
| "highest5DayPercent": -11.6, | |
| "lowest5Day": 64.21, | |
| "lowest5DayPercent": -15.68 | |
| }, | |
| { | |
| "ticker": "FGI", | |
| "title": "8-K - FGI Industries Ltd. (0001864943) (Filer)", | |
| "companyName": "FGI Industries Ltd.", | |
| "filerName": null, | |
| "price": 7.81, | |
| "fav": "3.19", | |
| "volume": 144227, | |
| "averageVolume": 166147, | |
| "float": 530440, | |
| "sharesOutstanding": 1927326, | |
| "soRatio": "27.52%", | |
| "marketCap": 15052416, | |
| "isShort": true, | |
| "ftd": 146742, | |
| "intent": "Accounting Restatement, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Cayman Islands", | |
| "located": "New Jersey", | |
| "filingDate": "2026-04-23T16:12:56-04:00", | |
| "signals": { | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Item 4.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1864943", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Trading Companies & Distributors", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New Jersey (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "reverseSplitRatio": null, | |
| "reverseSplitReason": null, | |
| "recordedAt": "2026-04-23T20:13:59.216Z", | |
| "recordId": "FGI-1776975239216", | |
| "expiresAt": "2026-04-28T20:13:59.217Z", | |
| "direction": "SHORT", | |
| "highest5Day": 11, | |
| "highest5DayPercent": 40.85, | |
| "lowest5Day": 4.99, | |
| "lowest5DayPercent": 36.11 | |
| }, | |
| { | |
| "ticker": "KEX", | |
| "title": "8-K - KIRBY CORP (0000056047) (Filer)", | |
| "companyName": "KIRBY CORP", | |
| "filerName": null, | |
| "price": 148.235, | |
| "fav": "9.08", | |
| "volume": 523189, | |
| "averageVolume": 704863, | |
| "float": 6400000, | |
| "sharesOutstanding": 53621000, | |
| "soRatio": "11.94%", | |
| "marketCap": 7948509184, | |
| "isShort": false, | |
| "ftd": 9733, | |
| "intent": "Stock Buyback, Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Nevada", | |
| "located": "Texas", | |
| "filingDate": "2026-04-30T14:17:04-04:00", | |
| "signals": { | |
| "Stock Buyback": [ | |
| "Share Repurchase" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 6.4M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "Item 2.02", | |
| "Item 5.02", | |
| "Item 5.07", | |
| "Item 9.01" | |
| ], | |
| "cik": "56047", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Marine", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Nevada)", | |
| "filingTimeBonus": 1.1, | |
| "recordedAt": "2026-04-30T18:17:44.902Z", | |
| "recordId": "KEX-1777573064902", | |
| "expiresAt": "2026-05-05T18:17:44.902Z", | |
| "direction": "LONG", | |
| "highest5Day": 155.85, | |
| "highest5DayPercent": 5.14, | |
| "lowest5Day": 144.14, | |
| "lowest5DayPercent": -2.76 | |
| }, | |
| { | |
| "ticker": "SHPH", | |
| "title": "8-K - Shuttle Pharmaceuticals Holdings, Inc. (0001757499) (Filer)", | |
| "companyName": "Shuttle Pharmaceuticals Holdings, Inc.", | |
| "filerName": null, | |
| "price": 1.03, | |
| "fav": "9.37", | |
| "volume": 2003746, | |
| "averageVolume": 322938, | |
| "float": 3024749, | |
| "sharesOutstanding": 5546309, | |
| "soRatio": "54.54%", | |
| "marketCap": 5759028, | |
| "isShort": true, | |
| "ftd": 133663, | |
| "intent": "Merger/Acquisition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Maryland", | |
| "filingDate": "2026-05-01T09:23:59-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: a Governmental Authority; (c) any director", | |
| "Discount: 90%", | |
| "Shares: 0.0M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1757499", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Maryland (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-05-01T13:24:54.153Z", | |
| "recordId": "SHPH-1777641894154", | |
| "expiresAt": "2026-05-06T13:24:54.154Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.6617, | |
| "highest5DayPercent": -35.76, | |
| "lowest5Day": 0.6617, | |
| "lowest5DayPercent": 35.76 | |
| }, | |
| { | |
| "ticker": "HPP", | |
| "title": "8-K - Hudson Pacific Properties, Inc. (0001482512) (Filer)", | |
| "companyName": "Hudson Pacific Properties, Inc.", | |
| "filerName": null, | |
| "price": 10.63, | |
| "fav": "12.22", | |
| "volume": 1871566, | |
| "averageVolume": 1391468, | |
| "float": 17000000, | |
| "sharesOutstanding": 54242024, | |
| "soRatio": "31.34%", | |
| "marketCap": 583479296, | |
| "isShort": false, | |
| "ftd": 1832, | |
| "intent": "Asset Disposition, Partnership, Unregistered Equity Sales", | |
| "incorporated": "Maryland", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-05-07T09:00:12-04:00", | |
| "signals": { | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 7.01", | |
| "issuable under" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "Leverage Concern - Debt/Equity Exceeds 2.0" | |
| ], | |
| "severity": 0.65, | |
| "isDeterministic": true | |
| }, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1482512", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Real Estate", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Maryland)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-05-07T13:01:00.809Z", | |
| "recordId": "HPP-1778158860809", | |
| "expiresAt": "2026-05-12T13:01:00.809Z", | |
| "direction": "LONG", | |
| "highest5Day": 12.27, | |
| "highest5DayPercent": 15.43, | |
| "lowest5Day": 10.7, | |
| "lowest5DayPercent": 0.66 | |
| }, | |
| { | |
| "ticker": "NHTC", | |
| "title": "8-K - NATURAL HEALTH TRENDS CORP (0000912061) (Filer)", | |
| "companyName": "NATURAL HEALTH TRENDS CORP", | |
| "filerName": null, | |
| "price": 3.195, | |
| "fav": "41.33", | |
| "volume": 14370, | |
| "averageVolume": 26618, | |
| "float": 1100000, | |
| "sharesOutstanding": 8577848, | |
| "soRatio": "12.82%", | |
| "marketCap": 27406226, | |
| "isShort": true, | |
| "ftd": 369, | |
| "intent": "Convertible Debt, Asset Disposition, Partnership, Related-Party Transaction, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-05-07T14:39:17-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Family Member", | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: the Company or any entity in which the Company has a significant ownership interest as determined by", | |
| "Shares: 1.1M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-10.1", | |
| "Item 5.02", | |
| "Item 5.07", | |
| "Item 9.01" | |
| ], | |
| "cik": "912061", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Consumer products", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-05-07T18:40:08.629Z", | |
| "recordId": "NHTC-1778179208629", | |
| "expiresAt": "2026-05-12T18:40:08.629Z", | |
| "direction": "SHORT", | |
| "highest5Day": 3.0872, | |
| "highest5DayPercent": -3.37, | |
| "lowest5Day": 3.06, | |
| "lowest5DayPercent": 4.23 | |
| }, | |
| { | |
| "ticker": "AEIS", | |
| "title": "8-K - ADVANCED ENERGY INDUSTRIES INC (0000927003) (Filer)", | |
| "companyName": "ADVANCED ENERGY INDUSTRIES INC", | |
| "filerName": null, | |
| "price": 359.235, | |
| "fav": "3.48", | |
| "volume": 236271, | |
| "averageVolume": 689870, | |
| "float": 2400000, | |
| "sharesOutstanding": 38030657, | |
| "soRatio": "6.31%", | |
| "marketCap": 13661941760, | |
| "isShort": false, | |
| "ftd": 2264, | |
| "intent": "Merger/Acquisition, Asset Disposition, Commercial Inflection, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Colorado", | |
| "filingDate": "2026-05-08T12:34:34-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with", | |
| "Shares: 2.4M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Spouse Of", | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-10.1", | |
| "EX-3.1", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 5.07", | |
| "Item 9.01" | |
| ], | |
| "cik": "927003", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Electrical Equipment", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Colorado (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-05-08T16:35:22.008Z", | |
| "recordId": "AEIS-1778258122008", | |
| "expiresAt": "2026-05-13T16:35:22.008Z", | |
| "direction": "LONG", | |
| "highest5Day": 354.15, | |
| "highest5DayPercent": -1.42, | |
| "lowest5Day": 350, | |
| "lowest5DayPercent": -2.57 | |
| }, | |
| { | |
| "ticker": "STKE", | |
| "title": "6-K - SOL Strategies Inc. (0001846839) (Filer)", | |
| "companyName": "SOL Strategies Inc.", | |
| "filerName": null, | |
| "price": 1.82, | |
| "fav": "81.97", | |
| "volume": 397029, | |
| "averageVolume": 236662, | |
| "float": 19400079, | |
| "sharesOutstanding": 32985155, | |
| "soRatio": "58.81%", | |
| "marketCap": 61282108, | |
| "isShort": true, | |
| "ftd": 12995, | |
| "intent": "Convertible Debt, Credit Default, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Ottawa, Canada", | |
| "located": "Ontario, Canada", | |
| "filingDate": "2026-05-08T15:13:29-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Partnership Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Section 2" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Spouse Of", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-99.2" | |
| ], | |
| "cik": "1846839", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Financial Services", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Ontario, Canada (via Ottawa, Canada)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-05-08T19:14:38.846Z", | |
| "recordId": "STKE-1778267678846", | |
| "expiresAt": "2026-05-13T19:14:38.846Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.9346, | |
| "highest5DayPercent": 6.3, | |
| "lowest5Day": 1.5119, | |
| "lowest5DayPercent": 16.93 | |
| }, | |
| { | |
| "ticker": "MSW", | |
| "title": "6-K - Ming Shing Group Holdings Ltd (0001956166) (Filer)", | |
| "companyName": "Ming Shing Group Holdings Ltd", | |
| "filerName": null, | |
| "price": 1.76, | |
| "fav": "57.60", | |
| "volume": 39367, | |
| "averageVolume": 79166, | |
| "float": 4560200, | |
| "sharesOutstanding": 12975000, | |
| "soRatio": "35.15%", | |
| "marketCap": 22836000, | |
| "isShort": true, | |
| "ftd": 907, | |
| "intent": "Convertible Debt, Asset Disposition, Partnership, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Cayman Islands", | |
| "located": "Hong Kong", | |
| "filingDate": "2026-05-11T09:00:17-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-3.1" | |
| ], | |
| "cik": "1956166", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Construction", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Hong Kong (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-05-11T13:01:02.168Z", | |
| "recordId": "MSW-1778504462168", | |
| "expiresAt": "2026-05-15T13:01:02.168Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.74, | |
| "highest5DayPercent": -1.14, | |
| "lowest5Day": 1.63, | |
| "lowest5DayPercent": 7.39 | |
| }, | |
| { | |
| "ticker": "KZR", | |
| "title": "8-K - Kezar Life Sciences, Inc. (0001645666) (Filer)", | |
| "companyName": "Kezar Life Sciences, Inc.", | |
| "filerName": null, | |
| "price": 7.29, | |
| "fav": "66.79", | |
| "volume": 616015, | |
| "averageVolume": 88755, | |
| "float": 5927580, | |
| "sharesOutstanding": 7387701, | |
| "soRatio": "80.24%", | |
| "marketCap": 53856340, | |
| "isShort": true, | |
| "ftd": 628, | |
| "intent": "Merger/Acquisition, Going Dark, Asset Disposition, Partnership, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-05-11T09:30:08-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement" | |
| ], | |
| "Going Dark": [ | |
| "Form 15", | |
| "Deregistration" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Advisors LLC", | |
| "Shares: 5.9M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-3.1", | |
| "EX-3.2", | |
| "Item 2.01", | |
| "Item 3.01", | |
| "Item 3.03", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 9.01" | |
| ], | |
| "cik": "1645666", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-05-11T13:31:11.083Z", | |
| "recordId": "KZR-1778506271083", | |
| "expiresAt": "2026-05-15T13:31:11.084Z", | |
| "direction": "SHORT", | |
| "highest5Day": 7.47, | |
| "highest5DayPercent": 2.47, | |
| "lowest5Day": 7.27, | |
| "lowest5DayPercent": 0.27 | |
| }, | |
| { | |
| "ticker": "TRT", | |
| "title": "8-K - TRIO-TECH INTERNATIONAL (0000732026) (Filer)", | |
| "companyName": "TRIO-TECH INTERNATIONAL", | |
| "filerName": null, | |
| "price": 13.46, | |
| "fav": "16.64", | |
| "volume": 999163, | |
| "averageVolume": 901672, | |
| "float": 15000000, | |
| "sharesOutstanding": 10015541, | |
| "soRatio": "149.8%", | |
| "marketCap": 134809184, | |
| "isShort": false, | |
| "ftd": "N/A", | |
| "intent": "Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Toronto, Canada", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-05-14T10:24:24-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 15.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "F-1", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "732026", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Semiconductors", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-05-14T14:25:07.072Z", | |
| "recordId": "TRT-1778768707072", | |
| "expiresAt": "2026-05-19T14:25:07.073Z", | |
| "direction": "LONG", | |
| "highest5Day": 21.38, | |
| "highest5DayPercent": 58.84, | |
| "lowest5Day": 11.68, | |
| "lowest5DayPercent": -13.22 | |
| }, | |
| { | |
| "ticker": "INTG", | |
| "title": "8-K - INTERGROUP CORP (0000069422) (Filer)", | |
| "companyName": "INTERGROUP CORP", | |
| "filerName": null, | |
| "price": 38.6, | |
| "fav": "26.35", | |
| "volume": 11380, | |
| "averageVolume": 22777, | |
| "float": 600151, | |
| "sharesOutstanding": 2148812, | |
| "soRatio": "27.93%", | |
| "marketCap": 82944136, | |
| "isShort": true, | |
| "ftd": 9529, | |
| "intent": "Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-05-14T11:10:37-04:00", | |
| "signals": { | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "69422", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Real Estate", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "recordedAt": "2026-05-14T15:11:43.446Z", | |
| "recordId": "INTG-1778771503446", | |
| "expiresAt": "2026-05-19T15:11:43.446Z", | |
| "direction": "SHORT", | |
| "highest5Day": 35.8, | |
| "highest5DayPercent": -7.25, | |
| "lowest5Day": 35.8, | |
| "lowest5DayPercent": 7.25 | |
| }, | |
| { | |
| "ticker": "IPDN", | |
| "title": "8-K - Professional Diversity Network, Inc. (0001546296) (Filer)", | |
| "companyName": "Professional Diversity Network, Inc.", | |
| "filerName": null, | |
| "price": 0.6599, | |
| "fav": "11.73", | |
| "volume": 64661, | |
| "averageVolume": 95140, | |
| "float": 1116334, | |
| "sharesOutstanding": 10524032, | |
| "soRatio": "10.61%", | |
| "marketCap": 6944809, | |
| "isShort": false, | |
| "ftd": 5202, | |
| "intent": "Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Israel", | |
| "filingDate": "2026-05-15T09:01:14-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 7.01" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "F-4", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1546296", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Professional Services", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Israel (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-05-15T13:02:05.901Z", | |
| "recordId": "IPDN-1778850125901", | |
| "expiresAt": "2026-05-20T13:02:05.901Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.611, | |
| "highest5DayPercent": -7.41, | |
| "lowest5Day": 0.611, | |
| "lowest5DayPercent": -7.41 | |
| }, | |
| { | |
| "ticker": "SUUN", | |
| "title": "6-K - POWERBANK Corp (0002011053) (Filer)", | |
| "companyName": "POWERBANK Corp", | |
| "filerName": null, | |
| "price": 0.6489, | |
| "fav": "9.16", | |
| "volume": 184942, | |
| "averageVolume": 639851, | |
| "float": 5859561, | |
| "sharesOutstanding": 46568399, | |
| "soRatio": "12.58%", | |
| "marketCap": 30218234, | |
| "isShort": true, | |
| "ftd": 137371, | |
| "intent": "Bid Price Delisting, Asset Disposition, Commercial Inflection, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Ottawa, Canada", | |
| "located": "Ontario, Canada", | |
| "filingDate": "2026-05-15T10:38:16-04:00", | |
| "signals": { | |
| "Bid Price Delisting": [ | |
| "Minimum Bid Price" | |
| ], | |
| "Asset Disposition": [ | |
| "Divested" | |
| ], | |
| "Commercial Inflection": [ | |
| "Letter Of Intent" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: actively developing potential projects in Ontario" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "F-1", | |
| "20-F", | |
| "Form D", | |
| "EX-99.1" | |
| ], | |
| "cik": "2011053", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Construction", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Ontario, Canada (via Ottawa, Canada)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-05-15T14:39:03.701Z", | |
| "recordId": "SUUN-1778855943701", | |
| "expiresAt": "2026-05-20T14:39:03.701Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.602, | |
| "highest5DayPercent": -7.23, | |
| "lowest5Day": 0.602, | |
| "lowest5DayPercent": 7.23 | |
| }, | |
| { | |
| "ticker": "ACNT", | |
| "title": "8-K - ASCENT INDUSTRIES CO. (0000095953) (Filer)", | |
| "companyName": "ASCENT INDUSTRIES CO.", | |
| "filerName": null, | |
| "price": 14.035, | |
| "fav": "58.59", | |
| "volume": 15240, | |
| "averageVolume": 120455, | |
| "float": 7057129, | |
| "sharesOutstanding": 9038215, | |
| "soRatio": "78.08%", | |
| "marketCap": 126851344, | |
| "isShort": false, | |
| "ftd": 6022, | |
| "intent": "Underwritten Offering, Asset Disposition, Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Israel", | |
| "filingDate": "2026-05-18T11:18:06-04:00", | |
| "signals": { | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ], | |
| "Asset Disposition": [ | |
| "Asset Sale" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 7.01" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "95953", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Chemicals", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Israel (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "recordedAt": "2026-05-18T15:18:56.348Z", | |
| "recordId": "ACNT-1779117536348", | |
| "expiresAt": "2026-05-22T15:18:56.349Z", | |
| "direction": "LONG", | |
| "highest5Day": 13.125, | |
| "highest5DayPercent": -6.48, | |
| "lowest5Day": 13.125, | |
| "lowest5DayPercent": -6.48 | |
| }, | |
| { | |
| "ticker": "DPRO", | |
| "title": "6-K - Draganfly Inc. (0001786286) (Filer)", | |
| "companyName": "Draganfly Inc.", | |
| "filerName": null, | |
| "price": 5.15, | |
| "fav": "11.79", | |
| "volume": 638041, | |
| "averageVolume": 1896980, | |
| "float": 22364072, | |
| "sharesOutstanding": 36495939, | |
| "soRatio": "61.28%", | |
| "marketCap": 187954096, | |
| "isShort": false, | |
| "ftd": 581903, | |
| "intent": "Merger/Acquisition, Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Toronto, Canada", | |
| "located": "Vancouver, Canada", | |
| "filingDate": "2026-05-18T12:45:17-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Agreed To Acquire" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "purchase agreement" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "cik": "1786286", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Aerospace & Defense", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Vancouver, Canada (via Toronto, Canada)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-05-18T16:46:28.972Z", | |
| "recordId": "DPRO-1779122788972", | |
| "expiresAt": "2026-05-22T16:46:28.972Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.245, | |
| "highest5DayPercent": 21.26, | |
| "lowest5Day": 5.06, | |
| "lowest5DayPercent": -1.75 | |
| }, | |
| { | |
| "ticker": "EVTV", | |
| "title": "8-K - Envirotech Vehicles, Inc. (0001563568) (Filer)", | |
| "companyName": "Envirotech Vehicles, Inc.", | |
| "filerName": null, | |
| "price": 2.5, | |
| "fav": "4.26", | |
| "volume": 903957, | |
| "averageVolume": 665837, | |
| "float": 2837896, | |
| "sharesOutstanding": 12930719, | |
| "soRatio": "21.95%", | |
| "marketCap": 32326798, | |
| "isShort": true, | |
| "ftd": 305491, | |
| "intent": "Merger/Acquisition, Convertible Debt, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-05-20T09:15:16-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes", | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Partnership Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with such Person", | |
| "Shares: 100.0M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-4", | |
| "Item 1.01", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1563568", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Automobiles", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-05-20T13:15:50.816Z", | |
| "recordId": "EVTV-1779282950816", | |
| "expiresAt": "2026-05-25T13:15:50.817Z", | |
| "direction": "SHORT", | |
| "highest5Day": 2.1, | |
| "highest5DayPercent": -16, | |
| "lowest5Day": 2.1, | |
| "lowest5DayPercent": 16 | |
| }, | |
| { | |
| "ticker": "SINT", | |
| "title": "8-K - Sintx Technologies, Inc. (0001269026) (Filer)", | |
| "companyName": "Sintx Technologies, Inc.", | |
| "filerName": null, | |
| "price": 1.9, | |
| "fav": "51.99", | |
| "volume": 489441, | |
| "averageVolume": 36215, | |
| "float": 1882845, | |
| "sharesOutstanding": 4319279, | |
| "soRatio": "43.59%", | |
| "marketCap": 8206630, | |
| "isShort": false, | |
| "ftd": 9204, | |
| "intent": "Merger/Acquisition, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Utah", | |
| "filingDate": "2026-06-03T09:30:19-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 1.9M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-4.1", | |
| "EX-4.2", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1269026", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Utah (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-06-03T13:31:16.858Z", | |
| "recordId": "SINT-1780493476858", | |
| "expiresAt": "2026-06-08T13:31:16.858Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.3, | |
| "highest5DayPercent": 21.05, | |
| "lowest5Day": 1.86, | |
| "lowest5DayPercent": -2.11 | |
| }, | |
| { | |
| "ticker": "IPW", | |
| "title": "8-K - iPower Inc. (0001830072) (Filer)", | |
| "companyName": "iPower Inc.", | |
| "filerName": null, | |
| "price": 3.44, | |
| "fav": "3.74", | |
| "volume": 116742, | |
| "averageVolume": 159040, | |
| "float": 595580, | |
| "sharesOutstanding": 661240, | |
| "soRatio": "90.07%", | |
| "marketCap": 2274665, | |
| "isShort": true, | |
| "ftd": 66156, | |
| "intent": "Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Nevada", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-06-04T09:20:15-04:00", | |
| "signals": { | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1830072", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Trading Companies & Distributors", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Nevada)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-06-04T13:20:46.034Z", | |
| "recordId": "IPW-1780579246034", | |
| "expiresAt": "2026-06-09T13:20:46.034Z", | |
| "direction": "SHORT", | |
| "highest5Day": 2.8301, | |
| "highest5DayPercent": -17.73, | |
| "lowest5Day": 2.8301, | |
| "lowest5DayPercent": 17.73 | |
| }, | |
| { | |
| "ticker": "LOKV", | |
| "title": "8-K - Live Oak Acquisition Corp. V (0002048951) (Filer)", | |
| "companyName": "Live Oak Acquisition Corp. V", | |
| "filerName": null, | |
| "price": 10.5498, | |
| "fav": "83.39", | |
| "volume": 33946, | |
| "averageVolume": 233834, | |
| "float": 19499975, | |
| "sharesOutstanding": 23000000, | |
| "soRatio": "84.78%", | |
| "marketCap": 303306752, | |
| "isShort": false, | |
| "ftd": 14866, | |
| "intent": "Merger/Acquisition, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Cayman Islands", | |
| "located": "Tennessee", | |
| "filingDate": "2026-06-09T15:57:25-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "S-1", | |
| "S-4", | |
| "20-F", | |
| "20-F/A", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "2048951", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "N/A", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Tennessee (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-06-09T19:58:13.921Z", | |
| "recordId": "LOKV-1781035093921", | |
| "expiresAt": "2026-06-12T19:58:13.921Z", | |
| "direction": "LONG", | |
| "highest5Day": 11.44, | |
| "highest5DayPercent": 8.44, | |
| "lowest5Day": 10.255, | |
| "lowest5DayPercent": -2.79 | |
| }, | |
| { | |
| "ticker": "CPOP", | |
| "title": "6-K - Pop Culture Group Co., Ltd (0001807389) (Filer)", | |
| "companyName": "Pop Culture Group Co., Ltd", | |
| "filerName": null, | |
| "price": 0.36, | |
| "fav": "38.18", | |
| "volume": 121262176, | |
| "averageVolume": 147327, | |
| "float": 5625571, | |
| "sharesOutstanding": 71362733, | |
| "soRatio": "7.88%", | |
| "marketCap": 29498056, | |
| "isShort": false, | |
| "ftd": "N/A", | |
| "intent": "Merger/Acquisition, Asset Disposition, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Cayman Islands", | |
| "located": "Shadong, China", | |
| "filingDate": "2026-06-10T09:10:42-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Acquisition Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Discount: 90%", | |
| "Shares: 0.9M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Related Party" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.2" | |
| ], | |
| "cik": "1807389", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Media", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Shadong, China (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-06-10T13:11:50.414Z", | |
| "recordId": "CPOP-1781097110414", | |
| "expiresAt": "2026-06-15T13:11:50.414Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.55, | |
| "highest5DayPercent": 608.33, | |
| "lowest5Day": 0.1736, | |
| "lowest5DayPercent": -51.78 | |
| }, | |
| { | |
| "ticker": "BNAI", | |
| "title": "8-K - Brand Engagement Network Inc. (0001838163) (Filer)", | |
| "companyName": "Brand Engagement Network Inc.", | |
| "filerName": null, | |
| "price": 21.97, | |
| "fav": "6.06", | |
| "volume": 412427, | |
| "averageVolume": 668336, | |
| "float": 4048264, | |
| "sharesOutstanding": 6516107, | |
| "soRatio": "62.13%", | |
| "marketCap": 143158864, | |
| "isShort": true, | |
| "ftd": 13409, | |
| "intent": "Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Wilmington, Delaware", | |
| "filingDate": "2026-06-17T09:00:17-04:00", | |
| "signals": { | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.3M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1838163", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Technology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-06-17T13:01:20.076Z", | |
| "recordId": "BNAI-1781701280076", | |
| "expiresAt": "2026-06-22T13:01:20.076Z", | |
| "direction": "SHORT", | |
| "highest5Day": 18.52, | |
| "highest5DayPercent": -15.7, | |
| "lowest5Day": 18.52, | |
| "lowest5DayPercent": 15.7 | |
| }, | |
| { | |
| "ticker": "SILC", | |
| "title": "6-K - SILICOM LTD. (0000916793) (Filer)", | |
| "companyName": "SILICOM LTD.", | |
| "filerName": null, | |
| "price": 41.93, | |
| "fav": "37.80", | |
| "volume": 195049, | |
| "averageVolume": 142180, | |
| "float": 5374647, | |
| "sharesOutstanding": 5747611, | |
| "soRatio": "93.51%", | |
| "marketCap": 240997328, | |
| "isShort": true, | |
| "ftd": 5404, | |
| "intent": "Commercial Inflection, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Unknown", | |
| "located": "Tel Aviv, Israel", | |
| "filingDate": "2026-06-30T09:02:04-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-9", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "cik": "916793", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Communications", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Tel Aviv, Israel (via Unknown)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-06-30T13:02:46.920Z", | |
| "recordId": "SILC-1782824566920", | |
| "expiresAt": "2026-07-03T13:02:46.920Z", | |
| "direction": "SHORT", | |
| "highest5Day": 52.95, | |
| "highest5DayPercent": 26.28, | |
| "lowest5Day": 41.93, | |
| "lowest5DayPercent": 0, | |
| "manualOverride": true, | |
| "overrideSource": "overrides.json" | |
| }, | |
| { | |
| "ticker": "FLYX", | |
| "title": "8-K - FLYEXCLUSIVE INC. (0001843973) (Filer)", | |
| "companyName": "FLYEXCLUSIVE INC.", | |
| "filerName": null, | |
| "price": 1.58, | |
| "fav": "11.97", | |
| "volume": 135571, | |
| "averageVolume": 592714, | |
| "float": 7096117, | |
| "sharesOutstanding": 46104300, | |
| "soRatio": "15.39%", | |
| "marketCap": 151734208, | |
| "isShort": false, | |
| "ftd": 75003, | |
| "intent": "Merger/Acquisition, Underwritten Offering, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "North Carolina", | |
| "filingDate": "2026-07-14T08:59:23-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "FWG", | |
| "EX-99.1", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1843973", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Airlines", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "North Carolina (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-14T13:00:01.448Z", | |
| "recordId": "FLYX-1784034001448", | |
| "expiresAt": "2026-07-17T13:00:01.448Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.5, | |
| "highest5DayPercent": -5.06, | |
| "lowest5Day": 1.5, | |
| "lowest5DayPercent": -5.06, | |
| "priceAfter30m": 1.58, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 1.54, | |
| "percentAfter1h": -2.53, | |
| "priceAfter6h": 1.565, | |
| "percentAfter6h": -0.95, | |
| "priceAfter1d": 1.52, | |
| "percentAfter1d": -3.8, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "NWGL", | |
| "title": "6-K - CL Workshop Group Ltd (0001948294) (Filer)", | |
| "companyName": "CL Workshop Group Ltd", | |
| "filerName": null, | |
| "price": 0.249, | |
| "fav": "5.51", | |
| "volume": 331127, | |
| "averageVolume": 2233886, | |
| "float": 12300000, | |
| "sharesOutstanding": 4936559, | |
| "soRatio": "249.2%", | |
| "marketCap": 4121738, | |
| "isShort": false, | |
| "ftd": 450715, | |
| "intent": "Asset Disposition, Licensing Deal, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Hong Kong", | |
| "located": "Macau", | |
| "filingDate": "2026-07-14T09:09:57-04:00", | |
| "signals": { | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Licensing Deal": [ | |
| "Exclusive License" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Agreement", | |
| "Shares: 12.3M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-10.1", | |
| "EX-4.1" | |
| ], | |
| "cik": "1948294", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Paper & Forest", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "BNY Mellon", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T13:10:35.309Z", | |
| "recordId": "NWGL-1784034635309", | |
| "expiresAt": "2026-07-17T13:10:35.309Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.3, | |
| "highest5DayPercent": 20.48, | |
| "lowest5Day": 0.248, | |
| "lowest5DayPercent": -0.4, | |
| "priceAfter30m": 0.25, | |
| "percentAfter30m": 0.4, | |
| "priceAfter1h": 0.2901, | |
| "percentAfter1h": 16.51, | |
| "priceAfter6h": 0.26, | |
| "percentAfter6h": 4.42, | |
| "priceAfter1d": 0.2625, | |
| "percentAfter1d": 5.42, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 8.43 | |
| }, | |
| { | |
| "ticker": "XOMA", | |
| "title": "8-K - XOMA Royalty Corp (0000791908) (Filer)", | |
| "companyName": "XOMA Royalty Corp", | |
| "filerName": null, | |
| "price": 40.17, | |
| "fav": "53.23", | |
| "volume": 4217188, | |
| "averageVolume": 332104, | |
| "float": 17678742, | |
| "sharesOutstanding": 17678742, | |
| "soRatio": "100.0%", | |
| "marketCap": 710155008, | |
| "isShort": true, | |
| "ftd": 495, | |
| "intent": "Merger/Acquisition, Clinical Success, Contingent Value Rights, Going Dark, Asset Disposition, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Nevada", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-14T09:10:21-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ], | |
| "Contingent Value Rights": [ | |
| "Contingent Value Rights", | |
| "CVR", | |
| "contingent payments" | |
| ], | |
| "Going Dark": [ | |
| "Form 15", | |
| "Deregister" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 17.7M" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "Shell Recycling": "Shell Recycling" | |
| }, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 1.01", | |
| "Item 1.02", | |
| "Item 2.01", | |
| "Item 3.01", | |
| "Item 3.03", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 5.07", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "791908", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Nevada)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T13:11:00.331Z", | |
| "recordId": "XOMA-1784034660331", | |
| "expiresAt": "2026-07-17T13:11:00.331Z", | |
| "direction": "SHORT", | |
| "highest5Day": 43.97, | |
| "highest5DayPercent": 9.46, | |
| "lowest5Day": 39.77, | |
| "lowest5DayPercent": 1, | |
| "priceAfter30m": 40.17, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 40.17, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 40.17, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 40.17, | |
| "percentAfter1d": 0, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "CRMT", | |
| "title": "8-K - AMERICAS CARMART INC (0000799850) (Filer)", | |
| "companyName": "AMERICAS CARMART INC", | |
| "filerName": null, | |
| "price": 3.02, | |
| "fav": "5.27", | |
| "volume": 515214, | |
| "averageVolume": 1575118, | |
| "float": 8305520, | |
| "sharesOutstanding": 8302450, | |
| "soRatio": "100.0%", | |
| "marketCap": 25073398, | |
| "isShort": false, | |
| "ftd": 30481, | |
| "intent": "Merger/Acquisition, Accounting Restatement, Commercial Inflection, Unregistered Equity Sales", | |
| "incorporated": "Texas", | |
| "located": "Arkansas", | |
| "filingDate": "2026-07-14T09:15:30-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Strategic Alternatives" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness", | |
| "Substantial Doubt" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "799850", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Retail", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Arkansas (via Texas)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T13:16:16.235Z", | |
| "recordId": "CRMT-1784034976235", | |
| "expiresAt": "2026-07-17T13:16:16.235Z", | |
| "direction": "LONG", | |
| "highest5Day": 4.34, | |
| "highest5DayPercent": 43.71, | |
| "lowest5Day": 2.9, | |
| "lowest5DayPercent": -3.97, | |
| "priceAfter30m": 3.41, | |
| "percentAfter30m": 12.91, | |
| "priceAfter1h": 3.36, | |
| "percentAfter1h": 11.26, | |
| "priceAfter6h": 4.16, | |
| "percentAfter6h": 37.75, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 9.27 | |
| }, | |
| { | |
| "ticker": "LGND", | |
| "title": "8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer)", | |
| "companyName": "LIGAND PHARMACEUTICALS INC", | |
| "filerName": null, | |
| "price": 309.25, | |
| "fav": "59.40", | |
| "volume": 245695, | |
| "averageVolume": 329032, | |
| "float": 19545483, | |
| "sharesOutstanding": 20041061, | |
| "soRatio": "97.53%", | |
| "marketCap": 6197698048, | |
| "isShort": true, | |
| "ftd": 5619, | |
| "intent": "Merger/Acquisition, Clinical Success, Contingent Value Rights, Credit Default, Asset Disposition, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-14T09:20:16-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ], | |
| "Contingent Value Rights": [ | |
| "Contingent Value Rights", | |
| "CVR", | |
| "contingent payments" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 2.03", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "886163", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Pharmaceuticals", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T13:20:51.662Z", | |
| "recordId": "LGND-1784035251662", | |
| "expiresAt": "2026-07-17T13:20:51.662Z", | |
| "direction": "SHORT", | |
| "highest5Day": 300, | |
| "highest5DayPercent": -2.99, | |
| "lowest5Day": 300, | |
| "lowest5DayPercent": 2.99, | |
| "priceAfter30m": 307.135, | |
| "percentAfter30m": -0.68, | |
| "priceAfter1h": 303.45, | |
| "percentAfter1h": -1.88, | |
| "priceAfter6h": 303.8, | |
| "percentAfter6h": -1.76, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "VELO", | |
| "title": "8-K - Velo3D, Inc. (0001825079) (Filer)", | |
| "companyName": "Velo3D, Inc.", | |
| "filerName": null, | |
| "price": 12.79, | |
| "fav": "0.30", | |
| "volume": 1689743, | |
| "averageVolume": 3860018, | |
| "float": 1145830, | |
| "sharesOutstanding": 29801002, | |
| "soRatio": "3.84%", | |
| "marketCap": 381154816, | |
| "isShort": false, | |
| "ftd": 133715, | |
| "intent": "Merger/Acquisition, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-14T16:03:09-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Arun Jeldi", | |
| "Shares: 0.4M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "S-3", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "Item 1.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1825079", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Machinery", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T20:03:42.892Z", | |
| "recordId": "VELO-1784059422892", | |
| "expiresAt": "2026-07-17T20:03:42.892Z", | |
| "direction": "LONG", | |
| "highest5Day": 10.46, | |
| "highest5DayPercent": -18.22, | |
| "lowest5Day": 10.46, | |
| "lowest5DayPercent": -18.22, | |
| "priceAfter30m": 12.79, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 12.79, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 12.79, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 11.21, | |
| "percentAfter1d": -12.35, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.29 | |
| }, | |
| { | |
| "ticker": "JAGX", | |
| "title": "8-K - Jaguar Health, Inc. (0001585608) (Filer)", | |
| "companyName": "Jaguar Health, Inc.", | |
| "filerName": null, | |
| "price": 2.17, | |
| "fav": "0.59", | |
| "volume": 11090, | |
| "averageVolume": 92571, | |
| "float": 55020, | |
| "sharesOutstanding": 4857211, | |
| "soRatio": "1.13%", | |
| "marketCap": 10540148, | |
| "isShort": false, | |
| "ftd": 9165, | |
| "intent": "Merger/Acquisition, Asset Disposition, Partnership, Licensing Deal, Related-Party Transaction, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-14T16:15:12-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: owned in whole or in part by Napo or its Affiliates" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1585608", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Pharmaceuticals", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T20:15:53.752Z", | |
| "recordId": "JAGX-1784060153752", | |
| "expiresAt": "2026-07-17T20:15:53.752Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.83, | |
| "highest5DayPercent": -15.67, | |
| "lowest5Day": 1.83, | |
| "lowest5DayPercent": -15.67, | |
| "priceAfter30m": 2.17, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 2.17, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 2.17, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 1.94, | |
| "percentAfter1d": -10.6, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.76 | |
| }, | |
| { | |
| "ticker": "CRVO", | |
| "title": "8-K - CervoMed Inc. (0001053691) (Filer)", | |
| "companyName": "CervoMed Inc.", | |
| "filerName": null, | |
| "price": 3.08, | |
| "fav": "1.00", | |
| "volume": 863317, | |
| "averageVolume": 5619431, | |
| "float": 5610316, | |
| "sharesOutstanding": 9258719, | |
| "soRatio": "60.59%", | |
| "marketCap": 28516854, | |
| "isShort": false, | |
| "ftd": 31296, | |
| "intent": "Clinical Success, Clinical Milestone, Partnership, Unregistered Equity Sales, Failed Trial", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-07-14T16:21:27-04:00", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Positive Results", | |
| "Phase 1", | |
| "Phase 2", | |
| "Phase 3", | |
| "Efficacy", | |
| "Clinical Benefit" | |
| ], | |
| "Clinical Milestone": [ | |
| "First Patient", | |
| "First Patient" | |
| ], | |
| "Partnership": [ | |
| "Strategic Partnership" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 7.01" | |
| ], | |
| "Failed Trial": [ | |
| "Primary Endpoint Not Met" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1053691", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T20:22:23.753Z", | |
| "recordId": "CRVO-1784060543753", | |
| "expiresAt": "2026-07-17T20:22:23.753Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.88, | |
| "highest5DayPercent": -6.49, | |
| "lowest5Day": 2.88, | |
| "lowest5DayPercent": -6.49, | |
| "priceAfter30m": 3.08, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 3.08, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 3.08, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 3.07, | |
| "percentAfter1d": -0.32, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "FJET", | |
| "title": "8-K - Starfighters Space, Inc. (0001947016) (Filer)", | |
| "companyName": "Starfighters Space, Inc.", | |
| "filerName": null, | |
| "price": 4.73, | |
| "fav": "8.46", | |
| "volume": 571312, | |
| "averageVolume": 2179408, | |
| "float": 18436458, | |
| "sharesOutstanding": 49626351, | |
| "soRatio": "37.15%", | |
| "marketCap": 234732640, | |
| "isShort": true, | |
| "ftd": 2152481, | |
| "intent": "Accounting Restatement, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Florida", | |
| "filingDate": "2026-07-14T16:30:22-04:00", | |
| "signals": { | |
| "Accounting Restatement": [ | |
| "Substantial Doubt" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Item 4.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1947016", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Aerospace & Defense", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T20:31:09.040Z", | |
| "recordId": "FJET-1784061069040", | |
| "expiresAt": "2026-07-17T20:31:09.040Z", | |
| "direction": "SHORT", | |
| "highest5Day": 4.05, | |
| "highest5DayPercent": -14.38, | |
| "lowest5Day": 4.05, | |
| "lowest5DayPercent": 14.38, | |
| "priceAfter30m": 4.73, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 4.73, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 4.73, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 4.37, | |
| "percentAfter1d": -7.61, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.03 | |
| }, | |
| { | |
| "ticker": "AZO", | |
| "title": "8-K - AUTOZONE INC (0000866787) (Filer)", | |
| "companyName": "AUTOZONE INC", | |
| "filerName": null, | |
| "price": 3032.07, | |
| "fav": "42.64", | |
| "volume": 165312, | |
| "averageVolume": 381595, | |
| "float": 16273114, | |
| "sharesOutstanding": 16325355, | |
| "soRatio": "99.68%", | |
| "marketCap": 49499619328, | |
| "isShort": false, | |
| "ftd": 217, | |
| "intent": "Merger/Acquisition, Credit Default, Asset Disposition, Partnership, Unregistered Equity Sales", | |
| "incorporated": "Nevada", | |
| "located": "Tennessee", | |
| "filingDate": "2026-07-14T16:36:34-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default", | |
| "Mandatory Prepayment", | |
| "Default Under The" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "13D", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 9.01" | |
| ], | |
| "cik": "866787", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Retail", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "BNY Mellon", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T20:37:04.424Z", | |
| "recordId": "AZO-1784061424424", | |
| "expiresAt": "2026-07-17T20:37:04.424Z", | |
| "direction": "LONG", | |
| "highest5Day": 2944.52, | |
| "highest5DayPercent": -2.89, | |
| "lowest5Day": 2944.52, | |
| "lowest5DayPercent": -2.89, | |
| "priceAfter30m": 3032.07, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 3032.07, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 3032.07, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 2970.57, | |
| "percentAfter1d": -2.03, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "RACD", | |
| "title": "8-K - Research Alliance Corp IV (0002137777) (Filer)", | |
| "companyName": "Research Alliance Corp IV", | |
| "filerName": null, | |
| "price": 10.42, | |
| "fav": "1.97", | |
| "volume": 59723, | |
| "averageVolume": 671500, | |
| "float": 1323529, | |
| "sharesOutstanding": 7775000, | |
| "soRatio": "17.02%", | |
| "marketCap": 94806672, | |
| "isShort": true, | |
| "ftd": "N/A", | |
| "intent": "Merger/Acquisition, Underwritten Offering, Going Dark, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction", | |
| "incorporated": "Cayman Islands", | |
| "located": "New York", | |
| "filingDate": "2026-07-14T16:58:44-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Going Private", | |
| "Material Definitive Agreement" | |
| ], | |
| "Underwritten Offering": [ | |
| "IPO" | |
| ], | |
| "Going Dark": [ | |
| "Deregister" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: a written communication within the meaning of Rule 405 under the Act" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Related Party", | |
| "Affiliate Of", | |
| "Related Person" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "EX-1.1", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "2137777", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": null, | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "New York (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-14T20:59:34.780Z", | |
| "recordId": "RACD-1784062774780", | |
| "expiresAt": "2026-07-17T20:59:34.780Z", | |
| "direction": "SHORT", | |
| "highest5Day": 11.645, | |
| "highest5DayPercent": 11.76, | |
| "lowest5Day": 10.42, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": 10.42, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 10.42, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 10.42, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 10.64, | |
| "percentAfter1d": 2.11, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 11.76 | |
| }, | |
| { | |
| "ticker": "SNTI", | |
| "title": "8-K - Senti Biosciences Holdings, Inc. (0001854270) (Filer)", | |
| "companyName": "Senti Biosciences Holdings, Inc.", | |
| "filerName": null, | |
| "price": 0.9675, | |
| "fav": "39.57", | |
| "volume": 59299, | |
| "averageVolume": 204450, | |
| "float": 8089624, | |
| "sharesOutstanding": 31144754, | |
| "soRatio": "25.97%", | |
| "marketCap": 30132548, | |
| "isShort": false, | |
| "ftd": 12817, | |
| "intent": "Merger/Acquisition, Clinical Success, FDA Approved, Convertible Debt, Contingent Value Rights, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-15T07:32:12-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Merger Agreement", | |
| "Merger Consideration", | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Efficacy" | |
| ], | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Contingent Value Rights": [ | |
| "Contingent Value Rights", | |
| "CVR" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: its largest stockholder" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 2.02", | |
| "Item 5.01", | |
| "Item 7.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1854270", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-15T11:33:01.487Z", | |
| "recordId": "SNTI-1784115181487", | |
| "expiresAt": "2026-07-20T11:33:01.487Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.4702, | |
| "highest5DayPercent": -51.4, | |
| "lowest5Day": 0.4702, | |
| "lowest5DayPercent": -51.4, | |
| "priceAfter30m": 0.9675, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.9675, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 0.653, | |
| "percentAfter6h": -32.51, | |
| "priceAfter1d": 0.5833, | |
| "percentAfter1d": -39.71, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -23.51 | |
| }, | |
| { | |
| "ticker": "FRGT", | |
| "title": "6-K - Freight Technologies, Inc. (0001687542) (Filer)", | |
| "companyName": "Freight Technologies, Inc.", | |
| "filerName": null, | |
| "price": 4.39, | |
| "fav": "15.61", | |
| "volume": 26964, | |
| "averageVolume": 214865, | |
| "float": 3354309, | |
| "sharesOutstanding": 572125, | |
| "soRatio": "586.3%", | |
| "marketCap": 2511628, | |
| "isShort": true, | |
| "ftd": 92714, | |
| "intent": "Merger/Acquisition, Convertible Debt, Credit Default, Accounting Restatement, Partnership, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Hong Kong", | |
| "located": "Texas", | |
| "filingDate": "2026-07-15T09:00:14-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Agreed To Acquire" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default", | |
| "Default Under The" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: expected to raise net cash proceeds of approximately $1", | |
| "Shares: 3.4M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-1", | |
| "F-4", | |
| "20-F", | |
| "13D", | |
| "Form D", | |
| "EX-10.1" | |
| ], | |
| "cik": "1687542", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Logistics & Transportation", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Hong Kong)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-15T13:01:13.415Z", | |
| "recordId": "FRGT-1784120473415", | |
| "expiresAt": "2026-07-20T13:01:13.415Z", | |
| "direction": "SHORT", | |
| "highest5Day": 5.36, | |
| "highest5DayPercent": 22.1, | |
| "lowest5Day": 4.23, | |
| "lowest5DayPercent": 3.64, | |
| "priceAfter30m": 4.335, | |
| "percentAfter30m": -1.25, | |
| "priceAfter1h": 4.23, | |
| "percentAfter1h": -3.64, | |
| "priceAfter6h": 5.17, | |
| "percentAfter6h": 17.77, | |
| "priceAfter1d": 5.18, | |
| "percentAfter1d": 18, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 8.2 | |
| }, | |
| { | |
| "ticker": "AEON", | |
| "title": "8-K - AEON Biopharma, Inc. (0001837607) (Filer)", | |
| "companyName": "AEON Biopharma, Inc.", | |
| "filerName": null, | |
| "price": 0.2937, | |
| "fav": "16.39", | |
| "volume": 2009005, | |
| "averageVolume": 1089419, | |
| "float": 17851599, | |
| "sharesOutstanding": 26307211, | |
| "soRatio": "67.86%", | |
| "marketCap": 7726428, | |
| "isShort": true, | |
| "ftd": 5979, | |
| "intent": "Merger/Acquisition, Clinical Success, Convertible Debt, Regulatory Breach, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-15T16:01:21-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Clinical Success": [ | |
| "Phase 3" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Regulatory Breach": [ | |
| "Warning Letter" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: and otherwise in compliance with the requirements of Rule 163B under the Securities Act and", | |
| "Shares: 17.9M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "S-8", | |
| "EX-1.1", | |
| "Item 1.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1837607", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "N/A", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-15T20:02:20.168Z", | |
| "recordId": "AEON-1784145740168", | |
| "expiresAt": "2026-07-20T20:02:20.168Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.3116, | |
| "highest5DayPercent": 6.09, | |
| "lowest5Day": 0.276, | |
| "lowest5DayPercent": 6.03, | |
| "priceAfter30m": 0.2997, | |
| "percentAfter30m": 2.04, | |
| "priceAfter1h": 0.2997, | |
| "percentAfter1h": 2.04, | |
| "priceAfter6h": 0.2997, | |
| "percentAfter6h": 2.04, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "LABT", | |
| "title": "8-K - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Filer)", | |
| "companyName": "Lakewood-Amedex Biotherapeutics Inc.", | |
| "filerName": null, | |
| "price": 2.43, | |
| "fav": "1.60", | |
| "volume": 966670, | |
| "averageVolume": 292271, | |
| "float": 468918, | |
| "sharesOutstanding": 1750657, | |
| "soRatio": "26.79%", | |
| "marketCap": 4254096, | |
| "isShort": false, | |
| "ftd": 106442, | |
| "intent": "Clinical Success, Clinical Milestone, Unregistered Equity Sales", | |
| "incorporated": "Nevada", | |
| "located": "Florida", | |
| "filingDate": "2026-07-15T16:15:21-04:00", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Phase 3", | |
| "Primary Endpoint" | |
| ], | |
| "Clinical Milestone": [ | |
| "Enrollment Initiated" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 7.01" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-4", | |
| "S-9", | |
| "F-4", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "2079272", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Nevada)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-15T20:16:40.767Z", | |
| "recordId": "LABT-1784146600767", | |
| "expiresAt": "2026-07-20T20:16:40.767Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.85, | |
| "highest5DayPercent": 17.28, | |
| "lowest5Day": 2.1, | |
| "lowest5DayPercent": -13.58, | |
| "priceAfter30m": 2.43, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 2.43, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 2.43, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.19 | |
| }, | |
| { | |
| "ticker": "TGHL", | |
| "title": "6-K - GrowHub Ltd (0002024114) (Filer)", | |
| "companyName": "GrowHub Ltd", | |
| "filerName": null, | |
| "price": 0.8145, | |
| "fav": "6.73", | |
| "volume": 71377747, | |
| "averageVolume": 2971914, | |
| "float": 20000000, | |
| "sharesOutstanding": 14866470, | |
| "soRatio": "134.5%", | |
| "marketCap": 20606696, | |
| "isShort": true, | |
| "ftd": 1625699, | |
| "intent": "Convertible Debt, Credit Default, Accounting Restatement, Bid Price Delisting, Asset Disposition, Partnership, Regulation S Offering, Related-Party Transaction, Unregistered Equity Sales", | |
| "incorporated": "Cayman Islands", | |
| "located": "Singapore", | |
| "filingDate": "2026-07-15T16:20:10-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Credit Default": [ | |
| "Default Under The" | |
| ], | |
| "Accounting Restatement": [ | |
| "Material Weakness" | |
| ], | |
| "Bid Price Delisting": [ | |
| "Regained Compliance" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Related Person" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or on behalf of such member of the Target Group from and against unlawful", | |
| "Shares: 20.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "F-1", | |
| "20-F", | |
| "EX-10.1" | |
| ], | |
| "cik": "2024114", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Technology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Singapore (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-15T20:21:00.837Z", | |
| "recordId": "TGHL-1784146860837", | |
| "expiresAt": "2026-07-20T20:21:00.837Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.7, | |
| "highest5DayPercent": 108.72, | |
| "lowest5Day": 0.7835, | |
| "lowest5DayPercent": 3.81, | |
| "priceAfter30m": 0.8145, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.8145, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 0.8145, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 58.38 | |
| }, | |
| { | |
| "ticker": "CBIO", | |
| "title": "8-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer)", | |
| "companyName": "CRESCENT BIOPHARMA, INC.", | |
| "filerName": null, | |
| "price": 15.67, | |
| "fav": "26.01", | |
| "volume": 2187821, | |
| "averageVolume": 311240, | |
| "float": 8094793, | |
| "sharesOutstanding": 27571935, | |
| "soRatio": "29.36%", | |
| "marketCap": 432097504, | |
| "isShort": true, | |
| "ftd": 558, | |
| "intent": "Credit Default, Partnership, Licensing Deal, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Cayman Islands", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-07-15T16:58:01-04:00", | |
| "signals": { | |
| "Credit Default": [ | |
| "Is In Default" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Partnership Agreement" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: ”)", | |
| "Shares: 8.1M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "EX-1.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1253689", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-15T20:59:07.844Z", | |
| "recordId": "CBIO-1784149147844", | |
| "expiresAt": "2026-07-20T20:59:07.844Z", | |
| "direction": "SHORT", | |
| "highest5Day": 16.94, | |
| "highest5DayPercent": 8.1, | |
| "lowest5Day": 14.73, | |
| "lowest5DayPercent": 6, | |
| "priceAfter30m": 15.67, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 15.67, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 15.67, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 8.1 | |
| }, | |
| { | |
| "ticker": "LW", | |
| "title": "8-K - Lamb Weston Holdings, Inc. (0001679273) (Filer)", | |
| "companyName": "Lamb Weston Holdings, Inc.", | |
| "filerName": null, | |
| "price": 45.55, | |
| "fav": "1.02", | |
| "volume": 1046471, | |
| "averageVolume": 1504583, | |
| "float": 1538000, | |
| "sharesOutstanding": 138072803, | |
| "soRatio": "1.11%", | |
| "marketCap": 6289216000, | |
| "isShort": false, | |
| "ftd": 20971, | |
| "intent": "Asset Disposition, Partnership, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Idaho", | |
| "filingDate": "2026-07-15T17:24:09-04:00", | |
| "signals": { | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 1.5M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "13G", | |
| "EX-10.1", | |
| "Item 5.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "1679273", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Food Products", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Idaho (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-15T21:25:03.592Z", | |
| "recordId": "LW-1784150703592", | |
| "expiresAt": "2026-07-20T21:25:03.592Z", | |
| "direction": "LONG", | |
| "highest5Day": 47.2051, | |
| "highest5DayPercent": 3.63, | |
| "lowest5Day": 45.35, | |
| "lowest5DayPercent": -0.44, | |
| "priceAfter30m": 45.55, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 45.55, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 45.55, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "BGL", | |
| "title": "6-K - Blue Gold Ltd (0002019435) (Filer)", | |
| "companyName": "Blue Gold Ltd", | |
| "filerName": null, | |
| "price": 0.2422, | |
| "fav": "18.54", | |
| "volume": 513438, | |
| "averageVolume": 852193, | |
| "float": 15800300, | |
| "sharesOutstanding": 40837773, | |
| "soRatio": "38.69%", | |
| "marketCap": 9890908, | |
| "isShort": false, | |
| "ftd": 41968, | |
| "intent": "Convertible Debt, Bid Price Delisting, Asset Disposition, Partnership, Unregistered Equity Sales", | |
| "incorporated": "Cayman Islands", | |
| "located": "Cayman Islands", | |
| "filingDate": "2026-07-16T06:26:46-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Bid Price Delisting": [ | |
| "Minimum Bid Price" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "EX-99.1" | |
| ], | |
| "cik": "2019435", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Metals & Mining", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-16T10:27:35.364Z", | |
| "recordId": "BGL-1784197655364", | |
| "expiresAt": "2026-07-21T10:27:35.364Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.2269, | |
| "highest5DayPercent": -6.32, | |
| "lowest5Day": 0.2269, | |
| "lowest5DayPercent": -6.32, | |
| "priceAfter30m": 0.2422, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.2422, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "VRAX", | |
| "title": "6-K - Virax Biolabs Group Ltd (0001885827) (Filer)", | |
| "companyName": "Virax Biolabs Group Ltd", | |
| "filerName": null, | |
| "price": 3.45, | |
| "fav": "0.26", | |
| "volume": 138248, | |
| "averageVolume": 2016933, | |
| "float": 529040, | |
| "sharesOutstanding": 796988, | |
| "soRatio": "66.38%", | |
| "marketCap": 2749608, | |
| "isShort": false, | |
| "ftd": 1108368, | |
| "intent": "Bid Price Delisting", | |
| "incorporated": "Cayman Islands", | |
| "located": "London, UK", | |
| "filingDate": "2026-07-16T07:31:36-04:00", | |
| "signals": { | |
| "Bid Price Delisting": [ | |
| "Minimum Bid Price", | |
| "Regained Compliance" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "F-4", | |
| "20-F", | |
| "EX-99.1" | |
| ], | |
| "cik": "1885827", | |
| "skipReason": "", | |
| "alertType": "CTB Squeeze", | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "London, UK (via Cayman Islands)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-16T11:32:22.602Z", | |
| "recordId": "VRAX-1784201542602", | |
| "expiresAt": "2026-07-21T11:32:22.602Z", | |
| "direction": "LONG", | |
| "highest5Day": 3.95, | |
| "highest5DayPercent": 14.49, | |
| "lowest5Day": 3.32, | |
| "lowest5DayPercent": -3.77, | |
| "priceAfter30m": 3.45, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 3.45, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 8.12 | |
| }, | |
| { | |
| "ticker": "SDOT", | |
| "title": "8-K - Sadot Group Inc. (0001701756) (Filer)", | |
| "companyName": "Sadot Group Inc.", | |
| "filerName": null, | |
| "price": 15.25, | |
| "fav": "0.22", | |
| "volume": 264373, | |
| "averageVolume": 3318902, | |
| "float": 740919, | |
| "sharesOutstanding": 1056803, | |
| "soRatio": "70.11%", | |
| "marketCap": 16116246, | |
| "isShort": true, | |
| "ftd": 1124245, | |
| "intent": "Merger/Acquisition, Credit Default, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Nevada", | |
| "located": "Texas", | |
| "filingDate": "2026-07-16T08:31:01-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.0M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 1.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "1701756", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Food Products", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Nevada)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T12:31:40.455Z", | |
| "recordId": "SDOT-1784205100455", | |
| "expiresAt": "2026-07-21T12:31:40.455Z", | |
| "direction": "SHORT", | |
| "highest5Day": 18.68, | |
| "highest5DayPercent": 22.49, | |
| "lowest5Day": 13.21, | |
| "lowest5DayPercent": 13.38, | |
| "priceAfter30m": 15.25, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 13.988, | |
| "percentAfter1h": -8.28, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -11.48 | |
| }, | |
| { | |
| "ticker": "CRDF", | |
| "title": "8-K - Cardiff Oncology, Inc. (0001213037) (Filer)", | |
| "companyName": "Cardiff Oncology, Inc.", | |
| "filerName": null, | |
| "price": 0.8893, | |
| "fav": "6.03", | |
| "volume": 12632447, | |
| "averageVolume": 1420927, | |
| "float": 8571429, | |
| "sharesOutstanding": 68369896, | |
| "soRatio": "12.54%", | |
| "marketCap": 60801348, | |
| "isShort": false, | |
| "ftd": 2941572, | |
| "intent": "Merger/Acquisition, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-16T08:38:12-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 8.6M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-3", | |
| "EX-4.1", | |
| "EX-4.2", | |
| "Item 1.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1213037", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T12:38:55.240Z", | |
| "recordId": "CRDF-1784205535241", | |
| "expiresAt": "2026-07-21T12:38:55.241Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.95, | |
| "highest5DayPercent": 6.83, | |
| "lowest5Day": 0.83, | |
| "lowest5DayPercent": -6.67, | |
| "priceAfter30m": 0.8893, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.921, | |
| "percentAfter1h": 3.56, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "GCDT", | |
| "title": "6-K - Green Circle Decarbonize Technology Ltd (0001926293) (Filer)", | |
| "companyName": "Green Circle Decarbonize Technology Ltd", | |
| "filerName": "Chan Kam Biu Richard Chan Kam Biu Richard Chief Executive Officer and Director", | |
| "price": 0.57, | |
| "fav": "5.50", | |
| "volume": 14618, | |
| "averageVolume": 1818216, | |
| "float": 10000000, | |
| "sharesOutstanding": 12500000, | |
| "soRatio": "80.00%", | |
| "marketCap": 7125000, | |
| "isShort": false, | |
| "ftd": 828045, | |
| "intent": "Merger/Acquisition, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Cayman Islands", | |
| "located": "Kowloon Bay, Hong Kong", | |
| "filingDate": "2026-07-16T10:18:54-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Purchase Agreement", | |
| "Placement Agent" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F" | |
| ], | |
| "cik": "1926293", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": null, | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Kowloon Bay, Hong Kong (via Cayman Islands)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T14:19:44.423Z", | |
| "recordId": "GCDT-1784211584423", | |
| "expiresAt": "2026-07-21T14:19:44.423Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.601, | |
| "highest5DayPercent": 5.44, | |
| "lowest5Day": 0.4581, | |
| "lowest5DayPercent": -19.63, | |
| "priceAfter30m": 0.57, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.5235, | |
| "percentAfter1h": -8.16, | |
| "priceAfter6h": 0.5081, | |
| "percentAfter6h": -10.86, | |
| "priceAfter1d": 0.465, | |
| "percentAfter1d": -18.42, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.77 | |
| }, | |
| { | |
| "ticker": "INBX", | |
| "title": "8-K - Inhibrx Biosciences, Inc. (0002007919) (Filer)", | |
| "companyName": "Inhibrx Biosciences, Inc.", | |
| "filerName": null, | |
| "price": 89.07, | |
| "fav": "22.83", | |
| "volume": 289083, | |
| "averageVolume": 476088, | |
| "float": 10867769, | |
| "sharesOutstanding": 14671186, | |
| "soRatio": "74.08%", | |
| "marketCap": 1306762496, | |
| "isShort": false, | |
| "ftd": 4349, | |
| "intent": "Merger/Acquisition, Credit Default, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-16T16:06:13-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default", | |
| "Default Has Occurred" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-4", | |
| "F-1", | |
| "FWG", | |
| "EX-99.1", | |
| "EX-10.1", | |
| "Item 1.01", | |
| "Item 2.03", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "2007919", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-16T20:07:08.891Z", | |
| "recordId": "INBX-1784232428891", | |
| "expiresAt": "2026-07-21T20:07:08.891Z", | |
| "direction": "LONG", | |
| "highest5Day": 85.21, | |
| "highest5DayPercent": -4.33, | |
| "lowest5Day": 85.21, | |
| "lowest5DayPercent": -4.33, | |
| "priceAfter30m": 89.07, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 89.07, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 89.07, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "YYAI", | |
| "title": "8-K - AIRWA INC. (0001674440) (Filer)", | |
| "companyName": "AIRWA INC.", | |
| "filerName": null, | |
| "price": 9.73, | |
| "fav": "21.89", | |
| "volume": 23780, | |
| "averageVolume": 18313, | |
| "float": 400885, | |
| "sharesOutstanding": 1053561, | |
| "soRatio": "38.05%", | |
| "marketCap": 10251148, | |
| "isShort": false, | |
| "ftd": 4301, | |
| "intent": "Asset Disposition, Partnership, Regulation S Offering, Related-Party Transaction, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Wilmington, Delaware", | |
| "filingDate": "2026-07-16T16:10:18-04:00", | |
| "signals": { | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Affiliate Of", | |
| "Family Relationship" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: the Company" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "Item 5.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "1674440", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Leisure Products", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-16T20:10:55.025Z", | |
| "recordId": "YYAI-1784232655025", | |
| "expiresAt": "2026-07-21T20:10:55.025Z", | |
| "direction": "LONG", | |
| "highest5Day": 10.78, | |
| "highest5DayPercent": 10.79, | |
| "lowest5Day": 8.86, | |
| "lowest5DayPercent": -8.94, | |
| "priceAfter30m": 9.73, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 9.73, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 9.73, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.94 | |
| }, | |
| { | |
| "ticker": "ASPI", | |
| "title": "8-K - ASP Isotopes Inc. (0001921865) (Filer)", | |
| "companyName": "ASP Isotopes Inc.", | |
| "filerName": null, | |
| "price": 3.945, | |
| "fav": "0.41", | |
| "volume": 8063835, | |
| "averageVolume": 4900255, | |
| "float": 2000000, | |
| "sharesOutstanding": 125903447, | |
| "soRatio": "1.59%", | |
| "marketCap": 496689088, | |
| "isShort": false, | |
| "ftd": 494574, | |
| "intent": "Convertible Debt, Licensing Deal, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-07-16T16:15:46-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Licensing Deal": [ | |
| "License Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Discount: 50%", | |
| "Shares: 2.0M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Related Party" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "S-3", | |
| "S-8", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1921865", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Chemicals", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-16T20:16:54.423Z", | |
| "recordId": "ASPI-1784233014423", | |
| "expiresAt": "2026-07-21T20:16:54.423Z", | |
| "direction": "LONG", | |
| "highest5Day": 4.36, | |
| "highest5DayPercent": 10.52, | |
| "lowest5Day": 3.61, | |
| "lowest5DayPercent": -8.49, | |
| "priceAfter30m": 3.945, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 3.945, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 3.945, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.11 | |
| }, | |
| { | |
| "ticker": "GCDT", | |
| "title": "6-K/A - Green Circle Decarbonize Technology Ltd (0001926293) (Filer)", | |
| "companyName": "Green Circle Decarbonize Technology Ltd", | |
| "filerName": null, | |
| "price": 0.5081, | |
| "fav": "1.12", | |
| "volume": 231290, | |
| "averageVolume": 1818216, | |
| "float": 2034085, | |
| "sharesOutstanding": 12500000, | |
| "soRatio": "16.27%", | |
| "marketCap": 6351249, | |
| "isShort": true, | |
| "ftd": 828045, | |
| "intent": "Convertible Debt, Credit Default, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction, PIPE", | |
| "incorporated": "Cayman Islands", | |
| "located": "Kowloon Bay, Hong Kong", | |
| "filingDate": "2026-07-16T16:34:17-04:00", | |
| "signals": { | |
| "Convertible Debt": [ | |
| "Convertible Notes" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default", | |
| "Mandatory Prepayment" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with the Holder", | |
| "Discount: 20%" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "PIPE": [ | |
| "PIPE" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "20-F", | |
| "EX-4.1", | |
| "EX-4.2" | |
| ], | |
| "cik": "1926293", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": null, | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Kowloon Bay, Hong Kong (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-16T20:35:12.791Z", | |
| "recordId": "GCDT-1784234112791", | |
| "expiresAt": "2026-07-21T20:35:12.791Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.601, | |
| "highest5DayPercent": 18.28, | |
| "lowest5Day": 0.4581, | |
| "lowest5DayPercent": 9.84, | |
| "priceAfter30m": 0.5081, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.5081, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 0.5081, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -9.45 | |
| }, | |
| { | |
| "ticker": "ARRY", | |
| "title": "8-K - Array Technologies, Inc. (0001820721) (Filer)", | |
| "companyName": "Array Technologies, Inc.", | |
| "filerName": null, | |
| "price": 6.25, | |
| "fav": "1.71", | |
| "volume": 4852088, | |
| "averageVolume": 5850442, | |
| "float": 10000000, | |
| "sharesOutstanding": 153826378, | |
| "soRatio": "6.50%", | |
| "marketCap": 961414912, | |
| "isShort": false, | |
| "ftd": 123016, | |
| "intent": "Merger/Acquisition, Convertible Debt, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New Mexico", | |
| "filingDate": "2026-07-16T16:46:07-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Strategic Alliance" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: due" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1820721", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Electrical Equipment", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New Mexico (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-16T20:47:02.467Z", | |
| "recordId": "ARRY-1784234822467", | |
| "expiresAt": "2026-07-21T20:47:02.467Z", | |
| "direction": "LONG", | |
| "highest5Day": 5.875, | |
| "highest5DayPercent": -6, | |
| "lowest5Day": 5.875, | |
| "lowest5DayPercent": -6, | |
| "priceAfter30m": 6.25, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 6.25, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 6.25, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "CABR", | |
| "title": "8-K - Caring Brands, Inc. (0002020737) (Filer)", | |
| "companyName": "Caring Brands, Inc.", | |
| "filerName": null, | |
| "price": 1.28, | |
| "fav": "12.69", | |
| "volume": 34361, | |
| "averageVolume": 82940, | |
| "float": 1052632, | |
| "sharesOutstanding": 9091506, | |
| "soRatio": "11.58%", | |
| "marketCap": 11637127, | |
| "isShort": false, | |
| "ftd": 15641, | |
| "intent": "Merger/Acquisition, Convertible Debt, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction, PIPE", | |
| "incorporated": "Nevada", | |
| "located": "Florida", | |
| "filingDate": "2026-07-16T17:12:45-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with a Person", | |
| "Discount: 5%", | |
| "Shares: 0.0M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "PIPE": [ | |
| "PIPE" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-10.1", | |
| "EX-3.1", | |
| "EX-4.1", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 3.03", | |
| "Item 9.01" | |
| ], | |
| "cik": "2020737", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Consumer products", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Nevada)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T21:13:54.698Z", | |
| "recordId": "CABR-1784236434698", | |
| "expiresAt": "2026-07-21T21:13:54.698Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.34, | |
| "highest5DayPercent": 4.69, | |
| "lowest5Day": 1.2414, | |
| "lowest5DayPercent": -3.02, | |
| "priceAfter30m": 1.28, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 1.28, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 1.28, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "JSPR", | |
| "title": "8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)", | |
| "companyName": "Jasper Therapeutics, Inc.", | |
| "filerName": null, | |
| "price": 0.774, | |
| "fav": "24.67", | |
| "volume": 795704, | |
| "averageVolume": 558534, | |
| "float": 13779087, | |
| "sharesOutstanding": 28009802, | |
| "soRatio": "49.19%", | |
| "marketCap": 21679586, | |
| "isShort": false, | |
| "ftd": 11440, | |
| "intent": "Merger/Acquisition, Clinical Success, Contingent Value Rights, Commercial Inflection, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-16T17:15:34-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Strategic Alternatives" | |
| ], | |
| "Clinical Success": [ | |
| "Priority Review", | |
| "Phase 3" | |
| ], | |
| "Contingent Value Rights": [ | |
| "CVR" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway", | |
| "Strengthened Foundation" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.0M" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1788028", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T21:16:47.867Z", | |
| "recordId": "JSPR-1784236607867", | |
| "expiresAt": "2026-07-21T21:16:47.867Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.5807, | |
| "highest5DayPercent": -24.97, | |
| "lowest5Day": 0.5807, | |
| "lowest5DayPercent": -24.97, | |
| "priceAfter30m": 0.774, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.774, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 0.774, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -9.74 | |
| }, | |
| { | |
| "ticker": "CETY", | |
| "title": "8-K - Clean Energy Technologies, Inc. (0001329606) (Filer)", | |
| "companyName": "Clean Energy Technologies, Inc.", | |
| "filerName": null, | |
| "price": 1.03, | |
| "fav": "33.28", | |
| "volume": 184075, | |
| "averageVolume": 67645, | |
| "float": 2250941, | |
| "sharesOutstanding": 12166106, | |
| "soRatio": "18.50%", | |
| "marketCap": 12531089, | |
| "isShort": true, | |
| "ftd": 10283, | |
| "intent": "Accounting Restatement, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Nevada", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-16T17:17:27-04:00", | |
| "signals": { | |
| "Accounting Restatement": [ | |
| "Substantial Doubt" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "F-3", | |
| "20-F", | |
| "20-F/A", | |
| "Item 4.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1329606", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Energy", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Nevada)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T21:18:18.043Z", | |
| "recordId": "CETY-1784236698043", | |
| "expiresAt": "2026-07-21T21:18:18.043Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.8655, | |
| "highest5DayPercent": -15.97, | |
| "lowest5Day": 0.8655, | |
| "lowest5DayPercent": 15.97, | |
| "priceAfter30m": 1.03, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 1.03, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 1.03, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -15.53 | |
| }, | |
| { | |
| "ticker": "POLA", | |
| "title": "8-K - Polar Power, Inc. (0001622345) (Filer)", | |
| "companyName": "Polar Power, Inc.", | |
| "filerName": null, | |
| "price": 1.61, | |
| "fav": "26.14", | |
| "volume": 27490, | |
| "averageVolume": 191245, | |
| "float": 5000000, | |
| "sharesOutstanding": 3640159, | |
| "soRatio": "137.4%", | |
| "marketCap": 5860656, | |
| "isShort": false, | |
| "ftd": 23836, | |
| "intent": "Asset Disposition, Partnership, Licensing Deal, Unregistered Equity Sales, Related-Party Transaction", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-16T17:28:19-04:00", | |
| "signals": { | |
| "Asset Disposition": [ | |
| "Asset Sale", | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture", | |
| "Development Agreement" | |
| ], | |
| "Licensing Deal": [ | |
| "Exclusive License", | |
| "License Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: the Holder", | |
| "Discount: 4.99%", | |
| "Shares: 0.0M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "S-1", | |
| "EX-3.1", | |
| "Item 5.03", | |
| "Item 9.01" | |
| ], | |
| "cik": "1622345", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Electrical Equipment", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-16T21:29:08.064Z", | |
| "recordId": "POLA-1784237348064", | |
| "expiresAt": "2026-07-21T21:29:08.064Z", | |
| "direction": "LONG", | |
| "highest5Day": 1.5607, | |
| "highest5DayPercent": -3.06, | |
| "lowest5Day": 1.5607, | |
| "lowest5DayPercent": -3.06, | |
| "priceAfter30m": 1.61, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 1.61, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 1.61, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "UBXG", | |
| "title": "6-K - MindForge Inc. (0001888525) (Filer)", | |
| "companyName": "MindForge Inc.", | |
| "filerName": "Jian Chen 2", | |
| "price": 5.04, | |
| "fav": "0.47", | |
| "volume": 572312, | |
| "averageVolume": 1269913, | |
| "float": 593084, | |
| "sharesOutstanding": 1511651, | |
| "soRatio": "39.23%", | |
| "marketCap": 9162881, | |
| "isShort": false, | |
| "ftd": 100933, | |
| "intent": "Press Release", | |
| "incorporated": "Cayman Islands", | |
| "located": "China", | |
| "filingDate": "2026-07-17T06:03:18-04:00", | |
| "signals": { | |
| "Press Release": [ | |
| "Press Release" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F" | |
| ], | |
| "cik": "1888525", | |
| "skipReason": "", | |
| "alertType": "CTB Squeeze", | |
| "predatoryFinancing": null, | |
| "sector": "Technology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "China (via Cayman Islands)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-17T10:04:28.303Z", | |
| "recordId": "UBXG-1784282668303", | |
| "expiresAt": "2026-07-22T10:04:28.303Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.47, | |
| "highest5DayPercent": 28.37, | |
| "lowest5Day": 4.86, | |
| "lowest5DayPercent": -3.57, | |
| "priceAfter30m": 5.04, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 5.04, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 5.0379, | |
| "percentAfter6h": -0.04, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "VIVS", | |
| "title": "8-K - VivoSim Labs, INC. (0001497253) (Filer)", | |
| "companyName": "VivoSim Labs, INC.", | |
| "filerName": null, | |
| "price": 0.6136, | |
| "fav": "2.17", | |
| "volume": 10295076, | |
| "averageVolume": 2165008, | |
| "float": 4705883, | |
| "sharesOutstanding": 3494071, | |
| "soRatio": "134.7%", | |
| "marketCap": 2143962, | |
| "isShort": false, | |
| "ftd": 30565, | |
| "intent": "Merger/Acquisition, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-17T08:45:07-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 4.7M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Form D", | |
| "EX-4.1", | |
| "EX-4.2", | |
| "Item 1.01", | |
| "Item 3.02", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1497253", | |
| "skipReason": "", | |
| "alertType": "CTB Squeeze", | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-17T12:45:48.224Z", | |
| "recordId": "VIVS-1784292348224", | |
| "expiresAt": "2026-07-22T12:45:48.224Z", | |
| "direction": "LONG", | |
| "highest5Day": 0.5197, | |
| "highest5DayPercent": -15.3, | |
| "lowest5Day": 0.5197, | |
| "lowest5DayPercent": -15.3, | |
| "priceAfter30m": 0.6136, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.524, | |
| "percentAfter1h": -14.6, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -9.83 | |
| }, | |
| { | |
| "ticker": "OMH", | |
| "title": "6-K - Ohmyhome Ltd (0001944902) (Filer)", | |
| "companyName": "Ohmyhome Ltd", | |
| "filerName": null, | |
| "price": 0.275, | |
| "fav": "20.79", | |
| "volume": 261227, | |
| "averageVolume": 256473, | |
| "float": 5333331, | |
| "sharesOutstanding": 22259591, | |
| "soRatio": "23.96%", | |
| "marketCap": 6352811, | |
| "isShort": true, | |
| "ftd": 393149, | |
| "intent": "Merger/Acquisition, Credit Default, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction", | |
| "incorporated": "Cayman Islands", | |
| "located": "Singapore", | |
| "filingDate": "2026-07-17T09:00:19-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Credit Default": [ | |
| "Is In Default" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with a Person" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S", | |
| "Rule 902", | |
| "Non-U.S. Persons" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "VStock": "VStock Setup", | |
| "Third Party": [ | |
| "VStock Transfer" | |
| ] | |
| }, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "EX-10.1", | |
| "EX-4.1" | |
| ], | |
| "cik": "1944902", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Real Estate", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Singapore (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-17T13:01:08.677Z", | |
| "recordId": "OMH-1784293268677", | |
| "expiresAt": "2026-07-22T13:01:08.677Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.321, | |
| "highest5DayPercent": 16.73, | |
| "lowest5Day": 0.23, | |
| "lowest5DayPercent": 16.36, | |
| "priceAfter30m": 0.275, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 0.275, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": null, | |
| "percentAfter6h": null, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -9.09 | |
| }, | |
| { | |
| "ticker": "BGDE", | |
| "title": "8-K - Big Digital Energy, Inc. (0001218683) (Filer)", | |
| "companyName": "Big Digital Energy, Inc.", | |
| "filerName": null, | |
| "price": 5.71, | |
| "fav": "21.49", | |
| "volume": 93846, | |
| "averageVolume": 167380, | |
| "float": 3596531, | |
| "sharesOutstanding": 5521252, | |
| "soRatio": "65.14%", | |
| "marketCap": 31526350, | |
| "isShort": false, | |
| "ftd": 18948, | |
| "intent": "Merger/Acquisition, Asset Disposition, Partnership, Commercial Inflection, Regulation S Offering, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Pennsylvania", | |
| "filingDate": "2026-07-20T08:35:36-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1218683", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Technology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Pennsylvania (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-20T12:36:14.378Z", | |
| "recordId": "BGDE-1784550974378", | |
| "expiresAt": "2026-07-24T12:36:14.378Z", | |
| "direction": "LONG", | |
| "highest5Day": 6.16, | |
| "highest5DayPercent": 7.88, | |
| "lowest5Day": 5.54, | |
| "lowest5DayPercent": -2.98, | |
| "priceAfter30m": 5.71, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 5.7, | |
| "percentAfter1h": -0.18, | |
| "priceAfter6h": 5.7, | |
| "percentAfter6h": -0.18, | |
| "priceAfter1d": 5.7, | |
| "percentAfter1d": -0.18, | |
| "priceAfter3d": 6.06, | |
| "percentAfter3d": 6.13, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 10.77 | |
| }, | |
| { | |
| "ticker": "IEP", | |
| "title": "8-K - ICAHN ENTERPRISES L.P. (0000813762) (Filer)", | |
| "companyName": "ICAHN ENTERPRISES L.P.", | |
| "filerName": null, | |
| "price": 7.54, | |
| "fav": "38.24", | |
| "volume": 482879, | |
| "averageVolume": 900919, | |
| "float": 34447302, | |
| "sharesOutstanding": 672050553, | |
| "soRatio": "5.13%", | |
| "marketCap": 5067261440, | |
| "isShort": false, | |
| "ftd": 64449, | |
| "intent": "Merger/Acquisition, Unregistered Equity Sales, Regulation S Offering", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Florida", | |
| "filingDate": "2026-07-21T08:29:38-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Material Definitive Agreement" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: HoldCo" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "6-K/A", | |
| "8-K", | |
| "S-4", | |
| "20-F", | |
| "20-F/A", | |
| "EX-99.1", | |
| "Item 1.01", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "813762", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Industrial Conglomerates", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Florida (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "recordedAt": "2026-07-21T12:30:23.213Z", | |
| "recordId": "IEP-1784637023213", | |
| "expiresAt": "2026-07-24T12:30:23.213Z", | |
| "direction": "LONG", | |
| "highest5Day": 7.795, | |
| "highest5DayPercent": 3.38, | |
| "lowest5Day": 7.54, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": 7.54, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 7.54, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 7.6673, | |
| "percentAfter6h": 1.69, | |
| "priceAfter1d": 7.76, | |
| "percentAfter1d": 2.92, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "FWRD", | |
| "title": "8-K - FORWARD AIR CORP (0000912728) (Filer)", | |
| "companyName": "FORWARD AIR CORP", | |
| "filerName": null, | |
| "price": 13.2, | |
| "fav": "17.63", | |
| "volume": 466374, | |
| "averageVolume": 1391632, | |
| "float": 24527938, | |
| "sharesOutstanding": 31625046, | |
| "soRatio": "77.56%", | |
| "marketCap": 417450592, | |
| "isShort": false, | |
| "ftd": 473037, | |
| "intent": "Merger/Acquisition, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Texas", | |
| "filingDate": "2026-07-21T08:56:52-04:00", | |
| "signals": { | |
| "Merger/Acquisition": [ | |
| "Strategic Alternatives" | |
| ], | |
| "Asset Disposition": [ | |
| "Strategic Sale" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "8-K", | |
| "S-8", | |
| "S-9", | |
| "13D", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "912728", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Logistics & Transportation", | |
| "hasTuesdayBonus": true, | |
| "custodianVerified": true, | |
| "custodianName": "Texas (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-21T12:57:39.064Z", | |
| "recordId": "FWRD-1784638659064", | |
| "expiresAt": "2026-07-24T12:57:39.064Z", | |
| "direction": "LONG", | |
| "highest5Day": 16.04, | |
| "highest5DayPercent": 21.52, | |
| "lowest5Day": 13.2, | |
| "lowest5DayPercent": 0, | |
| "priceAfter30m": 13.2, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 15.8, | |
| "percentAfter1h": 19.7, | |
| "priceAfter6h": 15.94, | |
| "percentAfter6h": 20.76, | |
| "priceAfter1d": 16.07, | |
| "percentAfter1d": 21.74, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 15.91 | |
| }, | |
| { | |
| "ticker": "CNTN", | |
| "title": "8-K - Canton Strategic Holdings, Inc. (0001861657) (Filer)", | |
| "companyName": "Canton Strategic Holdings, Inc.", | |
| "filerName": null, | |
| "price": 2.09, | |
| "fav": "33.70", | |
| "volume": 596911, | |
| "averageVolume": 899988, | |
| "float": 30328481, | |
| "sharesOutstanding": 77122584, | |
| "soRatio": "39.33%", | |
| "marketCap": 161186192, | |
| "isShort": true, | |
| "ftd": 1857266, | |
| "intent": "Partnership, Licensing Deal, Convertible Debt, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction, Credit Default, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "New Jersey", | |
| "filingDate": "2026-07-23T08:40:28-04:00", | |
| "signals": { | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Licensing Deal": [ | |
| "Exclusive License" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: affiliated with Vincent LoPriore" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By" | |
| ], | |
| "Credit Default": [ | |
| "Event Of Default", | |
| "Mandatory Prepayment", | |
| "Default Has Occurred" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets", | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-10.1", | |
| "EX-10.2", | |
| "Item 1.01", | |
| "Item 2.01", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1861657", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New Jersey (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-23T12:41:09.623Z", | |
| "recordId": "CNTN-1784810469623", | |
| "expiresAt": "2026-07-28T12:41:09.623Z", | |
| "direction": "SHORT", | |
| "highest5Day": 1.915, | |
| "highest5DayPercent": -8.37, | |
| "lowest5Day": 1.915, | |
| "lowest5DayPercent": 8.37, | |
| "priceAfter30m": 2.09, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 2.09, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 2.06, | |
| "percentAfter6h": -1.44, | |
| "priceAfter1d": 2.06, | |
| "percentAfter1d": -1.44, | |
| "priceAfter3d": 1.94, | |
| "percentAfter3d": -7.18, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.13 | |
| }, | |
| { | |
| "ticker": "SST", | |
| "title": "8-K - System1, Inc. (0001805833) (Filer)", | |
| "companyName": "System1, Inc.", | |
| "filerName": "Not Applicable", | |
| "price": 1.81, | |
| "fav": "17.83", | |
| "volume": 33907, | |
| "averageVolume": 443124, | |
| "float": 7900179, | |
| "sharesOutstanding": 8217390, | |
| "soRatio": "96.14%", | |
| "marketCap": 18111128, | |
| "isShort": false, | |
| "ftd": 81959, | |
| "intent": "Partnership, Licensing Deal, Convertible Debt, Unregistered Equity Sales, Related-Party Transaction, Asset Disposition", | |
| "incorporated": "Cayman Islands", | |
| "located": "Toronto, Canada", | |
| "filingDate": "2026-07-24T09:07:17-04:00", | |
| "signals": { | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Licensing Deal": [ | |
| "Exclusive License" | |
| ], | |
| "Convertible Debt": [ | |
| "Convertible Securities" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with the Person specified", | |
| "Shares: 0.0M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Related Party" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "13D", | |
| "EX-3.1", | |
| "Item 3.03", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 5.07", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1805833", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Media", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Toronto, Canada (via Cayman Islands)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-24T13:07:41.611Z", | |
| "recordId": "SST-1784898461611", | |
| "expiresAt": "2026-07-29T13:07:41.611Z", | |
| "direction": "LONG", | |
| "highest5Day": 2.12, | |
| "highest5DayPercent": 17.13, | |
| "lowest5Day": 1.77, | |
| "lowest5DayPercent": -2.21, | |
| "priceAfter30m": 1.81, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 1.965, | |
| "percentAfter1h": 8.56, | |
| "priceAfter6h": 1.9801, | |
| "percentAfter6h": 9.4, | |
| "priceAfter1d": 1.83, | |
| "percentAfter1d": 1.1, | |
| "priceAfter3d": 1.83, | |
| "percentAfter3d": 1.1, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 8.29 | |
| }, | |
| { | |
| "ticker": "NIVF", | |
| "title": "6-K - NewGenIvf Group Ltd (0001981662) (Filer)", | |
| "companyName": "NewGenIvf Group Ltd", | |
| "filerName": null, | |
| "price": 1.1, | |
| "fav": "1.80", | |
| "volume": 172793, | |
| "averageVolume": 2078394, | |
| "float": 3750000, | |
| "sharesOutstanding": 3419922, | |
| "soRatio": "109.7%", | |
| "marketCap": 3761914, | |
| "isShort": true, | |
| "ftd": 887427, | |
| "intent": "Unregistered Equity Sales, Regulation S Offering, Credit Default, Nasdaq Delisting", | |
| "incorporated": "Hong Kong", | |
| "located": "W1", | |
| "filingDate": "2026-07-27T08:30:01-04:00", | |
| "signals": { | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: a “Party” and together the “Parties”" | |
| ], | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Credit Default": [ | |
| "Is In Default" | |
| ], | |
| "Nasdaq Delisting": [ | |
| "Delisting Determination" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "20-F", | |
| "Form D", | |
| "EX-99.1", | |
| "EX-10.1" | |
| ], | |
| "cik": "1981662", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "W1 (via Hong Kong)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-27T12:30:56.313Z", | |
| "recordId": "NIVF-1785155456313", | |
| "expiresAt": "2026-07-31T12:30:56.313Z", | |
| "direction": "SHORT", | |
| "highest5Day": 0.8186, | |
| "highest5DayPercent": -25.58, | |
| "lowest5Day": 0.8186, | |
| "lowest5DayPercent": 25.58, | |
| "priceAfter30m": 1.1, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 1.07, | |
| "percentAfter1h": -2.73, | |
| "priceAfter6h": 1.02, | |
| "percentAfter6h": -7.27, | |
| "priceAfter1d": 1.05, | |
| "percentAfter1d": -4.55, | |
| "priceAfter3d": 0.8539, | |
| "percentAfter3d": -22.37, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.18 | |
| }, | |
| { | |
| "ticker": "RBNE", | |
| "title": "6-K - Robin Energy Ltd. (0002039060) (Filer)", | |
| "companyName": "Robin Energy Ltd.", | |
| "filerName": null, | |
| "price": 3.2, | |
| "fav": "29.15", | |
| "volume": 832788, | |
| "averageVolume": 102913, | |
| "float": 3000000, | |
| "sharesOutstanding": 582297, | |
| "soRatio": "515.2%", | |
| "marketCap": 1863350, | |
| "isShort": true, | |
| "ftd": 14760, | |
| "intent": "Partnership, Unregistered Equity Sales, Related-Party Transaction, Credit Default, Regulatory Breach", | |
| "incorporated": "Athens, Greece", | |
| "located": "New York, United States", | |
| "filingDate": "2026-07-27T09:11:10-04:00", | |
| "signals": { | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: or is under common control with such Person as such terms are used in and construed under Rule 405 u", | |
| "Shares: 0.8M" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "Credit Default": [ | |
| "Is In Default" | |
| ], | |
| "Regulatory Breach": [ | |
| "Warning Letter" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-3", | |
| "F-3", | |
| "20-F", | |
| "EX-1.1" | |
| ], | |
| "cik": "2039060", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Marine", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "New York, United States (via Athens, Greece)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-27T13:11:57.168Z", | |
| "recordId": "RBNE-1785157917168", | |
| "expiresAt": "2026-07-31T13:11:57.168Z", | |
| "direction": "SHORT", | |
| "highest5Day": 2.44, | |
| "highest5DayPercent": -23.75, | |
| "lowest5Day": 2.13, | |
| "lowest5DayPercent": 33.44, | |
| "priceAfter30m": 3.17, | |
| "percentAfter30m": -0.94, | |
| "priceAfter1h": 3.27, | |
| "percentAfter1h": 2.19, | |
| "priceAfter6h": 3.0937, | |
| "percentAfter6h": -3.32, | |
| "priceAfter1d": 3.1, | |
| "percentAfter1d": -3.13, | |
| "priceAfter3d": 2.51, | |
| "percentAfter3d": -21.56, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -8.13 | |
| }, | |
| { | |
| "ticker": "PAG", | |
| "title": "8-K - PENSKE AUTOMOTIVE GROUP, INC. (0001019849) (Filer)", | |
| "companyName": "PENSKE AUTOMOTIVE GROUP, INC.", | |
| "filerName": null, | |
| "price": 221.95, | |
| "fav": "49.93", | |
| "volume": 247646, | |
| "averageVolume": 352485, | |
| "float": 17598446, | |
| "sharesOutstanding": 65749255, | |
| "soRatio": "26.77%", | |
| "marketCap": 14593047552, | |
| "isShort": false, | |
| "ftd": 52448, | |
| "intent": "Stock Buyback, Merger/Acquisition, Unregistered Equity Sales", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Michigan", | |
| "filingDate": "2026-07-29T12:04:41-04:00", | |
| "signals": { | |
| "Stock Buyback": [ | |
| "Repurchase Program" | |
| ], | |
| "Merger/Acquisition": [ | |
| "Take Private" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer", | |
| "Shares: 0.3M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1019849", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Retail", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Michigan (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-29T16:05:50.250Z", | |
| "recordId": "PAG-1785341150250", | |
| "expiresAt": "2026-08-03T16:05:50.250Z", | |
| "direction": "LONG", | |
| "highest5Day": 215.1725, | |
| "highest5DayPercent": -3.05, | |
| "lowest5Day": 215.1725, | |
| "lowest5DayPercent": -3.05, | |
| "priceAfter30m": 222.55, | |
| "percentAfter30m": 0.27, | |
| "priceAfter1h": 222.71, | |
| "percentAfter1h": 0.34, | |
| "priceAfter6h": 223.44, | |
| "percentAfter6h": 0.67, | |
| "priceAfter1d": 223.07, | |
| "percentAfter1d": 0.5, | |
| "priceAfter3d": 217.31, | |
| "percentAfter3d": -2.09, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "PN", | |
| "title": "6-K - PN Smart Energy Ltd (0002001288) (Filer)", | |
| "companyName": "PN Smart Energy Ltd", | |
| "filerName": null, | |
| "price": 10.72, | |
| "fav": "1.81", | |
| "volume": 255249, | |
| "averageVolume": 1915227, | |
| "float": 3472591, | |
| "sharesOutstanding": 7744775, | |
| "soRatio": "44.84%", | |
| "marketCap": 149008272, | |
| "isShort": false, | |
| "ftd": 1, | |
| "intent": "Regulation S Offering, Related-Party Transaction, Merger/Acquisition, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Unknown", | |
| "located": "China", | |
| "filingDate": "2026-07-30T08:30:45-04:00", | |
| "signals": { | |
| "Regulation S Offering": [ | |
| "Regulation S" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Related Party" | |
| ], | |
| "Merger/Acquisition": [ | |
| "Acquisition Agreement" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: Unknown Buyer" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "F-1", | |
| "F-3", | |
| "F-4", | |
| "20-F", | |
| "EX-99.1", | |
| "EX-99.2" | |
| ], | |
| "cik": "2001288", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Electrical Equipment", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "China (via Unknown)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-07-30T12:31:33.539Z", | |
| "recordId": "PN-1785414693539", | |
| "expiresAt": "2026-08-04T12:31:33.539Z", | |
| "direction": "LONG", | |
| "highest5Day": 24, | |
| "highest5DayPercent": 123.88, | |
| "lowest5Day": 8.78, | |
| "lowest5DayPercent": -18.1, | |
| "priceAfter30m": 10.72, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 17.7999, | |
| "percentAfter1h": 66.04, | |
| "priceAfter6h": 18.05, | |
| "percentAfter6h": 68.38, | |
| "priceAfter1d": 23.67, | |
| "percentAfter1d": 120.8, | |
| "priceAfter3d": 17.27, | |
| "percentAfter3d": 61.1, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": 89.83, | |
| "manualOverride": true, | |
| "overrideSource": "overrides.json" | |
| }, | |
| { | |
| "ticker": "KPTI", | |
| "title": "8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer)", | |
| "companyName": "Karyopharm Therapeutics Inc.", | |
| "filerName": null, | |
| "price": 7.01, | |
| "fav": "26.07", | |
| "volume": 674033, | |
| "averageVolume": 568206, | |
| "float": 14811820, | |
| "sharesOutstanding": 22662943, | |
| "soRatio": "65.36%", | |
| "marketCap": 158867248, | |
| "isShort": true, | |
| "ftd": 143694, | |
| "intent": "Clinical Success, Commercial Inflection, Accounting Restatement, Strategic Review", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Massachusetts", | |
| "filingDate": "2026-07-31T08:30:33-04:00", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Priority Review", | |
| "Phase 3", | |
| "Primary Endpoint", | |
| "Topline Data", | |
| "Statistically Significant" | |
| ], | |
| "Commercial Inflection": [ | |
| "Cash Runway" | |
| ], | |
| "Accounting Restatement": [ | |
| "Substantial Doubt" | |
| ], | |
| "Strategic Review": [ | |
| "Strategic Alternatives" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "Item 8.01" | |
| ], | |
| "cik": "1503802", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Biotechnology", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Massachusetts (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.15, | |
| "direction": "SHORT", | |
| "recordedAt": "2026-07-31T12:31:30.961Z", | |
| "recordId": "KPTI-1785501090961", | |
| "expiresAt": "2026-08-05T12:31:30.961Z", | |
| "highest5Day": 2.43, | |
| "highest5DayPercent": -65.34, | |
| "lowest5Day": 1.8, | |
| "lowest5DayPercent": 74.32, | |
| "priceAfter30m": 7.01, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 2.19, | |
| "percentAfter1h": -68.76, | |
| "priceAfter6h": 1.855, | |
| "percentAfter6h": -73.54, | |
| "priceAfter1d": 1.92, | |
| "percentAfter1d": -72.61, | |
| "priceAfter3d": 1.92, | |
| "percentAfter3d": -72.61, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -68.05, | |
| "manualOverride": true, | |
| "overrideSource": "overrides.json" | |
| }, | |
| { | |
| "ticker": "SKYT", | |
| "title": "8-K - SkyWater Technology, Inc (0001819974) (Filer)", | |
| "companyName": "SkyWater Technology, Inc", | |
| "filerName": null, | |
| "price": 32.46, | |
| "fav": "37.26", | |
| "volume": 2037656, | |
| "averageVolume": 964983, | |
| "float": 35954295, | |
| "sharesOutstanding": 49204602, | |
| "soRatio": "73.07%", | |
| "marketCap": 1597181312, | |
| "isShort": true, | |
| "ftd": 350, | |
| "intent": "Partnership, Asset Disposition, Going Dark", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Minnesota", | |
| "filingDate": "2026-07-31T09:00:16-04:00", | |
| "signals": { | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Asset Disposition": [ | |
| "Disposition" | |
| ], | |
| "Going Dark": [ | |
| "Form 15", | |
| "Deregistration" | |
| ] | |
| }, | |
| "bonusSignals": { | |
| "Shell Recycling": "Shell Recycling" | |
| }, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-3.1", | |
| "EX-3.2", | |
| "Item 1.02", | |
| "Item 2.01", | |
| "Item 3.01", | |
| "Item 3.03", | |
| "Item 5.01", | |
| "Item 5.02", | |
| "Item 5.03", | |
| "Item 9.01" | |
| ], | |
| "cik": "1819974", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Semiconductors", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Minnesota (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-07-31T13:01:06.887Z", | |
| "recordId": "SKYT-1785502866887", | |
| "expiresAt": "2026-08-05T13:01:06.887Z", | |
| "direction": "SHORT", | |
| "highest5Day": 32.46, | |
| "highest5DayPercent": 0, | |
| "lowest5Day": 31.13, | |
| "lowest5DayPercent": 4.1, | |
| "priceAfter30m": 32.46, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 32.46, | |
| "percentAfter1h": 0, | |
| "priceAfter6h": 32.46, | |
| "percentAfter6h": 0, | |
| "priceAfter1d": 32.46, | |
| "percentAfter1d": 0, | |
| "priceAfter3d": 32.46, | |
| "percentAfter3d": 0, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "TK", | |
| "title": "6-K - TEEKAY CORP LTD (0000911971) (Filer)", | |
| "companyName": "TEEKAY CORP LTD", | |
| "filerName": "Brody Speers Brody Speers Chief Financial Officer (Principal Financial and Accounting Officer)", | |
| "price": 11.6429, | |
| "fav": "41.03", | |
| "volume": 215229, | |
| "averageVolume": 609282, | |
| "float": 25000000, | |
| "sharesOutstanding": 87011821, | |
| "soRatio": "28.73%", | |
| "marketCap": 1013070016, | |
| "isShort": false, | |
| "ftd": 147542, | |
| "intent": "Partnership, Stock Buyback, Related-Party Transaction, Asset Disposition, Unregistered Equity Sales", | |
| "incorporated": "Hamilton, Canada", | |
| "located": "Hamilton, Canada", | |
| "filingDate": "2026-07-31T12:54:39-04:00", | |
| "signals": { | |
| "Partnership": [ | |
| "Joint Venture" | |
| ], | |
| "Stock Buyback": [ | |
| "Share Repurchase" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets" | |
| ], | |
| "Unregistered Equity Sales": [ | |
| "Item 3.02: the Company and Wah Kwong Maritime Transport Holdings Limited", | |
| "Discount: 125%", | |
| "Shares: 725.0M" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F" | |
| ], | |
| "cik": "911971", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Energy", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-31T16:55:30.947Z", | |
| "recordId": "TK-1785516930947", | |
| "expiresAt": "2026-08-05T16:55:30.947Z", | |
| "direction": "LONG", | |
| "highest5Day": 11.395, | |
| "highest5DayPercent": -2.13, | |
| "lowest5Day": 11.275, | |
| "lowest5DayPercent": -3.16, | |
| "priceAfter30m": 11.69, | |
| "percentAfter30m": 0.4, | |
| "priceAfter1h": 11.7, | |
| "percentAfter1h": 0.49, | |
| "priceAfter6h": 11.65, | |
| "percentAfter6h": 0.06, | |
| "priceAfter1d": 11.65, | |
| "percentAfter1d": 0.06, | |
| "priceAfter3d": 11.64, | |
| "percentAfter3d": -0.02, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "TEX", | |
| "title": "8-K - TEREX CORP (0000097216) (Filer)", | |
| "companyName": "TEREX CORP", | |
| "filerName": null, | |
| "price": 64.04, | |
| "fav": "35.51", | |
| "volume": 1110880, | |
| "averageVolume": 1369941, | |
| "float": 48641758, | |
| "sharesOutstanding": 114216576, | |
| "soRatio": "42.59%", | |
| "marketCap": 7314429440, | |
| "isShort": true, | |
| "ftd": 7046, | |
| "intent": "Credit Default, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Connecticut", | |
| "filingDate": "2026-07-31T13:01:55-04:00", | |
| "signals": { | |
| "Credit Default": [ | |
| "Event Of Default", | |
| "Default Under The" | |
| ], | |
| "Asset Disposition": [ | |
| "Divested" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": { | |
| "signals": [ | |
| "High Leverage - Debt/Equity Exceeds 3.0" | |
| ], | |
| "severity": 0.75, | |
| "isDeterministic": true | |
| }, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 8.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "97216", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Machinery", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Connecticut (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.05, | |
| "recordedAt": "2026-07-31T17:02:46.120Z", | |
| "recordId": "TEX-1785517366120", | |
| "expiresAt": "2026-08-05T17:02:46.120Z", | |
| "direction": "SHORT", | |
| "highest5Day": 66.96, | |
| "highest5DayPercent": 4.56, | |
| "lowest5Day": 62, | |
| "lowest5DayPercent": 3.19, | |
| "priceAfter30m": 64.135, | |
| "percentAfter30m": 0.15, | |
| "priceAfter1h": 64.43, | |
| "percentAfter1h": 0.61, | |
| "priceAfter6h": 62.84, | |
| "percentAfter6h": -1.87, | |
| "priceAfter1d": 62.84, | |
| "percentAfter1d": -1.87, | |
| "priceAfter3d": 64.095, | |
| "percentAfter3d": 0.09, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "AIDX", | |
| "title": "8-K - 20/20 Biolabs, Inc. (0001139685) (Filer)", | |
| "companyName": "20/20 Biolabs, Inc.", | |
| "filerName": null, | |
| "price": 0.448, | |
| "fav": "5.29", | |
| "volume": 44666, | |
| "averageVolume": 809614, | |
| "float": 4280710, | |
| "sharesOutstanding": 12251198, | |
| "soRatio": "34.94%", | |
| "marketCap": 5488537, | |
| "isShort": true, | |
| "ftd": 1305538, | |
| "intent": "Clinical Success, FDA Approved, Commercial Inflection, Failed Trial", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Maryland", | |
| "filingDate": "2026-08-05T12:00:42-04:00", | |
| "signals": { | |
| "Clinical Success": [ | |
| "Primary Endpoint" | |
| ], | |
| "FDA Approved": [ | |
| "FDA Approval" | |
| ], | |
| "Commercial Inflection": [ | |
| "Revenue Growth", | |
| "Repeat Business" | |
| ], | |
| "Failed Trial": [ | |
| "Primary Endpoint Missed" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "F-1", | |
| "F-3", | |
| "13D", | |
| "EX-99.1", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "1139685", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Maryland (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.1, | |
| "direction": "SHORT", | |
| "recordedAt": "2026-08-05T16:01:51.759Z", | |
| "recordId": "AIDX-1785945711759", | |
| "expiresAt": "2026-08-10T16:01:51.759Z", | |
| "highest5Day": 0.4749, | |
| "highest5DayPercent": 6, | |
| "lowest5Day": 0.4304, | |
| "lowest5DayPercent": 3.93, | |
| "priceAfter30m": 0.4431, | |
| "percentAfter30m": -1.09, | |
| "priceAfter1h": 0.4431, | |
| "percentAfter1h": -1.09, | |
| "priceAfter6h": 0.4413, | |
| "percentAfter6h": -1.5, | |
| "priceAfter1d": 0.4396, | |
| "percentAfter1d": -1.88, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "LEE", | |
| "title": "8-K - LEE ENTERPRISES, Inc (0000058361) (Filer)", | |
| "companyName": "LEE ENTERPRISES, Inc", | |
| "filerName": null, | |
| "price": 8.14, | |
| "fav": "62.45", | |
| "volume": 35980, | |
| "averageVolume": 79288, | |
| "float": 4951621, | |
| "sharesOutstanding": 22229936, | |
| "soRatio": "22.27%", | |
| "marketCap": 180951680, | |
| "isShort": false, | |
| "ftd": 63722, | |
| "intent": "Commercial Inflection, Asset Disposition", | |
| "incorporated": "Wilmington, Delaware", | |
| "located": "Iowa", | |
| "filingDate": "2026-08-06T15:45:39-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Asset Disposition": [ | |
| "Divested" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "EX-99.2", | |
| "Item 2.02", | |
| "Item 7.01", | |
| "Item 9.01" | |
| ], | |
| "cik": "58361", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Media", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Iowa (via Wilmington, Delaware)", | |
| "filingTimeBonus": 1.2, | |
| "recordedAt": "2026-08-06T19:46:49.360Z", | |
| "recordId": "LEE-1786045609361", | |
| "expiresAt": "2026-08-11T19:46:49.361Z", | |
| "direction": "LONG", | |
| "highest5Day": 8.19, | |
| "highest5DayPercent": 0.61, | |
| "lowest5Day": 7.92, | |
| "lowest5DayPercent": -2.7, | |
| "priceAfter30m": 8.12, | |
| "percentAfter30m": -0.25, | |
| "priceAfter1h": 8.12, | |
| "percentAfter1h": -0.25, | |
| "priceAfter6h": 8.12, | |
| "percentAfter6h": -0.25, | |
| "priceAfter1d": 8.175, | |
| "percentAfter1d": 0.43, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| }, | |
| { | |
| "ticker": "GEOS", | |
| "title": "8-K - GEOSPACE TECHNOLOGIES CORP (0001001115) (Filer)", | |
| "companyName": "GEOSPACE TECHNOLOGIES CORP", | |
| "filerName": null, | |
| "price": 6.82, | |
| "fav": "6.28", | |
| "volume": 116720, | |
| "averageVolume": 159267, | |
| "float": 1000000, | |
| "sharesOutstanding": 12935603, | |
| "soRatio": "7.73%", | |
| "marketCap": 88220816, | |
| "isShort": false, | |
| "ftd": 454, | |
| "intent": "Commercial Inflection, Revenue Loss, Asset Disposition", | |
| "incorporated": "Texas", | |
| "located": "Texas", | |
| "filingDate": "2026-08-07T08:36:48-04:00", | |
| "signals": { | |
| "Commercial Inflection": [ | |
| "Revenue Growth" | |
| ], | |
| "Revenue Loss": [ | |
| "Decrease In Revenue" | |
| ], | |
| "Asset Disposition": [ | |
| "Sale Of Assets" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "8-K", | |
| "EX-99.1", | |
| "Item 2.02", | |
| "Item 9.01" | |
| ], | |
| "cik": "1001115", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Energy", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": false, | |
| "custodianName": null, | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-08-07T12:37:55.524Z", | |
| "recordId": "GEOS-1786106275524", | |
| "expiresAt": "2026-08-12T12:37:55.525Z", | |
| "direction": "LONG", | |
| "highest5Day": 5.85, | |
| "highest5DayPercent": -14.22, | |
| "lowest5Day": 5.495, | |
| "lowest5DayPercent": -19.43, | |
| "priceAfter30m": 6.82, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 6.22, | |
| "percentAfter1h": -8.8, | |
| "priceAfter6h": 5.52, | |
| "percentAfter6h": -19.06, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": true, | |
| "personalPriceAlertPercent": -10.56 | |
| }, | |
| { | |
| "ticker": "PRE", | |
| "title": "6-K - Prenetics Global Ltd (0001876431) (Filer)", | |
| "companyName": "Prenetics Global Ltd", | |
| "filerName": null, | |
| "price": 17.86, | |
| "fav": "52.93", | |
| "volume": 126884, | |
| "averageVolume": 238689, | |
| "float": 12634526, | |
| "sharesOutstanding": 15419419, | |
| "soRatio": "81.94%", | |
| "marketCap": 303627008, | |
| "isShort": true, | |
| "ftd": 18092, | |
| "intent": "Licensing Deal, Related-Party Transaction, Credit Default", | |
| "incorporated": "Cayman Islands", | |
| "located": "Kowloon Bay, Hong Kong", | |
| "filingDate": "2026-08-07T08:51:06-04:00", | |
| "signals": { | |
| "Licensing Deal": [ | |
| "Exclusive License" | |
| ], | |
| "Related-Party Transaction": [ | |
| "Controlled By", | |
| "Affiliate Of" | |
| ], | |
| "Credit Default": [ | |
| "Loan Default", | |
| "Event Of Default" | |
| ] | |
| }, | |
| "bonusSignals": {}, | |
| "financialRatioSignals": {}, | |
| "formType": [ | |
| "6-K", | |
| "S-8", | |
| "F-3", | |
| "20-F", | |
| "EX-99.1", | |
| "EX-99.2" | |
| ], | |
| "cik": "1876431", | |
| "skipReason": "", | |
| "alertType": null, | |
| "predatoryFinancing": null, | |
| "sector": "Health Care", | |
| "hasTuesdayBonus": false, | |
| "custodianVerified": true, | |
| "custodianName": "Kowloon Bay, Hong Kong (via Cayman Islands)", | |
| "filingTimeBonus": 1.15, | |
| "recordedAt": "2026-08-07T12:52:10.900Z", | |
| "recordId": "PRE-1786107130900", | |
| "expiresAt": "2026-08-12T12:52:10.900Z", | |
| "direction": "SHORT", | |
| "highest5Day": 18.97, | |
| "highest5DayPercent": 6.22, | |
| "lowest5Day": 17.7101, | |
| "lowest5DayPercent": 0.84, | |
| "priceAfter30m": 17.86, | |
| "percentAfter30m": 0, | |
| "priceAfter1h": 18.37, | |
| "percentAfter1h": 2.86, | |
| "priceAfter6h": 18.33, | |
| "percentAfter6h": 2.63, | |
| "priceAfter1d": null, | |
| "percentAfter1d": null, | |
| "priceAfter3d": null, | |
| "percentAfter3d": null, | |
| "personalPriceAlertSent": false | |
| } | |
| ] |
We can't make this file beautiful and searchable because it's too large.
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| CIK,Ticker,Company Name,Price,Incorporated,Located,Market Cap,Float,Shares Outstanding,S/O Ratio,F/AV,Direction,FTD,Volume,Avg Volume,Sector,News,Skip Reason,Timestamp\n1144967,HDB,HDFC BANK LTD,26.51,United States,India,136095342592,25557866000,5133735719,497.8%,2979.40,LONG,1003642,4656449,8578188,Banking,Press Release,"Location not whitelisted (New York, United States, India)",1783937034000 | |
| 1321851,SEED,Origin Agritech LTD,1.0098,Barbados,China,12248470,6871000,12129600,56.65%,306.80,LONG,N/A,4931,22396,Food Products,Capital Raise; Partnership; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,"Volume 4,931 below 5k minimum",1783942426000 | |
| 2064764,PLSM,Pulsenmore Ltd.,3.86,Israel,Israel,25100978,2941300,6502844,45.23%,2.93,LONG,7495,36531,1003170,Health Care,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783942656000 | |
| 1999480,ANRO,"Alto Neuroscience, Inc.",26.48,Delaware,Canada,929287488,23659300,35093940,67.42%,53.72,LONG,2533,457439,440437,Pharmaceuticals,Clinical Success; Regulation S Offering; Unregistered Equity Sales,Float too large: 23.7M exceeds 13M limit (8-K),1783942747000 | |
| 1822492,HLMN,Hillman Solutions Corp.,7.73,Delaware,Ohio,1516700160,193957000,196209606,98.85%,126.47,LONG,4177,876081,1533635,Machinery,Unregistered Equity Sales,Float too large: 194.0M exceeds 13M limit (8-K),1783942994000 | |
| 1567529,KMDA,KAMADA LTD,7.12,Israel,Israel,410783200,31451600,57694272,54.51%,698.55,LONG,N/A,10238,45024,Biotechnology,Commercial Inflection,Float too large: 31.5M exceeds 20M limit (6-K),1783943176000 | |
| 1986247,BYAH,"Park Ha Biological Technology Co., Ltd.",0.58,China,China,3660505,5983216,5930216,100.9%,1.31,N/A,443998,1490241,4578185,N/A,Clinical Success; Asset Disposition; Partnership; Unregistered Equity Sales,F/AV 1.31x below 3x absolute minimum (untradeable liquidity),1783943259000 | |
| 1997377,ISOU,IsoEnergy Ltd.,10.5,Canada,Canada,682379264,37964000,64988500,58.42%,281.30,LONG,38462,36711,134959,Energy,Unregistered Equity Sales,Float too large: 38.0M exceeds 20M limit (6-K),1783943870000 | |
| 2030617,PMI,"Picard Medical, Inc.",0.154,Delaware,Arizona,15815174,39507300,102695935,38.47%,1.32,LONG,52444708,1381768,29953796,Health Care,Press Release,Price too low: $0.1540 below $0.35 minimum,1783943877000 | |
| 1920406,ASST,"Strive, Inc.",12.36,Nevada,Texas,1012838016,56745000,72164809,78.63%,12.62,LONG,225623,1985423,4496339,Health Care,Unregistered Equity Sales,Float too large: 56.7M exceeds 13M limit (8-K),1783943968000 | |
| 1852767,MRT,"Marti Technologies, Inc.",1.32,Cayman Islands,Cayman Islands,113445808,24458700,85943792,28.46%,542.77,LONG,931,24899,45063,Road & Rail,Partnership,Float too large: 24.5M exceeds 20M limit (6-K),1783944016000 | |
| 1050446,MSTR,Strategy Inc,94.64,Delaware,Virginia,33859211264,329887000,338128276,97.56%,15.30,LONG,424725,16284456,21561577,Technology,Stock Buyback; Unregistered Equity Sales,Float too large: 329.9M exceeds 13M limit (8-K),1783944014000 | |
| 1596812,ENLV,Enlivex Ltd.,6.86,Israel,Israel,115467632,3847800,16832015,22.86%,125.16,N/A,4402,96543,30742,N/A,Clinical Success; Clinical Milestone; FDA Approved,F/AV 125.16x exceeds max threshold of 70x,1783944016000 | |
| 2040290,LGPS,LOGPROSTYLE INC.,0.8309,Japan,Japan,19618272,18966969,23610870,80.33%,14.40,LONG,412210,91867,1317249,Real Estate,Underwritten Offering; Commercial Inflection,"Location not whitelisted (Tokyo, Japan, Tokyo, Japan)",1783944067000 | |
| 1877971,POM,POMDOCTOR Ltd,1.53,Cayman Islands,China,11406537,157230,6774573,2.32%,0.37,SHORT,N/A,30967,427257,Health Care,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1783944317000 | |
| 1781730,TCBX,"Third Coast Bancshares, Inc.",39.85,Texas,Texas,661193984,15180600,16592071,91.49%,143.50,LONG,1648,47330,105786,Banking,Partnership,Float too large: 15.2M exceeds 13M limit (8-K),1783944342000 | |
| 1846253,OABIW,"OmniAb, Inc.",0.0887,Delaware,Canada,N/A,113851000,144972580,78.53%,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,Price too low: $0.0887 below $0.35 minimum,1783944394000 | |
| 1570827,VCTR,"Victory Capital Holdings, Inc.",92.24,Delaware,Ohio,5767868928,48601700,62531106,77.72%,100.24,LONG,85760,278756,484867,Financial Services,Press Release,Float too large: 48.6M exceeds 13M limit (8-K),1783945703000 | |
| 2074123,CCHH,CCH Holdings Ltd,1.9,Cayman Islands,Malaysia,57437000,5000000000,30230000,16539.9%,7896.65,SHORT,1059991,3498980,633180,"Hotels, Restaurants & Leisure",Bid Price Delisting,Float too large: 5000.0M exceeds 20M limit (6-K),1783945801000 | |
| 1654595,MDRR,"Medalist Diversified, Inc.",11.5199,Maryland,Virginia,18760158,637700,1628500,39.16%,293.47,LONG,N/A,359,2173,Real Estate,Press Release,"Location not whitelisted (Maryland, Virginia)",1783945852000 | |
| 1372299,OCGN,"Ocugen, Inc.",1.47,Delaware,Pennsylvania,497627136,316843000,338521856,93.60%,40.12,LONG,745676,3513278,7898070,Biotechnology,Clinical Success; FDA Approved; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,Float too large: 316.8M exceeds 13M limit (8-K),1783945843000 | |
| 1500435,GPRO,"GoPro, Inc.",0.7628,Delaware,Canada,131962184,25706940,146738559,17.52%,2.94,LONG,1167955,4579840,8738291,Consumer products,Merger/Acquisition; Unregistered Equity Sales,Float too large: 25.7M exceeds 13M limit (8-K),1783945870000 | |
| 1794669,FOUR,"Shift4 Payments, Inc.",50.81,Unknown,Pennsylvania,5036792832,43306500,79328924,54.59%,25.74,SHORT,355895,799204,1682716,Financial Services,Merger/Acquisition; Convertible Debt; Bankruptcy Filing; Credit Default; Asset Disposition; Related-Party Transaction; Unregistered Equity Sales,"Location not whitelisted (Unknown, Pennsylvania)",1783945911000 | |
| 1710072,EWTX,"Edgewise Therapeutics, Inc.",45.41,Delaware,Colorado,4885798400,67120000,107593006,62.38%,45.42,LONG,22569,1068174,1477822,Pharmaceuticals,Clinical Success; Asset Disposition; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering,Float too large: 67.1M exceeds 13M limit (8-K),1783946232000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,14.72,Unknown,United Kingdom,33896562688,3603899000,2302755593,156.5%,895.58,LONG,99516,17052726,4024085,Telecommunication,Press Release,"Location not whitelisted (Unknown, United Kingdom)",1783946298000 | |
| 1104485,NOG,"NORTHERN OIL & GAS, INC.",18.52,Unknown,Minnesota,2014682496,102211429,108784154,93.96%,33.41,LONG,49947,2137904,3058855,Energy,Stock Buyback,"Location not whitelisted (Unknown, Minnesota)",1783946455000 | |
| 1640266,VYGR,"Voyager Therapeutics, Inc.",3.44,Delaware,Massachusetts,207849232,50396560,60421287,83.41%,84.56,LONG,2023,716461,595954,Biotechnology,Clinical Success; Clinical Milestone; Regulation S Offering; Unregistered Equity Sales,Float too large: 50.4M exceeds 13M limit (8-K),1783946659000 | |
| 2019435,BGL,Blue Gold Ltd,0.251,Cayman Islands,Cayman Islands,10250280,15800255,40837773,38.69%,18.48,LONG,41968,276762,854955,Metals & Mining,Press Release,Price too low: $0.2510 below $0.35 minimum,1783946686000 | |
| 1829311,BMNR,"BITMINE IMMERSION TECHNOLOGIES, INC.",14.98,Delaware,Connecticut,8532260864,3500000,569576819,0.61%,0.09,LONG,1200711,28436863,38141924,Technology,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783946724000 | |
| 1661458,Unknown,"Highlands REIT, Inc.",N/A,Maryland,Israel,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Related-Party Transaction; Unregistered Equity Sales,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1783947067000 | |
| 1564708,NWSA,NEWS CORP,27.37,Delaware,New York,14849744896,545733252,361550838,150.9%,106.66,LONG,N/A,2165792,5116490,Media,Stock Buyback,Float too large: 545.7M exceeds 13M limit (8-K),1783947372000 | |
| 764038,SSB,SouthState Bank Corp,99.68,Florida,Florida,9735549952,96685030,97668043,98.99%,117.34,LONG,N/A,353080,823962,Banking,Press Release,"Location not whitelisted (Florida, Florida)",1783947511000 | |
| 1401914,DARE,"Dare Bioscience, Inc.",2.02,Delaware,Canada,30258594,9370042,14979502,62.55%,14.49,LONG,2645,49125,646442,Pharmaceuticals,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783947619000 | |
| 1129928,ONCY,ONCOLYTICS BIOTECH INC,0.8873,Nevada,Canada,105902864,116895373,119354067,97.94%,88.28,LONG,745029,1016921,1324155,Biotechnology,Clinical Success; FDA Approved,Float too large: 116.9M exceeds 13M limit (8-K),1783947834000 | |
| 2011641,FERG,Ferguson Enterprises Inc. /DE/,227.46,Delaware,Virginia,44113096704,193528617,193937826,99.79%,138.53,LONG,2192,722212,1396998,Trading Companies & Distributors,Unregistered Equity Sales,Float too large: 193.5M exceeds 13M limit (8-K),1783947907000 | |
| 1434868,ESPR,"Esperion Therapeutics, Inc.",3.18,Delaware,Michigan,819464832,207908719,257693347,80.68%,13.32,SHORT,343236,59090465,15608719,Pharmaceuticals,Merger/Acquisition; Clinical Success; Convertible Debt; Credit Default; Going Dark; Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,Float too large: 207.9M exceeds 13M limit (8-K),1783948249000 | |
| 1867729,WRD,WeRide Inc.,5.57,Cayman Islands,China,1832285696,281548713,310684647,90.62%,105.33,LONG,688014,2227166,2673136,Auto Components,Press Release,Float too large: 281.5M exceeds 20M limit (6-K),1783948316000 | |
| 107263,WMB,"WILLIAMS COMPANIES, INC.",75.02,Delaware,Oklahoma,91749326848,1215953795,1222998265,99.42%,178.02,LONG,431,3995507,6830529,Energy,Partnership; Unregistered Equity Sales,Float too large: 1216.0M exceeds 13M limit (8-K),1783948807000 | |
| 1966287,GFR,Greenfire Resources Ltd.,5.57,Canada,Canada,698639552,19404404,125429000,15.47%,100.08,N/A,134,46138,193893,N/A,Merger/Acquisition; Unregistered Equity Sales,F/AV 100.08x exceeds max threshold of 70x,1783949069000 | |
| 904851,YPF,YPF SOCIEDAD ANONIMA,47.58,Argentina,Argentina,18657396736,5474570,392075056,1.40%,2.82,LONG,3382,587608,1938783,Energy,Unregistered Equity Sales,"Location not whitelisted (Buenos Aires, Argentina, Argentina)",1783949079000 | |
| 353278,NVO,NOVO NORDISK A S,49.48,Unknown,Denmark,218939375616,11200000,3349933520,0.33%,0.77,LONG,436380,6128283,14631011,Pharmaceuticals,Stock Buyback,"Location not whitelisted (Unknown, Copenhagen, Denmark)",1783949077000 | |
| 2113060,IQMX,IQM Quantum Computers Oyj,12.35,H9,Finland,2605710336,210988684,210988684,100.0%,387.61,LONG,N/A,171953,544327,N/A,Press Release,"Location not whitelisted (H9, Finland)",1783951030000 | |
| 717826,ERIC,ERICSSON LM TELEPHONE CO,11.4801,Sweden,Sweden,37933150208,3371351735,3042496794,110.8%,313.48,LONG,1836837,4550723,10754432,Communications,Press Release,"Location not whitelisted (Stockholm, Sweden, Stockholm, Sweden)",1783950836000 | |
| 904851,YPF,YPF SOCIEDAD ANONIMA,47.93,Argentina,Argentina,18794641408,5474570,392075056,1.40%,2.82,LONG,3382,109441,1938783,Energy,Unregistered Equity Sales,"Location not whitelisted (Buenos Aires, Argentina, Argentina)",1783949079000 | |
| 353278,NVO,NOVO NORDISK A S,49.36,Unknown,Denmark,218408402944,11200000,3349933520,0.33%,0.77,LONG,436380,1722689,14631011,Pharmaceuticals,Stock Buyback,"Location not whitelisted (Unknown, Copenhagen, Denmark)",1783949077000 | |
| 1966287,GFR,Greenfire Resources Ltd.,5.94,Canada,Canada,745048256,19404404,125429000,15.47%,100.08,N/A,134,19458,193893,N/A,Merger/Acquisition; Unregistered Equity Sales,F/AV 100.08x exceeds max threshold of 90x,1783949069000 | |
| 1867729,WRD,WeRide Inc.,5.52,Cayman Islands,China,1815837824,281548713,310684647,90.62%,105.33,LONG,688014,221046,2673136,Auto Components,Press Release,Float too large: 281.5M exceeds 50M limit (6-K),1783948316000 | |
| 2019435,BGL,Blue Gold Ltd,0.2449,Cayman Islands,Cayman Islands,10001170,15800255,40837773,38.69%,18.48,LONG,41968,30437,854955,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783946686000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,15.29,Unknown,United Kingdom,35209134080,2302520513,2302755593,99.99%,572.18,LONG,99516,1641131,4024085,Telecommunication,Press Release,"Location not whitelisted (Unknown, United Kingdom)",1783946298000 | |
| 2074123,CCHH,CCH Holdings Ltd,1.68,Cayman Islands,Malaysia,50786400,5000000000,30230000,16539.9%,7896.65,SHORT,1059991,230754,633180,"Hotels, Restaurants & Leisure",Bid Price Delisting,Float too large: 5000.0M exceeds 50M limit (6-K),1783945801000 | |
| 1877971,POM,POMDOCTOR Ltd,1.6213,Cayman Islands,China,12087202,157230,6774573,2.32%,0.37,SHORT,N/A,8228,427257,Health Care,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1783944317000 | |
| 2040290,LGPS,LOGPROSTYLE INC.,1.18,Japan,Japan,27860826,18966969,23610870,80.33%,14.40,LONG,412210,62080749,1317249,Real Estate,Underwritten Offering; Commercial Inflection,"Location not whitelisted (Tokyo, Japan, Tokyo, Japan)",1783944067000 | |
| 1852767,MRT,"Marti Technologies, Inc.",1.39,Cayman Islands,Cayman Islands,119461872,29150320,85943792,33.92%,646.88,LONG,931,35876,45063,Road & Rail,Partnership,"Insufficient core signal categories (need 2+, found 0)",1783944016000 | |
| 1596812,ENLV,Enlivex Ltd.,6.81,Israel,Israel,114626024,16747025,16832015,99.50%,544.76,N/A,4402,52940,30742,N/A,Clinical Success; Clinical Milestone; FDA Approved,F/AV 544.76x exceeds max threshold of 90x,1783944016000 | |
| 1997377,ISOU,IsoEnergy Ltd.,10.3973,Canada,Canada,675704896,37964018,64988500,58.42%,281.30,LONG,38462,2519,134959,Energy,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783943870000 | |
| 1986247,BYAH,"Park Ha Biological Technology Co., Ltd.",0.5025,China,China,3171386,5983216,5930216,100.9%,1.31,N/A,443998,200063,4578185,N/A,Clinical Success; Asset Disposition; Partnership; Unregistered Equity Sales,S/O 100.89% very high - needs extreme catalyst to be tradeable,1783943259000 | |
| 1567529,KMDA,KAMADA LTD,7.1499,Israel,Israel,412508288,31451591,57694272,54.51%,698.55,LONG,N/A,31573,45024,Biotechnology,Commercial Inflection,"Insufficient core signal categories (need 2+, found 0)",1783943176000 | |
| 2064764,PLSM,Pulsenmore Ltd.,4.2001,Israel,Israel,27312594,3859747,6502844,59.35%,3.79,LONG,7495,21669761,1019465,Health Care,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783942656000 | |
| 1321851,SEED,Origin Agritech LTD,1.005,Barbados,China,12190248,6643976,12129600,54.77%,295.10,LONG,N/A,1426,22514,Food Products,Capital Raise; Partnership; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,"Volume 1,426 below 2k minimum",1783942426000 | |
| 1953575,CNL,Collective Mining Ltd.,12.34,Canada,Canada (Federal Level),1144405504,302823098,92739507,326.5%,4751.58,LONG,22976,807,63731,Metals & Mining,Capital Raise; Unregistered Equity Sales,Float too large: 302.8M exceeds 50M limit (6-K),1783940706000 | |
| 2113060,IQMX,IQM Quantum Computers Oyj,12.14,H9,Finland,2561402624,210988684,210988684,100.0%,387.61,LONG,N/A,209738,544327,N/A,Press Release,"Location not whitelisted (H9, Finland)",1783951030000 | |
| 717826,ERIC,ERICSSON LM TELEPHONE CO,11.52,Sweden,Sweden,38064992256,3371351735,3042496794,110.8%,313.48,LONG,1836837,7217449,10754432,Communications,Press Release,"Location not whitelisted (Stockholm, Sweden, Stockholm, Sweden)",1783950836000 | |
| 904851,YPF,YPF SOCIEDAD ANONIMA,49.2,Argentina,Argentina,19292643328,5474570,392075056,1.40%,2.82,LONG,3382,282271,1938783,Energy,Unregistered Equity Sales,"Location not whitelisted (Buenos Aires, Argentina, Argentina)",1783949079000 | |
| 353278,NVO,NOVO NORDISK A S,49.215,Unknown,Denmark,217766789120,11200000,3349933520,0.33%,0.77,LONG,436380,2308998,14631011,Pharmaceuticals,Stock Buyback,"Location not whitelisted (Unknown, Copenhagen, Denmark)",1783949077000 | |
| 1966287,GFR,Greenfire Resources Ltd.,5.83,Canada,Canada,731251072,19404404,125429000,15.47%,100.08,N/A,134,29144,193893,N/A,Merger/Acquisition; Unregistered Equity Sales,F/AV 100.08x exceeds max threshold of 80x,1783949069000 | |
| 1867729,WRD,WeRide Inc.,5.535,Cayman Islands,China,1820772096,281548713,310684647,90.62%,105.33,LONG,688014,293850,2673136,Auto Components,Press Release,Float too large: 281.5M exceeds 50M limit (6-K),1783948316000 | |
| 2019435,BGL,Blue Gold Ltd,0.2457,Cayman Islands,Cayman Islands,10033841,15800255,40837773,38.69%,18.48,LONG,41968,33789,854955,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783946686000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,15.265,Unknown,United Kingdom,35151564800,2302520513,2302755593,99.99%,572.18,LONG,99516,2073177,4024085,Telecommunication,Press Release,"Location not whitelisted (Unknown, United Kingdom)",1783946298000 | |
| 2074123,CCHH,CCH Holdings Ltd,1.6858,Cayman Islands,Malaysia,50961732,5000000000,30230000,16539.9%,7896.65,SHORT,1059991,267546,633180,"Hotels, Restaurants & Leisure",Bid Price Delisting,Float too large: 5000.0M exceeds 50M limit (6-K),1783945801000 | |
| 1877971,POM,POMDOCTOR Ltd,1.56,Cayman Islands,China,11630194,157230,6774573,2.32%,0.37,SHORT,N/A,10097,427257,Health Care,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1783944317000 | |
| 2040290,LGPS,LOGPROSTYLE INC.,1.2699,Japan,Japan,29983442,18966969,23610870,80.33%,14.40,LONG,412210,67801288,1317249,Real Estate,Underwritten Offering; Commercial Inflection,"Location not whitelisted (Tokyo, Japan, Tokyo, Japan)",1783944067000 | |
| 1852767,MRT,"Marti Technologies, Inc.",1.385,Cayman Islands,Cayman Islands,119032152,29150320,85943792,33.92%,646.88,LONG,931,39065,45063,Road & Rail,Partnership,"Insufficient core signal categories (need 2+, found 0)",1783944016000 | |
| 1596812,ENLV,Enlivex Ltd.,6.78,Israel,Israel,114121072,16747025,16832015,99.50%,544.76,N/A,4402,59752,30742,N/A,Clinical Success; Clinical Milestone; FDA Approved,F/AV 544.76x exceeds max threshold of 80x,1783944016000 | |
| 1997377,ISOU,IsoEnergy Ltd.,10.23,Canada,Canada,664832320,37964018,64988500,58.42%,281.30,LONG,38462,10570,134959,Energy,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783943870000 | |
| 1986247,BYAH,"Park Ha Biological Technology Co., Ltd.",0.485,China,China,3060939,5983216,5930216,100.9%,1.31,N/A,443998,294889,4578185,N/A,Clinical Success; Asset Disposition; Partnership; Unregistered Equity Sales,S/O 100.89% very high - needs extreme catalyst to be tradeable,1783943259000 | |
| 1567529,KMDA,KAMADA LTD,7.19,Israel,Israel,414821824,31451591,57694272,54.51%,698.55,LONG,N/A,35112,45024,Biotechnology,Commercial Inflection,"Insufficient core signal categories (need 2+, found 0)",1783943176000 | |
| 2064764,PLSM,Pulsenmore Ltd.,4.24,Israel,Israel,27572058,3859747,6502844,59.35%,3.79,LONG,7495,22270063,1019465,Health Care,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783942656000 | |
| 1321851,SEED,Origin Agritech LTD,1.01,Barbados,China,12250896,6643976,12129600,54.77%,295.10,LONG,N/A,3227,22514,Food Products,Capital Raise; Partnership; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783942426000 | |
| 1953575,CNL,Collective Mining Ltd.,12.35,Canada,Canada (Federal Level),1145332864,302823098,92739507,326.5%,4751.58,LONG,22976,4699,63731,Metals & Mining,Capital Raise; Unregistered Equity Sales,Float too large: 302.8M exceeds 50M limit (6-K),1783940706000 | |
| 1514597,FURY,FURY GOLD MINES LTD,0.555,Canada,Canada,105523368,175985608,190132195,92.56%,619.95,LONG,386,40761,283872,Metals & Mining,Clinical Success,Float too large: 176.0M exceeds 50M limit (6-K),1783940343000 | |
| 1001085,BN,BROOKFIELD Corp /ON/,43.758,Canada,Canada,97737678848,1335891155,2233510540,59.81%,285.16,LONG,498175,642147,4684631,Financial Services,Press Release,Float too large: 1335.9M exceeds 50M limit (6-K),1783939503000 | |
| 1132924,CHT,CHUNGHWA TELECOM CO LTD,41.635,Unknown,Taiwan,32298127360,775744224,775744655,100.00%,5638.25,LONG,4317,8540,137586,Telecommunication,Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,"Location not whitelisted (Unknown, Taiwan)",1783939429000 | |
| 1503584,CMRE,Costamare Inc.,15.445,Greece,Monaco,1864803968,45193575,120738359,37.43%,98.18,LONG,251,54790,460309,Marine,Merger/Acquisition,"Location not whitelisted (Athens, Greece, Monaco)",1783939274000 | |
| 1038683,RYAAY,RYANAIR HOLDINGS PLC,63.69,Unknown,Ireland,33085087744,479117677,519470673,92.23%,327.59,LONG,18771,583111,1462559,Airlines,Press Release,"Location not whitelisted (Unknown, Ireland)",1783939064000 | |
| 1989930,FGL,"Lee Seng Chi Name: Lee Seng Chi Title: Chief Executive Officer, Director, and Chairman of the Board of Directors Date: July 13, 2026 2",1.3399,Hong Kong,Malaysia,1323144,813764,894247,91.00%,0.80,LONG,109638,11835,1018570,Construction,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783939038000 | |
| 2000530,GMHS,Gamehaus Holdings Inc.,0.9021,Cayman Islands,China,51707664,4157133,49520156,8.39%,3.91,SHORT,640180,5809,1063608,Media,Nasdaq Delisting; Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1783938626000 | |
| 1978867,CDLR,Mikkel Gleerup Title: Chief Executive Officer 3,22.69,Denmark,Denmark,2188927488,96460743,96471019,99.99%,1052.20,LONG,20745,14778,91675,Construction,Press Release,"Location not whitelisted (Copenhagen, Denmark, Copenhagen, Denmark)",1783938606000 | |
| 1867102,EVTL,Vertical Aerospace Ltd.,1.64,Cayman Islands,UK,208817920,95179345,127328004,74.75%,30.68,LONG,734413,525412,3102160,Aerospace & Defense,Press Release,Float too large: 95.2M exceeds 50M limit (6-K),1783938575000 | |
| 1131399,GSK,GSK plc,52.135,UK,United Kingdom,104415854592,1946202600,2002797682,97.17%,504.08,LONG,2228,517662,3860900,Pharmaceuticals,Clinical Success; Licensing Deal,"Location not whitelisted (London, UK, United Kingdom)",1783938540000 | |
| 1791706,LI,Li Auto Inc.,12.255,Cayman Islands,China,12138719232,28625440,812961253,3.52%,6.83,LONG,1107422,765863,4192677,Automobiles,Convertible Debt; Stock Buyback,"Insufficient core signal categories (need 2+, found 1)",1783937439000 | |
| 1116578,PUK,PRUDENTIAL PLC,28.365,UK,United Kingdom,35376889856,2508297062,1247202235,201.1%,2391.75,LONG,159285,260432,1048727,Insurance,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1783937418000 | |
| 1677250,ZTO,ZTO Express (Cayman) Inc.,24.17,Cayman Islands,China,18381688832,69900693,554416690,12.61%,42.40,LONG,24711,140665,1648649,Logistics & Transportation,Convertible Debt; Stock Buyback,Float too large: 69.9M exceeds 50M limit (6-K),1783937088000 | |
| 1973832,AU,AngloGold Ashanti PLC,80.225,UK,United Kingdom,40563695616,504901946,505624114,99.86%,171.41,LONG,13711,420060,2945622,Metals & Mining,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1783937053000 | |
| 1144967,HDB,HDFC BANK LTD,26.47,United States,India,135889985536,1703998296,5133735719,33.19%,198.74,LONG,1003642,1616623,8574049,Banking,Press Release,"Location not whitelisted (New York, United States, India)",1783937034000 | |
| 1809587,BEKE,KE Holdings Inc.,16.125,Cayman Islands,China,17862948864,3462439068,1062462853,325.9%,736.81,LONG,56776,966600,4699227,Real Estate,Convertible Debt; Stock Buyback,Float too large: 3462.4M exceeds 50M limit (6-K),1783936959000 | |
| 16859,SRL,Scully Royalty Ltd.,5.365,Cayman Islands,China,81689368,11162783,15226351,73.31%,1136.28,LONG,N/A,15684,9824,Metals & Mining,Partnership; Related-Party Transaction; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783936954000 | |
| 1027664,ESLT,ELBIT SYSTEMS LTD,735.15,Israel,Israel,34442297344,27190215,46850704,58.04%,248.12,LONG,998,29748,109586,Aerospace & Defense,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783936912000 | |
| 1835724,ZH,Zhihu Inc.,3.265,Cayman Islands,China,281969152,9311032,81283228,11.46%,40.61,LONG,56231,19152,229303,Media,Convertible Debt; Stock Buyback,"Insufficient core signal categories (need 2+, found 1)",1783936860000 | |
| 1828253,EVAX,Evaxion A/S,3.12,Denmark,Denmark,26021470,5102445,8340215,61.18%,168.59,LONG,N/A,6621,30265,Biotechnology,Press Release,"Location not whitelisted (Copenhagen, Denmark, Denmark)",1783936814000 | |
| 1584547,GP,GREENPOWER MOTOR Co INC.,1.46,Canada,Canada,10283275,2198076,7043339,31.21%,3.86,LONG,42968,52869,569134,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783723022000 | |
| 1429937,BTG,B2GOLD CORP,3.79,Canada,Canada,5049862656,1251748631,1332417631,93.95%,46.84,LONG,1474130,5116850,26721754,Metals & Mining,Press Release,Float too large: 1251.7M exceeds 50M limit (6-K),1783719903000 | |
| 1924064,RLNDF,RoyaLand Co Ltd.,2.5,Canada,Canada,N/A,50000000,14,357142857.1%,357142.86,SHORT,300,100,140,Media,Underwritten Offering; Accounting Restatement; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Volume 100 below 2k minimum,1783718965000 | |
| 917851,VALE,Vale S.A.,14.325,Unknown,Brazil,60987355136,3965376710,4257407053,93.14%,165.61,LONG,196746,3450375,23943742,Metals & Mining,Underwritten Offering,"Location not whitelisted (Unknown, Brazil)",1783718336000 | |
| 1027552,BSAC,BANCO SANTANDER CHILE,33.6,France,Chile,15829474304,1895212,471115317,0.40%,4.27,LONG,37547,33028,444327,Banking,Press Release,"Location not whitelisted (Paris, France, Chile)",1783718244000 | |
| 1565025,ABEV,Guilherme Fleury de Figueiredo Ferraz Parolari Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer,3.085,Brazil,Brazil,47865925632,30679627,15515697304,0.20%,1.13,LONG,1725247,4619104,27263945,Beverages,Press Release,"Location not whitelisted (Sao Paulo, Brazil, Brazil)",1783717610000 | |
| 1565025,ABEV,Guilherme Fleury de Figueiredo Ferraz Parolari Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer,3.085,Brazil,Brazil,47865925632,247967585,15515697304,1.60%,9.10,LONG,1725247,4620124,27263945,Beverages,Press Release,"Location not whitelisted (Sao Paulo, Brazil, Brazil)",1783717432000 | |
| 1954694,LGCL,Lucas GC Ltd,1.365,Cayman Islands,China,58408900,333372,42790404,0.78%,0.13,N/A,383,112662,2472045,N/A,Executive Departure; Regulation S Offering; Unregistered Equity Sales,F/AV 0.13x below 1.2x absolute minimum (untradeable liquidity),1783717201000 | |
| 1584547,GP,GREENPOWER MOTOR Co INC.,1.475,Canada,Canada,10388925,1494423,7043339,21.22%,2.63,SHORT,42968,52969,569134,N/A,Credit Default; Accounting Restatement; Asset Disposition; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [SHORT] Credit Default, Accounting Restatement, Asset Disposition, Unregistered Equity Sales, Related-Party Transaction (Bonus: Filing Time 1.2x)",1783716991000 | |
| 2001699,HPAI,Helport AI Ltd,0.6299,Cayman Islands,Singapore,23713790,7586883,37646910,20.15%,7.29,SHORT,297419,13120,1040375,Technology,Credit Default; Partnership; Licensing Deal; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Alert sent: [SHORT] Credit Default, Partnership, Licensing Deal, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction (Bonus: Singapore (via Cayman Islands) 1.3x + Filing Time 1.2x)",1783716301000 | |
| 1456346,FNV,FRANCO NEVADA Corp,203.545,Canada,Canada,39254777856,9700876,192855530,5.03%,11.71,LONG,232540,86659,828304,Metals & Mining,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783715972000 | |
| 924613,NOK,NOKIA CORP,11.935,H9,H9,66627547136,5699859627,5582534171,102.1%,51.57,LONG,708384,44292277,110516931,Communications,Press Release,"Location not whitelisted (H9, H9)",1783715423000 | |
| 1334388,OBE,OBSIDIAN ENERGY LTD.,8.71,Canada,Canada,581625664,59696912,66776768,89.40%,59.88,SHORT,19981,136019,997014,Energy,Credit Default; Partnership; Regulation S Offering; Unregistered Equity Sales,Float too large: 59.7M exceeds 50M limit (6-K),1783715402000 | |
| 1739016,ELVR,Elevra Lithium Ltd,61.335,Australia,Australia,1111478656,66488184,16932911,392.7%,481.64,LONG,5998,15916,138045,Metals & Mining,Press Release,"Location not whitelisted (Brisbane, Australia, Australia)",1783715194000 | |
| 1738758,CHR,"Cheer Holding, Inc.",1.93,Cayman Islands,China,3561724,3333333,1845453,180.6%,18.51,LONG,56678,8922,180083,Media,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783714928000 | |
| 1901215,BNRG,Ofir Zimmerman Title: Chief Financial Officer 2,0.6748,Israel,Israel,1430127,489419,2119336,23.09%,0.36,LONG,273737,615469,1369207,Electrical Equipment,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783714258000 | |
| 1943421,RUBI,"Nikolaos Papastratis Name: Nikolaos Papastratis Title: Chief Financial Officer Date: July 10, 2026",4.59,Greece,Greece,2777005,756645,605012,125.1%,1.67,LONG,646086,7077,452965,Energy,Press Release,"Location not whitelisted (Athens, Greece, Greece)",1783714177000 | |
| 1885827,VRAX,Virax Biolabs Group Ltd,4.355,Cayman Islands,UK,3470882,19566104,796988,2455.0%,9.56,N/A,1108368,477559,2047502,N/A,Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,S/O 2455.01% very high - needs extreme catalyst to be tradeable,1783714012000 | |
| 2000366,SCAG,Chao Gao Title: Chairman and Chief Executive Officer 2,0.3978,Cayman Islands,China,28884124,26762107,72609665,36.86%,5.68,LONG,3173485,195963,4707495,Machinery,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783713922000 | |
| 2053033,PLTS,Platinum Analytics Cayman Ltd,17.5,Cayman Islands,Singapore,316034432,7545818,11205435,67.34%,N/A,SHORT,N/A,N/A,N/A,Technology,Nasdaq Delisting,"Insufficient core signal categories (need 2+, found 0)",1783713918000 | |
| 2027360,RCT,"Justin Floyd Name: Justin Floyd Title: Chief Executive Officer Date: July 10, 2026",0.2503,UK,UK,14858314,62038019,59362026,104.5%,9.12,LONG,8665,25729884,6800009,Distributors,Press Release,"Location not whitelisted (London, UK, London, UK)",1783713917000 | |
| 1649313,BWLP,BW LPG Ltd,20.175,Singapore,Singapore,3062859520,81515331,151814604,53.69%,173.40,LONG,45600,177260,470093,Energy,Asset Disposition,"Location not whitelisted (Singapore, Singapore)",1783713917000 | |
| 2000756,KWM,Ted Kim Title: Chief Executive Officer 4,0.1337,Cayman Islands,Cayman Islands,9155286,67442701,68476338,98.49%,55.75,LONG,10331,177803,1209827,Media,Unregistered Equity Sales,Price too low: $0.1337 below $0.2 minimum,1783713913000 | |
| 1829118,TUYA,Tuya Inc.,1.815,Cayman Islands,China,1112795904,800000000,542948046,147.3%,750.20,LONG,N/A,195880,1066381,Technology,Press Release,Float too large: 800.0M exceeds 50M limit (6-K),1783713801000 | |
| 1577552,BABA,Alibaba Group Holding Ltd,113.04,Hong Kong,Hong Kong,270964228096,2209767961,2397065032,92.19%,176.35,LONG,433762,3317315,12530739,Retail,Convertible Debt; Stock Buyback,Float too large: 2209.8M exceeds 50M limit (6-K),1783713691000 | |
| 1892500,CMND,Clearmind Medicine Inc.,2.08,Canada,Canada,3089946,757397,1485551,50.98%,0.32,N/A,995977,3754968,2396313,N/A,Press Release,F/AV 0.32x below 1.2x absolute minimum (untradeable liquidity),1783713617000 | |
| 917851,VALE,Vale S.A.,14.295,Unknown,Brazil,60859633664,3965376710,4257407053,93.14%,165.61,LONG,196746,3536055,23943742,Metals & Mining,Unregistered Equity Sales,"Location not whitelisted (Unknown, Brazil)",1783713094000 | |
| 1912884,RPGL,Republic Power Group Ltd,1.94,Hong Kong,Singapore,2123782,20793,1077531,1.93%,0.02,N/A,306185,80589,877380,N/A,Underwritten Offering; Accounting Restatement; Commercial Inflection; Related-Party Transaction; Unregistered Equity Sales,F/AV 0.02x below 1.2x absolute minimum (untradeable liquidity),1783707043000 | |
| 1160106,LYG,Lloyds Banking Group plc,5.915,UK,UK,85960114176,7000000,14532563782,0.05%,0.32,LONG,2087493,6955766,21666878,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1783706067000 | |
| 844150,NWG,NatWest Group plc,17.465,UK,UK,69507252224,1610933,3979802251,0.04%,0.37,LONG,202225,1073149,4350460,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1783702672000 | |
| 1232384,TRP,TC ENERGY CORP,67.55,Canada,Canada,70371360768,999010000,1041766896,95.90%,407.81,LONG,15130,233008,2449665,Energy,Press Release,Float too large: 999.0M exceeds 50M limit (6-K),1783694415000 | |
| 1691493,NU,Nu Holdings Ltd.,13.745,Cayman Islands,Brazil,66395009024,3642202775,3807883872,95.65%,66.02,LONG,83301,11203014,55171540,Banking,Unregistered Equity Sales,Float too large: 3642.2M exceeds 50M limit (6-K),1783692009000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,15.325,Unknown,United Kingdom,35289726976,2302520513,2302755593,99.99%,572.18,LONG,99516,2217873,4024085,Telecommunication,Press Release,"Location not whitelisted (Unknown, United Kingdom)",1783689291000 | |
| 1440972,LAR,Lithium Argentina AG,7.085,Switzerland,Switzerland,1160763904,137811492,163834000,84.12%,54.83,LONG,309421,156905,2513580,Metals & Mining,Partnership; Unregistered Equity Sales; Related-Party Transaction,"Location not whitelisted (Geneva, Switzerland, Switzerland)",1783689184000 | |
| 2039060,RBNE,Robin Energy Ltd.,6.24,Greece,United States,3619199,167301,580000,28.84%,3.45,LONG,318891,132972,48470,Marine,Unregistered Equity Sales,"Location not whitelisted (Athens, Greece, New York, United States)",1783688714000 | |
| 1899005,BMR,Beamr Imaging Ltd.,1.3982,Israel,Israel,21713844,10910188,15529854,70.25%,106.88,LONG,35228,21849,102078,Technology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783688620000 | |
| 2020228,MSGY,Masonglory Ltd,0.4599,Cayman Islands,Hong Kong,6542077,62500000,14225000,439.4%,71.44,SHORT,101398,10686,874822,Construction,Going Dark; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 62.5M exceeds 50M limit (6-K),1783688404000 | |
| 1965473,CCG,Cheche Group Inc.,0.4479,Unknown,China,37185356,35956775,64425057,55.81%,247.52,SHORT,N/A,32759,145268,Insurance,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1783688401000 | |
| 107263,WMB,"WILLIAMS COMPANIES, INC.",74.7999,Delaware,Oklahoma,91480145920,1215953795,1222998265,99.42%,178.02,LONG,431,3149216,6830529,Energy,Partnership; Unregistered Equity Sales,Float too large: 1216.0M exceeds 25M limit (8-K),1783948807000 | |
| 1434868,ESPR,"Esperion Therapeutics, Inc.",3.18,Delaware,Michigan,819464832,207908719,257693347,80.68%,13.32,SHORT,343236,59090465,15608719,Pharmaceuticals,Merger/Acquisition; Clinical Success; Convertible Debt; Credit Default; Going Dark; Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,Float too large: 207.9M exceeds 25M limit (8-K),1783948249000 | |
| 2011641,FERG,Ferguson Enterprises Inc. /DE/,231.245,Delaware,Virginia,44847153152,193528617,193937826,99.79%,138.53,LONG,2192,336164,1396998,Trading Companies & Distributors,Unregistered Equity Sales,Float too large: 193.5M exceeds 25M limit (8-K),1783947907000 | |
| 1129928,ONCY,ONCOLYTICS BIOTECH INC,0.9917,Nevada,Canada,118363424,116895373,119354067,97.94%,88.28,LONG,745029,5674577,1324155,Biotechnology,Clinical Success; FDA Approved,Float too large: 116.9M exceeds 25M limit (8-K),1783947834000 | |
| 1401914,DARE,"Dare Bioscience, Inc.",2.1301,Delaware,Canada,31907838,9370042,14979502,62.55%,14.49,LONG,2645,52471,646442,Pharmaceuticals,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783947619000 | |
| 764038,SSB,SouthState Bank Corp,99.48,Florida,Florida,9716017152,96685030,97668043,98.99%,117.34,LONG,N/A,45449,823962,Banking,Press Release,"Location not whitelisted (Florida, Florida)",1783947511000 | |
| 1564708,NWSA,NEWS CORP,27.78,Delaware,New York,15072192512,545733252,361550838,150.9%,106.66,LONG,N/A,447887,5116490,Media,Stock Buyback,Float too large: 545.7M exceeds 25M limit (8-K),1783947372000 | |
| 1661458,Unknown,"Highlands REIT, Inc.",N/A,Maryland,Israel,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Related-Party Transaction; Unregistered Equity Sales,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1783947067000 | |
| 1829311,BMNR,"BITMINE IMMERSION TECHNOLOGIES, INC.",14.615,Delaware,Connecticut,8324365312,3500000,569576819,0.61%,0.09,LONG,1200711,7967727,38141924,Technology,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783946724000 | |
| 1640266,VYGR,"Voyager Therapeutics, Inc.",3.255,Delaware,Massachusetts,196671296,50396560,60421287,83.41%,84.56,LONG,2023,402440,595954,Biotechnology,Clinical Success; Clinical Milestone; Regulation S Offering; Unregistered Equity Sales,Float too large: 50.4M exceeds 25M limit (8-K),1783946659000 | |
| 1104485,NOG,"NORTHERN OIL & GAS, INC.",19.75,Unknown,Minnesota,2148486912,102211429,108784154,93.96%,33.41,LONG,49947,1064129,3058855,Energy,Stock Buyback,"Location not whitelisted (Unknown, Minnesota)",1783946455000 | |
| 1661998,QTTB,Q32 Bio Inc.,19.7999,Delaware,Massachusetts,335735328,6403251,16956415,37.76%,7.92,LONG,5907,18115872,808221,Biotechnology,Clinical Success; Commercial Inflection; Unregistered Equity Sales,"Alert sent: [LONG] Clinical Success, Commercial Inflection, Unregistered Equity Sales (Bonus: Massachusetts (via Wilmington, Delaware) 1.3x + Filing Time 1.15x)",1783946394000 | |
| 1710072,EWTX,"Edgewise Therapeutics, Inc.",43.75,Delaware,Colorado,4707193856,79580194,107593006,73.96%,53.85,LONG,22569,206936,1477822,Pharmaceuticals,Clinical Success; Asset Disposition; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering,Float too large: 79.6M exceeds 25M limit (8-K),1783946232000 | |
| 1794669,FOUR,"Shift4 Payments, Inc.",51.335,Unknown,Pennsylvania,5088836096,43306453,79328924,54.59%,25.74,SHORT,355895,125205,1682716,Financial Services,Merger/Acquisition; Convertible Debt; Bankruptcy Filing; Credit Default; Asset Disposition; Related-Party Transaction; Unregistered Equity Sales,"Location not whitelisted (Unknown, Pennsylvania)",1783945911000 | |
| 1500435,GPRO,"GoPro, Inc.",0.7334,Delaware,Canada,126876072,25706940,146738559,17.52%,2.94,LONG,1167955,1507943,8738291,Consumer products,Merger/Acquisition; Unregistered Equity Sales,Float too large: 25.7M exceeds 25M limit (8-K),1783945870000 | |
| 1654595,MDRR,"Medalist Diversified, Inc.",11.5199,Maryland,Virginia,18760158,637704,1628500,39.16%,293.47,LONG,N/A,31,2173,Real Estate,Press Release,"Location not whitelisted (Maryland, Virginia)",1783945852000 | |
| 1372299,OCGN,"Ocugen, Inc.",1.435,Delaware,Pennsylvania,485778848,316842916,338521856,93.60%,40.12,LONG,745676,1731417,7898070,Biotechnology,Clinical Success; FDA Approved; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,Float too large: 316.8M exceeds 25M limit (8-K),1783945843000 | |
| 1570827,VCTR,"Victory Capital Holdings, Inc.",91.26,Delaware,Ohio,5706588672,48601677,62531106,77.72%,100.24,LONG,85760,67601,484867,Financial Services,Press Release,Float too large: 48.6M exceeds 25M limit (8-K),1783945703000 | |
| 1846253,OABIW,"OmniAb, Inc.",0.0809,Delaware,Canada,N/A,118094953,144972580,81.46%,N/A,LONG,N/A,490,N/A,N/A,Press Release,Price too low: $0.0809 below $0.2 minimum,1783944394000 | |
| 1781730,TCBX,"Third Coast Bancshares, Inc.",40,Texas,Texas,663682816,11050619,16592071,66.60%,104.46,LONG,1648,11527,105786,Banking,Partnership,"Insufficient core signal categories (need 2+, found 0)",1783944342000 | |
| 1582554,MTNB,"Matinas BioPharma Holdings, Inc.",0.4153,Delaware,New Jersey,2660491,1642856,6406191,25.64%,8.94,LONG,N/A,3926465,183821,Biotechnology,Merger/Acquisition; Convertible Debt; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [LONG] Merger/Acquisition, Convertible Debt, Commercial Inflection, Unregistered Equity Sales, Regulation S Offering (Bonus: Foreign Depositary 1.3x + Filing Time 1.1x)",1783944322000 | |
| 1590976,MBUU,"MALIBU BOATS, INC.",26.87,Delaware,Tennessee,527647296,75000000,19637041,381.9%,207.04,SHORT,N/A,38672,362242,Leisure Products,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 75.0M exceeds 25M limit (8-K),1783944306000 | |
| 1050446,MSTR,Strategy Inc,92.35,Delaware,Virginia,33039921152,329887095,338128276,97.56%,15.30,LONG,424725,4780896,21561577,Technology,Stock Buyback; Unregistered Equity Sales,Float too large: 329.9M exceeds 25M limit (8-K),1783944014000 | |
| 1920406,ASST,"Strive, Inc.",11.95,Nevada,Texas,979240640,56745009,72164809,78.63%,12.62,LONG,225623,888659,4496339,Health Care,Unregistered Equity Sales,Float too large: 56.7M exceeds 25M limit (8-K),1783943968000 | |
| 2030617,PMI,"Picard Medical, Inc.",0.1527,Delaware,Arizona,15681670,26138639,102695935,25.45%,0.87,LONG,52444708,636398,29953796,Health Care,Press Release,Price too low: $0.1527 below $0.2 minimum,1783943877000 | |
| 1822492,HLMN,Hillman Solutions Corp.,8.06,Delaware,Ohio,1581449472,193957120,196209606,98.85%,126.54,LONG,4177,470522,1532765,Machinery,Unregistered Equity Sales,Float too large: 194.0M exceeds 25M limit (8-K),1783942994000 | |
| 1999480,ANRO,"Alto Neuroscience, Inc.",26.23,Delaware,Canada,920514048,31723447,35093940,90.40%,72.97,LONG,2533,650884,434752,Pharmaceuticals,Clinical Success; Regulation S Offering; Unregistered Equity Sales,Float too large: 31.7M exceeds 25M limit (8-K),1783942747000 | |
| 1093691,PLUG,PLUG POWER INC,2.215,Delaware,New York,3090077952,1086576764,1395069082,77.89%,14.98,SHORT,3518739,11425937,72525165,Electrical Equipment,Merger/Acquisition; Credit Default; Commercial Inflection; Unregistered Equity Sales; Related-Party Transaction,Float too large: 1086.6M exceeds 25M limit (8-K),1783941341000 | |
| 36377,FHB,"FIRST HAWAIIAN, INC.",28.895,Delaware,Hawaii,3515047168,120664833,121648973,99.19%,69.75,LONG,2149,3794880,1729890,Banking,Merger/Acquisition; Unregistered Equity Sales,Float too large: 120.7M exceeds 25M limit (8-K),1783941325000 | |
| 1740332,REZI,"RESIDEO TECHNOLOGIES, INC.",34.145,Delaware,Texas,5170449408,132873515,151426260,87.75%,90.38,LONG,48,387726,1470088,Building,Asset Disposition; Commercial Inflection; Unregistered Equity Sales,Float too large: 132.9M exceeds 25M limit (8-K),1783941275000 | |
| 356171,TCBK,TRICO BANCSHARES /,59.58,Canada,Canada,1915534720,30267514,31910590,94.85%,209.46,LONG,181,1215718,144503,Banking,Merger/Acquisition; Unregistered Equity Sales,Float too large: 30.3M exceeds 25M limit (8-K),1783941136000 | |
| 921114,ARMP,"Armata Pharmaceuticals, Inc.",4.135,Washington,Canada,151799200,11547018,36710810,31.45%,96.89,N/A,39799,41992,119175,N/A,Clinical Success; Clinical Milestone; Unregistered Equity Sales; Regulation S Offering,F/AV 96.89x exceeds max threshold of 80x,1783941085000 | |
| 1430306,TNXP,Tonix Pharmaceuticals Holding Corp.,11.99,Nevada,New Jersey,191130208,15889040,15940801,99.68%,32.16,N/A,15374,305883,494022,N/A,Clinical Success; Unregistered Equity Sales; Regulation S Offering,S/O 99.68% very high - needs extreme catalyst to be tradeable,1783940737000 | |
| 2048519,AEBI,Aebi Schmidt Holding AG,11.98,Switzerland,Switzerland,928523392,36736353,77506125,47.40%,136.67,LONG,5055,57052,268791,Machinery,Merger/Acquisition; Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (Geneva, Switzerland, Geneva, Switzerland)",1783940422000 | |
| 1070985,CXW,"CoreCivic, Inc.",31.345,Maryland,Tennessee,3099658752,95946528,98888460,97.02%,78.24,LONG,1502,91415,1226365,Commercial Services & Supplies,Press Release,"Location not whitelisted (Maryland, Tennessee)",1783940407000 | |
| 1630805,BW,"Babcock & Wilcox Enterprises, Inc.",11.47,Delaware,Ohio,1707189504,102698777,148839531,69.00%,26.80,LONG,N/A,1019093,3832395,Electrical Equipment,Stock Buyback; Unregistered Equity Sales; Regulation S Offering,Float too large: 102.7M exceeds 25M limit (8-K),1783939628000 | |
| 1834488,NABL,"N-able, Inc.",4.365,Unknown,Delaware,822271168,73162360,188378290,38.84%,39.56,LONG,762,495199,1849618,Technology,Press Release,Float too large: 73.2M exceeds 25M limit (8-K),1783939513000 | |
| 1260221,TDG,TransDigm Group INC,1240.14,Delaware,Ohio,69365473280,55650000,55933583,99.49%,138.71,LONG,1087,178048,401186,Aerospace & Defense,Unregistered Equity Sales,Float too large: 55.6M exceeds 25M limit (8-K),1783939513000 | |
| 2010653,FVN,Future Vision II Acquisition Corp.,11,Cayman Islands,Cayman Islands,82984000,5612502,7544000,74.40%,99.55,N/A,5,15,56377,N/A,Merger/Acquisition; Credit Default; Unregistered Equity Sales; Regulation S Offering,F/AV 99.55x exceeds max threshold of 80x,1783938626000 | |
| 1345126,CODI,Compass Diversified Holdings,10.235,Delaware,Connecticut,770040128,3000000,75235966,3.99%,3.11,LONG,1,389122,965578,Financial Services,Merger/Acquisition; Underwritten Offering; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [LONG] Merger/Acquisition, Underwritten Offering, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction (Bonus: Connecticut (via Wilmington, Delaware) 1.3x + Filing Time 1.05x)",1783937476000 | |
| 1345122,Unknown,Compass Group Diversified Holdings LLC,N/A,Delaware,Connecticut,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Underwritten Offering; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,No Price Data,1783937476000 | |
| 1857816,GCT,GigaCloud Technology Inc,34.79,Cayman Islands,Canada,1266769920,30132340,29255162,103.0%,40.15,LONG,1845,163840,750477,Distributors,Press Release,Float too large: 30.1M exceeds 25M limit (8-K),1783937023000 | |
| 1098146,PNBK,PATRIOT NATIONAL BANCORP INC,1.155,Connecticut,Connecticut,135823280,82794494,110329351,75.04%,161.14,LONG,49325,49173,513796,Banking,Unregistered Equity Sales,"Location not whitelisted (Connecticut, Connecticut)",1783936865000 | |
| 1694617,ROYL,"Royale Energy, Inc.",0.07,Delaware,Canada,6762021,80000000,96600302,82.82%,2465.94,SHORT,N/A,10000,32442,Energy,Accounting Restatement; Asset Disposition; Regulation S Offering; Unregistered Equity Sales,Price too low: $0.0700 below $0.2 minimum,1783735097000 | |
| 1393311,PSA,Public Storage,321.56,Maryland,Texas,56459390976,157436449,175579656,89.67%,163.94,SHORT,2242,155010,960311,Real Estate,Merger/Acquisition; Credit Default; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 157.4M exceeds 25M limit (8-K),1783727667000 | |
| 1514183,SILO,"Silo Pharma, Inc.",5.18,Nevada,Florida,5846199,863743,1128610,76.53%,4.22,LONG,58648,86702,204596,Biotechnology,Merger/Acquisition; Asset Disposition; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Asset Disposition, Unregistered Equity Sales (Bonus: Florida (via Nevada) 1.3x + Filing Time 1.1x)",1783722567000 | |
| 1467760,ARI,"Apollo Commercial Real Estate Finance, Inc.",10.3169,Maryland,New York,1350969728,7005450,130947251,5.35%,2.93,LONG,63086,474477,2391693,Real Estate,Press Release,"Location not whitelisted (Maryland, New York)",1783720498000 | |
| 1757715,ATER,"Aterian, Inc.",1.2,Delaware,New Jersey,12982693,5278277,10818910,48.79%,1.12,N/A,22145,57500,4699406,N/A,Asset Disposition; Unregistered Equity Sales,F/AV 1.12x below 1.2x absolute minimum (untradeable liquidity),1783718912000 | |
| 1560293,TNON,"Tenon Medical, Inc.",0.2156,Delaware,Canada,3746263,6624199,17375989,38.12%,0.92,N/A,24715,364030,7168306,N/A,Regulation S Offering; Unregistered Equity Sales,F/AV 0.92x below 1.2x absolute minimum (untradeable liquidity),1783718341000 | |
| 1058290,CTSH,COGNIZANT TECHNOLOGY SOLUTIONS CORP,44.515,Unknown,New Jersey,21055594496,472637408,473000000,99.92%,45.68,LONG,20978,2197562,10345980,Technology,Unregistered Equity Sales,"Location not whitelisted (Unknown, New Jersey)",1783718009000 | |
| 1618563,NSA,National Storage Affiliates Trust,45.17,Maryland,Colorado,6631890432,71208940,77212533,92.22%,84.02,LONG,3234,322260,847513,Real Estate,Merger/Acquisition; Asset Disposition,"Location not whitelisted (Maryland, Colorado)",1783717927000 | |
| 1335730,MFG,MIZUHO FINANCIAL GROUP INC,10.525,Unknown,Japan,128217579520,2436097580,12182192875,20.00%,630.87,LONG,132971,914573,3861506,Banking,Unregistered Equity Sales,"Location not whitelisted (Unknown, Tokyo, Japan)",1783955663000 | |
| 1648416,RACE,Ferrari N.V.,374.57,Spain,Italy,65893056512,18034969,175916530,10.25%,29.38,LONG,193966,115617,613755,Automobiles,Press Release,"Location not whitelisted (Madrid, Spain, Milan, Italy)",1783955643000 | |
| 1131399,GSK,GSK plc,52.275,UK,United Kingdom,104696250368,1946202600,2002797682,97.17%,504.08,LONG,2228,694777,3860900,Pharmaceuticals,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1783956486000 | |
| 1650107,CCEP,COCA-COLA EUROPACIFIC PARTNERS plc,105.715,UK,United Kingdom,46808174592,199633994,442777049,45.09%,106.70,LONG,8084,340050,1871057,Beverages,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1783956579000 | |
| 1160106,LYG, Douglas Radcliffe Title: Group Investor Relations Director          Date:  13 July 2026,5.9,UK,UK,85742125056,14536816570,14532563782,100.0%,670.92,LONG,2087493,10389379,21666878,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1783956910000 | |
| 19745,CPK,CHESAPEAKE UTILITIES CORP,130.69,Delaware,Delaware,3137182208,23733267,24004761,98.87%,144.37,LONG,N/A,57098,164393,Utilities,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783957527000 | |
| 1998560,MIMI,Mint Inc Ltd,2.745,Cayman Islands,Hong Kong,6975731,6361627,2051250,310.1%,3.80,N/A,39016,41249736,1675827,N/A,Credit Default; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,F/AV 3.80x below the preferred 5x threshold for general alerts,1783958401000 | |
| 1585101,Unknown,"HINES GLOBAL INCOME TRUST, INC.",N/A,Maryland,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783959074000 | |
| 1715925,HYFT,MindWalk Holdings Corp.,1.385,Canada,Canada,64695932,45371224,46711866,97.13%,129.53,LONG,57308,80911,350280,Life Sciences Tools & Services,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783960423000 | |
| 1160106,LYG,Lloyds Banking Group plc,5.9,UK,UK,85742125056,7000000,14532563782,0.05%,0.32,LONG,2087493,12895102,21666878,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1783964326000 | |
| 1045520,CM,CANADIAN IMPERIAL BANK OF COMMERCE /CAN/,117.4,Cayman Islands,Canada,107162804224,913748169,912800674,100.1%,632.20,SHORT,171401,487431,1445344,Banking,Credit Default; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 913.7M exceeds 50M limit (6-K),1783965628000 | |
| 1605484,STLA,Stellantis N.V.,5.555,Spain,Spain,16095655936,2022971356,2897507765,69.82%,109.79,LONG,2169815,14677134,18425832,Automobiles,Partnership; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (Madrid, Spain, Madrid, Spain)",1783966425000 | |
| 1811216,BAOS,Baosheng Media Group Holdings Ltd,2.64,Cayman Islands,China,4051045,30000000,1534487,1955.1%,387.94,N/A,19560,5835,77332,N/A,Convertible Debt; Credit Default; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,F/AV 387.94x exceeds max threshold of 80x,1783967432000 | |
| 1341335,FSM,FORTUNA MINING CORP.,8.3099,Canada,Canada,2517545472,299670299,302957387,98.91%,57.42,LONG,1450417,2970629,5218700,Metals & Mining,Partnership; Unregistered Equity Sales,Float too large: 299.7M exceeds 50M limit (6-K),1783967790000 | |
| 1160330,BBD,BANK BRADESCO,3.62,Unknown,Brazil,38265974784,3811582,5277491247,0.07%,0.12,LONG,1294,23277148,31804598,Banking,Press Release,"Location not whitelisted (Unknown, Brazil)",1783968472000 | |
| 720515,Unknown,BASIN ELECTRIC POWER COOPERATIVE,N/A,North Dakota,North Dakota,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (North Dakota, North Dakota)",1783969655000 | |
| 91668,SODI,SOLITRON DEVICES INC,27.5,Delaware,Florida,59061832,10000000,2147703,465.6%,4564.13,N/A,N/A,3447,2191,N/A,Merger/Acquisition; Unregistered Equity Sales,F/AV 4564.13x exceeds max threshold of 80x,1783971296000 | |
| 1892500,CMND,Clearmind Medicine Inc.,1.99,Canada,Canada,2956246,757397,1485551,50.98%,0.32,N/A,995977,4022824,2396313,N/A,Clinical Success; Clinical Milestone,F/AV 0.32x below 1.2x absolute minimum (untradeable liquidity),1783972861000 | |
| 1091223,MTLS,MATERIALISE NV,6.84,Unknown,Belgium,396630016,1106406,57986844,1.91%,8.31,LONG,29780,47762,133216,Technology,Press Release,"Location not whitelisted (Unknown, Belgium)",1783972874000 | |
| 1802450,MSPR,"MSP Recovery, Inc.",0.0199,Cayman Islands,Florida,284060,13515716,13774399,98.12%,185.09,LONG,N/A,3690,73021,Health Care,Merger/Acquisition; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,Price too low: $0.0199 below $0.2 minimum,1783972884000 | |
| 1539838,FANG,"Diamondback Energy, Inc.",191.6,Delaware,Texas,53899632640,281202,281313297,0.10%,0.11,LONG,115,2362275,2586601,Energy,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783973007000 | |
| 2059654,BACC,Blue Acquisition Corp/Cayman,11.02,Cayman Islands,Canada,308143072,9250000,20892250,44.27%,64.92,LONG,274,33664,142490,N/A,Merger/Acquisition; Underwritten Offering; Asset Disposition; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [LONG] Merger/Acquisition, Underwritten Offering, Asset Disposition, Unregistered Equity Sales, Regulation S Offering (Bonus: Toronto, Canada (via Cayman Islands) 1.3x + Filing Time 1.2x)",1783973137000 | |
| 1766502,CHWY,"Chewy, Inc.",20.33,Delaware,Florida,8323593728,406855005,232945978,174.7%,43.42,LONG,711691,8612281,9369309,Retail,Press Release,Float too large: 406.9M exceeds 25M limit (8-K),1783973117000 | |
| 1810560,REVB,"REVELATION BIOSCIENCES, INC.",0.9869,Delaware,Canada,3857219,2894366,3908420,74.05%,48.96,LONG,324,18771,59116,Biotechnology,Merger/Acquisition; Convertible Debt; Partnership; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [LONG] Merger/Acquisition, Convertible Debt, Partnership, Unregistered Equity Sales, Related-Party Transaction (Bonus: Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1783973114000 | |
| 1048477,BMRN,BIOMARIN PHARMACEUTICAL INC,59.2,Delaware,Canada,11442438144,192093806,193284438,99.38%,92.96,LONG,4654,1563511,2066411,Biotechnology,Merger/Acquisition; Clinical Success; Licensing Deal; Unregistered Equity Sales; Related-Party Transaction,Float too large: 192.1M exceeds 25M limit (8-K),1783973189000 | |
| 1173489,CEVA,CEVA INC,42.71,Delaware,Maryland,1189873536,24693987,27859369,88.64%,27.67,LONG,1050,521404,892400,Semiconductors,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783973177000 | |
| 1069878,TREX,TREX CO INC,45.89,Delaware,Virginia,4767912448,103219231,103898729,99.35%,52.87,LONG,193,990011,1952286,Building,Press Release,Float too large: 103.2M exceeds 25M limit (8-K),1783973236000 | |
| 726728,O,REALTY INCOME CORP,64.18,Maryland,Canada,59847372800,930291848,932492530,99.76%,155.35,SHORT,60719,3069553,5988178,Real Estate,Merger/Acquisition; Bankruptcy Filing; Credit Default; Unregistered Equity Sales; Related-Party Transaction; Offering At A Discount,Float too large: 930.3M exceeds 25M limit (8-K),1783973454000 | |
| 2126198,Unknown,Expro Ltd,N/A,Cayman Islands,Cayman Islands,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Convertible Debt; Credit Default; Going Dark; Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1783973481000 | |
| 1581178,EPRX,EUPRAXIA PHARMACEUTICALS INC.,6.43,Canada,Canada,420052256,25830246,65326947,39.54%,88.03,LONG,247904,189481,293431,Biotechnology,Clinical Success; Executive Departure; Licensing Deal,"Insufficient core signal categories (need 2+, found 1)",1783973722000 | |
| 1855175,CTNM,"Contineum Therapeutics, Inc.",14.62,Delaware,Canada,546588800,27588529,32723877,84.31%,83.24,LONG,551,257334,331429,Pharmaceuticals,Clinical Success; FDA Approved; Partnership; Commercial Inflection; Unregistered Equity Sales,Float too large: 27.6M exceeds 25M limit (8-K),1783973717000 | |
| 932787,STM,STMicroelectronics N.V.,68.47,Spain,Spain,61102616576,5797437,892399817,0.65%,0.46,LONG,323422,10825490,12584181,Semiconductors,Stock Buyback,"Location not whitelisted (Madrid, Spain, Madrid, Spain)",1783973948000 | |
| 1718227,ROAD,Not Applicable,93.51,Delaware,UK,5286563840,47371591,47985624,98.72%,75.72,LONG,653,490769,625593,Construction,Unregistered Equity Sales,Float too large: 47.4M exceeds 25M limit (8-K),1783974001000 | |
| 825313,AB,ALLIANCEBERNSTEIN HOLDING L.P.,37.35,Delaware,Tennessee,3488633856,91415048,93403853,97.87%,295.40,LONG,90,174739,309462,Financial Services,Unregistered Equity Sales,Float too large: 91.4M exceeds 25M limit (8-K),1783974124000 | |
| 1109448,Unknown,ALLIANCEBERNSTEIN L.P.,N/A,Delaware,Tennessee,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783974289000 | |
| 1840199,WALD,Manuel Manfredi Title: Chief Financial Officer and Principal Financial Officer 3,1.67,Unknown,UK,214193984,120766576,118239889,102.1%,86.70,LONG,391631,290201,1392957,Consumer products,Press Release,"Location not whitelisted (Unknown, London, UK)",1783974439000 | |
| 2015691,ELPW,Elong Power Holding Ltd.,0.369,Cayman Islands,China,1160605,7975000,3030757,263.1%,0.89,N/A,788227,147079968,8986111,N/A,Convertible Debt; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,F/AV 0.89x below 1.2x absolute minimum (untradeable liquidity),1783974598000 | |
| 1553788,SBEV,"SPLASH BEVERAGE GROUP, INC.",0.124,Nevada,Florida,2003566,2264392,16157793,14.01%,0.09,LONG,19571045,3647441,26117957,Beverages,Merger/Acquisition; Regulation S Offering; Unregistered Equity Sales,Price too low: $0.1240 below $0.2 minimum,1783974658000 | |
| 1956648,NOEM,CO2 Energy Transition Corp.,10.4828,Unknown,Texas,100485496,7020747,9585750,73.24%,1217.19,N/A,310,8632,5768,N/A,Merger/Acquisition; Underwritten Offering; Credit Default; Asset Disposition; Unregistered Equity Sales; Regulation S Offering,F/AV 1217.19x exceeds max threshold of 80x,1783974643000 | |
| 1565687,INTA,"Intapp, Inc.",28.56,Delaware,Canada,2200879104,68990707,77061595,89.53%,70.16,LONG,40981,692622,983363,Technology,Merger/Acquisition,Float too large: 69.0M exceeds 25M limit (8-K),1783974628000 | |
| 1421876,LKFT,Lakefront Biotherapeutics NV,29.8,C9,Belgium,1954680704,49189615,65593315,74.99%,299.00,LONG,6330,156329,164514,Biotechnology,Press Release,"Location not whitelisted (C9, Belgium)",1783974762000 | |
| 1433309,PLTYF,"Plastec Technologies, Ltd.",0.25,Cayman Islands,Hong Kong,3234532,1547008,12938128,11.96%,N/A,SHORT,N/A,400,N/A,Chemicals,Going Dark,"Insufficient core signal categories (need 2+, found 1)",1783974807000 | |
| 712534,FRME,FIRST MERCHANTS CORP,43.3,Indiana,Indiana,2728884480,61870685,63022741,98.17%,164.50,LONG,2,460556,376111,Banking,Press Release,"Location not whitelisted (Indiana, Indiana)",1783974825000 | |
| 1417663,SNWV,"SANUWAVE Health, Inc.",11.26,Nevada,Minnesota,96824472,8132837,8598976,94.58%,54.84,LONG,1490,95130,148313,Health Care,FDA Approved,"Insufficient core signal categories (need 2+, found 1)",1783975101000 | |
| 811596,KALU,KAISER ALUMINUM CORP,158.28,Delaware,Tennessee,2586391040,15947657,16340606,97.60%,56.01,LONG,495,228011,284719,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783975215000 | |
| 14693,BF-A,BROWN FORMAN CORP,N/A,Delaware,Cayman Islands,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,Beverages,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783975200000 | |
| 1123452,ASR,SOUTHEAST AIRPORT GROUP,278.66,Unknown,Mexico,8368736256,27703726,27705000,100.00%,381.76,LONG,13476,86813,72568,Transportation Infrastructure,Press Release,"Location not whitelisted (Unknown, Mexico)",1783975240000 | |
| 1123452,ASR,SOUTHEAST AIRPORT GROUP,278.66,Unknown,Mexico,8368736256,30201236,27705000,109.0%,416.18,LONG,13476,86813,72568,Transportation Infrastructure,Merger/Acquisition; Stock Buyback; Licensing Deal; Unregistered Equity Sales; Related-Party Transaction,"Location not whitelisted (Unknown, Mexico)",1783975473000 | |
| 1561861,AERO,"Grupo Aeromexico, S.A.B. de C.V.",15.3,Mexico,Mexico,2232322048,136416761,145903409,93.50%,507.59,LONG,N/A,268548,268754,Airlines,Underwritten Offering; Commercial Inflection,"Location not whitelisted (Mexico City, Mexico, Mexico City, Mexico)",1783975635000 | |
| 2023311,AAPG,ASCENTAGE PHARMA GROUP INTERNATIONAL,19.6,Cayman Islands,China,1829409408,6596448,93337216,7.07%,600.61,LONG,3647,3063,10983,Biotechnology,Underwritten Offering,"Insufficient core signal categories (need 2+, found 0)",1783975680000 | |
| 1203464,IAG,IAMGOLD CORP,14.82,Canada,Canada,8565959680,576664820,578000000,99.77%,93.66,LONG,353152,4636425,6156896,Metals & Mining,Press Release,Float too large: 576.7M exceeds 50M limit (6-K),1783976537000 | |
| 1775734,BENF,Beneficient,3.15,Nevada,Texas,45638964,4077642,14488560,28.14%,141.97,LONG,111539,30454,28722,Financial Services,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1783976729000 | |
| 1630176,HYEX,HEALTHY EXTRACTS INC.,2.2,Nevada,Nevada,32408966,826228,14731348,5.61%,1686.18,LONG,N/A,100,490,N/A,Press Release,Volume 100 below 2k minimum,1783976768000 | |
| 1702924,WRAP,"WRAP TECHNOLOGIES, INC.",2.11,Delaware,Florida,117607696,37949198,55738250,68.08%,26.50,SHORT,5685,3433421,1432042,Electrical Equipment,Merger/Acquisition; Capital Raise; Convertible Debt; Bankruptcy Filing; Accounting Restatement; Stock Buyback; Partnership; Licensing Deal; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 37.9M exceeds 25M limit (8-K),1783976990000 | |
| 1834026,GROY,Gold Royalty Corp.,2.56,Canada,Canada,590871552,195612739,230809201,84.75%,102.28,LONG,16258,1817118,1912609,Metals & Mining,Press Release,Float too large: 195.6M exceeds 50M limit (6-K),1783977121000 | |
| 2015502,LPAA,Launch One Acquisition Corp.,11,Cayman Islands,Canada,316249984,2000000,28749999,6.96%,52.47,N/A,22000,257,38119,N/A,Merger/Acquisition; Underwritten Offering; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,Minimal Volume,1783977319000 | |
| 1724965,TALO,TALOS ENERGY INC.,14.23,Delaware,Texas,2375354368,124318639,166925818,74.48%,65.53,SHORT,7764,2346001,1897131,Energy,Merger/Acquisition; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,Float too large: 124.3M exceeds 25M limit (8-K),1783977307000 | |
| 1786835,Unknown,Star Mountain Lower Middle-Market Capital Corp,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1783977303000 | |
| 2138743,Unknown,GM Financial Consumer Automobile Receivables Trust 2026-3,N/A,Unknown,Texas,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Unregistered Equity Sales; Regulation S Offering,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1783977292000 | |
| 1347185,Unknown,AFS SENSUB CORP.,N/A,Unknown,Texas,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Unregistered Equity Sales; Regulation S Offering,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1783977292000 | |
| 750004,Unknown,"Light & Wonder, Inc.",N/A,Nevada,Nevada,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Asset Disposition; Stock Buyback; Unregistered Equity Sales; Regulation S Offering,No Price Data,1783977358000 | |
| 1530766,STEX,Streamex Corp.,0.84,Delaware,Florida,179209696,25400968,104274817,24.36%,14.23,SHORT,451300,1030101,1785560,Health Care,Accounting Restatement; Regulation S Offering; Unregistered Equity Sales,Float too large: 25.4M exceeds 25M limit (8-K),1783977559000 | |
| 1087294,CPIX,CUMBERLAND PHARMACEUTICALS INC,6.54,Tennessee,Tennessee,97989520,8750134,14983107,58.40%,8.74,LONG,1952,326781,1001006,Pharmaceuticals,Clinical Success; Stock Buyback; Related-Party Transaction,"Location not whitelisted (Tennessee, Tennessee)",1783978081000 | |
| 892450,KT,Sanghyun Cho Title: IR Team Leader,17.38,Unknown,Republic of,8319173120,37631385,478663616,7.86%,23.99,LONG,56313,1179988,1568862,Telecommunication,Press Release,"Location not whitelisted (Unknown, Korea, Republic of)",1784023428000 | |
| 1163653,NMR,NOMURA HOLDINGS INC,9.62,Japan,Japan,28118978560,46861200,2922970836,1.60%,31.52,LONG,35167,958675,1486813,Financial Services,Asset Disposition; Stock Buyback; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (Tokyo, Japan, Japan)",1784023419000 | |
| 1140625,EQNR,EQUINOR ASA,36.06,Unknown,Norway,85732261888,36322889,2377489052,1.53%,8.67,LONG,110165,5557844,4191518,Energy,Press Release,"Location not whitelisted (Unknown, Oslo, Norway)",1784023504000 | |
| 1039765,ING,ING GROEP NV,32.3,Spain,Spain,92364890112,26985940,2859594153,0.94%,8.28,LONG,331175,2407157,3259560,Banking,Unregistered Equity Sales,"Location not whitelisted (Madrid, Spain, Madrid, Spain)",1784023504000 | |
| 892450,KT,Sanghyun Cho Title: IR Team Leader,17.38,Unknown,Republic of,8319173120,163844300,478663616,34.23%,104.44,LONG,56313,1179988,1568862,Telecommunication,Press Release,"Location not whitelisted (Unknown, Korea, Republic of)",1784023552000 | |
| 313807,BP,BP PLC,40.83,UK,UK,105142566912,10014074000,2575130228,388.9%,1040.45,LONG,35,9617852,9624798,Energy,Press Release,"Location not whitelisted (London, UK, London, UK)",1784023711000 | |
| 1881472,MEGL,Magic Empire Global Ltd,1.17,Hong Kong,Hong Kong,5924938,1912700,4064050,47.06%,44.86,LONG,2450,3491,42636,Financial Services,Underwritten Offering; Convertible Debt; Partnership; Regulation S Offering; Unregistered Equity Sales,"Alert sent: [LONG] Underwritten Offering, Convertible Debt, Partnership, Regulation S Offering, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Foreign Depositary 1.3x + Filing Time 1.05x + Transfer Agent Change + Services: VStock Transfer)",1784023813000 | |
| 2000530,GMHS,Gamehaus Holdings Inc.,0.9031,Cayman Islands,China,51764980,27787487,49520156,56.11%,26.13,SHORT,640180,9192,1063608,Media,Convertible Debt; Credit Default; Going Dark; Partnership; Related-Party Transaction; Unregistered Equity Sales,"Alert sent: [SHORT] Convertible Debt, Credit Default, Going Dark, Partnership, Related-Party Transaction, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Foreign Depositary 1.3x + Filing Time 1.05x)",1784023805000 | |
| 1998560,MIMI,Mint Inc Ltd,2.96,Cayman Islands,Hong Kong,7522100,2051277,2051250,100.0%,1.22,N/A,39016,45104354,1685104,N/A,Convertible Debt; Partnership; Unregistered Equity Sales,S/O 100.00% very high - needs extreme catalyst to be tradeable,1784023890000 | |
| 1967631,NAMI,Jinxin Technology Holding Co,3.4,Cayman Islands,China,10753711,731820,3162856,23.14%,17.62,SHORT,511093,59755,41533,Diversified Consumer Services,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1784024623000 | |
| 72971,WFC,WELLS FARGO & COMPANY/MN,87.67,Delaware,Canada,268286803968,3051805000,3060189494,99.73%,183.17,LONG,36791,14994618,16660842,Banking,Asset Disposition; Partnership; Commercial Inflection; Unregistered Equity Sales,Float too large: 3051.8M exceeds 25M limit (8-K),1784024901000 | |
| 1744676,TME,Tencent Music Entertainment Group,8.83,Cayman Islands,China,14457127936,571573000,804799234,71.02%,55.75,LONG,147708,4704031,10251750,Media,Press Release,Float too large: 571.6M exceeds 50M limit (6-K),1784024926000 | |
| 1701108,SPRO,"Spero Therapeutics, Inc.",2.18,Delaware,Massachusetts,126225256,46382600,57901493,80.11%,46.41,LONG,32813,703343,999504,Biotechnology,Merger/Acquisition; Clinical Success; Clinical Milestone; FDA Approved; Credit Default; Licensing Deal; Commercial Inflection; Unregistered Equity Sales,Float too large: 46.4M exceeds 25M limit (8-K),1784025009000 | |
| 901832,AZN,ASTRAZENECA PLC,169.47,UK,United Kingdom,262827114496,1541224000,1550876987,99.38%,733.42,LONG,591,4465264,2101419,Pharmaceuticals,Clinical Success; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (London, UK, United Kingdom)",1784025441000 | |
| 1944885,APLM,Apollomics Inc.,14.21,Unknown,Canada,31205900,1241900,2196052,56.55%,119.10,SHORT,902,141553,10427,Biotechnology,Clinical Success; Bid Price Delisting,"Insufficient core signal categories (need 2+, found 1)",1784026803000 | |
| 1964946,YAAS,Youxin Technology Ltd,0.9292,Cayman Islands,China,21178284,200000000,13846647,1444.4%,62.83,LONG,3170,37180,3183380,Technology,Underwritten Offering; Unregistered Equity Sales,Float too large: 200.0M exceeds 50M limit (6-K),1784026809000 | |
| 1907982,QBTS,D-Wave Quantum Inc.,18.66,Delaware,Canada,6912506880,358154000,367269074,97.52%,10.08,LONG,735098,16919850,35540755,Technology,Unregistered Equity Sales,Float too large: 358.2M exceeds 25M limit (8-K),1784026854000 | |
| 51143,IBM,INTERNATIONAL BUSINESS MACHINES CORP,290.23,New York,New York,272782917632,937883000,939885280,99.79%,103.13,LONG,267493,3895515,9093852,Technology,Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (New York, New York)",1784026912000 | |
| 1536196,CANF,Can-Fite BioPharma Ltd.,3.26,Israel,Israel,6984703,2142500,2142547,100.00%,1.12,N/A,2082,84648,1907903,N/A,Clinical Success; FDA Approved; Commercial Inflection,F/AV 1.12x below 1.2x absolute minimum (untradeable liquidity),1784027525000 | |
| 314590,SSL,SASOL LTD,10.89,South Africa,South Africa,6980900864,578457000,634706335,91.14%,349.61,LONG,69424,1607978,1654565,Chemicals,Press Release,"Location not whitelisted (Johannesburg, South Africa, Johannesburg, South Africa)",1784027731000 | |
| 1075124,TRI,THOMSON REUTERS CORP /CAN/,94.29,Canada,Canada,41161248768,127164000,436538837,29.13%,63.68,LONG,90854,2643799,1997009,Professional Services,Partnership; Licensing Deal,Float too large: 127.2M exceeds 50M limit (6-K),1784027759000 | |
| 64463,SLNH,"Soluna Holdings, Inc",1.12,Nevada,New York,176677040,101785000,157747354,64.52%,4.28,LONG,1052938,12400784,23807014,Technology,Clinical Success; Commercial Inflection; Unregistered Equity Sales,Float too large: 101.8M exceeds 25M limit (8-K),1784028625000 | |
| 1780201,LVLU,"Lulu's Fashion Lounge Holdings, Inc.",8.32,Delaware,Canada,23834320,1327900,2864702,46.35%,96.11,N/A,2132,376407,13816,N/A,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering,F/AV 96.11x exceeds max threshold of 80x,1784028655000 | |
| 1275187,ANGO,ANGIODYNAMICS INC,12.775,Delaware,New York,527849152,34610700,41318915,83.76%,97.72,LONG,957,427023,354170,Health Care,Clinical Success; Clinical Milestone; FDA Approved; Asset Disposition; Partnership; Unregistered Equity Sales,Float too large: 34.6M exceeds 25M limit (8-K),1784028653000 | |
| 1101215,BFH,"BREAD FINANCIAL HOLDINGS, INC.",97.18,Delaware,Ohio,3926758400,39756500,40407065,98.39%,56.36,LONG,3797,585001,705396,Financial Services,Unregistered Equity Sales,Float too large: 39.8M exceeds 25M limit (8-K),1784028716000 | |
| 1702123,CRDL,Cardiol Therapeutics Inc.,1.06,Canada,Canada,122188568,302824974,115272240,262.7%,638.81,LONG,28923,1268233,474042,Pharmaceuticals,Clinical Success; Clinical Milestone,Float too large: 302.8M exceeds 50M limit (6-K),1784029078000 | |
| 860730,HCA,"HCA Healthcare, Inc.",390.74,Unknown,Tennessee,86681681920,149493000,221839800,67.39%,97.25,LONG,2349,2335861,1537239,Health Care,Unregistered Equity Sales,"Location not whitelisted (Unknown, Tennessee)",1784029257000 | |
| 1787740,VBIO,"Valion Bio, Inc.",0.508,Delaware,Texas,1626018,3065800,3200824,95.78%,9.38,N/A,170503,135282,326873,N/A,Clinical Success; Capital Raise; Unregistered Equity Sales; Regulation S Offering,S/O 95.78% very high - needs extreme catalyst to be tradeable,1784029515000 | |
| 1769697,FNUC,Frontier Nuclear & Minerals Inc.,1.63,Canada,Canada,42898884,7436200,26318334,28.25%,16.75,LONG,80738,176874,444024,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784029625000 | |
| 1345099,MESO,MESOBLAST LTD,16.22,Australia,Australia,2096962944,83384000,129282554,64.50%,441.63,LONG,16755,342062,188809,Biotechnology,Clinical Success; FDA Approved,"Location not whitelisted (Brisbane, Australia, Brisbane, Australia)",1784030082000 | |
| 1592386,VIRT,"Virtu Financial, Inc.",64.67,Delaware,New York,13915567104,82489036,87024431,94.79%,62.83,LONG,4547,900211,1312811,Financial Services,Underwritten Offering; Unregistered Equity Sales,Float too large: 82.5M exceeds 25M limit (8-K),1784030128000 | |
| 1866782,CDRO,"Codere Online Luxembourg, S.A.",9.56,Netherlands,Netherlands,434692416,14893938,45469915,32.76%,427.19,LONG,12957,7580,34865,"Hotels, Restaurants & Leisure",Press Release,"Location not whitelisted (Amsterdam, Netherlands, Amsterdam, Netherlands)",1784030406000 | |
| 1581091,RMAX,"RE/MAX Holdings, Inc.",10.6,Colorado,Colorado,584167680,16086967,21317742,75.46%,21.35,LONG,3754,310599,753560,Real Estate,Merger/Acquisition; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (Colorado, Colorado)",1784030436000 | |
| 1280776,IMUX,"IMMUNIC, INC.",14.64,Delaware,Luxembourg,199418512,9560810,13621483,70.19%,35.60,LONG,42766,251660,268535,Biotechnology,Clinical Success; Commercial Inflection; Unregistered Equity Sales,"Alert sent: [LONG] Clinical Success, Commercial Inflection, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Luxembourg City, Luxembourg (via Wilmington, Delaware) 1.3x + Filing Time 1.1x)",1784030460000 | |
| 815556,FAST,FASTENAL CO,47.05,Minnesota,Minnesota,54015049728,1147,1148035061,0.00%,0.00,LONG,193995,10339068,7080580,Trading Companies & Distributors,Press Release,"Location not whitelisted (Minnesota, Minnesota)",1784030478000 | |
| 1828098,STKH,Steakholder Foods Ltd.,0.5202,Israel,Israel,923389,497648,1775067,28.04%,7.63,LONG,51465,99378,65255,Food Products,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784030544000 | |
| 1861841,ARBE,Arbe Robotics Ltd.,0.6881,Israel,Israel,84395288,96816087,122649743,78.94%,37.67,LONG,511349,832472,2569944,Electrical Equipment,Press Release,Float too large: 96.8M exceeds 50M limit (6-K),1784030708000 | |
| 1862461,REAX,Alexandra Lumpkin Alexandra Lumpkin Chief Legal Officer,2.07,Canada,Florida,451144352,146603990,217944140,67.27%,36.19,LONG,50164,4904086,4050978,Real Estate,Merger/Acquisition; Regulation S Offering; Unregistered Equity Sales,Float too large: 146.6M exceeds 50M limit (6-K),1784030992000 | |
| 1750149,IKT,"Inhibikase Therapeutics, Inc.",1.96,Delaware,Delaware,258783984,25000000,132032636,18.93%,30.16,LONG,84143,356364,828922,Biotechnology,Clinical Success; Commercial Inflection,"Insufficient core signal categories (need 2+, found 1)",1784031071000 | |
| 1566044,VYNE,VYNE Therapeutics Inc.,0.6579,Delaware,New Jersey,21964028,43149256,33385055,129.2%,90.42,LONG,N/A,2889338,477231,Pharmaceuticals,Clinical Success; Clinical Milestone; FDA Approved; Commercial Inflection; Unregistered Equity Sales,Float too large: 43.1M exceeds 25M limit (8-K),1784031143000 | |
| 29002,DIOD,DIODES INC /DEL/,92.29,Delaware,Texas,4240239616,45037785,45944734,98.03%,64.63,SHORT,N/A,230103,696896,Semiconductors,Merger/Acquisition; Credit Default; Asset Disposition; Partnership; Licensing Deal; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 45.0M exceeds 25M limit (8-K),1784031314000 | |
| 1978527,GVH,Globavend Holdings Ltd,4.62,Cayman Islands,Australia,10565104,296542,2286819,12.97%,0.71,N/A,16176,19796,414759,N/A,Underwritten Offering; Asset Disposition; Commercial Inflection; Unregistered Equity Sales; Related-Party Transaction,F/AV 0.71x below 1.2x absolute minimum (untradeable liquidity),1784031762000 | |
| 1331284,DHT,"DHT Holdings, Inc.",17.31,Greece,Bermuda,2787630592,144164473,161041637,89.52%,42.96,LONG,N/A,2616045,3356139,Energy,Press Release,Float too large: 144.2M exceeds 50M limit (6-K),1784031832000 | |
| 1857047,MDA,MDA Space Ltd.,31.47,Canada,Canada,4371785216,23000000,138919141,16.56%,17.56,LONG,164304,3224746,1309596,Aerospace & Defense,Underwritten Offering,"Insufficient core signal categories (need 2+, found 0)",1784031971000 | |
| 1285170,ITMSF,INTERMAP TECHNOLOGIES CORP,0.7,Canada,Canada,51647188,50154515,73781696,67.98%,335.42,LONG,N/A,5200,149529,Technology,Commercial Inflection,Float too large: 50.2M exceeds 50M limit (6-K),1784032207000 | |
| 1653384,RWAY,Runway Growth Finance Corp.,5.29,Maryland,Israel,224637440,35598819,42464546,83.83%,53.49,LONG,43523,993437,665463,Financial Services,Stock Buyback; Unregistered Equity Sales; Related-Party Transaction,Float too large: 35.6M exceeds 25M limit (8-K),1784032216000 | |
| 878518,TGB,Trekor Metals Ltd,7.02,Canada,Canada,2566844160,359363856,365647317,98.28%,72.62,LONG,760860,4525512,4948642,Metals & Mining,Unregistered Equity Sales,Float too large: 359.4M exceeds 50M limit (6-K),1784032481000 | |
| 1676163,SSII,"SS Innovations International, Inc.",3.64,Florida,India,728478784,7729880,200131535,3.86%,137.12,LONG,24077,38947,56373,Health Care,FDA Approved; Asset Disposition; Partnership; Unregistered Equity Sales,"Location not whitelisted (Florida, India)",1784032522000 | |
| 1670061,ALM,Almonty Industries Inc.,15.015,Canada,Montana,4260384000,212679099,283741849,74.96%,39.26,LONG,182085,6246772,5417332,Metals & Mining,Unregistered Equity Sales,Float too large: 212.7M exceeds 50M limit (6-K),1784032545000 | |
| 1822928,HLLY,Holley Inc.,2.53,Delaware,Tennessee,304535712,51914994,120369848,43.13%,60.69,LONG,N/A,997412,855403,Auto Components,Press Release,Float too large: 51.9M exceeds 25M limit (8-K),1784032698000 | |
| 1331754,Unknown,Federal Home Loan Bank of Indianapolis,N/A,Luxembourg,Indiana,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure,"Location not whitelisted (Luxembourg City, Luxembourg, Indiana)",1784032763000 | |
| 917851,VALE,Vale S.A.,14.18,Unknown,Brazil,60346716160,3965376710,4255762753,93.18%,167.79,LONG,196746,14848567,23633283,Metals & Mining,Press Release,"Location not whitelisted (Unknown, Brazil)",1784033487000 | |
| 1843973,FLYX,FLYEXCLUSIVE INC.,1.58,Delaware,North Carolina,151734208,7096117,46104300,15.39%,11.97,LONG,75003,135571,592714,Airlines,Merger/Acquisition; Underwritten Offering; Asset Disposition,"Alert sent: [LONG] Merger/Acquisition, Underwritten Offering, Asset Disposition (Bonus: Tuesday 1.2x + North Carolina (via Wilmington, Delaware) 1.3x + Filing Time 1.15x)",1784033963000 | |
| 1837493,QTEX,QTREX Quantum Ltd.,1.48,Israel,Israel,82448984,41596093,55708771,74.67%,1.38,LONG,5811210,1955721,30111786,Health Care,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784034023000 | |
| 1609253,CRC,California Resources Corp,53.34,Delaware,Canada,4736320000,81121422,88794901,91.36%,99.43,LONG,175002,731940,815896,Energy,Press Release,Float too large: 81.1M exceeds 25M limit (8-K),1784034034000 | |
| 1034957,CRESY,CRESUD INC,10.67,Argentina,Argentina,756771904,28553518,70925196,40.26%,94.34,LONG,2527,150226,302657,Food Products,Press Release,"Location not whitelisted (Buenos Aires, Argentina, Buenos Aires, Argentina)",1784034197000 | |
| 1425355,SUIG,SUI Group Holdings Ltd.,1.19,Minnesota,Minnesota,96271008,69255248,80900000,85.61%,184.01,LONG,1839,117659,376373,Financial Services,Press Release,"Location not whitelisted (Minnesota, Minnesota)",1784034419000 | |
| 1325878,Unknown,Federal Home Loan Bank of Topeka,N/A,Unknown,Kansas,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Unknown, Kansas)",1784034460000 | |
| 1948294,NWGL,CL Workshop Group Ltd,0.249,Hong Kong,Macau,4121738,12300000,4936559,249.2%,5.51,LONG,450715,331127,2233886,Paper & Forest,Asset Disposition; Licensing Deal; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [LONG] Asset Disposition, Licensing Deal, Unregistered Equity Sales, Regulation S Offering (Bonus: Tuesday 1.2x + BNY Mellon 1.3x + Filing Time 1.2x)",1784034597000 | |
| 791908,XOMA,XOMA Royalty Corp,40.17,Nevada,Canada,710155008,17678742,17678742,100.0%,53.23,SHORT,495,4217188,332104,Biotechnology,Merger/Acquisition; Clinical Success; Contingent Value Rights; Going Dark; Asset Disposition; Regulation S Offering; Unregistered Equity Sales,"Alert sent: [SHORT] Merger/Acquisition, Clinical Success, Contingent Value Rights, Going Dark, Asset Disposition, Regulation S Offering, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Toronto, Canada (via Nevada) 1.3x + Filing Time 1.2x + Shell Recycling)",1784034621000 | |
| 808439,TATT,TAT TECHNOLOGIES LTD,42.33,Unknown,Israel,549576192,12961715,12983137,99.84%,57.50,LONG,19186,164576,225403,Aerospace & Defense,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784034902000 | |
| 799850,CRMT,AMERICAS CARMART INC,3.02,Texas,Arkansas,25073398,8305520,8302450,100.0%,5.27,LONG,30481,515214,1575118,Retail,Merger/Acquisition; Accounting Restatement; Commercial Inflection; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Accounting Restatement, Commercial Inflection, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Arkansas (via Texas) 1.3x + Filing Time 1.2x)",1784034930000 | |
| 1330399,Unknown,Federal Home Loan Bank of Pittsburgh,N/A,Pennsylvania,Pennsylvania,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Pennsylvania, Pennsylvania)",1784035069000 | |
| 886163,LGND,LIGAND PHARMACEUTICALS INC,309.25,Delaware,Canada,6197698048,19545483,20041061,97.53%,59.40,SHORT,5619,245695,329032,Pharmaceuticals,Merger/Acquisition; Clinical Success; Contingent Value Rights; Credit Default; Asset Disposition; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [SHORT] Merger/Acquisition, Clinical Success, Contingent Value Rights, Credit Default, Asset Disposition, Unregistered Equity Sales, Regulation S Offering (Bonus: Tuesday 1.2x + Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784035216000 | |
| 1132597,ITUB,Itau Unibanco Holding S.A.,8.47,Brazil,Brazil,93355261952,5849586251,5404129565,108.2%,258.32,LONG,59204,19329318,22645004,Banking,Contingent Value Rights; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (Sao Paulo, Brazil, Sao Paulo, Brazil)",1784035243000 | |
| 1595248,GNPX,"Genprex, Inc.",0.5352,Texas,Texas,5848244,11108577,10927213,101.7%,17.68,SHORT,85749,91984,628303,Biotechnology,Clinical Success; Clinical Milestone; FDA Approved; Nasdaq Delisting; Bid Price Delisting; Unregistered Equity Sales,"Alert sent: [SHORT] Clinical Success, Clinical Milestone, FDA Approved, Nasdaq Delisting, Bid Price Delisting, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Filing Time 1.2x)",1784035403000 | |
| 1034957,CRESY,CRESUD INC,10.67,Argentina,Argentina,756771904,46778518,70925196,65.95%,154.56,LONG,2527,150226,302657,Food Products,Press Release,"Location not whitelisted (Buenos Aires, Argentina, Buenos Aires, Argentina)",1784035625000 | |
| 313838,SONY,Sony Group Corp,20.965,Japan,Japan,123103543296,37076600,5871859854,0.63%,5.68,LONG,76670,116547,6522534,Consumer products,Asset Disposition,"Location not whitelisted (Tokyo, Japan, Japan)",1784035797000 | |
| 1581804,NVGS,Navigator Holdings Ltd.,20.645,Greece,UK,1274248192,26766909,61721879,43.37%,56.98,LONG,2828,55921,469752,Energy,Partnership; Commercial Inflection; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (Athens, Greece, London, UK)",1784036140000 | |
| 831001,C,CITIGROUP INC,142.67,Delaware,New York,243334660096,1700067941,1705576955,99.68%,142.01,LONG,4718,1492339,11971342,Banking,Commercial Inflection,Float too large: 1700.1M exceeds 25M limit (8-K),1784036387000 | |
| 1849867,CLST,"Catalyst Bancorp, Inc.",17,Unknown,Louisiana,68882232,3293129,4051896,81.27%,839.66,LONG,4,13,3922,Banking,Merger/Acquisition; Asset Disposition,"Location not whitelisted (Unknown, Louisiana)",1784036490000 | |
| 1069878,TREX,TREX CO INC,45.68,Delaware,Virginia,4746094080,103219231,103898729,99.35%,52.94,LONG,193,733302,1949557,Building,Unregistered Equity Sales,Float too large: 103.2M exceeds 25M limit (8-K),1784037614000 | |
| 717826,ERIC,ERICSSON LM TELEPHONE CO,10.335,Sweden,Sweden,34123571200,2904660003,3039992440,95.55%,262.27,LONG,1836837,10110303,11074962,Communications,Press Release,"Location not whitelisted (Stockholm, Sweden, Stockholm, Sweden)",1784038485000 | |
| 1756770,CURLF,"Curaleaf Holdings, Inc.",9.76,Canada,New York,2578925824,167216694,232910632,71.79%,414.71,LONG,17600,9536,403209,Pharmaceuticals,Press Release,Float too large: 167.2M exceeds 50M limit (6-K),1784039549000 | |
| 1756770,CURLF,"Curaleaf Holdings, Inc.",9.76,Canada,New York,2578925824,167216694,232910632,71.79%,414.71,LONG,17600,9536,403209,Pharmaceuticals,Contingent Value Rights,Float too large: 167.2M exceeds 50M limit (6-K),1784039579000 | |
| 1756770,CURLF,"Curaleaf Holdings, Inc.",9.76,Canada,New York,2578925824,167216694,232910632,71.79%,414.71,LONG,17600,9536,403209,Pharmaceuticals,Contingent Value Rights,Float too large: 167.2M exceeds 50M limit (6-K),1784039579000 | |
| 1331757,Unknown,Federal Home Loan Bank of Dallas,N/A,Unknown,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784040612000 | |
| 1131399,GSK,GSK plc,51.295,UK,United Kingdom,102733504512,1946202600,2002797682,97.17%,507.75,LONG,2228,888758,3832986,Pharmaceuticals,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1784042402000 | |
| 1325814,Unknown,Federal Home Loan Bank of Des Moines,N/A,Luxembourg,Iowa,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Luxembourg City, Luxembourg, Iowa)",1784046942000 | |
| 1326771,Unknown,Federal Home Loan Bank of Cincinnati,N/A,Luxembourg,Ohio,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure,"Location not whitelisted (Luxembourg City, Luxembourg, Ohio)",1784048092000 | |
| 1331451,Unknown,Federal Home Loan Bank of Chicago,N/A,Luxembourg,Israel,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784048547000 | |
| 875729,BNET,BION ENVIRONMENTAL TECHNOLOGIES INC,0.19,Colorado,New York,10908339,46490872,57412311,80.98%,5044.58,SHORT,N/A,3000,9216,Commercial Services & Supplies,Merger/Acquisition; Convertible Debt; Credit Default; Licensing Deal; Unregistered Equity Sales; Regulation S Offering,Price too low: $0.1900 below $0.2 minimum,1784048611000 | |
| 1160106,LYG,Lloyds Banking Group plc,5.93,UK,UK,86167724032,7000000,14530813782,0.05%,0.32,LONG,2087493,13154137,21608173,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1784050575000 | |
| 1692951,Unknown,"Cottonwood Communities, Inc.",N/A,Maryland,Utah,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Unregistered Equity Sales,"Location not whitelisted (Maryland, Utah)",1784050844000 | |
| 894671,OVBC,OHIO VALLEY BANC CORP,43.35,Ohio,Ohio,204221936,3345564,4711001,71.02%,107.96,LONG,174,25858,30990,Banking,Press Release,"Location not whitelisted (Ohio, Ohio)",1784051118000 | |
| 740806,FMBM,F&M BANK CORP,38.4,Virginia,Virginia,136671632,3008294,3559157,84.52%,1482.65,LONG,95,100,2029,Banking,Unregistered Equity Sales,"Location not whitelisted (Virginia, Virginia)",1784051217000 | |
| 721994,LKFN,LAKELAND FINANCIAL CORP,60.6,Indiana,Indiana,1509763328,24061541,24913586,96.58%,117.78,LONG,134,35494,204296,Banking,Unregistered Equity Sales,"Location not whitelisted (Indiana, Indiana)",1784052982000 | |
| 1331463,Unknown,Federal Home Loan Bank of Boston,N/A,Luxembourg,Massachusetts,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Luxembourg City, Luxembourg, Massachusetts)",1784054225000 | |
| 2035428,Unknown,"Franklin BSP Real Estate Debt, Inc.",N/A,Maryland,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784054852000 | |
| 889609,CPSS,"CONSUMER PORTFOLIO SERVICES, INC.",9.355,Canada,Nevada,202990064,9098439,21698565,41.93%,335.79,N/A,644,6480,27096,N/A,Merger/Acquisition; Regulation S Offering; Unregistered Equity Sales,F/AV 335.79x exceeds max threshold of 200x,1784056235000 | |
| 277638,Unknown,DAVEY TREE EXPERT CO,N/A,Ohio,Ohio,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Location not whitelisted (Ohio, Ohio)",1784057131000 | |
| 1924064,RLNDF,RoyaLand Co Ltd.,2.5,Canada,Canada,N/A,50000000,14,357142857.1%,357142.86,SHORT,300,100,140,Media,Underwritten Offering; Accounting Restatement; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Volume 100 below 2k minimum,1784058646000 | |
| 1754913,Unknown,Not Applicable,N/A,Unknown,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784058828000 | |
| 1772527,Unknown,Not Applicable,N/A,Unknown,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784059071000 | |
| 1866030,AZ,A2Z CUST2MATE SOLUTIONS CORP.,5.54,Canada,Canada,246708192,38240999,44532164,85.87%,90.11,LONG,37000,131607,424363,Aerospace & Defense,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784059218000 | |
| 908259,OTLC,"Oncotelic Therapeutics, Inc.",0.035,Delaware,Canada,15526550,223257660,443615716,50.33%,731.70,LONG,N/A,49990,305122,Biotechnology,Press Release,Price too low: $0.0350 below $0.2 minimum,1784059233000 | |
| 1987240,SHMD,SCHMID Group N.V.,4.52,Spain,Germany,296854304,13725817,65675726,20.90%,12.40,SHORT,373509,267302,1106606,Electrical Equipment,Convertible Debt; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Location not whitelisted (Madrid, Spain, Germany)",1784059266000 | |
| 1517681,PPCB,"Propanc Biopharma, Inc.",1.63,Delaware,Australia,3713744,786733,2278371,34.53%,0.20,SHORT,610843,92171,4028277,Biotechnology,Executive Departure; Unregistered Equity Sales; Regulation S Offering,"Insufficient core signal categories (need 2+, found 1)",1784059288000 | |
| 1749360,Unknown,Not Applicable,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784059285000 | |
| 1825079,VELO,"Velo3D, Inc.",12.79,Delaware,Canada,381154816,1145830,29801002,3.84%,0.30,LONG,133715,1689743,3860018,Machinery,Merger/Acquisition; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [LONG] Merger/Acquisition, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction (Bonus: Tuesday 1.2x + Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784059389000 | |
| 1753233,Unknown,Not Applicable,N/A,North Carolina,North Carolina,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (North Carolina, North Carolina)",1784059373000 | |
| 879526,WNC,WABASH NATIONAL Corp,13.425,Delaware,Indiana,546048000,37244745,40673967,91.57%,42.72,LONG,N/A,421130,871891,Machinery,Merger/Acquisition; Convertible Debt; Credit Default; Unregistered Equity Sales,Float too large: 37.2M exceeds 25M limit (8-K),1784059476000 | |
| 2018462,PCLA,PicoCELA Inc.,4.5,Japan,Japan,43262124,733509,9613805,7.63%,0.44,LONG,144693,163017,1654259,Communications,Press Release,"Location not whitelisted (Tokyo, Japan, Tokyo, Japan)",1784059497000 | |
| 1720592,RPAY,Repay Holdings Corp,3.92,Delaware,Georgia,345300384,63756935,82800952,77.00%,51.51,LONG,26373,295009,1237816,Financial Services,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 63.8M exceeds 25M limit (8-K),1784059530000 | |
| 1253689,CBIO,"CRESCENT BIOPHARMA, INC.",15.305,Cayman Islands,Massachusetts,422032704,21323859,27571935,77.34%,67.97,LONG,558,71684,313722,Biotechnology,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784059525000 | |
| 1600222,PXED,"Phoenix Education Partners, Inc.",34.425,Delaware,Arizona,1232792832,30027289,35810977,83.85%,294.12,LONG,1060,118083,102093,Diversified Consumer Services,Merger/Acquisition; Underwritten Offering; Stock Buyback; Unregistered Equity Sales,Float too large: 30.0M exceeds 25M limit (8-K),1784059515000 | |
| 1652958,EDGM,"Edgemode, Inc.",0.0036,Nevada,Florida,12765633,7000000,3546009459,0.20%,0.44,SHORT,N/A,34820620,15987312,N/A,Merger/Acquisition; Credit Default; Asset Disposition; Unregistered Equity Sales; Related-Party Transaction,Price too low: $0.0036 below $0.2 minimum,1784059514000 | |
| 1527541,WHLR,"Wheeler Real Estate Investment Trust, Inc.",0.39,Maryland,Virginia,1181987,1018585,3030738,33.61%,0.84,LONG,268001,797814,1208264,Real Estate,Convertible Debt; Unregistered Equity Sales,"Location not whitelisted (Maryland, Virginia)",1784059599000 | |
| 1819810,RDW,Redwire Corp,9.745,Cayman Islands,Florida,2327352832,123244609,238825345,51.60%,3.07,LONG,106397,12118363,40134281,Aerospace & Defense,Underwritten Offering; Regulation S Offering; Unregistered Equity Sales,Float too large: 123.2M exceeds 25M limit (8-K),1784059636000 | |
| 1877184,KMTS,"KESTRA MEDICAL TECHNOLOGIES, LTD.",24.18,Canada,Washington,1411467648,32767298,58373353,56.13%,97.38,LONG,7532,418613,336478,Health Care,Merger/Acquisition; Commercial Inflection,Float too large: 32.8M exceeds 25M limit (8-K),1784059713000 | |
| 1944399,PDC,Perpetuals.com Ltd,4.06,Japan,Japan,27504620,3195752,6774537,47.17%,27.90,LONG,12582,320712,114559,Professional Services,Commercial Inflection,"Location not whitelisted (Tokyo, Japan, Japan)",1784059810000 | |
| 2018462,PCLA,PicoCELA Inc.,4.5,Japan,Japan,43262124,38455220,9613805,400.0%,23.25,LONG,144693,163017,1654259,Communications,Unregistered Equity Sales,"Location not whitelisted (Tokyo, Japan, Tokyo, Japan)",1784059799000 | |
| 1464591,GPRK,GeoPark Ltd,10.335,Canada,Columbia,668499584,39958335,64683076,61.78%,67.35,LONG,39121,311318,593290,Energy,Contingent Value Rights,"Insufficient core signal categories (need 2+, found 1)",1784059879000 | |
| 1585608,JAGX,"Jaguar Health, Inc.",2.17,Delaware,Canada,10540148,55020,4857211,1.13%,0.59,LONG,9165,11090,92571,Pharmaceuticals,Merger/Acquisition; Asset Disposition; Partnership; Licensing Deal; Related-Party Transaction; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Asset Disposition, Partnership, Licensing Deal, Related-Party Transaction, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784060112000 | |
| 10456,BAX,BAXTER INTERNATIONAL INC,21.8,Delaware,Israel,11259023360,511543435,516469008,99.05%,71.65,SHORT,397134,4196684,7139275,Health Care,Accounting Restatement; Unregistered Equity Sales,Float too large: 511.5M exceeds 25M limit (8-K),1784060149000 | |
| 33213,EQT,EQT Corp,49.82,Pennsylvania,Pennsylvania,31161315328,619917501,625478000,99.11%,82.55,LONG,390321,4716897,7510024,Energy,Press Release,"Location not whitelisted (Pennsylvania, Pennsylvania)",1784060132000 | |
| 1053691,CRVO,CervoMed Inc.,3.08,Delaware,Massachusetts,28516854,5610316,9258719,60.59%,1.00,LONG,31296,863317,5619431,Biotechnology,Clinical Success; Clinical Milestone; Partnership; Unregistered Equity Sales; Failed Trial,"Alert sent: [LONG] Clinical Success, Clinical Milestone, Partnership, Unregistered Equity Sales, Failed Trial (Bonus: Tuesday 1.2x + Massachusetts (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784060487000 | |
| 1662991,SEZL,Sezzle Inc.,182.39,Delaware,Minnesota,6133232128,17015608,33627019,50.60%,24.70,LONG,33976,741002,688970,Financial Services,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784060826000 | |
| 1588272,Unknown,"NexPoint Capital, Inc.",N/A,Delaware,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784060900000 | |
| 105770,WST,WEST PHARMACEUTICAL SERVICES INC,357.65,Pennsylvania,Pennsylvania,25267109888,N/A,70647595,N/A,N/A,LONG,289,549971,851701,Life Sciences Tools & Services,Merger/Acquisition,"Location not whitelisted (Pennsylvania, Pennsylvania)",1784060965000 | |
| 1403568,ULTA,"Ulta Beauty, Inc.",469.12,Unknown,Israel,20167145472,42849166,42989311,99.67%,55.07,LONG,4579,432020,778039,Retail,Partnership; Unregistered Equity Sales,Float too large: 42.8M exceeds 25M limit (8-K),1784061025000 | |
| 1947016,FJET,"Starfighters Space, Inc.",4.73,Delaware,Florida,234732640,18436458,49626351,37.15%,8.46,SHORT,2152481,571312,2179408,Aerospace & Defense,Accounting Restatement; Regulation S Offering; Unregistered Equity Sales,"Alert sent: [SHORT] Accounting Restatement, Regulation S Offering, Unregistered Equity Sales (Bonus: Tuesday 1.2x + Florida (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784061022000 | |
| 1786108,TRIN,Trinity Capital Inc.,17.65,Maryland,Arizona,1586516992,70488328,89887651,78.42%,64.54,LONG,207993,927812,1092209,Financial Services,Unregistered Equity Sales,"Location not whitelisted (Maryland, Arizona)",1784061015000 | |
| 1618835,EVFM,"Evofem Biosciences, Inc.",0.0083,Delaware,Canada,1099999,132528542,132530081,100.00%,437.17,SHORT,12504,109993,303150,Pharmaceuticals,Merger/Acquisition; Credit Default; Unregistered Equity Sales; Regulation S Offering,Price too low: $0.0083 below $0.2 minimum,1784061066000 | |
| 866787,AZO,AUTOZONE INC,3032.07,Nevada,Tennessee,49499619328,16273114,16325355,99.68%,42.64,LONG,217,165312,381595,Retail,Merger/Acquisition; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Credit Default, Asset Disposition, Partnership, Unregistered Equity Sales (Bonus: Tuesday 1.2x + BNY Mellon 1.3x + Filing Time 1.2x)",1784061394000 | |
| 1393584,AMWL,American Well Corp,10.88,Delaware,Massachusetts,181788304,13315516,15061188,88.41%,140.18,LONG,N/A,199723,94986,Health Care,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784061584000 | |
| 1579214,EEX,"Emerald Holding, Inc.",5.04,Delaware,Canada,997505920,16721225,197917833,8.45%,58.87,N/A,23402,121992,284021,N/A,Merger/Acquisition; Going Dark; Asset Disposition; Partnership; Regulation S Offering; Unregistered Equity Sales,SHORT signal but S/O 8.45% < 10% minimum (unborrowable),1784061577000 | |
| 899051,ALL,ALLSTATE CORP,250.35,Delaware,Israel,64445329408,255860959,257420930,99.39%,149.12,LONG,213,1381756,1715840,Insurance,Unregistered Equity Sales,Float too large: 255.9M exceeds 25M limit (8-K),1784061571000 | |
| 2028516,ATII,Archimedes Tech SPAC Partners II Co.,10.8,Cayman Islands,Delaware,319572000,2300000,29590000,7.77%,7.11,N/A,8904,98227,323414,N/A,Merger/Acquisition; Underwritten Offering; Credit Default; Asset Disposition; Partnership; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction; PIPE,SHORT signal but S/O 7.77% < 10% minimum (unborrowable),1784061716000 | |
| 65172,MSB,MESABI TRUST,25.46,New York,New York,334035456,13109908,13120010,99.92%,237.64,LONG,447,25103,55167,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784061914000 | |
| 1752363,Unknown,"Matt Smith Name: Matt Smith Title: Director Dated: July 14, 2026",N/A,Unknown,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784062124000 | |
| 2069785,GLOO,"Gloo Holdings, Inc.",3.38,Delaware,Colorado,295994336,5550588,28523881,19.46%,23.93,LONG,10613,1063459,231918,Technology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784062210000 | |
| 1175535,WSR,Whitestone REIT,18.99,Texas,Texas,988012416,49480065,51393977,96.28%,85.11,SHORT,N/A,633668,581395,Real Estate,Merger/Acquisition; Going Dark; Asset Disposition; Partnership; Regulation S Offering; Unregistered Equity Sales,Float too large: 49.5M exceeds 25M limit (8-K),1784062410000 | |
| 2087398,TMCR,Metals Royalty Co Inc.,5.785,Canada,Canada,358928736,18881761,62044729,30.43%,193.58,LONG,109403,33279,97542,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784062540000 | |
| 1852575,SGST,"Strategic Storage Trust VI, Inc.",N/A,Maryland,Canada,N/A,N/A,12,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Asset Disposition; Partnership; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,No Price Data,1784062585000 | |
| 2137777,RACD,Research Alliance Corp IV,10.42,Cayman Islands,New York,94806672,1323529,7775000,17.02%,1.97,SHORT,N/A,59723,671500,N/A,Merger/Acquisition; Underwritten Offering; Going Dark; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Alert sent: [SHORT] Merger/Acquisition, Underwritten Offering, Going Dark, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction (Bonus: Tuesday 1.2x + New York (via Cayman Islands) 1.3x + Filing Time 1.2x)",1784062724000 | |
| 898437,ANIK,"Anika Therapeutics, Inc.",15.52,Delaware,Massachusetts,206503296,50000000,13305624,375.8%,555.39,SHORT,1223,41780,90027,Biotechnology,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,Float too large: 50.0M exceeds 25M limit (8-K),1784062816000 | |
| 1378590,BLIN,"Bridgeline Digital, Inc.",1.22,Delaware,Massachusetts,15371853,10174276,12599879,80.75%,119.76,N/A,6716,92521,84955,N/A,Merger/Acquisition; Credit Default; Accounting Restatement; Regulatory Breach; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,F/AV 119.76x above 65x (overextended blowoff/meme volume),1784062908000 | |
| 1761918,ERAS,"Erasca, Inc.",19.5,Delaware,Canada,6064198656,31428572,310984542,10.11%,4.60,SHORT,87162,10425876,6838722,Biotechnology,Clinical Success; Convertible Debt; Regulatory Breach; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,Float too large: 31.4M exceeds 25M limit (8-K),1784062983000 | |
| 314489,BUSE,FIRST BUSEY CORP /NV/,29.31,Nevada,Kansas,2478956544,80686733,84577160,95.40%,111.13,LONG,N/A,604704,726072,Banking,Unregistered Equity Sales,Float too large: 80.7M exceeds 25M limit (8-K),1784063185000 | |
| 2140978,Unknown,BANK5 2026-5YR23,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784063344000 | |
| 1988776,MRNO,Murano Global Investments Plc,0.248,Cyprus,UK,19770270,1396220,79718832,1.75%,0.22,SHORT,236878,142876,6471014,Real Estate,Executive Departure; Regulation S Offering,"Location not whitelisted (Nicosia, Cyprus, London, UK)",1784063432000 | |
| 2061670,Unknown,Monroe Capital Enhanced Corporate Lending Fund,N/A,Delaware,Israel,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784063489000 | |
| 1430725,GSL,"Global Ship Lease, Inc.",41.24,Greece,Greece,1486101248,31866698,36035434,88.43%,99.75,LONG,23,275579,319475,Marine,Asset Disposition; Partnership; Related-Party Transaction,"Location not whitelisted (Athens, Greece, Greece)",1784063598000 | |
| 917851,VALE,Vale S.A.,14.59,Unknown,Brazil,62091579392,3965376710,4255762753,93.18%,167.79,LONG,196746,20407326,23633283,Metals & Mining,Press Release,"Location not whitelisted (Unknown, Brazil)",1784063775000 | |
| 1945422,Unknown,Oak Woods Acquisition Corp,N/A,Canada,Canada (Federal Level),N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Underwritten Offering; Regulation S Offering; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784063840000 | |
| 1947244,USGO,U.S. GoldMining Inc.,7.95,Nevada,Canada,110324504,1552491,13877296,11.19%,24.06,LONG,3918,47166,64534,Metals & Mining,Partnership; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784063891000 | |
| 2128045,BCCQ,Bleichroeder Acquisition Corp. III,N/A,Cayman Islands,New York,N/A,2015750,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Underwritten Offering; Commercial Inflection; Unregistered Equity Sales; Related-Party Transaction,"Insufficient core signal categories (need 2+, found 1)",1784064118000 | |
| 1868275,CEG,Constellation Energy Corp,256.43,Pennsylvania,Maryland,91571666944,337745216,357102017,94.58%,91.82,LONG,5823,3080167,3678463,Utilities,Press Release,"Location not whitelisted (Pennsylvania, Maryland)",1784064204000 | |
| 1168165,Unknown,CONSTELLATION ENERGY GENERATION LLC,N/A,Unknown,Pennsylvania,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (Unknown, Pennsylvania)",1784064204000 | |
| 893847,HWBK,"HAWTHORN BANCSHARES, INC.",38.5,Missouri,Missouri,265518528,6175123,6896585,89.54%,530.65,LONG,236,9232,11637,Banking,Unregistered Equity Sales,"Location not whitelisted (Missouri, Missouri)",1784064184000 | |
| 1616262,RMCF,"Rocky Mountain Chocolate Factory, Inc.",1.02,Delaware,Colorado,9628381,46000000,9439589,487.3%,515.18,LONG,4,31293,89290,Food Products,Contingent Value Rights; Regulation S Offering; Unregistered Equity Sales,Float too large: 46.0M exceeds 25M limit (8-K),1784064263000 | |
| 2064124,FIGR,"Figure Technology Solutions, Inc.",29.96,Delaware,Nevada,6624181248,118339900,182622749,64.80%,29.46,SHORT,247529,2321427,4017295,Financial Services,Merger/Acquisition; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 118.3M exceeds 25M limit (8-K),1784064247000 | |
| 1826011,BNZI,"Banzai International, Inc.",2.74,Delaware,Washington,5880536,128038,2112325,6.06%,0.33,N/A,662796,453196,392110,N/A,Merger/Acquisition; Credit Default; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,SHORT signal but S/O 6.06% < 10% minimum (unborrowable),1784064314000 | |
| 2084026,QMLS,"QumulusAI, Inc.",N/A,Georgia,Georgia,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Partnership; Unregistered Equity Sales,"Location not whitelisted (Georgia, Georgia)",1784064433000 | |
| 1692819,VST,Vistra Corp.,158.43,Delaware,Texas,53419814912,314479972,337182468,93.27%,67.59,LONG,254,5305207,4652972,Utilities,Unregistered Equity Sales,Float too large: 314.5M exceeds 25M limit (8-K),1784064577000 | |
| 1650696,LSF,"Laird Superfood, Inc.",4.51,Nevada,Colorado,49629612,8310924,11004348,75.52%,130.43,LONG,N/A,20608,63718,Food Products,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784064629000 | |
| 2120882,SKHY,"Seonghwan Park (Signature) Name: Seonghwan Park Title: Head of Investor Relations Date: July 15, 2026",193.92,M5,Republic of,1376550518784,5255504500,7098548910,74.04%,64.01,LONG,N/A,72595986,82102147,Semiconductors,Press Release,"Location not whitelisted (M5, Korea, Republic of)",1784110178000 | |
| 1084201,SVA,SINOVAC BIOTECH LTD,6.47,Bermuda,China,N/A,59508000,99294704,59.93%,N/A,LONG,N/A,N/A,N/A,Biotechnology,Press Release,Float too large: 59.5M exceeds 50M limit (6-K),1784110177000 | |
| 891478,SAN,"Banco Santander, S.A.",13.63,Spain,Spain,195153068032,14300854000,14317906744,99.88%,1727.50,LONG,2895243,7129475,8278350,Banking,Press Release,"Location not whitelisted (Madrid, Spain, Madrid, Spain)",1784110278000 | |
| 1103838,IBN,ICICI BANK LTD,29,Unknown,United States,104011145216,3565286000,3586591207,99.41%,466.41,LONG,97754,4250543,7644086,Banking,Unregistered Equity Sales,Float too large: 3565.3M exceeds 50M limit (6-K),1784110657000 | |
| 1116578,PUK,PRUDENTIAL PLC,28.59,UK,United Kingdom,35618811904,5007279000,1245848531,401.9%,4751.06,LONG,159285,776561,1053929,Insurance,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1784110790000 | |
| 1962738,CASIF,"Wei-Wu He Name: Wei-Wu He Title: Chairman to the Board Date: July 15, 2026",0.14,Cayman Islands,China,2877822,9717378,20555873,47.27%,666.62,LONG,N/A,181,14577,Biotechnology,Press Release,Price too low: $0.1400 below $0.2 minimum,1784111432000 | |
| 1390777,BNY,Bank of New York Mellon Corp,154.5,Delaware,New York,106045562880,684484639,686379045,99.72%,175.85,LONG,2079,4771487,3892409,Financial Services,Partnership; Unregistered Equity Sales,Float too large: 684.5M exceeds 25M limit (8-K),1784111421000 | |
| 1795139,GTBIF,Green Thumb Industries Inc.,7.52,Unknown,Israel,1646802176,190140969,195073442,97.47%,324.73,LONG,1702,71253,585529,Pharmaceuticals,Unregistered Equity Sales,Float too large: 190.1M exceeds 25M limit (8-K),1784113218000 | |
| 893949,MD,"Pediatrix Medical Group, Inc.",24.11,Florida,Florida,1979959296,80807621,82121911,98.40%,100.63,LONG,588,1247331,802988,Health Care,Contingent Value Rights; Unregistered Equity Sales,"Location not whitelisted (Florida, Florida)",1784113215000 | |
| 1995075,MGN,Megan Holdings Ltd.,0.11,Cayman Islands,Malaysia,4070000,257003827,32000000,803.1%,20.73,SHORT,81830,888727,12395224,Construction,Going Dark; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,Price too low: $0.1100 below $0.2 minimum,1784113226000 | |
| 897322,GILT,GILAT SATELLITE NETWORKS LTD,11.94,Unknown,Virginia,901123008,74998259,75470948,99.37%,86.22,LONG,11416,409880,869862,Communications,Press Release,"Location not whitelisted (Unknown, Virginia)",1784113218000 | |
| 1579428,AXSM,"Axsome Therapeutics, Inc.",235.26,Delaware,New York,12106424320,43559663,51459766,84.65%,46.84,LONG,2131,482756,930004,Pharmaceuticals,FDA Approved; Commercial Inflection,Float too large: 43.6M exceeds 25M limit (8-K),1784113515000 | |
| 1718405,HYMC,HYCROFT MINING HOLDING CORP,21.86,Delaware,Nevada,1997142784,47893875,91360601,52.42%,21.44,LONG,346276,1253166,2233673,Metals & Mining,Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 47.9M exceeds 25M limit (8-K),1784113531000 | |
| 1927719,CRGO,Freightos Ltd,1.25,Cayman Islands,Spain,64604368,23471238,51683498,45.41%,281.80,LONG,52348,54678,83290,Logistics & Transportation,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784114021000 | |
| 1101302,ENTG,ENTEGRIS INC,140.63,Delaware,Massachusetts,21417949184,151768000,152300000,99.65%,45.29,LONG,210426,2038377,3351165,Semiconductors,Contingent Value Rights; Unregistered Equity Sales,Float too large: 151.8M exceeds 25M limit (8-K),1784114095000 | |
| 1434265,GMAB,GENMAB A/S,28.73,Unknown,Denmark,17638377472,606427690,613935890,98.78%,306.79,LONG,138782,1633338,1976700,Biotechnology,Contingent Value Rights,"Location not whitelisted (Unknown, Copenhagen, Denmark)",1784114540000 | |
| 1968487,WS,"Worthington Steel, Inc.",33.94,Ohio,Ohio,1694294784,32397882,49920298,64.90%,112.50,LONG,N/A,238670,287990,Metals & Mining,Unregistered Equity Sales,"Location not whitelisted (Ohio, Ohio)",1784114642000 | |
| 1801198,LEGN,"Ying Huang Name: Ying Huang, Ph.D. Title: Chief Executive Officer",25.67,Cayman Islands,New Jersey,4965599232,178182956,193439792,92.11%,64.84,LONG,87371,1582458,2748136,Biotechnology,Clinical Success; Licensing Deal,Float too large: 178.2M exceeds 50M limit (6-K),1784115004000 | |
| 1854270,SNTI,"Senti Biosciences Holdings, Inc.",0.9675,Delaware,Canada,30132548,8089624,31144754,25.97%,39.57,LONG,12817,59299,204450,Biotechnology,Merger/Acquisition; Clinical Success; FDA Approved; Convertible Debt; Contingent Value Rights; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Alert sent: [LONG] Merger/Acquisition, Clinical Success, FDA Approved, Convertible Debt, Contingent Value Rights, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction (Bonus: Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.05x)",1784115132000 | |
| 23217,CAG,CONAGRA BRANDS INC.,14.15,Delaware,Israel,6769885696,1200000000,478437156,250.8%,68.91,LONG,169642,16852062,17414434,Food Products,Asset Disposition; Partnership; Unregistered Equity Sales,Float too large: 1200.0M exceeds 25M limit (8-K),1784115186000 | |
| 200406,JNJ,JOHNSON & JOHNSON,253.85,New Jersey,New Jersey,611072016384,2403220991,2407216971,99.83%,295.14,LONG,356545,8770522,8142677,Pharmaceuticals,Clinical Success; FDA Approved; Unregistered Equity Sales,"Location not whitelisted (New Jersey, New Jersey)",1784116144000 | |
| 895421,MS,MORGAN STANLEY,227.67,Delaware,New York,359100448768,1196323215,1577284817,75.85%,208.84,LONG,3448,9305194,5728363,Financial Services,Stock Buyback; Regulation S Offering; Unregistered Equity Sales,Float too large: 1196.3M exceeds 25M limit (8-K),1784116258000 | |
| 1628808,PROF,Profound Medical Corp.,7.1,Canada,Canada,257997216,29021928,36337637,79.87%,387.71,LONG,13552,67006,74855,Health Care,Clinical Success; Unregistered Equity Sales; Regulation S Offering,Float too large: 29.0M exceeds 25M limit (8-K),1784116832000 | |
| 1848731,GLAS,Glass House Brands Inc.,11.42,Canada,Canada,974213888,83437842,78940962,105.7%,243.64,SHORT,N/A,145693,342467,Consumer products,Clinical Success; Credit Default; Accounting Restatement; Regulatory Breach; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 83.4M exceeds 50M limit (6-K),1784116868000 | |
| 1877971,POM,POMDOCTOR Ltd,1.44,Cayman Islands,China,10735565,157230,6774573,2.32%,0.37,LONG,N/A,22307,421525,Health Care,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784117124000 | |
| 924383,GNSS,Genasys Inc.,1.7,Delaware,Canada,77421416,15206812,45542009,33.39%,113.36,N/A,24,57957,134145,N/A,Merger/Acquisition; Convertible Debt; Credit Default; Asset Disposition; Unregistered Equity Sales,F/AV 113.36x above 65x (overextended blowoff/meme volume),1784117228000 | |
| 1977102,BIRK,Birkenstock Holding plc,44.36,Cyprus,United Kingdom,8158072320,42751719,183906056,23.25%,17.27,LONG,1570817,1037285,2476081,"Textiles, Apparel & Luxury Goods",Press Release,"Location not whitelisted (Nicosia, Cyprus, United Kingdom)",1784117690000 | |
| 1781193,QH,"Leslie Yu Name: Leslie Yu Title: Chairman and Chief Executive Officer Date: July 15, 2026 2",6.03,Cayman Islands,China,19637378,88049087,3256380,2703.9%,123.52,LONG,186337,26247,712840,Commercial Services & Supplies,Press Release,Float too large: 88.0M exceeds 50M limit (6-K),1784117715000 | |
| 1805077,EOSE,"Eos Energy Enterprises, Inc.",4.29,Delaware,Pennsylvania,1522100992,284354117,354802119,80.14%,10.81,LONG,580329,18535283,26300226,Electrical Equipment,Commercial Inflection; Unregistered Equity Sales,Float too large: 284.4M exceeds 25M limit (8-K),1784117937000 | |
| 350852,CTBI,COMMUNITY TRUST BANCORP INC /KY/,72.25,Cayman Islands,Cayman Islands,1312328832,16687010,18163721,91.87%,158.00,LONG,N/A,120388,105616,Banking,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784117997000 | |
| 1871321,DRTS,Alpha Tau Medical Ltd.,12.34,Israel,Israel,1114621312,61944646,90325876,68.58%,69.93,LONG,161857,391923,885836,Health Care,Clinical Success; Clinical Milestone; Unregistered Equity Sales,Float too large: 61.9M exceeds 50M limit (6-K),1784118616000 | |
| 1962011,KAPA,"Kairos Pharma, LTD.",0.34,Delaware,Canada,7279808,8968187,21411198,41.89%,65.23,N/A,13186,54513,137495,N/A,Clinical Success; Regulation S Offering; Unregistered Equity Sales,F/AV 65.23x above 65x (overextended blowoff/meme volume),1784118636000 | |
| 723254,CTAS,CINTAS CORP,184.33,Washington,Ohio,73757237248,400216,400136881,0.10%,0.19,LONG,11991,3091682,2102086,Commercial Services & Supplies,Merger/Acquisition; Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (Washington, Ohio)",1784118676000 | |
| 1431852,ODV,Osisko Development Corp.,2.38,Canada,Canada,725236928,89847855,304721378,29.49%,27.58,LONG,86674,1275407,3257367,Metals & Mining,Commercial Inflection; Unregistered Equity Sales,Float too large: 89.8M exceeds 50M limit (6-K),1784119187000 | |
| 2031009,KAZR,Skyline Builders Group Holding Ltd,2.8,Cayman Islands,Hong Kong,69374176,9472782,22781491,41.58%,33.20,LONG,N/A,76422,285309,Construction,Executive Departure; Partnership; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784119287000 | |
| 1827635,MANE,"Veradermics, Inc",110.17,Delaware,Connecticut,4602758144,35082327,41778687,83.97%,53.27,LONG,7353,524998,658537,Pharmaceuticals,Clinical Success; FDA Approved; Commercial Inflection; Unregistered Equity Sales; Failed Trial,Float too large: 35.1M exceeds 25M limit (8-K),1784120076000 | |
| 1943421,RUBI,Rubico Inc.,4.28,Greece,Greece,2589451,756645,605012,125.1%,1.67,LONG,646086,13872,453419,Energy,Press Release,"Location not whitelisted (Athens, Greece, Greece)",1784120370000 | |
| 1854964,NLCP,Not Applicable,15.35,Maryland,Connecticut,321634784,18118689,20580766,88.04%,202.02,LONG,N/A,19941,89688,Real Estate,Unregistered Equity Sales,"Location not whitelisted (Maryland, Connecticut)",1784120409000 | |
| 1965473,CCG,Cheche Group Inc.,0.4413,Unknown,China,38697568,35956775,69093430,52.04%,250.22,SHORT,N/A,81511,143703,Insurance,Nasdaq Delisting; Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1784120420000 | |
| 1687542,FRGT,"Freight Technologies, Inc.",4.39,Hong Kong,Texas,2511628,3354309,572125,586.3%,15.61,SHORT,92714,26964,214865,Logistics & Transportation,Merger/Acquisition; Convertible Debt; Credit Default; Accounting Restatement; Partnership; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [SHORT] Merger/Acquisition, Convertible Debt, Credit Default, Accounting Restatement, Partnership, Unregistered Equity Sales, Related-Party Transaction (Bonus: Texas (via Hong Kong) 1.3x + Filing Time 1.2x)",1784120414000 | |
| 700565,FMBH,"FIRST MID BANCSHARES, INC.",48.04,Delaware,Israel,1278622848,23909425,26615796,89.83%,183.37,N/A,1,139502,130390,N/A,Merger/Acquisition; Credit Default; Regulation S Offering; Unregistered Equity Sales,F/AV 183.37x above 65x (overextended blowoff/meme volume),1784120431000 | |
| 1168455,PLBC,PLUMAS BANCORP,58.32,Canada,Nevada,406381696,6397655,6968136,91.81%,113.33,LONG,N/A,87062,56454,Banking,Stock Buyback,"Insufficient core signal categories (need 2+, found 0)",1784120415000 | |
| 1393781,QIND,Quality Industrial Corp.,0.0071,Nevada,Canada,815626,55316513,114876965,48.15%,312.39,LONG,99567,42520,177073,Machinery,Merger/Acquisition; Credit Default; Unregistered Equity Sales,Price too low: $0.0071 below $0.2 minimum,1784120456000 | |
| 1861560,NUVL,"Nuvalent, Inc.",123.96,Delaware,Massachusetts,9792580608,72518967,73562661,98.58%,31.02,SHORT,5119,3085847,2338172,Biotechnology,Merger/Acquisition; Going Dark; Asset Disposition; Partnership; Regulation S Offering; Unregistered Equity Sales,Float too large: 72.5M exceeds 25M limit (8-K),1784120598000 | |
| 1981519,MMA,MIXED MARTIAL ARTS GROUP LTD,0.4784,Australia,Australia,12669725,10574203,26483541,39.93%,10.91,LONG,13,42673,969383,Diversified Consumer Services,Press Release,"Location not whitelisted (Brisbane, Australia, Australia)",1784120698000 | |
| 1168455,PLBC,PLUMAS BANCORP,58.32,Canada,Nevada,406381696,6397655,6968136,91.81%,113.33,LONG,N/A,87062,56454,Banking,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784120757000 | |
| 1780652,CAN,Canaan Inc.,0.29,Cayman Islands,Singapore,216004800,555050424,724069203,76.66%,53.31,SHORT,221829,3174941,10411475,Technology,Bid Price Delisting; Unregistered Equity Sales,Float too large: 555.1M exceeds 50M limit (6-K),1784121100000 | |
| 1131399,GSK,GSK plc,51.25,UK,United Kingdom,102643384320,1946202600,2002797682,97.17%,507.89,LONG,2228,3315365,3831937,Pharmaceuticals,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1784121108000 | |
| 1912966,RGNT,REGENTIS BIOMATERIALS LTD.,2.54,Israel,Israel,17840760,2371812,7023921,33.77%,0.43,LONG,1984210,253711,5460093,N/A,Clinical Success; FDA Approved; Unregistered Equity Sales,"Alert sent: [LONG] Clinical Success, FDA Approved, Unregistered Equity Sales (Bonus: Israel (via Tel Aviv, Israel) 1.3x + Filing Time 1.2x)",1784121301000 | |
| 1979414,NTHI,"NEONC TECHNOLOGIES HOLDINGS, INC.",3.68,Delaware,Canada,95429264,4409012,25931865,17.00%,46.29,LONG,4835,169983,95247,Pharmaceuticals,Clinical Success; Clinical Milestone; FDA Approved; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [LONG] Clinical Success, Clinical Milestone, FDA Approved, Unregistered Equity Sales, Regulation S Offering (Bonus: Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784121328000 | |
| 1826836,AYA,Aya Gold & Silver Inc.,20.04,Canada,Canada,2872729088,137096069,143349749,95.64%,312.15,LONG,17130,444559,439200,Metals & Mining,Commercial Inflection; Unregistered Equity Sales,Float too large: 137.1M exceeds 50M limit (6-K),1784121524000 | |
| 1844450,ELVA,Electrovaya Inc.,7.89,Canada,Canada,390614016,13880345,49507480,28.04%,33.58,SHORT,19140,492117,413413,Electrical Equipment,Convertible Debt; Credit Default; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [SHORT] Convertible Debt, Credit Default, Unregistered Equity Sales, Related-Party Transaction (Bonus: Filing Time 1.2x)",1784122003000 | |
| 2014254,KBSX,FST Corp.,0.8399,Cayman Islands,Taiwan,37598968,34451915,44766003,76.96%,174.54,N/A,81938,7425,197388,N/A,Asset Disposition; Unregistered Equity Sales,F/AV 174.54x above 65x (overextended blowoff/meme volume),1784122158000 | |
| 1801834,PRFX,PRF Technologies Ltd.,1.2101,Israel,Israel,3680918,N/A,3041830,N/A,N/A,LONG,321483,150676,2596331,Pharmaceuticals,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784122474000 | |
| 1904501,ZTEK,Zentek Ltd.,0.4807,Canada,Canada,60866008,N/A,126619532,N/A,N/A,LONG,16470,1784,204155,Health Care,Unregistered Equity Sales,"Volume 1,784 below 2k minimum",1784122513000 | |
| 1783036,NCEL,NewcelX Ltd.,3.965,Switzerland,Switzerland,21347048,N/A,5383871,N/A,N/A,LONG,8261,1736,59070,Biotechnology,Clinical Success; Accounting Restatement; Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (Geneva, Switzerland, Switzerland)",1784122892000 | |
| 1135951,RDY,DR REDDYS LABORATORIES LTD,12.925,United States,India,10762779648,N/A,832710225,N/A,N/A,N/A,90674,33689,2670359,N/A,Regulatory Breach; Regulation S Offering; Unregistered Equity Sales,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784123142000 | |
| 80661,PGR,PROGRESSIVE CORP/OH/,207.22,Ohio,Ohio,120643485696,N/A,582200000,N/A,N/A,LONG,N/A,753449,3130090,Insurance,Unregistered Equity Sales,"Location not whitelisted (Ohio, Ohio)",1784123455000 | |
| 1810997,XPEV,XPENG INC.,14.055,Cayman Islands,China,13444923392,1255122,782239490,0.16%,0.17,LONG,290598,3101206,7223006,Automobiles,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784125920000 | |
| 1347242,LIPO,LIPELLA PHARMACEUTICALS INC.,0.069,Delaware,Pennsylvania,318837,N/A,4620837,N/A,N/A,LONG,N/A,10000,38391,Biotechnology,Merger/Acquisition; Clinical Milestone; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,Price too low: $0.0690 below $0.2 minimum,1784126288000 | |
| 2081628,Unknown,Rithm Perpetual Life Residential Trust,N/A,Maryland,Maryland,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (Maryland, Maryland)",1784126381000 | |
| 1023512,DRD,DRDGOLD LTD,20.93,Unknown,South Africa,1815463424,N/A,86739770,N/A,N/A,LONG,3345,115113,311173,Metals & Mining,Press Release,"Location not whitelisted (Unknown, South Africa)",1784127033000 | |
| 1023512,DRD,DRDGOLD LTD,20.95,Unknown,South Africa,1817198208,N/A,86739770,N/A,N/A,LONG,3345,120835,311173,Metals & Mining,Press Release,"Location not whitelisted (Unknown, South Africa)",1784127481000 | |
| 1943421,RUBI,Rubico Inc.,3.7299,Greece,Greece,2256634,N/A,605012,N/A,N/A,LONG,646086,1015131,453419,Energy,Unregistered Equity Sales,"Location not whitelisted (Athens, Greece, Greece)",1784127718000 | |
| 788611,NTRP,"NextTrip, Inc.",2.02,Nevada,New Mexico,29377806,N/A,14543468,N/A,N/A,LONG,919,3951,54431,Technology,Merger/Acquisition; Regulation S Offering; Unregistered Equity Sales,No Float Data,1784128252000 | |
| 908315,WINA,WINMARK CORP,362.61,Minnesota,Minnesota,1297299200,72900500,3577671,2037.7%,1560.40,LONG,1256,16626,46719,Retail,Unregistered Equity Sales,"Location not whitelisted (Minnesota, Minnesota)",1784129395000 | |
| 1994754,Unknown,BMO 2023-5C2 Mortgage Trust,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Credit Default; Asset Disposition,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784130363000 | |
| 1031203,GPI,GROUP 1 AUTOMOTIVE INC,313.23,Delaware,Texas,3726871040,N/A,11898193,N/A,N/A,LONG,2389,49432,183367,Retail,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784130985000 | |
| 4962,AXP,AMERICAN EXPRESS CO,362.38,New York,New York,247261462528,N/A,682326443,N/A,N/A,LONG,3548,845247,3236514,Financial Services,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784131229000 | |
| 2006440,Unknown,Not Applicable,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784131355000 | |
| 1992084,Unknown,Not Applicable,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784131419000 | |
| 2002215,Unknown,Not Applicable,N/A,North Carolina,North Carolina,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (North Carolina, North Carolina)",1784132703000 | |
| 1991524,Unknown,Not Applicable,N/A,Delaware,North Carolina,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784133017000 | |
| 1996001,Unknown,Not Applicable,N/A,North Carolina,North Carolina,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (North Carolina, North Carolina)",1784133473000 | |
| 1998392,Unknown,BBCMS Mortgage Trust 2023-5C23,N/A,Unknown,New York,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Credit Default; Asset Disposition; Related-Party Transaction,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784134205000 | |
| 2012265,Unknown,Not Applicable,N/A,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784134414000 | |
| 887028,RTNTF,RIO TINTO LTD,109.99,Australia,Australia,178871468032,N/A,371750238,N/A,N/A,LONG,N/A,300,119,Metals & Mining,Partnership; Unregistered Equity Sales,"Location not whitelisted (Brisbane, Australia, Brisbane, Australia)",1784134666000 | |
| 863064,RIO,RIO TINTO PLC,92.63,UK,UK,150639738880,N/A,1254502027,N/A,N/A,LONG,47665,1322229,2641490,Metals & Mining,Partnership; Unregistered Equity Sales,"Location not whitelisted (London, UK, London, UK)",1784134666000 | |
| 1160106,LYG,Lloyds Banking Group plc,6.045,UK,UK,87828193280,7000000,14529063782,0.05%,0.32,LONG,2087493,10805370,21597334,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1784136286000 | |
| 1581178,EPRX,EUPRAXIA PHARMACEUTICALS INC.,6.435,Canada,Canada,420378912,N/A,65326947,N/A,N/A,SHORT,247904,31063,296514,Biotechnology,Executive Departure,"Insufficient core signal categories (need 2+, found 0)",1784136360000 | |
| 1477960,LMED,LataMed AI Corp.,0.986,Nevada,Venezuela,55348908,N/A,56134795,N/A,N/A,LONG,31818,78300,743731,N/A,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784137270000 | |
| 1648416,RACE,Ferrari N.V.,376.41,Spain,Italy,66206199808,N/A,175888530,N/A,N/A,LONG,193966,158788,609152,Automobiles,Press Release,"Location not whitelisted (Madrid, Spain, Milan, Italy)",1784137361000 | |
| 713676,PNC,"PNC FINANCIAL SERVICES GROUP, INC.",254.635,Pennsylvania,Pennsylvania,102252412928,N/A,401564632,N/A,N/A,LONG,95,1285473,2058131,Banking,Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (Pennsylvania, Pennsylvania)",1784137426000 | |
| 1009001,CCJ,CAMECO CORP,91.04,Unknown,Canada (Federal Level),39650922496,N/A,435532978,N/A,N/A,LONG,12705,1875750,3275706,Energy,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784137830000 | |
| 706863,UNB,UNION BANKSHARES INC,24.735,Vermont,Vermont,114128576,N/A,4614052,N/A,N/A,LONG,5342,518,18867,Banking,Press Release,"Location not whitelisted (Vermont, Vermont)",1784138353000 | |
| 1321766,Unknown,SLM Student Loan Trust 2004-1,N/A,Unknown,Virginia,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (Unknown, Virginia)",1784138558000 | |
| 1697851,REKR,"Rekor Systems, Inc.",0.6812,Delaware,Maryland,93738648,N/A,137608115,N/A,N/A,LONG,165867,3838968,3118101,Technology,Commercial Inflection; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784139208000 | |
| 1321783,Unknown,SLM Student Loan Trust 2004-2,N/A,Unknown,Virginia,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (Unknown, Virginia)",1784139328000 | |
| 1976927,Unknown,"Invesco Commercial Real Estate Finance Trust, Inc.",N/A,Maryland,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784140466000 | |
| 1376986,TVE,Tennessee Valley Authority,23.63,Unknown,Tennessee,N/A,N/A,525000,N/A,N/A,SHORT,308,8386,9208,N/A,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,"Location not whitelisted (Unknown, Tennessee)",1784141075000 | |
| 1283337,KTN,STRUCTURED PRODUCTS CORP CRED ENHANCE CORTS TR FOR AON CAP A,25.31,Delaware,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,2190,1334,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784141602000 | |
| 2138743,Unknown,GM Financial Consumer Automobile Receivables Trust 2026-3,N/A,Unknown,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Asset Disposition; Unregistered Equity Sales,No Price Data,1784142104000 | |
| 1347185,Unknown,AFS SENSUB CORP.,N/A,Unknown,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Asset Disposition; Unregistered Equity Sales,No Price Data,1784142104000 | |
| 1692951,Unknown,"Cottonwood Communities, Inc.",N/A,Maryland,Utah,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Unregistered Equity Sales,"Location not whitelisted (Maryland, Utah)",1784143859000 | |
| 1471727,SRXH,SRX Global Inc.,2.2499,Delaware,Florida,43913176,4793382,19517834,24.56%,1.30,LONG,11775591,3584826,3686717,Retail,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784144714000 | |
| 1468522,FER,Ferrovial N.V.,64.05,Spain,Netherlands,45836505088,458825335,715636287,64.11%,290.63,LONG,644356,551202,1578724,Construction,Press Release,"Location not whitelisted (Madrid, Spain, Netherlands)",1784144779000 | |
| 1131383,STN,STANTEC INC,68.7,Unknown,Canada,7836402176,113686472,114066995,99.67%,258.15,SHORT,4678,282928,440381,Construction,Credit Default,Float too large: 113.7M exceeds 25M limit (6-K),1784145603000 | |
| 1747068,MCBS,"MetroCity Bankshares, Inc.",35.83,Georgia,Georgia,1026889344,21906303,28660042,76.43%,252.93,LONG,N/A,69319,86611,Banking,Press Release,"Location not whitelisted (Georgia, Georgia)",1784145619000 | |
| 1611746,SPRC,SciSparc Ltd.,4.9,Israel,Israel,2808890,57798,573243,10.08%,0.05,N/A,234456,128495,1110195,N/A,Press Release,F/AV 0.05x below absolute minimum (untradeable liquidity),1784145689000 | |
| 1828102,KARO,Karooooo Ltd.,58.58,Singapore,Singapore,1809729536,20331894,30893300,65.81%,192.82,LONG,44,297846,105445,Technology,Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (Singapore, Singapore)",1784145670000 | |
| 1837607,AEON,"AEON Biopharma, Inc.",0.2937,Delaware,Canada,7726428,17851599,26307211,67.86%,16.39,SHORT,5979,2009005,1089419,N/A,Merger/Acquisition; Clinical Success; Convertible Debt; Regulatory Breach; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Alert sent: [SHORT] Merger/Acquisition, Clinical Success, Convertible Debt, Regulatory Breach, Partnership, Unregistered Equity Sales, Regulation S Offering, Related-Party Transaction (Bonus: Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784145681000 | |
| 1544206,CGBD,"Carlyle Secured Lending, Inc.",10.6,Maryland,New York,736669568,68969061,69497128,99.24%,114.01,LONG,137104,621681,604944,Financial Services,Unregistered Equity Sales,Float too large: 69.0M exceeds 20M limit (8-K),1784145675000 | |
| 1295947,PBH,Prestige Consumer Healthcare Inc.,48.32,Unknown,New York,2289023232,46702499,47372166,98.59%,67.15,SHORT,8310,307353,695532,Pharmaceuticals,Merger/Acquisition; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 46.7M exceeds 20M limit (8-K),1784145795000 | |
| 2104204,ALMR,"Alamar Biosciences, Inc.",26.13,Delaware,Canada,1811101184,5623561,69311186,8.11%,14.04,LONG,12440,209959,400456,Life Sciences Tools & Services,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784145862000 | |
| 1517767,CCIF,Carlyle Credit Income Fund,2.84,Delaware,New York,60204084,21070179,21198622,99.39%,183.18,LONG,4890,146624,115024,N/A,Press Release,Float too large: 21.1M exceeds 20M limit (8-K),1784145862000 | |
| 1932737,AIIO,ROBO.AI INC.,4.54,Cayman Islands,United Arab Emirates,760769536,12485686,158752877,7.86%,0.92,N/A,1388822,2771638,13621813,N/A,Convertible Debt; Credit Default; Asset Disposition; Unregistered Equity Sales,SHORT signal but S/O 7.86% < 10% minimum (unborrowable),1784145915000 | |
| 1755058,AUC,Dr. Kamran Khan Title: Chief Executive Officer 2,8.3,Hong Kong,Canada,85601000,10019395,10313373,97.15%,1660.49,LONG,2,8416,6034,Professional Services,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784145914000 | |
| 1652958,EDGM,"Edgemode, Inc.",0.0014,Nevada,Florida,4964413,365706405,3546009459,10.31%,22.25,SHORT,N/A,57606918,16436510,N/A,Credit Default; Regulation S Offering; Unregistered Equity Sales,Price too low: $0.0014 below $0.2 minimum,1784145914000 | |
| 1074902,LCNB,LCNB CORP,17.895,Ohio,Ohio,254932304,14070417,14246007,98.77%,524.06,LONG,3,28445,26849,Banking,Unregistered Equity Sales,"Location not whitelisted (Ohio, Ohio)",1784146010000 | |
| 916076,MLM,MARTIN MARIETTA MATERIALS INC,569.36,North Carolina,North Carolina,34187732992,59586608,60045900,99.24%,103.10,SHORT,131,317214,577940,Construction,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,"Location not whitelisted (North Carolina, North Carolina)",1784146153000 | |
| 2030522,MWYN,"Marwynn Holdings, Inc.",0.99,Nevada,Canada,19992856,4440852,20194804,21.99%,3.49,SHORT,91979,71640,1270665,Trading Companies & Distributors,Bid Price Delisting; Regulation S Offering; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784146194000 | |
| 1701478,AZTR,"Azitra, Inc.",0.1367,Delaware,Connecticut,2213506,10194733,16192438,62.96%,0.87,LONG,345167,6311133,11671127,Biotechnology,Clinical Success,Price too low: $0.1367 below $0.2 minimum,1784146242000 | |
| 1330979,Unknown,SLM Student Loan Trust 2005-5,N/A,Unknown,Virginia,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Credit Default; Asset Disposition; Unregistered Equity Sales; Related-Party Transaction,"Location not whitelisted (Unknown, Virginia)",1784146284000 | |
| 926617,AWHL,Aspira Women's Health Inc.,0.3605,Delaware,Texas,16871548,N/A,46800411,N/A,N/A,N/A,N/A,1,49136,N/A,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784146356000 | |
| 96223,JEF,Jefferies Financial Group Inc.,57.15,New York,New York,11623853056,154978900,194145000,79.83%,70.24,LONG,N/A,1373808,2206454,Financial Services,Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales,Float too large: 155.0M exceeds 20M limit (8-K),1784146350000 | |
| 2057463,GLIBA,Liberty Capital Corp/NV,21.97,Nevada,Colorado,876712640,36737336,3650938,1006.2%,372.03,LONG,N/A,89722,98747,Telecommunication,Unregistered Equity Sales,Float too large: 36.7M exceeds 20M limit (8-K),1784146333000 | |
| 880117,JBSS,SANFILIPPO JOHN B & SON INC,83.26,Delaware,Israel,973274048,11435198,9092149,125.8%,94.74,LONG,N/A,99869,120703,Food Products,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784146447000 | |
| 1481241,PSHG,Performance Shipping Inc.,1.71,Greece,Greece,21258990,11397554,12432158,91.68%,208.33,LONG,35080,38668,54709,Marine,Unregistered Equity Sales,"Location not whitelisted (Athens, Greece, Greece)",1784146533000 | |
| 1173643,TRX,TRX GOLD Corp,0.7469,Canada,Canada,243252544,317723175,325682864,97.56%,122.95,LONG,54590,2030380,2584178,Metals & Mining,Unregistered Equity Sales,Float too large: 317.7M exceeds 25M limit (6-K),1784146522000 | |
| 1341766,CELH,"Celsius Holdings, Inc.",30.21,Nevada,Florida,7722894848,195879313,255640360,76.62%,20.96,SHORT,106330,5532630,9346511,Beverages,Merger/Acquisition; Bankruptcy Filing; Credit Default; Regulatory Breach; Asset Disposition; Partnership; Licensing Deal; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 195.9M exceeds 20M limit (8-K),1784146524000 | |
| 2079272,LABT,Lakewood-Amedex Biotherapeutics Inc.,2.43,Nevada,Florida,4254096,468918,1750657,26.79%,1.60,LONG,106442,966670,292271,Biotechnology,Clinical Success; Clinical Milestone; Unregistered Equity Sales,"Alert sent: [LONG] Clinical Success, Clinical Milestone, Unregistered Equity Sales (Bonus: Florida (via Nevada) 1.3x + Filing Time 1.2x)",1784146521000 | |
| 1690012,ICR-PA,"InPoint Commercial Real Estate Income, Inc.",N/A,Maryland,Israel,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784146517000 | |
| 1831915,CTKB,"Cytek Biosciences, Inc.",4.65,Delaware,Canada,600513024,118259602,129142587,91.57%,84.83,LONG,8307,557942,1394014,Life Sciences Tools & Services,Press Release,Float too large: 118.3M exceeds 20M limit (8-K),1784146511000 | |
| 1780312,ASTS,"AST SpaceMobile, Inc.",66.31,Delaware,Texas,25736540160,265964942,298746383,89.03%,11.88,LONG,867408,9546340,22380929,Telecommunication,Convertible Debt; Partnership; Unregistered Equity Sales; Regulation S Offering,Float too large: 266.0M exceeds 20M limit (8-K),1784146713000 | |
| 2024114,TGHL,GrowHub Ltd,0.8145,Cayman Islands,Singapore,20606696,20000000,14866470,134.5%,6.73,SHORT,1625699,71377747,2971914,Technology,Convertible Debt; Credit Default; Accounting Restatement; Bid Price Delisting; Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,"Alert sent: [SHORT] Convertible Debt, Credit Default, Accounting Restatement, Bid Price Delisting, Asset Disposition, Partnership, Regulation S Offering, Related-Party Transaction, Unregistered Equity Sales (Bonus: Singapore (via Cayman Islands) 1.3x + Filing Time 1.2x)",1784146810000 | |
| 1437071,IVR,Invesco Mortgage Capital Inc.,8.14,Maryland,Georgia,799348032,71385537,98200000,72.69%,28.28,LONG,117104,2331830,2524416,Real Estate,Unregistered Equity Sales,"Location not whitelisted (Maryland, Georgia)",1784146791000 | |
| 8177,AAME,ATLANTIC AMERICAN CORP,1.63,Georgia,Georgia,33247482,4033552,20397228,19.78%,319.31,LONG,1,18798,12632,Insurance,Press Release,"Location not whitelisted (Georgia, Georgia)",1784146951000 | |
| 1403161,V,VISA INC.,355.14,Delaware,Canada,675385311232,1655590599,1659709932,99.75%,198.03,SHORT,37285,8846866,8360326,Financial Services,Regulatory Breach; Asset Disposition; Unregistered Equity Sales,Float too large: 1655.6M exceeds 20M limit (8-K),1784147004000 | |
| 1137774,PRU,PRUDENTIAL FINANCIAL INC,115.04,New Jersey,New Jersey,39956283392,345910420,347325107,99.59%,169.17,LONG,N/A,1179135,2044726,Insurance,Asset Disposition; Unregistered Equity Sales,"Location not whitelisted (New Jersey, New Jersey)",1784147002000 | |
| 36377,FHB,"FIRST HAWAIIAN, INC.",28.75,Delaware,Hawaii,3498318080,50000000,121680634,41.09%,25.40,LONG,2149,2720991,1968306,Banking,Merger/Acquisition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,Float too large: 50.0M exceeds 20M limit (8-K),1784146991000 | |
| 1739445,ACA,"Arcosa, Inc.",144.85,Delaware,Texas,7113121280,48099217,48815089,98.53%,85.49,LONG,1319,1074304,562647,Construction,Press Release,Float too large: 48.1M exceeds 20M limit (8-K),1784147130000 | |
| 728535,JBHT,HUNT J B TRANSPORT SERVICES INC,276.28,Arkansas,Arkansas,26052982784,73624103,94299203,78.08%,74.52,LONG,1304,1380680,987975,Road & Rail,Stock Buyback,"Location not whitelisted (Arkansas, Arkansas)",1784147182000 | |
| 1994214,NOMA,Nomadar Corp.,2.87,Delaware,Texas,49884708,4387939,14881433,29.49%,455.32,N/A,5393,7493,9637,N/A,Merger/Acquisition; Regulation S Offering; Unregistered Equity Sales,F/AV 455.32x exceeds max threshold of 200x,1784147311000 | |
| 1095052,PLG,PLATINUM GROUP METALS LTD,1.3,Canada,Canada,164873632,14844543,126825879,11.70%,11.12,LONG,14393,429356,1334916,Metals & Mining,Partnership; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Insufficient core signal categories (need 2+, found 1)",1784147432000 | |
| 1837821,ZJYL,Erqi Wang Title: CEO Indemnitee Signature: Name: Ning Xue 7,1.94,Cayman Islands,China,15185123,1831110,6827383,26.82%,6.36,LONG,32616,4760,287993,Health Care,Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784147413000 | |
| 1495240,LAND,GLADSTONE LAND Corp,8.66,Maryland,Virginia,373562720,41746281,43136573,96.78%,66.00,LONG,4529,430588,632491,Real Estate,Stock Buyback,"Location not whitelisted (Maryland, Virginia)",1784147422000 | |
| 29002,DIOD,DIODES INC /DEL/,96.92,Delaware,Texas,4452963840,45037785,45944734,98.03%,65.24,LONG,N/A,298524,690309,Semiconductors,Unregistered Equity Sales,Float too large: 45.0M exceeds 20M limit (8-K),1784147414000 | |
| 1914496,Unknown,"Sculptor Diversified Real Estate Income Trust, Inc.",N/A,Maryland,New York,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Partnership,"Insufficient core signal categories (need 2+, found 0)",1784147591000 | |
| 1331696,Unknown,SLM Student Loan Trust 2005-7,N/A,Unknown,Virginia,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Credit Default; Asset Disposition; Unregistered Equity Sales; Related-Party Transaction,"Location not whitelisted (Unknown, Virginia)",1784147652000 | |
| 1766600,SNDL,SNDL Inc.,1.29,Canada,Canada (Federal Level),335786976,225820662,260300000,86.75%,96.20,LONG,5640,913384,2347403,Pharmaceuticals,Press Release,Float too large: 225.8M exceeds 25M limit (6-K),1784147708000 | |
| 2027360,RCT,RedCloud Holdings plc,0.251,UK,UK,14899867,4488244,59362026,7.56%,0.63,LONG,8665,850567,7120013,Distributors,Partnership; Licensing Deal,"Location not whitelisted (London, UK, London, UK)",1784147840000 | |
| 49938,IMO,IMPERIAL OIL LTD,120.42,Unknown,Canada,59877396480,146970683,483592715,30.39%,256.12,LONG,53359,375363,573839,Energy,Unregistered Equity Sales,Float too large: 147.0M exceeds 20M limit (8-K),1784147930000 | |
| 1004989,SGRP,"SPAR Group, Inc.",0.832,Delaware,North Carolina,23627602,28398560,28398560,100.0%,371.52,LONG,11188,92255,76439,Media,Commercial Inflection; Unregistered Equity Sales,Float too large: 28.4M exceeds 20M limit (8-K),1784147977000 | |
| 2086771,ELE,Elemental Royalty Corp,15.74,Canada,Colorado,1013388928,28391767,64383030,44.10%,72.16,LONG,211843,288487,393442,Metals & Mining,Press Release,Float too large: 28.4M exceeds 25M limit (6-K),1784148013000 | |
| 1173643,TRX,TRX GOLD Corp,0.7469,Canada,Canada,243252544,317723175,325682864,97.56%,122.95,LONG,54590,2030380,2584178,Metals & Mining,Contingent Value Rights; Unregistered Equity Sales,Float too large: 317.7M exceeds 25M limit (6-K),1784148265000 | |
| 1784930,MAKO,Mako Mining Corp.,7.24,Canada,Canada,633968000,84940335,87564647,97.00%,484.54,LONG,3540,95237,175300,Metals & Mining,Unregistered Equity Sales,Float too large: 84.9M exceeds 25M limit (6-K),1784148325000 | |
| 1529864,ENVA,"Enova International, Inc.",235.66,Delaware,Israel,5864374784,23793693,24884896,95.61%,74.19,LONG,180,316461,320731,Financial Services,Press Release,Float too large: 23.8M exceeds 20M limit (8-K),1784148328000 | |
| 1341235,ALDX,"Aldeyra Therapeutics, Inc.",1.92,Delaware,Massachusetts,115816448,52675373,60321068,87.33%,38.26,LONG,33199,849358,1376627,Biotechnology,Press Release,Float too large: 52.7M exceeds 20M limit (8-K),1784148388000 | |
| 1951294,VSME,VS MEDIA Holdings Ltd,1.37,Hong Kong,Hong Kong,3807717,2712257,2765070,98.09%,0.40,N/A,544318,37898,6844281,N/A,Convertible Debt; Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,S/O 98.09% very high - needs extreme catalyst to be tradeable,1784148439000 | |
| 1653384,RWAY,Runway Growth Finance Corp.,5.62,Maryland,Israel,238650736,35598819,42464546,83.83%,53.34,SHORT,43523,768251,667429,Financial Services,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Related-Party Transaction; Unregistered Equity Sales,Float too large: 35.6M exceeds 20M limit (8-K),1784148560000 | |
| 1794776,PSBD,Palmer Square Capital BDC Inc.,10.25,Maryland,Kansas,318988352,12837676,31120814,41.25%,86.81,SHORT,33407,176368,147890,Financial Services,Merger/Acquisition; Credit Default; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Location not whitelisted (Maryland, Kansas)",1784148752000 | |
| 2071778,FRMI,Fermi Inc.,6.25,Texas,Texas,3988020736,603383437,638083359,94.56%,30.24,SHORT,579871,15441063,19950778,Real Estate,Merger/Acquisition; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 603.4M exceeds 20M limit (8-K),1784148872000 | |
| 1612042,ASND,Ascendis Pharma A/S,268.57,Denmark,Denmark,17616267264,1539503,65592830,2.35%,1.99,LONG,79,434929,773139,Biotechnology,Convertible Debt; Contingent Value Rights; Unregistered Equity Sales,"Location not whitelisted (Copenhagen, Denmark, Denmark)",1784149028000 | |
| 1253689,CBIO,"CRESCENT BIOPHARMA, INC.",15.67,Cayman Islands,Massachusetts,432097504,8094793,27571935,29.36%,26.01,SHORT,558,2187821,311240,Biotechnology,Credit Default; Partnership; Licensing Deal; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [SHORT] Credit Default, Partnership, Licensing Deal, Unregistered Equity Sales, Regulation S Offering (Bonus: Massachusetts (via Cayman Islands) 1.3x + Filing Time 1.2x)",1784149081000 | |
| 1854640,CGAU,Centerra Gold Inc.,15.71,Canada,Canada,3119928320,198116441,198595055,99.76%,123.72,LONG,2843,1547338,1601336,Metals & Mining,Press Release,Float too large: 198.1M exceeds 25M limit (6-K),1784149203000 | |
| 1769624,ILLR,Triller Group Inc.,1.28,Delaware,Canada,22645888,17902845,17692101,101.2%,3.02,N/A,532546,1526128,5923891,N/A,Regulation S Offering; Unregistered Equity Sales,F/AV 3.02x below the preferred 5x threshold for general alerts,1784149214000 | |
| 2125567,SAMO,Samos Energy Acquisition Corp,N/A,Cayman Islands,Cayman Islands,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Convertible Debt; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,No Price Data,1784149698000 | |
| 1124105,GYRE,"GYRE THERAPEUTICS, INC.",6.56,Delaware,Canada,731366848,57821355,111488849,51.86%,605.42,LONG,25382,40440,95506,Biotechnology,Contingent Value Rights; Asset Disposition; Licensing Deal; Related-Party Transaction; Unregistered Equity Sales,Float too large: 57.8M exceeds 20M limit (8-K),1784149748000 | |
| 1514597,FURY,FURY GOLD MINES LTD,0.531,Canada,Canada,100960200,175985608,190132195,92.56%,635.45,LONG,386,97304,276947,Metals & Mining,Press Release,Float too large: 176.0M exceeds 25M limit (6-K),1784149803000 | |
| 1615219,DCOY,Decoy Therapeutics Inc.,6.18,Delaware,Texas,3287562,528856,531968,99.42%,2.27,LONG,2630,12958,232608,Biotechnology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784150058000 | |
| 944695,THG,"HANOVER INSURANCE GROUP, INC.",206.9,Delaware,Massachusetts,7238766080,34642867,34986787,99.02%,112.48,LONG,23895,415336,307988,Insurance,Press Release,Float too large: 34.6M exceeds 20M limit (8-K),1784150035000 | |
| 1716621,VTAK,"Catheter Precision, Inc.",0.58,Delaware,South Carolina,2093493,10000000,3609471,277.0%,1.40,N/A,22913,53048155,7142924,N/A,Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction,S/O 277.05% very high - needs extreme catalyst to be tradeable,1784150100000 | |
| 1965143,NVNI,Nvni Group Ltd,1.61,Cayman Islands,Cayman Islands,18824334,7362324,11692133,62.97%,13.81,LONG,316290,352557,533196,Technology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784150195000 | |
| 1661998,QTTB,Q32 Bio Inc.,15.7,Delaware,Massachusetts,266215728,6027399,16956415,35.55%,4.56,N/A,5907,7046838,1321432,N/A,Merger/Acquisition; Credit Default; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,F/AV 4.56x below the preferred 5x threshold for general alerts,1784150339000 | |
| 1848309,SGML,Sigma Lithium Corp,11.29,Canada,Brazil,1265209856,59866847,112064646,53.42%,19.73,LONG,122173,1484659,3033693,Metals & Mining,Clinical Success; Unregistered Equity Sales,Float too large: 59.9M exceeds 25M limit (6-K),1784150395000 | |
| 3453,MATX,"Matson, Inc.",208.9,Hawaii,Hawaii,6321998848,29505446,30263281,97.50%,109.05,LONG,2747,282071,270577,Marine,Stock Buyback; Partnership; Unregistered Equity Sales,"Location not whitelisted (Hawaii, Hawaii)",1784150431000 | |
| 1848309,SGML,Sigma Lithium Corp,11.29,Canada,Brazil,1265209856,81553499,112064646,72.77%,26.88,LONG,122173,1484659,3033693,Metals & Mining,Press Release,Float too large: 81.6M exceeds 25M limit (6-K),1784150473000 | |
| 1679273,LW,"Lamb Weston Holdings, Inc.",45.55,Delaware,Idaho,6289216000,1538000,138072803,1.11%,1.02,LONG,20971,1046471,1504583,Food Products,Asset Disposition; Partnership; Unregistered Equity Sales,"Alert sent: [LONG] Asset Disposition, Partnership, Unregistered Equity Sales (Bonus: Idaho (via Wilmington, Delaware) 1.3x + Filing Time 1.15x)",1784150649000 | |
| 1519449,SKWD,"Skyward Specialty Insurance Group, Inc.",56.87,Delaware,Texas,2305683968,36729584,40543065,90.59%,73.12,LONG,N/A,664649,502331,Insurance,Stock Buyback,Float too large: 36.7M exceeds 20M limit (8-K),1784150813000 | |
| 1799207,AUNA,AUNA S.A.,5.05,Unknown,Luxembourg,373984416,56147261,30138747,186.3%,183.79,LONG,26319,73018,305503,Health Care,Press Release,"Location not whitelisted (Unknown, Luxembourg)",1784150850000 | |
| 1034054,SBAC,SBA COMMUNICATIONS CORP,187.09,Florida,Florida,19843330048,105268605,106063017,99.25%,108.47,SHORT,96752,472164,970457,Real Estate,Merger/Acquisition; Credit Default; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,"Location not whitelisted (Florida, Florida)",1784150992000 | |
| 1640147,SNOW,Snowflake Inc.,271.87,Delaware,Canada,94230142976,1000000,346600000,0.29%,0.12,LONG,56126,3788577,8192035,Technology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784197336000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,15.08,Cayman Islands,United Kingdom,34725552128,3603899000,2302755593,156.5%,887.41,LONG,99516,3436895,4061124,Telecommunication,Press Release,Float too large: 3603.9M exceeds 25M limit (6-K),1784197391000 | |
| 891478,SAN,"Banco Santander, S.A.",13.82,Spain,Spain,197873467392,3899027,14317906744,0.03%,0.47,LONG,2895243,9402987,8271614,Banking,Press Release,"Location not whitelisted (Madrid, Spain, Madrid, Spain)",1784197517000 | |
| 2019435,BGL,Blue Gold Ltd,0.2422,Cayman Islands,Cayman Islands,9890908,15800300,40837773,38.69%,18.54,LONG,41968,513438,852193,Metals & Mining,Convertible Debt; Bid Price Delisting; Asset Disposition; Partnership; Unregistered Equity Sales,"Alert sent: [LONG] Convertible Debt, Bid Price Delisting, Asset Disposition, Partnership, Unregistered Equity Sales (Bonus: Filing Time 1.05x)",1784197606000 | |
| 1329099,BIDU,"Baidu, Inc.",111.48,Cayman Islands,China,37931368448,265855000,274750119,96.76%,103.72,LONG,199924,2787298,2563250,Media,Unregistered Equity Sales,Float too large: 265.9M exceeds 25M limit (6-K),1784197603000 | |
| 764401,IIIN,INSTEEL INDUSTRIES INC,29.64,North Carolina,North Carolina,576001472,18511300,19433247,95.26%,53.65,LONG,33,264477,345037,Building,Asset Disposition; Stock Buyback; PIPE,"Location not whitelisted (North Carolina, North Carolina)",1784197809000 | |
| 759944,CFG,CITIZENS FINANCIAL GROUP INC/RI,71.12,Delaware,Rhode Island,30075365376,418666000,422881942,99.00%,90.50,LONG,911,3601758,4626133,Banking,Commercial Inflection; Unregistered Equity Sales,Float too large: 418.7M exceeds 20M limit (8-K),1784197941000 | |
| 1041792,ELPC,ENERGY CO OF PARANA,11.79,Cayman Islands,Brazil,8752926720,118803492,742402648,16.00%,335.95,LONG,16669,737438,353633,Utilities,Unregistered Equity Sales,Float too large: 118.8M exceeds 25M limit (6-K),1784198367000 | |
| 1041792,ELPC,ENERGY CO OF PARANA,11.79,Unknown,Brazil,8752926720,118803492,742402648,16.00%,335.95,LONG,16669,737438,353633,Utilities,Contingent Value Rights,"Location not whitelisted (Unknown, Brazil)",1784198526000 | |
| 1626115,PJT,PJT Partners Inc.,168.56,Delaware,New York,6876928512,23987400,25824598,92.89%,55.35,SHORT,784,299945,433358,Financial Services,Executive Departure,Float too large: 24.0M exceeds 20M limit (8-K),1784199016000 | |
| 36104,USB,Not Applicable,63.01,Delaware,Minnesota,98152669184,1547550000,1557731728,99.35%,174.82,LONG,649085,6605139,8852459,Banking,Unregistered Equity Sales,Float too large: 1547.5M exceeds 20M limit (8-K),1784199575000 | |
| 897322,GILT,GILAT SATELLITE NETWORKS LTD,11.84,Unknown,Virginia,893576000,73592000,75470948,97.51%,85.09,LONG,11416,575665,864851,Communications,PIPE,"Location not whitelisted (Unknown, Virginia)",1784199622000 | |
| 840489,FCFS,"FirstCash Holdings, Inc.",215.23,Texas,Texas,9434970112,40164000,43836687,91.62%,95.27,LONG,7101,386964,421567,Financial Services,Commercial Inflection; Unregistered Equity Sales,Float too large: 40.2M exceeds 20M limit (8-K),1784199626000 | |
| 1104506,INSM,INSMED Inc,109.81,Virginia,New Jersey,23801585664,198422000,216752451,91.54%,52.32,LONG,9995,2116548,3792211,Biotechnology,Clinical Success; Clinical Milestone; Unregistered Equity Sales,"Location not whitelisted (Virginia, New Jersey)",1784199646000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,15.08,Unknown,United Kingdom,34725552128,3603899000,2302755593,156.5%,887.41,LONG,99516,3436895,4061124,Telecommunication,Press Release,"Location not whitelisted (Unknown, United Kingdom)",1784200918000 | |
| 53456,Unknown,JERSEY CENTRAL POWER & LIGHT CO,N/A,New Jersey,Ohio,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Location not whitelisted (New Jersey, Ohio)",1784201009000 | |
| 2081043,ATAI,AtaiBeckley Inc.,5.36,Delaware,New York,1973373440,50000000,368166674,13.58%,6.34,SHORT,269559,6141406,7885230,Pharmaceuticals,Merger/Acquisition; Clinical Success; Contingent Value Rights; Accounting Restatement; Asset Disposition; Unregistered Equity Sales; Regulation S Offering,Float too large: 50.0M exceeds 20M limit (8-K),1784201250000 | |
| 871763,MAN,ManpowerGroup Inc.,39.02,Wisconsin,Wisconsin,1814716544,41936600,46507342,90.17%,37.89,LONG,25040,928924,1106903,Professional Services,Commercial Inflection,"Location not whitelisted (Wisconsin, Wisconsin)",1784201419000 | |
| 93751,STT,STATE STREET CORP,186.59,Massachusetts,Massachusetts,51641962496,346815000,276767033,125.3%,151.38,LONG,3695,3168709,2290962,Financial Services,Stock Buyback; Unregistered Equity Sales,"Location not whitelisted (Massachusetts, Massachusetts)",1784201428000 | |
| 1447028,ABUS,Arbutus Biopharma Corp,4.56,Canada,Pennsylvania,900771968,121369000,197537710,61.44%,57.35,LONG,7768,1482523,2116104,Biotechnology,Merger/Acquisition; Licensing Deal; Regulation S Offering; Unregistered Equity Sales,Float too large: 121.4M exceeds 20M limit (8-K),1784201477000 | |
| 1885827,VRAX,Virax Biolabs Group Ltd,3.45,Cayman Islands,UK,2749608,529040,796988,66.38%,0.26,LONG,1108368,138248,2016933,Health Care,Bid Price Delisting,"Alert sent: [LONG] Bid Price Delisting (Bonus: London, UK (via Cayman Islands) 1.3x + Filing Time 1.05x)",1784201496000 | |
| 1800,ABT,ABBOTT LABORATORIES,89.27,Israel,Israel,155491647488,1731135000,1741813154,99.39%,129.56,LONG,333,12532549,13361666,Health Care,Press Release,Float too large: 1731.1M exceeds 20M limit (8-K),1784201779000 | |
| 1094324,SIFY,SIFY TECHNOLOGIES LTD,14.34,Unknown,India,1038712384,11746700,72434615,16.22%,162.69,LONG,12839,95168,72203,Telecommunication,Press Release,"Location not whitelisted (Unknown, India)",1784201822000 | |
| 1505065,BWAY,Brainsway Ltd.,14.89,Israel,Israel,597526912,28442600,40129409,70.88%,239.18,LONG,1088,163798,118917,Health Care,Unregistered Equity Sales,Float too large: 28.4M exceeds 25M limit (6-K),1784201856000 | |
| 1543418,TMQ,Trilogy Metals Inc.,3.14,Canada,Canada,542421312,107956921,172745639,62.49%,44.71,LONG,24480,971479,2414580,Metals & Mining,Partnership; Unregistered Equity Sales,Float too large: 108.0M exceeds 20M limit (8-K),1784201869000 | |
| 1595353,GLMD,Galmed Pharmaceuticals Ltd.,0.5135,Israel,Israel,3388922,5413835,6599654,82.03%,10.64,LONG,587108,20082,508609,Biotechnology,Clinical Success,"Insufficient core signal categories (need 2+, found 1)",1784202199000 | |
| 912562,ROCK,"GIBRALTAR INDUSTRIES, INC.",44.205,Delaware,New York,1311205248,29236489,29661919,98.57%,79.59,LONG,1173,322254,367337,Building,Asset Disposition,Float too large: 29.2M exceeds 20M limit (8-K),1784202284000 | |
| 899051,ALL,ALLSTATE CORP,239.48,Delaware,Israel,61647163392,255858385,257420930,99.39%,146.84,LONG,213,3086594,1742485,Insurance,Unregistered Equity Sales,Float too large: 255.9M exceeds 20M limit (8-K),1784202322000 | |
| 1046179,TSM,TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD,419.48,Unknown,Taiwan,2175622184960,5181832914,5186474013,99.91%,372.14,LONG,28718,16826838,13924500,Semiconductors,Partnership; Regulation S Offering; Unregistered Equity Sales,"Location not whitelisted (Unknown, Taiwan)",1784202343000 | |
| 839923,VOD,VODAFONE GROUP PUBLIC LTD CO,15.08,Unknown,United Kingdom,34725552128,2302520513,2302755593,99.99%,566.22,LONG,99516,3436895,4066454,Telecommunication,Press Release,"Location not whitelisted (Unknown, United Kingdom)",1784203041000 | |
| 1690080,FRMM,FORUM MARKETS Inc,5.98,Unknown,Florida,78996664,5294991,13210145,40.08%,4.39,SHORT,83064,273670,1206986,Biotechnology,Merger/Acquisition; Convertible Debt; Going Dark; Stock Buyback; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,"Location not whitelisted (Unknown, Florida)",1784203214000 | |
| 1746129,BSVN,Bank7 Corp.,51.8,Unknown,Oklahoma,493101600,1712645,9519335,17.99%,103.78,LONG,3,33552,16503,Banking,Unregistered Equity Sales,"Location not whitelisted (Unknown, Oklahoma)",1784203235000 | |
| 314227,TOMZ,"TOMI Environmental Solutions, Inc.",0.749,Florida,Maryland,17302248,13737262,23100465,59.47%,19.93,LONG,3767,45236,689391,Commercial Services & Supplies,Press Release,"Location not whitelisted (Florida, Maryland)",1784203421000 | |
| 1980845,ENGN,enGene Therapeutics Inc.,1.9,Canada,Canada,127279984,21518973,66989466,32.12%,11.17,SHORT,184745,808714,1927014,Biotechnology,Executive Departure; Unregistered Equity Sales,Float too large: 21.5M exceeds 20M limit (8-K),1784203607000 | |
| 1914805,BANL,CBL International Ltd,0.4158,Cayman Islands,Malaysia,11412942,4180508,14273152,29.29%,5.56,SHORT,34585,86912,751667,Energy,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1784205003000 | |
| 1846715,WAVE,Eco Wave Power Global AB (publ),8.8,Sweden,Sweden,54909044,5605300,6239664,89.83%,75.88,LONG,140,8576,73872,Utilities,Press Release,"Location not whitelisted (Stockholm, Sweden, Stockholm, Sweden)",1784205001000 | |
| 1370637,ETSY,ETSY INC,85.74,Delaware,New York,8136402944,93761810,94896231,98.80%,29.82,LONG,211486,3887692,3144257,Retail,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering,Float too large: 93.8M exceeds 20M limit (8-K),1784205037000 | |
| 1266806,VANI,"Vivani Medical, Inc.",1.41,Delaware,Canada,121591496,23462955,86235104,27.21%,47.74,LONG,1192,304073,491495,Health Care,Unregistered Equity Sales,Float too large: 23.5M exceeds 20M limit (8-K),1784205030000 | |
| 1701756,SDOT,Sadot Group Inc.,15.25,Nevada,Texas,16116246,740919,1056803,70.11%,0.22,SHORT,1124245,264373,3318902,Food Products,Merger/Acquisition; Credit Default; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [SHORT] Merger/Acquisition, Credit Default, Unregistered Equity Sales, Regulation S Offering (Bonus: Texas (via Nevada) 1.3x + Filing Time 1.15x)",1784205061000 | |
| 1802665,HRMY,"Harmony Biosciences Holdings, Inc.",34.9,Delaware,Pennsylvania,2020454528,50375969,57892676,87.02%,58.44,SHORT,67403,759875,861991,Pharmaceuticals,Asset Disposition; Executive Departure; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 50.4M exceeds 20M limit (8-K),1784205313000 | |
| 1213037,CRDF,"Cardiff Oncology, Inc.",0.8893,Delaware,Canada,60801348,8571429,68369896,12.54%,6.03,LONG,2941572,12632447,1420927,Biotechnology,Merger/Acquisition; Asset Disposition; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Asset Disposition, Unregistered Equity Sales (Bonus: Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.15x)",1784205492000 | |
| 1892492,ORBS,Eightco Holdings Inc.,0.663,Texas,Pennsylvania,257251648,132651047,388011544,34.19%,7.07,LONG,1308431,6472873,18769631,Retail,Unregistered Equity Sales,Float too large: 132.7M exceeds 20M limit (8-K),1784205918000 | |
| 1829311,BMNR,"BITMINE IMMERSION TECHNOLOGIES, INC.",15.79,Delaware,Connecticut,9524943872,529618150,603226394,87.80%,14.05,LONG,1200711,37426612,37705172,Technology,Capital Raise; Unregistered Equity Sales,Float too large: 529.6M exceeds 20M limit (8-K),1784205925000 | |
| 1041792,ELPC,ENERGY CO OF PARANA,11.79,Unknown,Brazil,8752926720,118803492,742402648,16.00%,335.24,LONG,16669,737438,354385,Utilities,Press Release,"Location not whitelisted (Unknown, Brazil)",1784206224000 | |
| 1701605,BKR,Baker Hughes Co,57.25,Delaware,Texas,56795930624,989712836,992068697,99.76%,115.29,SHORT,32352,6900843,8584865,Energy,Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,Float too large: 989.7M exceeds 20M limit (8-K),1784206472000 | |
| 1296484,TOPS,TOP SHIPS INC.,0.7601,Greece,Greece,4212223,1011768,5541670,18.26%,1.12,LONG,106533,228005,904388,Energy,Commercial Inflection,"Location not whitelisted (Athens, Greece, Greece)",1784206792000 | |
| 1168455,PLBC,PLUMAS BANCORP,60.24,Canada,Nevada,419760512,6392702,6968136,91.74%,111.72,LONG,N/A,103887,57219,Banking,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784206807000 | |
| 892553,GTLS,CHART INDUSTRIES INC,209.9,Delaware,Texas,10047718400,47607232,47869076,99.45%,37.54,SHORT,17787,1271817,1268183,Machinery,Going Dark; Asset Disposition; Partnership; Regulation S Offering; Unregistered Equity Sales,Float too large: 47.6M exceeds 20M limit (8-K),1784206920000 | |
| 1899005,BMR,Beamr Imaging Ltd.,1.4,Israel,Israel,21741796,10910188,15529854,70.25%,110.77,LONG,35228,21409,98495,Technology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784206947000 | |
| 1692819,VST,Vistra Corp.,160.23,Delaware,Texas,54026743808,314476601,337182468,93.27%,66.49,LONG,254,5499156,4729968,Utilities,Merger/Acquisition; Unregistered Equity Sales,Float too large: 314.5M exceeds 20M limit (8-K),1784206943000 | |
| 1396440,MAIN,Main Street Capital CORP,53.41,Maryland,Texas,4966587392,89238777,92989838,95.97%,128.81,LONG,340674,613500,692801,Financial Services,Unregistered Equity Sales,Float too large: 89.2M exceeds 20M limit (8-K),1784207753000 | |
| 22356,CBSH,COMMERCE BANCSHARES INC /MO/,58.16,Missouri,Missouri,8478398976,144309038,145777158,98.99%,113.56,LONG,53255,1257077,1270790,Banking,Commercial Inflection,"Location not whitelisted (Missouri, Missouri)",1784208131000 | |
| 1330399,Unknown,Federal Home Loan Bank of Pittsburgh,N/A,Pennsylvania,Pennsylvania,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Pennsylvania, Pennsylvania)",1784208234000 | |
| 2003061,STFS,Liu Xiaohua Title: Chief Executive Officer and Director 4,16.4,Unknown,China,19577926,3671476,1161276,316.2%,13.90,LONG,28506,132985,264144,Media,Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784208307000 | |
| 1680637,NRRWF,Nuran Wireless Inc.,4.4981,Canada,Canada,58856360,96400235,13084716,736.7%,541574.35,LONG,N/A,100,178,N/A,Unregistered Equity Sales,Float too large: 96.4M exceeds 25M limit (6-K),1784208352000 | |
| 1325878,Unknown,Federal Home Loan Bank of Topeka,N/A,Unknown,Kansas,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Unknown, Kansas)",1784209891000 | |
| 1331421,HLLK,"SDR Drone, Inc.",1.01,Nevada,Canada,66838788,26092991,66177020,39.43%,16493.67,LONG,N/A,1181,1582,N/A,Press Release,Float too large: 26.1M exceeds 20M limit (8-K),1784210426000 | |
| 1787518,DFNS,T3 Defense Inc.,0.0658,Delaware,New York,8311324,50000000,126311902,39.58%,3.15,SHORT,1620361,2468205,15896977,Technology,Bid Price Delisting; Regulation S Offering; Unregistered Equity Sales,Price too low: $0.0658 below $0.2 minimum,1784210727000 | |
| 1649739,BAFN,BayFirst Financial Corp.,5.7914,Florida,Florida,31084992,3324053,5367440,61.93%,74.64,LONG,38044,460,44534,Banking,Unregistered Equity Sales,"Location not whitelisted (Florida, Florida)",1784210745000 | |
| 1969863,SUGP,SU Group Holdings Ltd,0.5235,Cayman Islands,Hong Kong,2809337,4019541,3563092,112.8%,0.53,LONG,892271,47472,7653072,Commercial Services & Supplies,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784211469000 | |
| 1926293,GCDT,Green Circle Decarbonize Technology Ltd,0.57,Cayman Islands,Hong Kong,7125000,10000000,12500000,80.00%,5.50,LONG,828045,14618,1818216,N/A,Merger/Acquisition; Asset Disposition; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Asset Disposition, Unregistered Equity Sales (Bonus: Kowloon Bay, Hong Kong (via Cayman Islands) 1.3x + Filing Time 1.15x)",1784211534000 | |
| 1331465,Unknown,Federal Home Loan Bank of Atlanta,N/A,Luxembourg,Georgia,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Luxembourg City, Luxembourg, Georgia)",1784212546000 | |
| 1131399,GSK,GSK plc,52.41,UK,United Kingdom,104966627328,1946202600,2002797682,97.17%,508.33,LONG,2228,680120,3828616,Pharmaceuticals,Press Release,"Location not whitelisted (London, UK, United Kingdom)",1784213141000 | |
| 1331754,Unknown,Federal Home Loan Bank of Indianapolis,N/A,Luxembourg,Indiana,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure,"Location not whitelisted (Luxembourg City, Luxembourg, Indiana)",1784213969000 | |
| 1331757,Unknown,Federal Home Loan Bank of Dallas,N/A,Unknown,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784215917000 | |
| 1326771,Unknown,Federal Home Loan Bank of Cincinnati,N/A,Luxembourg,Ohio,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure,"Location not whitelisted (Luxembourg City, Luxembourg, Ohio)",1784221146000 | |
| 1160106,LYG,Lloyds Banking Group plc,6.055,UK,UK,87962886144,7000000,14527313782,0.05%,0.33,LONG,2087493,17187345,21520675,Banking,Press Release,"Location not whitelisted (London, UK, London, UK)",1784222079000 | |
| 1641601,RVRF,River Financial Corp,48,UK,UK,375032896,N/A,7813185,N/A,N/A,LONG,N/A,100,51,Banking,Press Release,"Location not whitelisted (Birmingham, UK, Birmingham, UK)",1784222452000 | |
| 1329842,Unknown,Federal Home Loan Bank of New York,N/A,Luxembourg,New York,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784222840000 | |
| 1892500,CMND,Clearmind Medicine Inc.,2.01,Canada,Canada,2985957,N/A,1485551,N/A,N/A,N/A,995977,1320691,2408201,N/A,Press Release,LONG signal but S/O 0.00% < 5% (no squeeze potential),1784223557000 | |
| 311094,WABC,WESTAMERICA BANCORPORATION,61.41,Canada,Canada,1442395392,23306,23487955,0.10%,0.12,LONG,487,149558,198880,Banking,Stock Buyback,"Insufficient core signal categories (need 2+, found 0)",1784224032000 | |
| 1133818,BPTH,"BIO-PATH HOLDINGS, INC.",0.0375,Wyoming,Texas,1886154,2500000,50297451,4.97%,78.44,LONG,N/A,1,31873,Biotechnology,Clinical Success; Capital Raise; Partnership; Commercial Inflection; Unregistered Equity Sales; Regulation S Offering,Price too low: $0.0375 below $0.2 minimum,1784224603000 | |
| 2141933,Unknown,John Deere Owner Trust 2026-B,N/A,Nevada,Wisconsin,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Asset Disposition; Unregistered Equity Sales; Regulation S Offering,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784224660000 | |
| 1762590,Unknown,John Deere Receivables LLC,N/A,Nevada,Wisconsin,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Merger/Acquisition; Credit Default; Asset Disposition; Unregistered Equity Sales; Regulation S Offering,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784224660000 | |
| 1391933,QNTO,"QUAINT OAK BANCORP, INC.",14.1,Pennsylvania,Pennsylvania,37270124,N/A,2643271,N/A,N/A,LONG,3290,500,996,Banking,Press Release,"Location not whitelisted (Pennsylvania, Pennsylvania)",1784226491000 | |
| 1369085,NEWP,NEW PACIFIC METALS CORP,3.8548,Canada,Canada,713407296,N/A,185069855,N/A,N/A,LONG,116542,542652,1010357,Metals & Mining,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784226681000 | |
| 2142044,Unknown,CarMax Auto Owner Trust 2026-3,N/A,Delaware,Virginia,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering,No Price Data,1784227037000 | |
| 1259380,Unknown,CARMAX AUTO FUNDING LLC,N/A,Delaware,Virginia,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering,No Price Data,1784227037000 | |
| 1316944,Unknown,Federal Home Loan Bank of San Francisco,N/A,Luxembourg,Canada,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784229578000 | |
| 1846839,STKE,SOL Strategies Inc.,1.11,Canada,Canada,42649724,18901630,38423175,49.19%,56.52,LONG,50313,105317,334421,Financial Services,Partnership,"Insufficient core signal categories (need 2+, found 0)",1784231523000 | |
| 1163321,Unknown,Michael J. Pica Title: Agent [Class A(2026-2) Terms Document],N/A,Delaware,Delaware,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Credit Default,"Insufficient core signal categories (need 2+, found 1)",1784231555000 | |
| 1162387,Unknown,Michael J. Pica Title: Agent [Class A(2026-2) Terms Document],N/A,Unknown,Virginia,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Credit Default,"Location not whitelisted (Unknown, Virginia)",1784231555000 | |
| 922869,Unknown,Michael J. Pica Title: Agent [Class A(2026-2) Terms Document],N/A,New York,Virginia,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Credit Default,"Insufficient core signal categories (need 2+, found 1)",1784231555000 | |
| 933267,IRS,IRSA INVESTMENTS & REPRESENTATIONS INC,15.18,Unknown,Argentina,1284403968,51467822,84611592,60.83%,317.94,LONG,2719,68074,161877,Real Estate,Press Release,"Location not whitelisted (Unknown, Buenos Aires, Argentina)",1784231762000 | |
| 1849635,DJT,Trump Media & Technology Group Corp.,9.63,Florida,Florida,2667065344,159578026,276953828,57.62%,35.39,LONG,118795,6461399,4509231,Media,Press Release,"Location not whitelisted (Florida, Florida)",1784232142000 | |
| 1680139,HLYK,HealthLynked Corp,2.35,Nevada,Florida,6911594,1950519,2941104,66.32%,1060.06,LONG,N/A,2611,1840,Health Care,Partnership; Regulation S Offering; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784232140000 | |
| 1084765,RGP,"RESOURCES CONNECTION, INC.",4.69,Delaware,Texas,161004624,30196778,34329344,87.96%,67.89,SHORT,25976,854140,444770,Professional Services,Merger/Acquisition; Convertible Debt; Credit Default; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 30.2M exceeds 20M limit (8-K),1784232166000 | |
| 1980210,WFF,WF Holding Ltd,2.31,Cayman Islands,Malaysia,20952338,39570758,9070276,436.3%,385.22,SHORT,3228,4412,102722,Machinery,Convertible Debt; Credit Default; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 39.6M exceeds 25M limit (6-K),1784232314000 | |
| 1939780,UCAR,U Power Ltd,1.19,Cayman Islands,China,27586196,38044,23144871,0.16%,0.01,LONG,82988,60177,2695932,Retail,Partnership; Unregistered Equity Sales,"Insufficient core signal categories (need 2+, found 1)",1784232313000 | |
| 1472326,GRO,Brazil Potash Corp.,2.205,Canada,Canada,135155280,22023969,61294915,35.93%,44.15,LONG,51038,441167,498809,Chemicals,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784232309000 | |
| 1035267,ISRG,INTUITIVE SURGICAL INC,402.33,Delaware,Canada,142490337280,352098073,354162842,99.42%,137.74,LONG,6603,4747498,2556180,Health Care,Merger/Acquisition; Partnership; Unregistered Equity Sales,Float too large: 352.1M exceeds 20M limit (8-K),1784232317000 | |
| 1665300,PHUN,"Phunware, Inc.",2.13,Unknown,Texas,43553008,19683708,20447419,96.27%,144.60,LONG,311,114425,136121,Technology,Commercial Inflection,"Insufficient core signal categories (need 2+, found 0)",1784232316000 | |
| 17313,CSWC,CAPITAL SOUTHWEST CORP,24.21,Texas,Texas,1504427008,60187643,62140726,96.86%,90.75,LONG,389275,847708,663195,Financial Services,Press Release,Float too large: 60.2M exceeds 20M limit (8-K),1784232291000 | |
| 2007919,INBX,"Inhibrx Biosciences, Inc.",89.07,Delaware,Canada,1306762496,10867769,14671186,74.08%,22.83,LONG,4349,289083,476088,Biotechnology,Merger/Acquisition; Credit Default; Unregistered Equity Sales,"Alert sent: [LONG] Merger/Acquisition, Credit Default, Unregistered Equity Sales (Bonus: Toronto, Canada (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784232373000 | |
| 1638097,ENTX,Entera Bio Ltd.,2,Israel,Israel,98580464,40271029,49290234,81.70%,37.99,LONG,17,570166,1059931,Biotechnology,Unregistered Equity Sales,Float too large: 40.3M exceeds 20M limit (8-K),1784232423000 | |
| 1538849,CAPL,CrossAmerica Partners LP,22.62,Unknown,Pennsylvania,863051008,18278977,38154331,47.91%,422.51,LONG,1145,37355,43263,Energy,Merger/Acquisition; Credit Default; Unregistered Equity Sales,"Location not whitelisted (Unknown, Pennsylvania)",1784232414000 | |
| 1604028,WMS,"ADVANCED DRAINAGE SYSTEMS, INC.",151.375,Delaware,Ohio,11594676224,71207102,76595708,92.96%,76.06,LONG,1360,345544,936136,Building,PIPE,Float too large: 71.2M exceeds 20M limit (8-K),1784232512000 | |
| 1674440,YYAI,AIRWA INC.,9.73,Delaware,Delaware,10251148,400885,1053561,38.05%,21.89,LONG,4301,23780,18313,Leisure Products,Asset Disposition; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,"Alert sent: [LONG] Asset Disposition, Partnership, Regulation S Offering, Related-Party Transaction, Unregistered Equity Sales (Bonus: Filing Time 1.2x)",1784232618000 | |
| 894405,ARCB,ARCBEST CORP /DE/,157.61,Texas,Arkansas,3508994304,21858134,22263780,98.18%,55.58,LONG,1133,347322,393267,Road & Rail,Unregistered Equity Sales,Float too large: 21.9M exceeds 20M limit (8-K),1784232612000 | |
| 2135883,Unknown,XOMA Royalty Holdings Corp,N/A,Nevada,Canada,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Contingent Value Rights,"Insufficient core signal categories (need 2+, found 1)",1784232610000 | |
| 1826892,BCAB,"BioAtla, Inc.",3.99,Delaware,Canada,6621620,1070011,1659554,64.48%,20.35,LONG,13155,23535,52590,Biotechnology,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784232747000 | |
| 1675149,AA,Alcoa Corp,46.8414,Delaware,Pennsylvania,12361069568,262807927,263891991,99.59%,49.76,LONG,3239,5526353,5281896,Metals & Mining,Partnership; Unregistered Equity Sales,Float too large: 262.8M exceeds 20M limit (8-K),1784232768000 | |
| 1615165,VERI,"Veritone, Inc.",1.03,Delaware,Canada,95743032,44144748,92954401,47.49%,15.89,LONG,50439,3329084,2777375,Technology,Press Release,Float too large: 44.1M exceeds 20M limit (8-K),1784232855000 | |
| 893538,SM,SM Energy Co,30.21,Delaware,Colorado,7242808320,237439737,239748701,99.04%,57.22,LONG,50191,1771070,4149390,Energy,Press Release,Float too large: 237.4M exceeds 20M limit (8-K),1784232915000 | |
| 1921865,ASPI,ASP Isotopes Inc.,3.945,Delaware,Texas,496689088,2000000,125903447,1.59%,0.41,LONG,494574,8063835,4900255,Chemicals,Convertible Debt; Licensing Deal; Unregistered Equity Sales; Related-Party Transaction,"Alert sent: [LONG] Convertible Debt, Licensing Deal, Unregistered Equity Sales, Related-Party Transaction (Bonus: Texas (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784232946000 | |
| 1762506,VIST,"Vista Energy, S.A.B. de C.V.",62.38,Mexico,Mexico,6951777280,87247322,111442402,78.29%,82.55,LONG,26,973047,1056929,Energy,Commercial Inflection; Unregistered Equity Sales,"Location not whitelisted (Mexico City, Mexico, Mexico)",1784233005000 | |
| 1943421,RUBI,Rubico Inc.,3.49,Greece,Greece,2111492,756645,605012,125.1%,1.61,LONG,646086,25810713,471143,Energy,Unregistered Equity Sales,"Location not whitelisted (Athens, Greece, Greece)",1784233046000 | |
| 1718512,GTES,Gates Industrial Corp plc,26.95,UK,Colorado,6845298688,249017028,253999928,98.04%,123.40,LONG,7604,1185040,2018003,Machinery,Press Release,"Location not whitelisted (London, UK, Colorado)",1784233165000 | |
| 2092446,AVAT,Avalanche Treasury Corp,0.541,Delaware,Delaware,21377510,20710516,39514805,52.41%,46.54,SHORT,295851,237888,445032,N/A,Merger/Acquisition; Credit Default; Regulation S Offering; Unregistered Equity Sales,Float too large: 20.7M exceeds 20M limit (8-K),1784233223000 | |
| 21344,KO,COCA COLA CO,84.92,Delaware,Georgia,365366804480,4273020919,4302482418,99.32%,252.22,LONG,163007,14162250,16941929,Beverages,Press Release,Float too large: 4273.0M exceeds 20M limit (8-K),1784233256000 | |
| 1345126,CODI,Compass Diversified Holdings,10.46,Delaware,Connecticut,786968256,66786470,75235966,88.77%,69.54,SHORT,1,834255,960431,Financial Services,Accounting Restatement; Regulation S Offering; Unregistered Equity Sales,Float too large: 66.8M exceeds 20M limit (8-K),1784233500000 | |
| 1345122,Unknown,Compass Group Diversified Holdings LLC,N/A,Delaware,Connecticut,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,N/A,Accounting Restatement; Regulation S Offering; Unregistered Equity Sales,SHORT signal but S/O 0.00% < 10% minimum (unborrowable),1784233500000 | |
| 845877,AGM,FEDERAL AGRICULTURAL MORTGAGE CORP,206.23,Unknown,District of Columbia,2237388800,10198167,9317917,109.4%,78.76,LONG,597,87491,129490,Financial Services,Press Release,"Location not whitelisted (Unknown, District of Columbia)",1784233625000 | |
| 1903870,AFRI,Julien Benitah Title: Chief Financial Officer,10.51,Japan,Japan,283389728,1400000,26963815,5.19%,64.65,LONG,169,15220,21655,Food Products,Unregistered Equity Sales,"Location not whitelisted (Tokyo, Japan, Tokyo, Japan)",1784233693000 | |
| 2046656,HCHL,Happy City Holdings Ltd,3.96,Unknown,Hong Kong,118183824,1211306,17844401,6.79%,2.64,LONG,648875,N/A,458827,"Hotels, Restaurants & Leisure",Press Release,Volume 0 below 2k minimum,1784233801000 | |
| 72573,MOV,MOVADO GROUP INC,39.78,New York,New Jersey,884199232,25000000,15771631,158.5%,104.22,SHORT,148,113417,239875,"Textiles, Apparel & Luxury Goods",Merger/Acquisition; Bankruptcy Filing; Credit Default; Asset Disposition; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 25.0M exceeds 20M limit (8-K),1784233829000 | |
| 2007702,HKPD,"Cellyan Biotechnology Co., Ltd",0.4305,Cayman Islands,Hong Kong,10116744,3207617,16349986,19.62%,8.58,SHORT,149328,29159,373934,Logistics & Transportation,Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1784233861000 | |
| 1769256,XHG,XChange TEC.INC,0.8502,Cayman Islands,China,43826048,19363,46604623,0.04%,0.85,N/A,25222,41647,22778,N/A,Accounting Restatement; Asset Disposition; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction,SHORT signal but S/O 0.04% < 10% minimum (unborrowable),1784233848000 | |
| 1567683,CWEN,"Clearway Energy, Inc.",33.77,Delaware,New Jersey,8108067840,202026886,121168025,166.7%,155.26,LONG,3713,641644,1301239,Utilities,Press Release,Float too large: 202.0M exceeds 20M limit (8-K),1784233864000 | |
| 1553788,SBEV,"SPLASH BEVERAGE GROUP, INC.",0.093601,Nevada,Florida,2358745,2264392,25200000,8.99%,0.09,LONG,19571045,1127166,26267357,Beverages,Press Release,Price too low: $0.0936 below $0.2 minimum,1784233863000 | |
| 90498,SFNC,SIMMONS FIRST NATIONAL CORP,23.25,Arkansas,Arkansas,3372742912,142753336,145064209,98.41%,110.68,LONG,829,3457171,1289765,Banking,Stock Buyback; Commercial Inflection,"Location not whitelisted (Arkansas, Arkansas)",1784233853000 | |
| 2089661,SUNC,SunocoCorp LLC,72.94,Delaware,Texas,3757664768,42932597,51517198,83.34%,81.78,SHORT,13437,230359,524986,Energy,Accounting Restatement; Stock Buyback; Partnership; Related-Party Transaction; Unregistered Equity Sales,Float too large: 42.9M exceeds 20M limit (8-K),1784233922000 | |
| 1926293,GCDT,Green Circle Decarbonize Technology Ltd,0.5081,Cayman Islands,Hong Kong,6351249,2034085,12500000,16.27%,1.12,SHORT,828045,231290,1818216,N/A,Convertible Debt; Credit Default; Asset Disposition; Partnership; Unregistered Equity Sales; Related-Party Transaction; PIPE,"Alert sent: [SHORT] Convertible Debt, Credit Default, Asset Disposition, Partnership, Unregistered Equity Sales, Related-Party Transaction, PIPE (Bonus: Kowloon Bay, Hong Kong (via Cayman Islands) 1.3x + Filing Time 1.2x)",1784234057000 | |
| 1944902,OMH,Ohmyhome Ltd,0.275,Cayman Islands,Singapore,6352811,13201233,22259591,59.31%,52.31,SHORT,393149,261135,252345,Real Estate,Nasdaq Delisting; Bid Price Delisting,"Insufficient core signal categories (need 2+, found 0)",1784234101000 | |
| 1474167,COSM,Cosmos Health Inc.,0.2807,Nevada,Jersey,17425406,60043491,62078397,96.72%,6.74,LONG,931828,5291121,8912050,Health Care,Press Release,Float too large: 60.0M exceeds 20M limit (8-K),1784234118000 | |
| 1500375,HFBL,"Home Federal Bancorp, Inc. of Louisiana",22.8,Louisiana,Louisiana,69628664,1993000,3053889,65.26%,1125.99,LONG,94,377,1770,Banking,Contingent Value Rights,"Location not whitelisted (Louisiana, Louisiana)",1784234138000 | |
| 1284812,CNS,"COHEN & STEERS, INC.",81.07,Delaware,New York,4167452672,27675237,51405607,53.84%,92.65,LONG,424,275197,298716,Financial Services,Press Release,Float too large: 27.7M exceeds 20M limit (8-K),1784234441000 | |
| 1820721,ARRY,"Array Technologies, Inc.",6.25,Delaware,New Mexico,961414912,10000000,153826378,6.50%,1.71,LONG,123016,4852088,5850442,Electrical Equipment,Merger/Acquisition; Convertible Debt; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering,"Alert sent: [LONG] Merger/Acquisition, Convertible Debt, Asset Disposition, Partnership, Unregistered Equity Sales, Regulation S Offering (Bonus: New Mexico (via Wilmington, Delaware) 1.3x + Filing Time 1.2x)",1784234767000 | |
| 2099541,Unknown,Toyota Auto Receivables 2026-C Owner Trust,N/A,Delaware,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering,No Price Data,1784234761000 | |
| 1131131,Unknown,TOYOTA AUTO FINANCE RECEIVABLES LLC,N/A,Delaware,Texas,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Unregistered Equity Sales; Regulation S Offering,No Price Data,1784234761000 | |
| 1035002,VLO,VALERO ENERGY CORP/TX,300.26,Delaware,Texas,89157033984,295388732,296932782,99.48%,94.58,LONG,N/A,2136212,3123214,Energy,Press Release,Float too large: 295.4M exceeds 20M limit (8-K),1784234941000 | |
| 2113060,IQMX,IQM Quantum Computers Oyj,10.62,Finland,Finland,2240699904,210988684,210988684,100.0%,397.02,LONG,N/A,495932,531431,N/A,Press Release,"Location not whitelisted (Helsinki, Finland, Finland)",1784235003000 | |
| 1650132,FCPT,"Four Corners Property Trust, Inc.",26.42,Maryland,Canada,2899573760,108246975,109749197,98.63%,133.08,LONG,123,577977,813414,Real Estate,Press Release,Float too large: 108.2M exceeds 20M limit (8-K),1784235116000 | |
| 1801602,SBIG,"SpringBig Holdings, Inc.",0.0052,Delaware,Florida,253692,12499827,48786932,25.62%,285.43,SHORT,N/A,551,43793,Technology,Merger/Acquisition; Convertible Debt; Credit Default; Asset Disposition; Unregistered Equity Sales; Related-Party Transaction,Price too low: $0.0052 below $0.2 minimum,1784235205000 | |
| 1410636,AWK,"American Water Works Company, Inc.",134.33,Delaware,New Jersey,26232033280,194871105,195280521,99.79%,94.02,LONG,61719,1355655,2072631,Utilities,Press Release,Float too large: 194.9M exceeds 20M limit (8-K),1784235293000 | |
| 1894954,XPON,Expion360 Inc.,0.346,Nevada,Oregon,3957651,3479227,11438298,30.42%,24.57,LONG,13048,44725,141632,Electrical Equipment,Press Release,"Insufficient core signal categories (need 2+, found 0)",1784235580000 | |
| 1704720,CNNE,"Cannae Holdings, Inc.",15.27,Delaware,Nevada,670971520,36638335,43940506,83.38%,75.17,LONG,2015,450348,487429,Financial Services,Press Release,Float too large: 36.6M exceeds 20M limit (8-K),1784235668000 | |
| 1613780,DBVT,DBV Technologies S.A.,14.86,Ireland,Ireland,879514176,14539537,59186686,24.57%,57.96,LONG,60560,375453,250855,Biotechnology,Clinical Success; Commercial Inflection,"Location not whitelisted (Dublin, Ireland, Dublin, Ireland)",1784235724000 | |
| 1325814,Unknown,Federal Home Loan Bank of Des Moines,N/A,Luxembourg,Iowa,N/A,N/A,N/A,N/A,N/A,SHORT,N/A,N/A,N/A,N/A,Executive Departure; Unregistered Equity Sales,"Location not whitelisted (Luxembourg City, Luxembourg, Iowa)",1784235715000 | |
| 1935799,Unknown,"Bally's Chicago, Inc.",N/A,Delaware,Rhode Island,N/A,N/A,N/A,N/A,N/A,LONG,N/A,N/A,N/A,N/A,Merger/Acquisition; Asset Disposition; Unregistered Equity Sales; Related-Party Transaction,No Price Data,1784235898000 | |
| 1810806,U,Unity Software Inc.,30.19,Delaware,Canada,13178991616,357945601,436534997,82.00%,38.29,LONG,215745,4625551,9349300,Technology,Press Release,Float too large: 357.9M exceeds 20M limit (8-K),1784235875000 | |
| 46619,HEI,HEICO CORP,344.03,Florida,Florida,48073965568,123883365,55235561,224.3%,187.49,SHORT,16578,308963,660755,Aerospace & Defense,Merger/Acquisition; Credit Default; Partnership; Regulation S Offering; Related-Party Transaction; Unregistered Equity Sales,"Location not whitelisted (Florida, Florida)",1784236352000 | |
| 2020737,CABR,"Caring Brands, Inc.",1.28,Nevada,Florida,11637127,1052632,9091506,11.58%,12.69,LONG,15641,34361,82940,Consumer products,Merger/Acquisition; Convertible Debt; Asset Disposition; Partnership; Unregistered Equity Sales; Regulation S Offering; Related-Party Transaction; PIPE,"Aler |